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Abstract 
Novel axially chiral amines as organocatalysts 
Keywords: Axial chirality, asymmetric organocatalysis, Reformatsky reaction, Diels-
Alder reaction, amino acid. 
This body of research describes the recent developments our group has contributed 
towards the synthesis of novel axially chiral α- and β-functionalized amino acids and 
their application in asymmetric catalysis. This thesis is divided into three sections. 
The first chapter contains a review of the discovery and development of 
organocatalysis and includes key examples of its progression in terms of widening 
applications and improving selectivities. 
 
The second chapter consists of the results and discussion section of this thesis and it 
is divided into two parts. Part one contains works relating to the synthesis of a series 
of binaphthyl and biphenyl organocatalysts and describes key selective synthetic 
steps: a diastereoselective Reformatsky addition and asymmetric lithiation and 
chloroformate/carboxylation addition steps. Part two focuses on the observed 
enantio- and diastereoselectivity of these catalysts in the aldol, Michael and Diels-
Alder reactions.  
 
 
Key steps: i) 10 mol% 239.HCl, MeOH:H2O, 0 °C ii) LiAlH4 reduction 
 
Section three contains the experimental data for the compounds described in chapter 
two. 
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Chapter one: Introduction 
1.0 Asymmetric catalysis  
Stereochemistry is now an essential part of the design and synthesis of new drug 
targets. Prior to the 1980’s, the pharmaceutical industry was centred on the synthesis 
of drugs as racemic mixtures, until it was observed that the specificity of a drug 
increases with its structural and molecular complexity. Stereoisomers were shown to 
have strikingly different pharmacological and toxicological effects. In some cases 
while one enantiomer may yield the desired therapeutic response, the other can be 
inactive or even be antagonistic or damaging.1 In addition, authorities introduced 
procedures on the regulation of chiral drugs such as Policy Statement for the 
Development of New Stereoisomeric Drugs (FDA) and the Committee for 
Proprietary Medical Products (EU) stipulating that stereoisomers of chiral drugs 
should be separated and both stereoisomers’ activity and toxicology should be 
assessed.2 Therefore, production of racemic drugs became a higher risk, wasteful and 
costly route for pharmaceutical companies. This, along with the advent of new 
technologies, led to the industry’s growing preference for the synthesis of active 
compounds as single enantiomers.  
1.1 Classes of asymmetric catalysis  
The demand for more sophisticated drug precursors possessing multiple chiral 
centres has led to huge advances in stereoselective synthesis. Whilst the isolation of 
pure enantiomers can be achieved by different methods, i.e. resolution of racemic 
mixtures, kinetic resolutions, chiral auxiliaries, extraction of pure enantiomers from 
natural products (chiral pool approach), asymmetric catalysis is considered the least 
wasteful. Asymmetric catalysis can be separated in three main areas; organometallic 
catalysis, biocatalysis and organocatalysis. 
1.1.1 Organometallic catalysis 
Organometallic catalysis has enjoyed tremendous success over the past century in 
industrial procedures ranging from olefin polymerization to the catalytic cracking of 
hydrocarbons for petroleum refining. These processes were developed following the 
work of Ziegler and Natta for their titanium- and chromium-based catalysts and the 
work of Wilkinson for his eponymous rhodium-based catalyst.3 The success of these 
   
2 
systems naturally led to the use of metal catalysts being extended to the synthesis of 
chiral drugs. Indeed, Knowles developed the first industrial asymmetric catalytic 
process: the synthesis of the rare amino acid (S)-DOPA, 2, used in the treatment of 
Parkinson’s disease. The key enantioselective step was a hydrogenation in the 
presence of a catalytic amount of [Rh(R,R)-DiPAMP)COD]BF4 affording 1 in 95% 
e.e. and quantitative yield.4 
 
 
Reagents and conditions: i) H2, [Rh((R,R)-DiPAMP)COD]+BF4−, quant., 95% ee; ii) H3O+ 
Scheme 1: First industrial asymmetric catalytic hydrogenation in the synthesis of 
(S)-DOPA 2. 
 
Similarly, Noyori developed asymmetric olefin hydrogenations, employing 
ruthenium and C2 symmetric bidentate BINAP ligands such as 3. Industrial 
applications for this process have been widely demonstrated; for example, the 
synthesis of Naproxen®, an anti-inflammatory drug, was achieved in 97% 
enantiomeric excess. Other examples include highly selective syntheses of 
carbapenem antibiotics.5 
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Reagents and conditions: i) H2, Ru(II)(S)-BINAP, 92%, 97% e.e 
Scheme 2: Noyori’s ruthenium-BINAP catalyst 3 in the synthesis of Naproxen® 
 
Noyori and Knowles were awarded the 2001 Nobel Prize in chemistry sharing the 
prize with Sharpless. Sharpless was rewarded for his work on asymmetric 
oxidations, most famously his epoxidation reactions. In this catalytic system, allylic 
alcohols are transformed into their respective epoxyalcohols using titanium (IV) 
catalyst, the oxidant t-butylhydroperoxide and an enantiopure dialkyltartrate ligand.6 
Industry has adopted this highly predictable and selective methodology in the 
synthesis of stabilized enantio-enriched glycidol derivatives.7 In addition, key 
intermediates in the synthesis of antibiotics methymycin, erythromycin and 
leukotriene C-1 have been prepared using this process.8  
 
 
Reagents and conditions: i) Ti(OiPr)4, (+)-(DMT), TBHP, 79 %, >95% e.e 
Scheme 3: Sharpless epoxidation used in the synthesis of a key intermediate 4 in 
antibiotic methycin  
 
The Sharpless epoxidation is high yielding and very enantioselective as well as being 
applicable to a wide range of allylic alcohols. Conveniently, both stereoisomers of 
the desired epoxyalcohol product can be synthesised by changing the enantiomer of 
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the dialkyltartrate ligand. 
Despite its obvious successes, transition metal-mediated catalysis is inherently 
wasteful; the metal itself only plays an organizational role, while the organic ligands 
surrounding it create the chiral environment. Indeed, although metal-ligand catalysts 
are very tuneable, due to their molecular and structural diversity, they are generally 
expensive, frequently toxic, and require exacting reaction conditions such as the 
exclusion of air and moisture. 
 
1.1.2 Biocatalysis  
Biocatalysis, the use of enzymes or macromolecules such as proteins to perform 
chemical transformations on organic compounds is another area within asymmetric 
catalysis. Enzymatic catalysis is clean, safe, highly selective and can be as tuneable 
as metal catalysis as the performance of enzymes can often be optimized by 
mutation.  
Enzymatic catalysis has proven useful in the production of enantiomerically pure 
amino acids and their derivatives for application in pharmaceutical, cosmetic, 
agricultural and food industries. For example, (S)-aspartic acid 6 is a starting 
material in the synthesis of the artificial sweetener (S)-aspartyl (S)-phenylalanine 
methyl ester, 7 (Aspartame). (S)-Aspartic acid is produced from the aspartase-
catalysed addition of ammonia to fumaric acid 5. The amino acid (S)-alanine 8 can 
also be enzymatically synthesized from (S)-aspartic acid using immobilized aspartate 
β-decarboxylase.9  
   
5 
 
Scheme 4: Enzyme-catalysed production of enantiomerically pure (S)-aspartic acid 6 
and (S)-alanine 8 
 
However, enzymatic transformations can be highly substrate specific and sensitive to 
the reaction conditions. In general, they tolerate only a small number of solvents, 
such as H2O, ethanol and DMSO. In addition, reaction conditions are limited as most 
enzymes are unstable at high temperatures. 
In the drive to provide environmentally friendly, economical and reliable batch scale 
production of enantiopure drug precursors for the pharmaceutical industry, an 
obvious gap between biocatalysis and organometallic catalysis exists: the use of 
small chiral organic compounds as catalysts. 
 
1.1.3 Organocatalysis  
Asymmetric organocatalysis is the use of chiral organic molecules in sub-
stoichiometric amounts to catalyse asymmetric transformations. Asymmetric 
organocatalysis has become a hugely successful and rapidly evolving field over the 
past two decades, and has demonstrated impressive stereoselectivity in hundreds of 
different reaction types. The potential application of organocatalysis in the synthesis 
of various types of compounds and functional groups provides a solution to the 
increasing demand for cheap and sustainable drug production. Indeed, 
organocatalysis may overtake both metal and enzymes as the most popular method 
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of asymmetric catalysis.  
A large number of organocatalysts are either directly sourced from or related to the 
‘chiral pool’ and are readily available and inexpensive to produce in large quantities 
as single enantiomers. Several rationally designed synthetic organocatalysts are now 
commercially available; furthermore, ligands previously used for organometallic 
chemistry have been shown to function independently as asymmetric catalysts 
themselves. 
The first asymmetric organocatalytic reactions reported used cinchona alkaloids, a 
class of natural products. Cinchona alkaloids possess very useful moieties for 
organocatalysis. They contain a quinuclidine ring, which can act as a Lewis base,10 a 
nucleophilic catalyst,11 and, when alkylated, allows the compound to behave as a 
phase transfer catalyst.12 The hydroxyl group can function as a hydrogen bond donor 
or can be converted into an amine moiety, which can act as a hydrogen bond donor 
or an aminocatalyst centre.13  
 
Figure 1: Natural product-derived diastereoisomeric cinchona alkaloids quinine 
(R,S)-9 and quinidine (S,R)-10 
 
Bredig and Friske reported the first asymmetric organocatalysed reaction in 1912:14 
the presence of cinchona alkaloids accelerated the rate of addition of HCN to 
benzaldehyde and gave optically active cyanohydrins. The enantiomeric excess was 
less than 10% and the opposite rotation was recorded when quinine and quinidine 
were used.13 In 1940, Pracejus used O-acetyl-quinine 11 to catalyse the asymmetric 
addition of methanol to phenylmethylketene 12, giving the product 13 in 74% ee.15,16  
N
N
OH
H
OMe
N
N
HO
H
OMe
(R,S)−9 (S,R)−10
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Reagents and conditions: i) O-acetyl-quinine 11 (1 mol %), MeOH (1.1 equiv.), toluene, 93%, 74% ee 
Scheme 5: Pracejus’ O-acetyl quinine 11 catalysed addition to phenylmethylketene 
12 
1.2 Types of organocatalysts 
A large number of organic compounds with different functional groups have been 
shown to catalyse synthetic transformations, and, as a result, classification is 
difficult. However, organocatalysts can be generally classified according to how they 
activate substrates. This activation can be either active/dynamic (covalent) or passive 
(non-covalent).  
1.2.1 Examples of non-covalent organocatalysts 
Non-covalent catalysts include hydrophobic, electrostatic or Van der Waals type 
interactions such as Brønsted acid and base and hydrogen bonding catalysts. Phase 
transfer catalysts also operate through non-covalent catalysis as asymmetric 
inductions occur through a chiral ion pairing mechanism, which also transports 
reactants between organic and aqueous media. 
Phase transfer catalysts facilitate reactions between substrates in different phases by 
generating an onium-carbanion species that can travel between immiscible phases. 
Scheme 6 shows a base-promoted alkylation of glycine Schiff base 14 where 
structurally rigid chiral ammonium salt 15 is responsible for the increased rate and 
asymmetric induction. 
Ph
O•
H3C
Ph
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O
CH3
CH3H
N
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O
H
OCH3
CH3
O
11
O-acetyl-quinine
1312
i)
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Reagents and conditions: i) 10 mol% 15, CH3I, CsOH.H2O, CH2Cl2, −60 °C, 71%, 97% ee 
Scheme 6: Corey’s (1997) chiral quaternary ammonium salt phase transfer catalyst 
15 for alkylation of derivatised glycine imines17 
 
In this example, the Schiff base 14 reacts with the inorganic base, at the interface, to 
generate a caesium enolate. This metal enolate then exchanges with the cationic 
ammonium catalyst providing a chiral environment and increased lipophilicity, thus 
enabling it to pass into the organic phase of the reaction mixture and be alkylated, 
giving the product in 97% enantiomeric excess and regenerating the active catalyst 
15. 
Hydrogen bonding provided by urea and thiourea-based organocatalysts allow for 
activation of both the HCN and the N-benzyl imine partners in the Strecker reaction 
(Scheme 7). 
 
Reagents and conditions: i) HCN, 2 mol % 16, toluene, −78 °C, quant., 95% ee 
Scheme 7: Jacobsen’s (2000) Strecker HCN addition to ketoimines using hydrogen 
bonding urea catalyst 1618 
 
Catalyst 16 is composed of two important parts: the urea functionality is capable of 
hydrogen bonding to activate the substrate, and the α-amino acid and trans-1,2-
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diamino cyclohexane unit are the parts responsible for the asymmetric induction.  
 
1.2.2 Examples of covalent organocatalysts 
Covalent catalysis refers to interactions between catalysts and substrates at the 
reaction centre and includes atom transfer catalysts for epoxidation and aziridination 
reactions, Lewis base and aminocatalysts (specifically amines catalysing reactions 
via enamine and iminium ion intermediates). 
The Fu group designed planar chiral DMAP derivatives as Lewis basic 
(nucleophilic) organocatalysts. These catalysts can be classed as organocatalysts 
despite a ferrocenyl framework because the active centre is the 4-
(dimethylamino)pyridine unit and not the iron centre (Scheme 8). 
 
Reagents and conditions: i) 5 % 17, Et2O/CH2Cl2, r.t., 82%, 99% ee 
Scheme 8: Fu’s (1999) DMAP derivative 17 for nucleophilic catalysis in C-
acylations of silyl ketene acetals19 
 
DMAP derivative 17 was shown to catalyse the C-alkylation of silyl ketene acetals, 
such as 18, with dimethyl anhydride. Mechanistically, it is hypothesized that the 
pyridine sp2 nitrogen cleaves the anhydride to generate an acetate anion, which 
promotes the desilylation of compound 18 to generate a reactive enolate. The enolate 
then reacts with the chiral acylated pyridinium species to generate the product 19 in 
high enantioselectivity. 
The Page group has achieved great success using atom transfer catalysts in 
aziridination and epoxidation reactions.20,21,22 Similarly, Page reported moderate to 
excellent selectivities using oxocamphorsulfonylimine 20 in oxidations of dialkyl 
Me O Me
OO
OMe3SiO
Fe
Ph
Ph
Ph
Ph
Ph
O
O
Me
O
18 1719
i) N
NPh2
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sulfides using hydrogen peroxide (Scheme 9). 
 
Reagents and conditions: i) 20 (1 equiv.), H2O2/H2O, DBU, CH2Cl2, −20 °C, quant., 98% ee 
Scheme 9: Page’s (1995) catalytic oxidation of sulphide 21 using hydrogen 
peroxide23,24  
 
Sulfonylimine 20 reacts with hydrogen peroxide to produce highly reactive 
oxaziridine intermediates which transfer oxygen to the sulfides asymmetrically.25 
Four equivalents of DBU are used to suppress the direct oxidation of the substrates. 
Denmark published the first example of an asymmetric intermolecular aldol reaction 
catalysed by an organic base: phosphoramide catalyst 22. 
 
 
Reagents and conditions: i) 10 mol% 22, CH2Cl2, −78 °C, NaHCO3, 94%, anti/syn >99:1, 97% ee anti 
Scheme 10: Denmark’s (1999) neutral Lewis base catalysed aldol reaction using 
phosphoramide catalyst 2226 
 
This indirect aldol reaction uses highly reactive silyl enol ether nucleophiles and 
affords the aldol products in high conversions and excellent enantioselectivites using 
aromatic, α-β unsaturated and branched aliphatic aldehydes at low temperatures.  
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Figure 2: Denmark’s proposed chair-like transition state structure  
 
Denmark postulates an associative (closed) structure that assembles the reagents in 
such a way as to allow chirality to be transferred. A labile cationic hexa-coordinate 
silicon complex, which organizes the aldehyde, enol ether and two catalyst 
molecules around its centre, would account for the observed stereochemical control 
and predominant formation of the anti-product.27  
Friedel-Crafts type alkylations of pyrroles and indoles with enals were reported by 
the MacMillan group using secondary amine catalyst 23. 
 
 
Reagents and conditions: i) 20 mol % 23, CH2Cl2-iPrOH, −60 °C, 94%, 94% ee 
Scheme 11: MacMillan’s (2002) imidazolidinone catalysed indole alkylations28  
 
Higher activity and selectivity were observed at low temperatures whilst using one 
equivalent of trifluoroacetic acid as a co-catalyst. This type of Lewis basic catalysis, 
which concerns the activation of carbonyls by primary or secondary amines, can be 
classified as aminocatalysis.  
 
 
 
O
SiO
H
H
Ar
Cl
O
O
P
NR2
NR2
R2N
Cl
P
NR2
NR2
NR2
N
H
Me O
Me NH
Me
O
Me
N
H
NO
23
.TFA
i)
   
12 
2.0 Mechanisms of aminocatalysis  
Condensation of primary or secondary amine 24 with an aldehyde or a ketone results 
in the formation of an iminium species 25 and possible tautomerization to an 
enamine 26. These intermediates are highly reactive and undergo facile combination 
with reaction partners.  
 
Scheme 12: Condensation of amines and carbonyls 
 
When the reaction cycle is completed, the iminium and enamine moieties can be 
hydrolysed to release the labile amine catalyst and allow for substrate turnover. 
These types of activation have been described in similar terms to Lewis acid 
activation in catalysis. 
2.1 Iminium activation  
An iminium species is highly susceptible to nucleophilic attack. As the amine 
reversibly binds to the carbonyl substrate it results in a redistribution of π-electrons 
toward the electropositive nitrogen centre, making the π-system electron-deficient. 
This electronic redistribution lowers the energetic potential of the lowest unoccupied 
molecular orbital (LUMO), resulting in an increased susceptibility toward 
combination with the highest occupied molecular orbital (HOMO) of the reaction 
partner.  
2.2 Enamine activation  
Enamine catalysis involves the generation of a carbon nucleophile from an carbonyl 
and an amine through an iminium intermediate.  
HN
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iminium species
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Scheme 13: Keto-enol and iminum/enamine tautomerizations 
 
The conversion of an iminium species to the corresponding enamine is comparable 
to keto-enol tautomerism. However, whereas the ketone form is favoured in keto-
enol systems, in iminium/enamine systems, the formation of the enamine moiety is 
favoured. Enamines are more nucleophilic than enols due to the increased energy of 
the highest occupied molecular orbital (HOMO).29 
 
2.3 Non-selective aminocatalysis 
The first example of non-selective aminocatalysis was reported in 1896, when 
Knoevenagel described achiral primary and secondary amines, and their salts, 
catalysing the condensation of β-keto esters, and malonates, with aldehydes and 
ketones.30 
 
O OH
O N R
1R N R
1R
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Scheme 14: Piperidine-catalysed Knoevenagel condensation30,31 
 
This powerful C-C bond forming reaction, used widely in industry, provided an early 
foundation for the study of aminocatalysts. Indeed, based on this seminal reaction, 
primary amino acids were shown to catalyse the Knoevenagel condensation, and 
secondary amines were used as catalysts in the self- and cross-aldol condensations of 
aldehydes.31,32  
2.4 First asymmetric organocatalytic reactions 
In 1971, Hajos and Parrish reported that (S)-proline 27 could be used in the 
intramolecular aldol reaction of triketone 28.33 It was named the Hajos–Parrish–
Eder–Sauer–Wiechert reaction.34 In the years following, the role of proline was 
disputed despite the studies undertaken previously. Indeed, Miescher and Wieland 
(1950) synthesized the racemic dione 29 using achiral piperidinium acetate salts,35 
and Spencer et al. (1965) suggested that enamine and iminium ion intermediates 
were responsible for the accelerated reaction rates.36 Agami et al. also supported the 
intermediate enamine, and determined that the carbon nucleophile must discriminate 
between two enantiotopic carbonyl groups.37 
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Scheme 15: Miescher’s racemic diketone 29 synthesis and the proline-catalysed 
asymmetric version 
 
Initially Hajos and Parrish proposed a ‘simplified model of a biological system in 
which (S)-proline plays the role of enzyme’ nevertheless, despite the literature 
precedents, the enamine intermediate was dismissed and an ‘amino-carbinol’ 
intermediate was suggested.  
 
Figure 3: Hajos’ proposed amino-carbinol intermediate38 
 
However the suggestion was quickly abandoned, and the role of proline was 
investigated further, leading to the deduction that proline’s catalytic action mimics 
that of the aldolase enzymes.39 Indeed, the aldolase class 1 mechanism proposed by 
Rutter clearly describes enamine formation and subsequent aldol-type reaction at a 
partner carbonyl group.40 Chang et al. reported the amino acid sequence of the rabbit 
muscle aldolase, and showed that the position of the lysine active site residues were 
integral to the function of successive enamine and iminium ion catalysis.41  
Barbas and Lerner et al. worked extensively on recreating the action of class 1 
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aldolase enzymes in antibodies.42 The Hajos–Wiechert Robinson annelation was 
performed using antibody 38C2 giving a variant of the Wieland-Miescher ketone 30 
in 94% yield and 96% ee (when (S)-proline is used, the product is obtained in 83% 
yield and 71% ee). 
 
 
Scheme 16: Synthesis of the Wieland-Miescher ketone 30 by antibody 38C2 
 
Evidence for the mechanism of these reactions was provided when the Hajos–
Parrish–Eder–Sauer–Wiechert reaction was conducted in the presence of 18O-
enriched water, and the reaction mixtures were analysed using GC-MS detector.43  
 
 
Reagents and conditions: i) (S)-Proline (25 mol %), 3 vol% H2O18, d-6 DMSO, Ar, 4 d 
Scheme 17: Proof of enamine mechanism by 18O incorporation 
 
The product mixture was composed of aldol addition product 31, aldol condensation 
product 32 and dienamine 33. The aldol addition and the aldol condensation products 
incorporated a single 18O atom as their molecular ions were two mass units higher 
than the corresponding 16O products. Dienamine 33 did not incorporate the labelled 
oxygen indicating that the carbonyl group is where the addition occurs. 18O 
incorporation supports the enamine intermediate theory, as the final step in the 
catalytic cycle is the hydrolysis of the iminium ion to furnish the carbonyl group. 
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Houk attempted DFT mechanistic studies (using B3LYP and 6-31G basis set in 
Gaussian 98) to explain the selectivity observed when proline was used. The 
intramolecular aldol reaction of 4-methyl-heptane-2,6-dione 34 was chosen as the 
model.44 The transition state energies leading to each of the four possible 
diastereoisomers were calculated, and the formation of (R,R)-cyclization product 38 
was found to be favoured: the hydrolysis of (R,S)-iminium species 37 gives the 
(R,R)-ketol product. The enamine attack on the ketone, hypothesized to be the rate-
determining step, was studied in detail. Although both chair and boat transition state 
conformers were analysed, only the products from the favoured chair transition state 
are shown below.  
 
Scheme 18: Houk’s DFT mechanistic studies  
 
The preference for (R,R)-diastereoisomer 38 is attributed to the transition state 
leading to (R,S)-37 having favourable electrostatic interactions between the 
positively charged iminium ion and the alkoxide ion. This interaction means that the 
transition state δ+NCH--Oδ- distance was calculated as 2.5 Å, whereas the transition 
state leading to (S,R)-41 had a calculated δ+NCH--Oδ- distance of 3.2 Å. This 1 
kcal/mol difference in energy accounts for the experimentally detected 42% ee. 
Hydrogen bonding in transition state leading to (R,S)-37 also allows for a more 
planar iminium bond formation compared to the corresponding (S,R)-TS, where the 
forming iminium double bond is somewhat distorted. Hydrogen bonding has been 
shown to be essential in this reaction, providing charge stabilization in the formation 
of the alkoxide ion and being responsible for the observed enantioselectivity.45 
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Figure 4: Houk’s chair transition state model 
 
Variants of the Wieland-Miescher ketone are synthetically very useful, as 
octahydronaphtalene dione 43 can be used in the total synthesis of steroids cortisone, 
norethindrone and progesterone 44.46,47,48 
 
 
Reagents and conditions: i) (S)-phenylalanine (1 equiv.), (+)-camphor sulfonic acid, DMF, 23 °C, 24 
d, 77%, 95% ee 
Scheme 19: Hajos-Parrish-Eder-Sauer-Wiechert reaction used to install chiral 
centres in the framework of bioactive protostenediols in a total synthesis by Corey49 
 
3.0 Recent examples of asymmetric aminocatalysis  
In the late twentieth century examples of asymmetric amine-catalysed reactions had 
been sporadically reported with little attention or understanding about their 
mechanistic similarities. These reactions employed catalysts obtained directly from 
the chiral pool and gave increasingly impressive enantioselectivities. However, the 
early exciting results were largely ignored and it was not until a publication by List, 
Lerner and Barbas in 2000 that the use of (S)-proline was explored further.  
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3.1 Asymmetric aminocatalytic aldol 
The aldol reaction is an essential reaction in the formation of new C-C bonds. It 
relies on the formation of an enol from a carbonyl group which then reacts with an 
acceptor, usually a less readily enolisable carbonyl group, resulting in the formation 
of one or two new stereogenic centres. 
 
Reagents and conditions: i) 30 mol % (S)-proline 27, DMSO: acetone (4:1), r.t., 48 h, 97%, 96% ee 
Scheme 20: First proline-catalysed asymmetric organocatalytic intermolecular aldol 
 
In 2000, List et al. reported the first asymmetric aminocatalytic intermolecular aldol 
reaction using (S)-proline 27 as a catalyst (Scheme 20 and 21).50 List describes 
proline as a unique chiral pool catalyst and attributes the discovery of the proline-
catalysed direct intermolecular aldol to an examination of the action of a biocatalyst: 
the aldolase antibody 38C2.51 The similarities between the 38C2 antibody and 
proline’s ‘micro-aldolase’ activity were examined in an asymmetric Hajos–Parrish–
Eder–Sauer–Wiechert reaction (Scheme 16).48 
 
  
Scheme 21: Proposed Zimmerman-Traxler type transition state for the proline-
catalysed aldol reaction between acetone and 4-nitrobenzaldehyde 
 
High yields and enantioselectivities were observed when using 30-40 mol% of 
proline in aldol reactions with acetone and different aldehydes (Table 1). 
 
H
O O OH
45
i)
N
O
O N
O
OH
N
O
O
H
H
O
N
O
O
   
20 
Table 1: Proline-catalysed asymmetric aldol reaction  
 
Entry Aldehyde Yield (%) ee (%) 
1 
 
- - 
2 
 
94 69 
3 
 
68 76 
4 
 
97 96 
 
No conversion was observed when linear aldehydes, such as pentanal, were used; 
however, branched aldehyde isobutyraldehyde 45 gave the best result (96% ee), 
though a much longer reaction time of 48 h was required. Lower selectivities were 
reported when aromatic aldehydes were employed (Entries 2 and 3). Acetone was 
used in large excess to suppress self-aldolisation products, such as azomethine-ylide 
47 and subsequent irreversible formation of oxazole 48 or oxazolidinones 49-50 
(Scheme 22). 
The proline catalysed self-aldolisation of propionaldehyde was investigated by 
Gschwind et al. in an attempt to detect the ‘elusive’ enamine intermediate, as well as 
the unwanted species.52 Two diastereoisomeric oxazolidinones 49 and 50 in 
thermodynamic equilibrium and the enamine intermediate were identified (Scheme 
22). 
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Scheme 22: Possible products and intermediates from a proline catalysed self-
aldolisation  
 
The condensation of proline with a ketone or aldehyde substrate can lead to the 
formation of an oxazolidinone (49 and 50, Scheme 22), which is said to be in ‘a 
parasitic equilibrium’ with the catalytically active enamine intermediate.54 It has 
long been assumed that the iminium intermediate is crucial and responsible for rapid 
interconversions between aldehydes, oxazolidinones and enamine formation.53 
Interestingly, studies using NOESY NMR exchange spectroscopy found that E-
enamine intermediate was not formed directly from the condensation of proline and 
the aldehyde but via the oxazolidinones, suggested as a concerted E2 mechanism.52,54 
The presence of water was investigated and found to suppress the oxazolidinone 
formation by shifting the equilibrium from iminium ion 46 to the free proline and 
aldehyde, which is expected for a reversible condensation reaction. 
List et al. attempted to isolate enamine intermediates to confirm their structure; 
however, due to the thermodynamic preference for the formation of oxazolidinones, 
enamines are difficult to isolate. When 1,3-dicarbonyls are used as substrates, the 
equilibrium is shifted and the enaminone constitutional isomer 51 is preferred due to 
the extended conjugation (Scheme 23). 
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Scheme 23: Enaminone formation 
 
The transition state model of an enamine reacting with an electrophile exhibits 
similar electronic properties to the enaminone model: in both cases, the electron 
density is directed away from the electron rich enamine π-system. Crystal structure 
determination showed that the enamine double bond configuration is always (E) and 
that the position of the carboxylate is anti (or trans) relative to the enamine double 
bond.55 The same reasoning was applied to catalytic enamines, and this orientation 
leaves re and si faces exposed to allow for the adjacent carboxylic acid group to 
organise the substrates through enantio-discriminating hydrogen bonds, as well as 
providing stabilization of the transition state structures. 
Proline, 27, has also been applied successfully to intra and intermolecular 
nucleophilic C-C bond forming reactions (Mannich reaction,56 Michael reaction,57 
aldol-modified dihydroxylation,58 cross aldolization of non-equivalent aldehydes59) 
and the introduction of heteroatoms (α-oxygenation of aldehydes with 
nitrosobenzene,60 and α-amination of aldehydes with diazodicarboxylates61,62).  
3.2 Asymmetric aminocatalytic Diels-Alder  
The Diels-Alder reaction is a very useful pericyclic reaction between conjugated s-
cis-1, 3-diene and dienophile starting materials. The reaction is a [4+2] concerted 
cycloaddition where two new σ bonds and one new π bond are generated from three 
π bonds. Otto Paul Hermann Diels and Kurt Alder reported the first example in a 
landmark 1928 article whilst studying the reaction of benzoquinone 52 with 
cyclopentadiene where both the monadduct 53 and the diadduct 54 were isolated.63  
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Scheme 24: First reported Diels-Alder reaction  
 
The Diels-Alder reaction was a breakthrough in organic synthesis as it allows for the 
facile formation of six membered rings with the installation of up to four contiguous 
new chiral centres. The importance of the Diels-Alder reaction was realised 
immediately: ‘the possibility of synthesis of complex compounds related to or 
identical with natural products such as terpenes, sesquiterpenes, perhaps even 
alkaloids, has been moved near prospect’.62 The reaction has indeed been proven a 
vital tool in the total syntheses of many complex multicyclic compounds including 
steroids (cortisone,63 cholesterol,64 gibberellic acid65), alkaloids (reserpine 55,66 
norsecurinine,67 strychnine,68 gelsemine69), antifungals (ambruticin70) and antibiotics 
(myrocin C71). 
 
 
Scheme 25: Diels-Alder reaction in the total synthesis of alkaloid (−)-reserpine 5572 
 
The Diels-Alder reaction is stereospecific and the stereochemistry of the dienophile 
is retained in the product. Attempts to explain the Diels-Alder reaction’s observed 
regio, stereo and diastereo-selectivity have provided organic chemists with the 
Alder-endo and Frontier Molecular Orbital theories. The Frontier Molecular Orbital 
theory, especially, has provided increased understanding of complex pericyclic 
reactions and has helped to explain the patterns of reactivity that all pericyclic 
reactions show, thus allowing for far more predictability in synthesis.  
In the 1950s, Kenichi Fukui postulated that an approximation of the reactivity of two 
aromatic hydrocarbons could be predicted by looking at the ‘frontier orbitals’: the 
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Highest Occupied Molecular Orbital (abbreviated to HOMO) of one component and 
Lowest Unoccupied Molecular Orbitals (LUMO) of another.73 The assumption was 
that the reactivity of the two electrons (frontier electrons) occupying the HOMO in 
the ground state are distinct from the other π-electrons. Fukui’s theory is described 
as the Frontier Molecular Orbital Theory and its selection rules are equivalent to 
those obtained from the principle called “the conservation of orbital symmetry” by 
Woodward and Hoffmann.74 These two theories state that the ease by which two 
components react depends on the degree of overlap of orbitals and how close these 
orbitals are in energy. If the symmetries of the HOMO and LUMO of the diene and 
those of the LUMO and HOMO of the dienophile, respectively, are found to be of 
matching symmetry (i.e. in-phase with each other) then concerted cyclic interaction 
is favourable.75  
 
Figure 5: Frontier molecular orbitals of trans-cinnamaldehyde 56 and 
cyclopentadiene 57 
 
Essentially, the conservation of orbital symmetry requires that during the course of a 
reaction pathway, the symmetry of the molecular orbitals of the reactants remains 
identical to the symmetry of those of the resulting products. The Woodward-
Hoffmann rules govern all pericyclic reactions both thermal and photochemical: 
1) For thermal reactions: ‘A ground state pericyclic change is symmetry-
allowed when the total number of (4q+2)s and (4r)a components are odd.’  
2) For photochemical reactions: ‘A pericyclic change in the first electronically 
excited state is symmetry-allowed when the total number of (4q+2)s and (4r)a 
components are even.’ 
These equations relate to the number of electrons in the participating π bonds of the 
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two components in the reaction: the diene and the dienophile. The letters s and a are 
refer to suprafacial or antarafacial character in bond formation and the letters r and 
q are integer values. For example, the dienophile component, cinnamaldehyde 56, 
has a contributing π-bond containing two electrons and therefore counts as a (4q+2) 
component where q is an integer (and is equal to zero). The diene, 57, has two π-
bonds containing four electrons therefore is the (4r) component where r is equal to 
one. However, as in all Diels-Alder reactions, the new bonds are forming from the 
same face; and consequently, the geometry of approach is described as being 
suprafacial. The suprafacial character of the formation of these bonds is shown 
(Scheme 26).  
  
Scheme 26: Suprafacial bond formation  
 
Indeed, the formation of the new C1-C1’ and C4-C2’ bonds occurs on the same face 
the cyclopentadiene π-bond, and similarly from the same face of the dienophiles, 
therefore both components are labelled suprafacial or s. Consequently we can 
discount (4r)a as neither the diene or the dienophile will have bonds forming 
antarafacially. Only the (4q+2)s component is counted, as the dienophile satisfies the 
(4q+2) rule. Accordingly the number of total components is odd and the reaction of 
cinnamaldehyde and cyclopentadiene is therefore a symmetry-allowed thermal 
[π4S+π2S] pericyclic reaction (Figure 5). 
Alder’s Endo rule relates to the effect of the orientation of the substituents in the 
transition state on the resulting products. Indeed, two diastereoisomers can be 
formed in the Diels-Alder reaction: they have been termed exo and endo adducts 
with their names referring to the position of the substituents relative to that of the 
newly created double bond (Scheme 27).  
 
   
26 
 
Scheme 27: Diastereoisomeric products from the trans-cinnamaldehyde and 
cyclopentadiene Diels-Alder reaction  
 
The exo product is a result of the substituents pointing away from the conjugated 
system in the transition state. The endo has the substituent pointing towards the 
conjugated system. Alder’s endo rule describes that when permitting, non-bonding 
interactions between orbitals of the diene π bond and the group on the dienophile 
provide stabilization of the transition state resulting in a lower energy profile for the 
formation of the endo isomer. Scheme 26 shows that between C2 and C3 on the 
diene and the carbonyl group of the dienophile, the orbitals allow for an additional 
secondary orbital overlap leading to the preferential formation of the endo isomer. 
As a result, although the endo transition state experiences more steric repulsion, it is 
the favoured product under kinetic control, and, conversely, the more stable, less 
sterically crowded exo product is the thermodynamic product. 
 
3.2.1 Studies towards an asymmetric Diels-Alder reaction 
In 1976, Baum reported the use of iminium-activated acetylene tetrafluoroborate 
salts as substrates for a facile, high yielding cycloaddition reaction with 
cyclopentadiene.76 Later, Jung et al. reported the first asymmetric Diels-Alder 
reactions using cyclic amines, such as 59, as chiral auxiliaries: alkoxy-heterocyclic 
iminium salts, similar to 61, were shown to promote the reaction with 
enantioselectivities as high as 96% ee (Scheme 28).77  
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Reagents and conditions: i) CH2CHCOCl, iPr2NEt, Et2O, −78 °C; ii) Et2OBF4, CH2Cl2, 25 °C; iii) 
C5H6, 12 h, 0 °C, H2O, 2 h; iv) LiAlH4 Et2O, 85% ee 
Scheme 28: Jung’s enantioselective Diels-Alder reaction using chiral auxiliaries 
 
Later, Riant and Kagan demonstrated that cinchona alkaloids were capable of 
catalysing the Diels-Alder reaction. Riant screened a range of alkaloids and β-amino 
alcohols, and obtained the best results when quinidine 67 was used in chloroform; 
the reaction between the masked diene anthrone 65 and N-methylsuccinimide 66 at –
50 °C afforded the Diels-Alder cycloadduct 68 in 61% ee (Schemes 29 and 30).  
 
Reagents and conditions: i) 67 (10 mol%), CHCl3, −50 °C 97%, 61% ee;  
ii) 69 (20 mol %), KF (1 equiv.), toluene, 80%, 16% ee 
Scheme 29 and 30: Products 68, from the quinidine-catalysed Diels-Alder reaction, 
and 70 from phase transfer catalysis Michael reaction  
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This base-catalysed Diels-Alder reaction was thought to occur by the quinuclidine 
base abstracting a proton from anthrone to create an oxyanion diene. Hydrogen 
bonding from the free hydroxyl group on the catalyst and the ion pairing association 
of the enolate anthrone to the chiral amine counter-ion seem essential for asymmetric 
induction. Indeed, the transfer of chirality requires as much association between 
ionic species in the organic phase as possible as a racemic product was obtained 
when methanol was used as the solvent. When phase transfer catalysis conditions 
were employed, the Michael addition product 70 was obtained in 16% ee.78  
In 2000, MacMillan reported the first highly selective asymmetric organocatalytic 
Diels-Alder reaction.79 The work by Baume and Jung et al. using activated 
dienophiles containing electron-withdrawing groups inspired MacMillan’s research; 
indeed, he hypothesized that catalysis that typically employed Lewis acids and could 
be made enantioselective using chiral amine catalysts, such as 71 to generate 
activated iminium ion intermediates (Figure 6). 
  
Figure 6: Proposed reaction intermediates using Jung’s chiral auxiliary 61 and 
MacMillan’s catalyst 7179 
 
α,β-Unsaturated dienophiles were activated with chiral secondary amine catalyst 71 
and then subjected to cyclization reactions with a range of dienes (Table 2). 
MacMillan reported very high enantioselectivities and diastereoselectivities using 5-
20 mol% of catalyst 71. Cyclohexadiene gave the best results in terms of 
diastereoselectivity, 1:14 exo:endo isomers (Entry 3), whereas changing substituents 
on the dienophiles did not greatly affect the enantioselectivity. 
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Table 2: MacMillan’s asymmetric organocatalytic Diels-Alder 
 
Entry Diene R Product 
(endo:exo) 
 Yield  
(%) 
Exo:
Endo 
Exo 
ee 
(%) 
Endo 
ee 
(%) 
 
1  
Ph 
 
99 1.3:1 93 93 
 
2  
iPr 
 
81 1:1 84 93 
 
3  
H 
 
82 1:14 - 94 
 
4  
H 
 
72 1:11 - 85 
 
 
In a standard electron demand Diels-Alder reaction, the HOMO of the diene overlaps 
with the LUMO of the dienophiles, and the reaction can be accelerated by changing 
the electronic properties of the reactants. Substituting the diene with electron-
donating groups raises the energy of the HOMO, whereas the dienophile can be 
substituted with electron-withdrawing groups (or extended conjugation) to lower the 
energy of the LUMO. The Diels-Alder reaction can often be accelerated by the 
addition of Lewis acids such as AlCl3 or BF3. Lewis acids can coordinate at Lewis 
basic sites on the dienophile, withdrawing electron density and therefore making the 
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dienophile more reactive.80 Similarly, when imidazolinone catalyst 71 reversibly 
condenses with an α,β-unsaturated aldehyde, the electron density flows toward the 
electropositive nitrogen centre, lowering the energy profile of the LUMO. The 
lowering in energy creates a smaller energy gap between the HOMO and LUMO of 
the reaction partners and allows the reaction to proceed more rapidly. The positively 
charged iminium species is activated toward nucleophilic attack at the terminal 
carbon of the conjugated π-system because of the low energy of the empty π* orbital 
created. Both nucleophilic attacks and cycloadditions can occur as a result.78  
 
Catalyst 71 was designed with large enantio-discriminating groups to provide high 
levels of iminium geometry control, which is considered essential for asymmetric 
induction. Indeed, condensation of catalyst 71 with aldehyde substrates leads to the 
exclusive formation of the (E)-iminium isomer (Figure 7). This orientation avoids 
steric interactions between the geminal methyl groups on the catalyst and the olefinic 
substrate.79 The re face of the (E)-iminium isomer is shielded by the benzyl group, 
leaving the si face exposed for the cycloaddition to occur.81,82  
 
 
  
 
Figure 7: Si facial approach of the incoming diene79 
 
MacMillan went on to apply catalyst 71 to 1,3-dipolar [4+2]-nitrone additions to α-
β-unsaturated aldehydes,83 α-chlorination of aldehydes,84 and Friedel–Crafts 
alkylations of pyrrole systems.85 The group has also altered the structure of the 
imidazolidinone catalyst for amine conjugate additions,86 organocatalytic hydride 
reductions,87 and aldehyde α-nitroalkylation using SOMO catalysis.88  
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Figure 8: MacMillan’s catalysts 
 
MacMillan’s catalysts are now commercially available and are easily synthesized 
from enantiopure and readily available amino acid: (S)-tryptophan, (S)-
phenylalanine, (S)-alanine and glycine derivatives, and their condensation with 
various ketones and aldehydes in the presence of catalytic quantities of Lewis acid.89  
Table 3: Synthesis of MacMillan’s catalysts89 
 
Entry R1 R2 R3 Yield 
(%) 
Ee (%) Imidazolidinone 
1 Ph Me Me 96 >99 71 
2 Ph tBu H 22 >99 72 
3 Ph 
 
H 32 >99 73 
4 
 
tBu H 26 >99 74 
5 H H tBu 77 >99 75 
 
Recently, MacMillan published a collective total synthesis of structurally diverse 
terpene alkaloids from the Strychnos, Aspidospermine and Kopsia families: (−)-
strychnine, (−)-akuammiane, (−)-kopsinine, (−)-kopsanone, (+)-aspidospermidine, 
(+)-vincadifformine. These structures share a common tetracyclic spiroindoline 
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core 78 that can be accessed using an asymmetric organocatalytic Diels-
Alder/elimination/conjugate addition organocascade sequence from a tryptamine-
derived starting material (Scheme 31).90  
 
R=PMB, Reagents and conditions: i) propynal, 20 mol% 77.TBA, toluene, 40 °C→ rt, 82%, 97% 
ee; ii) (Ph3P)3RhCl, toluene, PhCN, 120 °C; iii) COCl2, Et3N, toluene, –45 °C→ rt, then MeOH, –
30 °C → rt; iv) DIBAL, CH2Cl2, –78 °C→ rt, then TFA, –78 °C→ rt, 61% over three steps; v) 
DBU, K2CO3, DMF, (Z)-4-bromo-3-iodobut-2-enyl acetate, rt; vi) DIBAL, CH2Cl2, –78 °C, 76% 
over two steps; vii) 25 mol% Pd(OAc)2, Bu4NCl, NaHCO3, EtOAc, rt, 58%; viii) PhSH, TFA, 45 
°C, 66%; ix) NaOAc, Ac2O, AcOH, malonic acid, 120 °C, 69%. 
Scheme 30: MacMillan’s total synthesis of (−)-strychnine 83 
 
The synthesis began with the organocatalytic endo-selective Diels-Alder reaction 
of 2-(vinyl-1-selenomethyl) tryptamine 76 and propynal in the presence of 20 
mol% of imidazolidinone catalyst 77, resulting in the isolation of the 
enantioenriched tetracyclic spiroindoline core 78 in 82% yield and 97% ee.91 The 
synthesis continued over eight additional steps including a decarbonylation step 
using Wilkinson’s rhodium catalyst, treatment with phosgene and methanol to 
install the methyl ester group, and DIBAL reduction of the cyclic enamine to 
introduce the ring junction stereocentre in 79 in 61% overall yield. The allylation 
reaction with (Z)-4-bromo-3-iodobut-2-enyl acetate and alkene isomerization 
followed by a DIBAL reduction of both ester functionalities gave 80 in 76% yield. 
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A palladium-catalysed cascade Jeffery-Heck cyclization/lactol formation gave the 
protected Wieland-Gumlich aldehyde 81 in 58% yield. Natural product strychnine 
83 was isolated following a TFA-mediated protecting group removal and 
subsequent lactam formation by heating in the presence of malonic acid, acetic 
anhydride and acetic acid (Scheme 30).89  
The asymmetric organocatalytic Diels-Alder/elimination/conjugate addition 
organocascade sequence started with the formation of iminium 84 from propynal 
and 77 (Scheme 31).  
 
Scheme 31: Organocatalytic Diels-Alder/elimination/conjugate addition 
organocascade sequence to common spiroindoline core intermediate 78  
 
The acetylenic functionality of iminium 84 is orientated as far from the bulky tert-
butyl group as possible, allowing the naphthyl group to shield the bottom face of 
the reacting alkyne to impart maximum enantiotopic discrimination. The 
organocatalytic Diels-Alder step generated solely the endo isomer. The in situ β-
elimination of methyl selenide yielded unsaturated iminium 85 which then 
underwent a second iminium-catalysed step: the Michael addition of the pendant 
N-carbamate to form the pyrrolidine ring. Hydrolysis yielded the enantioenriched 
tetracyclic spiroindoline core 78 in 82% yield and 97% ee.89  
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4.0 Proline-derived catalysts 
Proline has proven to be a very versatile catalyst, affording high enantio- and 
diastereoselectivities as well as being cheap and available in both enantiomeric 
forms. However, proline has limitations: its limited solubility in all but very polar 
solvents such as dimethyl sulphoxide, methanol and water restricts potential 
applications. It also requires high catalyst loadings in order to complete reactions 
in a tolerable timescale.  
In order to understand the structure-activity relationship of the secondary amine 
catalysts, proline-type catalysts were assessed in organocatalytic reactions. List 
screened commercially available amino acid derivatives in the aldol reaction of 
acetone and 4-nitrobenzaldehyde 86 (Table 4). 
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Table 4: Amino acid derivative screening in asymmetric aldol 
 
Entry Amino acid derivative Yield (%) Ee (%) 
1 
 
55 40 
2 
 
<10 - 
3 
 
<10 - 
4 
 
<10 - 
5 
 
68 76 
 
Both the pyrrolidine ring and carboxylic acid group were found to be necessary to 
catalyse the reaction and to impart chirality. The carboxylic acid functionality acts 
as a Brønsted acid co-catalyst, aiding the formation of the iminium ion; and the 
enamine species facilitates enantiofacial discrimination by hydrogen bonding. The 
bifunctional nature of proline allows for both Brønsted acid and nucleophilic 
Lewis base catalysis via enamines and iminium ions.50 
Ley synthesized tetrazole 90 and acyl sulphonamide 92 in order to improve 
solubility, whilst retaining the pKa profile of proline (Scheme 32).92 
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R= Cbz, Reagents and conditions: i) EDAC, HOBT, NH3 (aq), rt, 24 h, 100%; ii) p-TsCl, pyridine, 
CH2Cl2, rt, 72 h, 45%; iii) NaN3, NH4Cl, DMF, 95 °C, 8 h, 78%; iv) 10% Pd/C, H2, AcOH/H2O, rt, 
4 h, 89%; v) methanesulfonamide, EDAC, DMAP, CH2Cl2, 48 h, rt, 60%; vi) 10% Pd/C, H2, 
MeOH, rt, 20 h, 98%. 
Scheme 32: Synthesis of catalysts 90 and 9291  
 
The synthesis of tetrazole 90 was adapted from the reported synthesis of a 
pentapeptide; an EDAC and HOBt mediated coupling reaction quantitatively 
furnish amide 87, which is then converted to the corresponding nitrile by 
dehydration in the presence of p-TsCl.93 Addition of sodium azide and gentle 
heating resulted in tetrazole formation and the Cbz protecting group was removed 
by hydrogenation with Pd/C to give catalyst 90 in high yield. From the same 
commercially available N-benzyloxycarbonyl-(S)-proline, acyl sulphonamide 92 
was synthesised using another EDAC mediated coupling with 
methanesulphonamide facilitated by DMAP. The catalysts were assessed using 
the Mannich reaction between cyclohexanone and imine 93 (Table 5).  
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Table 5: Mannich reaction between imine 93 and cyclohexanone catalysed by 
proline-derived catalysts 
 
Entry Catalyst 
Time 
(h) 
Yield 
(%) 
d.r. 
syn:anti 
ee (%) 
 
1  
27 
2 0 - - 
 
2 
 
90 
2 65 19:1 >99 
 
3  
92 
24 65 19:1 83 
 
The use of catalysts 90 and 92 improved on the yields and selectivities observed 
when proline was used as the catalyst where, in the example shown (Table 5), no 
conversion was observed. Lower catalyst loadings (as low as 1 mol% in the case 
of catalyst 90) still provided fast reaction times and no detrimental effect on 
enantioselectivity was observed. Again, the diastereo- and enantioselectivity were 
thought to be induced by hydrogen bonding which provides a rigid chiral 
environment, as suggested by Houk.94 The tetrazole group causes the p-
methoxyphenyl group on the imine to sit axially to avoid gauche interactions, 
resulting in syn-product 94. 
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Scheme 33: The PMP group of imine 93 sits axially, resulting in preferential 
formation of syn-product 9492 
 
Tetrazole 90 was also used as a catalyst for nitro-Michael and aldol reactions95 as 
well as the N-nitroso aldol reaction of aldehydes and nitrosocarbonyl compounds 
generated in-situ.96 
Jørgensen was the first to describe organocatalyst 95, which was realised after a 
series of optimisation steps on prolinol derived catalysts for the α-sulfenylation 
reaction of isovaleraldehyde.97 Screening of catalysts began with (S)-proline 27 
which was shown to give racemic product in poor yield. The diaryl proline-
derived systems were explored because they were thought to provide effective 
enantiofacial shielding and therefore provide increased stereoselectivities. 
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Table 6: Proline-derived catalysts screened in α-sulfenylation of isovaleraldehyde 
 
Entry Catalyst Yield (%) Ee (%) 
1 27 16 0 
2 
 
56 25 
3 
 
- - 
4 
 
99 77 
5 
 
90 98 
 
While diarylmethylpyrrolidine 98 gave a low yield and disappointing 
enantioselectivity, diarylprolinol 99 gave no substrate turnover whatsoever. The 
potential formation of oxazolidine 101, a parasitic species similar to the 
oxazolidinones observed when using proline as a catalyst, was thought to be 
responsible.96 Various silyl protecting and aryl groups were tested and a 
combination of trimethylsilyl and bis(trifluoromethyl)phenyl groups greatly 
improved reactivity and selectivity. The large trimethylsilyl group and the biaryl 
system always favour the (E-s-trans) enamine, believed to have the lowest energy 
profile. Although organocatalyst 95 does not contain any Brønsted acid catalytic 
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sites, the asymmetric induction occurs through face-shielding stereocontrol, in a 
manner similar to MacMillan’s imidazolinone catalysts.  
 
 
Scheme 34: Catalyst 99 deactivation through oxazolidine formation 
 
Jørgensen’s TMS-protected diarylprolinol catalyst 95 can induce high 
enantioselectivity and turnover for both HOMO and LUMO pathways. It has since 
been employed in the benzylation of α,β-unsaturated aldehydes,98 cycloaddition 
reactions,99,100 aziridinations of 2,4-dienals,101 epoxidations of α-β unsaturated 
aldehydes,102 α-aminations of aldehydes103 and α-fluorinations of aldehydes.104  
Furthermore, as catalysts of this type are capable of both forms of activation, they 
can participate in cascade reactions as the formation of consecutive enamine and 
iminium ion is controlled to produce targets with multiple stereogenic centres. 
Recently, Enders employed diarylprolinol catalyst 100 in a Michael/Michael/aldol 
condensation sequence to produce tetra-substituted cyclohexene carbaldehydes.105  
 
Scheme 35: Michael/Michael/aldol condensation ‘domino’ reaction sequence  
 
Four stereocentres are formed with complete enantioselectivity and high 
diastereoselectivity from a three-component reaction catalysed by 20 mol % of 
100. First, aliphatic aldehyde 102 condenses with catalyst 100 to form an enamine 
intermediate, which undergoes a Michael-type addition reaction with β-
nitrostyrene 103. As β-nitrostyrene is a more reactive Michael acceptor than 
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cinnamaldehyde, the first step is completely chemoselective. Once the reaction is 
complete, the enamine adduct is hydrolysed to furnish the γ-nitroaldehyde product 
105, the only observable intermediate (using gas chromatography) as the 
subsequent steps are too fast. Catalyst 100 is then free to participate in the 
activation of cinnamaldehyde, generating the corresponding iminium ion. The 
iminium ion combines with the γ-nitroaldehyde and the resulting enamine 106 
undergoes ring closure through an intramolecular aldol condensation step to yield 
the polyfunctional cyclohexene derivative 107. Although the final product is an 
α,β-unsaturated aldehyde, its steric bulk prevents it from participating further in 
the catalytic cycle.  
 
Scheme 36: Catalytic cycle of Enders cascade reaction  
 
Theoretically, the production of 16 different stereoisomers (24 stereoisomers) is 
possible in a reaction that generates four stereogenic centres. In fact, only two 
enantiomerically pure diastereoisomers are formed. The selectivity is attributed to 
the first Michael addition step, which was previously shown to be highly selective 
when (S)-proline was used as the catalyst.106 The selectivity of the Michael 
reaction generates a product that allows, through sterically favourable interactions, 
the selectivity to be retained and improved in the following steps.  
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5.0 Axial chirality 
Although the most commonly encountered type of chirality arises from a chiral 
centre, such as a tetrahedral carbon atom with four different substituents, chirality in 
a compound can also originate from chiral planes, axes or helices. Axial chirality 
results from the non-planar arrangement of four groups in pairs about a chiral axis 
and is observed in compounds such as allenes, 2,2-disubstituted binaphthyls and 
tetra-ortho-substituted biphenyl compounds where steric hindrance prevents rotation 
about the Ar-Ar bond. 
In the biaryl systems, if the energy barrier to bond rotation is sufficiently large then 
isolation of separate rotational conformers, known as atropoisomers (from the Greek, 
a = not, tropos = turn), can be achieved.107,108 Atropoisomers with large rotational 
barriers to racemization have been used extensively as ligands in asymmetric 
catalysis.109 These axially chiral scaffolds are popular because they are 
configurationally stable and possess permanent stereochemical environments. 
Consequently, mechanistic studies are simplified due to a reduced number of 
possible diastereoisomeric pathways.110 Atropoisomerism is also a key feature in a 
number of natural products, chiral auxiliaries, drugs and, more recently, 
organocatalysts. Locked bridging aryl bonds have been shown to dramatically alter 
the chemistry of compounds; from completely changing natural product binding 
capacities to altering catalyst activity.  
 
Figure 10: Examples of axially chiral compounds 
 
BINAP 108, perhaps the most widely studied axially chiral compound, has been 
successfully used as a very selective ligand due to its rotationally stable axis and 
flexibility in coordinating a wide variety of metals.111 The natural product (–)-
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steganone 109 is biologically active and displays anticancer activity. The 
conformation of steganone is fixed at room temperature due to the rigidity of its 
eight membered ring. Only the (S)ax conformation can bind to the tubulin active site, 
inhibiting in vitro and in vivo polymerization of microtubules (halting cell 
division).112  
 
5.1 Axially chiral aminocatalysts 
Many of the most widely studied organocatalysts are derivatives of proline. 
However, as discussed above, proline can undergo decarboxylative decomposition 
upon condensation with electron-deficient aldehydes, removing it from the catalytic 
cycle.113 Alterations can be made to the structure of proline; however, due to 
difficulty in modifying the pyrrolidine scaffold, modifications are limited to 
functional group manipulations on the carboxylic acid functionality. These 
manipulations have led to far more soluble and reactive variants than the parent 
proline structure and have shown impressive catalytic activity (catalysts 90, 92, 95). 
Despite these successes, there is still great interest in developing more structurally 
varied organocatalysts with greater molecular diversity, steric influence and 
additional sources of chirality. 
Prolinamide (S)-110, synthesised from optically active 1,1’-binaphthyl-2,2’-diamine 
and (S)-proline, and ‘synthetic amino acid’ catalyst (S)-111 are both examples of 
successful axially chiral organocatalysts. Shi first synthesised compound 110 to 
catalyse the aldol reaction of ketone and aryl aldehyde substrates. High 
enantioselectivities (up to 98%) and diastereoselectivities (>98:2) were obtained 
when acetic acid was used as additive (10 mol%).114 For aldol reaction catalysis, 
Maruoka targeted catalyst 111, featuring a rigid binaphthyl backbone with a pendant 
carboxylic acid group.113 Catalyst 111 was designed to ease enamine formation: 
without an α-substituent, the steric hindrance would be lower, promoting the initial 
condensation step. Furthermore, because basicity and nucleophilicity profiles of 111 
are lower than that of proline, selectivity should also improve. Shi and Maruoka 
independently assessed their axially chiral catalyst variants against the corresponding 
prolinol species in the aldol reaction of 86 and acetone.  
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Table 7: Aldol reaction assessment114  
 
Entry Catalyst 
Catalyst loading 
(mol %) 
Solvent 
Time 
(h) 
Yield 
(%) 
Ee 
(%) 
1 
 
10 Acetone 48 80 30 (R) 
2 110 10 Acetone 72 58 65 (R) 
3 27 5 DMSO 24 18 71 (R) 
4 111 5 DMSO 24 70 93 (R) 
 
When compared to proline-derived amide 112, axially chiral prolinamide 110 was 
found to improve the selectivity, although a longer reaction time was needed.115,116 
The increase in enantioselectivity could be attributed to the extra aminocatalytic 
centre, increased steric bulk and chiral influence, arising from the binaphthyl 
backbone. 
When azepine 111 was used (Entry 4), improvements in yield and enantioselectivity 
were observed when compared to proline; the aldol product was generated in 71% 
yield and 93% ee.113 A kinetic study of amino acid catalysts 111 and 27 was 
performed under the same reaction conditions and the yield of the aldol product was 
monitored over a 24 h period.117 Although the rate of reaction with proline was 
initially higher, the conversion quickly stopped (18%) due to proline consumption 
through oxazolidine formation (48%). The design of catalyst 111 prevents 
degradation by decarboxylation, providing greater chemical stability while retaining 
the enantioselective hydrogen bonding ability. 
The success of catalyst 111 led it to be screened further with different solvents: high 
enantioselectivities identified N,N-dimethylformamide as optimal.116 Aldehyde 
substrate scope studies revealed that heteroaromatic, electron-deficient aromatic and 
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olefinic aldehydes were best tolerated, whereas simple aromatic aldehydes gave 
excellent enantioselectivities but disappointing yields (Entry 3).  
Table 8: Aldol reaction of acetone with aldehydes catalysed by (S)-111 
 
Entry Aldehyde Yield (%) Ee (%) 
1 
 
80 95 (R) 
2 
 
91 95 (R) 
3 
 
35 96 (R) 
4a 
 
81 96b 
a) 108 equivalents of acetone, entries 1-3; 27 equivalents b) absolute configuration not determined 
When cyclohexanone was used as the nucleophile with 4-nitrobenzaldehyde, the 
highest yields and diastereoselectivities were obtained using dimethylsulfoxide as 
the solvent alongside increasing the catalyst loading to 10 mol%.117 
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Table 9: Aldehydes screening in (S)-111 catalysed reaction with cyclohexanone 
 
Entry Aldehyde Yield (anti:syn) Anti ee (%) Syn ee (%) 
1 
 
98 (95:5) 98 5 
2 
 
38 (91:9) 98 16 
3 
 
99 (>95:5) 99 - 
4 
 
93 (>95:5) 97 12 
 
Screening aldehydes with cyclohexanone revealed that despite β-naphthyl- and 
benzaldehyde giving low yields, all the aldehydes employed gave outstanding levels 
of diastereoselectivity and enantioselectivity (Entry 1).116 The stereochemistry of the 
major anti-aldol product 113 was determined to be (2S,1R) which allowed the 
proposal of a tentative transition state in which the re face of the aldehyde 
approaches the re face of the enamine (Figure 11).  
 
 
Figure 11: E-s-trans transition state of (S)-111 enamine116 
 
N
O
O
H
O
R
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The enamine derived from 111 must therefore adopt an anti conformation with 
respect to the aryl carboxylic acid directing group, in a similar manner to the anti-
enamine postulated in the proline-catalysed aldol reaction (Scheme 16). 
5.2 Maruoka’s organocatalysts  
Maruoka synthesized a range of very successful axially chiral organocatalysts that 
operate by enamine (114, 116, 117),118 iminium (115),119 or phase transfer (118)120 
catalysis. 
 
Figure 11: Maruoka’s biphenyl and binaphthyl catalysts 
 
The Maruoka catalysts share a common feature: a biaryl axially chiral backbone, 
which provides chemical stability and allows for potential extensive derivatization.122 
Indeed, the group has capitalized on this tuneable feature to design a range of 
sophisticated organocatalysts with a variety of aryl pendant functionalities that 
dramatically alter the steric and electronic properties of each catalyst, allowing them 
to be tailored to fit the exacting conditions of each reaction type. 
 
5.2.1 Aldol reaction  
Despite the success of catalyst 111, a possible drawback was the high catalyst 
loading (10 mol%) required in the aldol reaction, hypothesized to be caused by the 
moderate nucleophility of the benzylic amine. To improve the activity, catalyst (S)-
114 was synthesized (Scheme 38).121  
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Reagents and conditions: i) BH3-SMe2, B(OMe)3, 0 °C → rt, 5 h; ii) Br2, pyridine, –20 °C → 0 °C, 5 
h, 95% over two steps; iii) PBr3, CH2Cl2, rt, 5 h, 78%; iv) allylamine, CH3CN, 50 °C, 12 h, 99%; v) n-
BuLi, THF, –78 °C, 1 h, then (EtO)2CO, rt, 1 h, 48%; vi) Pd(OAc)2, PPh3, N,N-dimethylbarbituric 
acid, CH2Cl2, 35 °C, 12 h, 98%; vii) 1M NaOH, MeOH-THF, reflux, 10 h, 98%. 
Scheme 37: Synthesis of catalyst (S)-114 
 
The synthesis of the catalyst commences with dicarboxylic acid compound 119, 
which is reduced to the corresponding diol using borane-dimethyl sulfide (BMS) 
followed by aromatic bromination using molecular bromine and pyridine at low 
temperature, affording 120 in 95% yield over the two steps. Using the Appel 
reaction, diol 120 was converted into the corresponding dibromide using phosphorus 
tribromide at room temperature in 78% yield. Ring closure using a double 
nucleophilic substitution with allylamine gave 122 in high yield. Lithiation with n-
BuLi and substitution with ethyl carbonate furnished ethyl ester 123 in 48% yield. A 
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palladium-catalysed deallylation and saponification of the ethyl ester gave 114 in 
almost quantitative yield over two steps.  
 
The presence of electron-donating methoxy groups on the biphenyl backbone of 114 
increases the nucleophilicity of the catalyst, making it far more reactive. As a result, 
the catalyst loading can be reduced to as little as 0.1 mol%, delivering the aldol 
product in comparable enantioselectivities albeit with longer reaction times (Table 7 
and 10).120  
Table 10: (S)-114 catalyst loading studies 
 
Entry Catalyst (mol %) Time (h) Yield (%) Ee (%) 
1 1 24 90 95 (R) 
2 0.5 44 90 96 (R) 
3 0.1 96 91 96 (R) 
 
5.2.2 Diels-Alder reaction 
A highly selective exo-selective Diels-Alder reaction was reported using diamine 
binaphthyl catalyst (R)-115 in the presence of co-catalyst p-toluenesufonic acid.122 
High diastereo- (up to 20:1) and enantioselectivities (up to 95% ee) were obtained in 
the reaction between α,β-unsaturated aldehydes and cyclopentadiene. Unfortunately, 
the scope of this reaction is limited as other dienes were not as well tolerated (Table 
11). 
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Table 11: Aldehyde screening in Diels-Alder reaction 
 
Entry Aldehyde 
Yield (%) 
(Exo:endo) 
Ee exo 
(%) 
1a 
 
90 
(5.5:1) 
83 
2  
72 
(>20:1) 
88 
3 
 
80 
(13:1) 
92 
4 
 
99 
(7.4:1) 
95 
a) Reaction conducted in toluene at −60 °C 
 
The design of catalyst 115 was developed over several screening steps. Substituents 
on the amine, both electron-donating and -withdrawing were tested: 2,2’-
bis(methylamino) derivatives were found to have the best activity, facilitating both 
fast iminium salt formation and hydrolysis. Introduction of increasingly large groups 
at the 3- and 3’-positions on the octahydrobinaphthyl rings resulted in increasing 
levels of exo selectivity and enantioselectivity. The large tert-butyl substituents at the 
3- and 3’-positions block one face of the iminium intermediate, leaving the other 
face free for the approach of cyclopentadiene.123 Mechanistic and NMR studies 
found that the presence of both methylamine functionalities on the catalyst is 
essential for rapid iminium formation and acceptable turnover. It is hypothesized that 
the condensation of the methylamine and aldehyde moieties is aided by the presence 
of an ammonium unit formed after protonation of the remaining amine moiety by p-
toluenesufonic acid.  
CHO
R
12 mol% (R)-115
10 mol% p-TsOH.H2O
PhCF3, −20 °C
R
CHO
tBu
tBu
NHMe
NHMe
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51 
5.2.3 Mannich reaction 
Amino sulfonamide (S)-116 (Figure 11) has been successfully used as a catalyst for 
the anti-Mannich reaction of activated ketimine 124 with aldehyde substrates.124  
 
 
Scheme 38: Anti-Mannich reaction using axially chiral amino sulfonamide catalyst 
116 
 
The stereochemistry of the products from this reaction have led to the proposal of a 
transition state model (Scheme 38) which suggests that while both the E-s-trans and 
E-s-cis enamines are formed upon condensation of catalyst 116 with 3-phenyl 
propanal, only the E-s-cis enamine is reacts to give the (3S,4R)-isomer 
predominantly.125  
 
 
Figure 12: (S)-Proline transition state E-s-trans model leading to the syn-
isomer123,124  
 
In comparison, in the (S)-proline catalysed reaction, the dominant species is the E-s-
trans enamine which reacts from its re face with the re face of 124 resulting in the 
major syn (3S,4S) isomer (Figure 12). 
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5.2.4 Hydroxyamination of aldehydes 
In addition to axially chiral proline analogues (S)-111 and (S)-114, Maruoka has also 
synthesized an axially chiral version of Jørgensen’s diaryl prolinol catalyst 95. 
Catalyst (S)-117 was used in the α-aminoxylation reactions between aldehydes and 
nitrosobenzene.122 
 
Figure 13: Axially chiral version of Jørgensen’s diaryl prolinol catalyst 
 
Reactions between aldehydes and nitrosobenzene 126 can result in either the O-
nitroso aldol product or the N-nitroso aldol product depending on the catalyst used. 
Catalysts with mild acid functionalities, such as tetrazole 90, proline 27 and glycolic 
acid, have been shown to afford the aminooxylation product 127 (O-nitroso 
product).126,127,128 The hydrogen bonding generated by the presence of an acid 
functionality causes nitrosobenzene 126 to behave as an oxy-electrophile, resulting 
in the introduction of oxygen at the α-position in aldehydes. Tertiary alcohols, such 
as TADDOL, in combination with pre-formed enamines result in the exclusive 
formation of the hydroxyamination product 128 (N-nitroso product). 
 
 
Scheme 39: N-nitroso 128 and O-nitroso 127 products 
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Maruoka wanted to create a catalyst that could activate both the aldehyde and 
nitrosobenzene component, through in situ enamine formation and hydrogen 
bonding, respectively, to provide a convenient route to hydroxyamination products. 
The group screened the reaction of propanal and nitrosobenzene with (S)-129, which 
contains no acid or alcohol functionality. Following a reduction with sodium 
borohydride, the resulting amino-alcohol was produced with excellent 
chemoselectivity. However, the reaction was low-yielding and gave poor ee. The 
addition of alcohol solvents, such as methanol or tert-butanol, was found to have a 
beneficial impact on enantioselectivity. Accordingly, catalyst 132, possessing two 
hydroxyl groups, was tested under the same reaction conditions, and improvements 
in yield and enantioselectivity were observed. Sterically congested catalyst 117 gave 
high yields and excellent regio- and enantioselectivity, whereas 99 gave very poor 
conversion; deactivation of 99 is thought to have occurred through oxazolidine 
formation.129 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
54 
Table 12: Catalyst screening for the hydroxyamination of propanal 
 
Entry Catalyst Ratio 130/131 Yield (%) Ee (%) 
1 
 
>99/1 22 29 (S) 
2 
 
>99/1 55 77 (S) 
3 117 >99/1 90 99 (S) 
4 99 >99/1 9 23 (R) 
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5.3 Page’s axially chiral atom transfer catalysts 
The Page group is well established in the field of organocatalysis; specializing in the 
development of electrophilic atom-transfer catalysts. These catalysts have evolved 
from dihydroisoquinoline-based such as 133 and 134, to more complex axially chiral 
backbones, such as 135 for epoxidations,20 and 136 and 137 for aziridinations.21 
 
 
Figure 14: Page’s epoxidation and aziridination catalysts 
 
5.3.1 Epoxidation catalysts 
In 1998, Page prepared catalysts using a dihydroisoquinoline backbone and a variety 
of primary amines.129 These catalysts were the first in the family to possess chiral 
exocyclic groups on the iminium nitrogen, a feature that was theorised to enhance 
the enantioselectivity by bringing a chiral element closer to the reaction centre.  
 
The dihydroisoquinoline-based catalyst synthesis began with the bromination of 
isochroman to afford 1-bromo-isochroman 138. Without purification, 138 was 
converted into 2-(2-bromoethyl)benzaldehyde 139 in the presence of hydrobromic 
acid (48% in water) in good yield. Condensation of 139 with a primary amine, 
acetonamine 141 in this case, led to the formation of the iminium moiety. Anion 
exchange with sodium tetraphenylborate allowed for the easy isolation of catalyst 
140 as a crystalline solid.129  
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Reagents and conditions: i) Br2, CCl4, reflux, 1 h; ii) HBr (48% in water), reflux, 10 min, 65%; iii) 
141, NaBPh4, EtOH/CH3CN, 2 h, 0 °C 
Scheme 40: Synthesis of dihydroisoquinoline catalyst 140133 
 
Iminium salt catalysts, in the presence of an oxidant (Oxone or TPPP), are thought to 
be converted into the corresponding oxaziridinium ions in situ, which, in turn, 
transfer the oxygen atom to the alkene substrates.130 This class of epoxidation 
catalysts were thoroughly investigated and the most successful combination was 
proved to involve the incorporation of chirality in the form of an axially chiral 
biphenyl or binaphthyl backbone and the use of acetonamine 141.131,132,133 
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Table 13: Page’s iminium salt-catalyzed epoxidations  
 
Reagents and conditions i); a) Oxone (2 equiv.), Na2CO3 (4 equiv.), CH3CN:H2O (1:1), 0 °C 1- 12 h; b) 
TPPP, CHCl3, −40 °C 
Entry 
Catalyst 
(mol%) 
Alkene Yield (%) 
Ee 
(%) 
Major 
Epoxide 
1a 
133 
(10 mol%)  
78 73 (+)-(1R,2R) 
2b 
134 
(10 mol%)  
59 97 (−)-(1S,2S) 
3a 
140 
(5 mol%)  
54 59 (−)-(S) 
4a 
135 
(5 mol%) 
 
66 95 (+)-(1R,1S) 
5 
 
142 
 
 
100 
 
 
60 
 
(−)-(1S,2S) 
 
The nature of the chiral exocyclic amine group was shown to be of great importance, 
with isopinocampheyl amine catalyst 133 giving the most promising result in early 
testing with trans-stilbene (Entry 1).129 Later, catalysts synthesized from amines 
containing a dioxane moiety and a pendant aryl group (or acetonamines), such as 
134, 135, 140 and 142 were found to impart increased enantioselectivity. In 
particular, catalyst 134 with a p-methylsulfonylphenyl group gave outstanding 
enantiomeric excesses for low-temperature epoxidation reactions of cyclic cis-
alkenes using TPPP (tetraphenylphosphonium mono-peroxysulfate)134 as an oxidant 
(Entry 2). The antihypertensive (−)-cromakalim was synthesized using Page’s 
conditions following the ring opening of epoxide 143 with 2-pyrrolidinone, giving 
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the (−)-(3S,4R) enantiomer in 52% yield (Scheme 41).135 
 
 
Reagents and conditions: i) 10 mol% 134, TPPP, CHCl3, −40 °C, 24 h, 59%, 97% ee; ii) 2-
pyrrolidone, NaH, DMSO, rt, 4h, 52% 
Scheme 41: Total synthesis of (−)-cromakalim 144 
 
Catalyst 140 gave good selectivity (59% ee) in the epoxidation of triphenylethylene 
(Entry 3).136 The selectivity of catalyst 140 has been attributed to the rigid chair 
conformation of the dioxane substituent, in which requires the dihydroisoquinoline 
appears to be axial; the conformation has also been observed in the solid state using 
single crystal X-ray crystallography (Scheme 42).136  
 
 
Scheme 42: Two possible conformations of 140 
 
The preferred thermodynamic conformer is believed to be 140b because the potential 
disfavoured 1,3-di-axial interaction present in conformer 140a is avoided. 
Additionally, conformer 140b is favoured by the gauche effect. The lone pairs of the 
oxygen atoms could help stabilize the electron-deficient iminium carbon, 
contributing to the overall preference for 140b. The favoured conformation 140b 
seemingly results in the phenyl group shielding one face of the iminium double bond 
of catalyst 140. The nucleophilic attack of the oxidant to either the si or re face of the 
iminium unit is the starting point of the catalytic cycle and results in the formation of 
two diastereoisomers: 145a and 145b (Scheme 43). It is hypothesized that the initial 
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attack onto the iminium unit is strongly influenced by the bulky phenyl group of 
catalyst 140 hindering the oxidant’s approach towards one face, resulting in an 
uneven rate of formation of these diastereoisomeric ions.129 Consequently, following 
ring-closure and predominant generation of one of the oxaziridinium species 146a 
and 146b, the oxygen atom is transferred to the prochiral alkene substrate, and, 
depending on the approach of the catalyst, gives rise to the observed enantiomeric 
excesses. 
 
 
Scheme 43: Proposed catalytic cycle using Oxone136 
 
Third generation catalyst 135 (Figure 14), a (S)-binaphthyl azepinium salt, was 
shown to be exceptionally efficient, affording phenyl-1,2-dihydronaphthalene oxide 
in 95% ee within 2 h (Entry 4, Table 13).20 As the fixed axial chirality of the 
binaphthyl backbone led to higher enantioselectivity, further improvements to the 
family of iminium catalysts were targeted: it was envisaged that the introduction of a 
substituent in the α-position to the azepinium nitrogen atom might improve 
selectivity by increasing the steric constraint about the iminium double bond. 
Additionally, in the case of biphenyl catalyst 142 (Entry 5, Table 13), it was 
hypothesized that the presence of the substituent could shift the equilibrium towards 
a single atropoisomer. 
 
Low-temperature 1H NMR experiments were performed on 142 to investigate the 
preferred lowest energy conformer. Four conformers, resulting from rotation around 
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the biphenyl C-C and N-C bonds, were identified. Analysis of the spectra showed the 
Rax conformation (89:11) was favoured for the biphenyl unit in order to reduce 
interactions with the nitrogen substituent. Indeed, the addition of Grignard reagents 
(MeMgX, iPrMgX, PhMgX, BnMgX) to iminium 142 at low temperature resulted in 
mixtures of two diastereoisomers. When MeMgBr was used, (Rax,R,S,S)-147 was 
isolated as the major diastereoisomer alongside (Sax,S,S,S)-148.136 NBS oxidation of 
(Rax,R,S,S)-147 produced catalyst 149 where the iminium double bond is positioned 
exclusively on the opposite side of the newly introduced Grignard substituent. We 
believe the remaining pseudoaxial proton is more exposed and therefore more 
reactive kinetically (Scheme 44). 
 
 
Reagents and conditions: i) MeMgBr, THF, −78 °C, 2 h, d.r. 6:1, 74%; ii) NBS, CH2Cl2, Δ, 30 min, 
NaBPh4, CH3CN, 10 min, 68%  
Scheme 44: Addition of a Grignard reagent onto iminium 142 
 
As predicted, the introduction of the new substituent prevented the rotation around 
the biaryl axis as the substituent assumed a pseudoaxial position to minimize the 
steric interaction with the acetonamine (Scheme 44). The orientation of the methyl 
group was deduced from characteristic 1H NMR chemical shifts (for 147 δMe 0.68 
ppm and for 148 δMe 0.41 ppm) as the protons on the pseudoaxial methyl group 
experienced significant deshielding because of the ring current effect. The absolute 
configuration of (Rax,R,S,S)-147 was then confirmed using single crystal X-ray 
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crystallography.136 
 
The diastereoselective formation of the two atropoisomers was described as the 
result of a ‘double stereochemical relay’: the chiral appendage on the nitrogen atom 
enforced a preference for a favoured atropoisomer of 142, which in turn influenced 
the addition of the Grignard reagent onto the iminium moiety. 137 
 
Wallace, well-known for his dynamic axial chirality studies, explored a similar 
‘stereochemical relay’ using a different approach. Wallace studied the effect of a N-
Boc substituent on the biaryl axial configuration of mono-alkylated 6,7-dihydro-5H-
dibenz[c,e]azepine 150 (Scheme 45).138 
 
 
Reagents and conditions: i) Boc2O, tBuOH, r.t., 92% 
Scheme 45: Conformational ‘switch’ of N-Boc derivatized 151  
 
In a similar manner to catalyst 142 (Scheme 44), where the axial conformation was 
directed by the steric interactions between the methyl group and the N-substituent, 
the conversion of 150 to tert-butylcarbamate derivative 151 triggered a conformation 
change: a ‘switch’ in the orientation of the methyl group at the C5 position from 
pseudoequatorial to pseudoaxial, and, as indicated by the change in the specific 
rotation, a concomittant inversion of the chirality at the biphenyl backbone from (Sax) 
to (Rax) occurred.  
 
Page’s ‘double stereochemical relay’ hypothesis was confirmed when the addition of 
Grignard reagents onto binaphthyl compound 135, a compound with fixed axial 
chirality, was found to be completely diastereoselective (Scheme 46).136 
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Reagents and conditions: i) MeMgBr, THF, −78 °C, 12 h; ii) NBS, CH2Cl2, rt, 10 min, NaBPh4, 
EtOH, 1 h 
Scheme 46: Diastereoselective Grignard reagent addition onto iminium salt 135 
 
Azepines (Rax,R,S,S)-147 and (Rax,R,S,S)-152 were oxidized to the corresponding 
iminium salt catalysts using NBS (Schemes 44 and 46). The novel catalysts, 149 and 
153, were evaluated using the epoxidation of 1-phenyl-1-cyclohexene. The presence 
of the substituent in the α-position to the azepinium nitrogen atom, in both the 
biphenyl and binaphthyl species, led to improvements in selectivity (Table 14). 
 
 
Table 14: Biphenyl and binaphthyl-based catalyst screening 
  
Reagents and conditions: i): (a) Oxone (2 equiv.), Na2CO3 (4 equiv.), CH3CN:H2O (1:1), 0 °C 1- 12 h; 
(b) Oxone (2 equiv.), NaHCO3 (5 equiv.), CH3CN:H2O (1:1), 0 °C, 17 min - 13 h 
Entry Catalyst Conversion (%) Ee (%) 
Major 
Epoxide 
1a 142 100 60 (−)-(1S,2S) 
2a 149 100 82 (−)-(1S,2S) 
3b 135 99 91 (−)-(1S,2S) 
4b 153 99 94 (−)-(1S,2S) 
 
5.3.2 Aziridination catalysts 
Similarly, Page has investigated the effect of structural modifications on the activity 
and selectivity of binaphthyl azepine catalysts, such as 136 and 137, used in the 
aziridination of trans-chalcone. The structural changes surveyed include the 
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introduction of substituents at the 3- or 3,3’-positions (C2 symmetric catalysts) and 
the steric bulk of the nitrogen substituent. The use of nitrogen transfer reagent O-
(diphenylphosphinyl)-hydroxylamine 154 (DppONH2) and NaOH as the base in 
dichloromethane were found to be the optimum conditions. N-Isopropyl azepine 137 
was shown to impart moderate enantioselectivity and allow for a reasonable turnover 
of substrate (Entries 1 and 3). The highest enantioselectivity (43% ee) was obtained 
using 3,3’-disubstituted catalyst 136, albeit with disappointing conversion, probably 
due to the sterically demanding 3,5-bis(trifluoromethyl)phenyl groups (Entry 2). 
 
Table 15: Page’s aziridination conditions 
 
Reagents and conditions: Catalyst (1 equiv.), 154 (1.1 equiv.), NaOH (1 equiv.), CH2Cl2, r.t. 
Entry Catalyst Time h Conversion 
(%) 
Ee (%) 
1 137 48 70 35 
2 136 48 10 43 
3 
 
155 
24 38 34 
 
Furthermore, azepine 155 and a stoichiometric amount of DppONH2 were submitted 
to the reaction conditions, leading to the isolation of the corresponding hydrazinium 
salt 156 in 77% yield. A counter-ion exchange with sodium tetraphenylborate gave 
product 157 in quantitative yield as a long-term bench stable aziridination reagent.  
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Reagents and conditions: i) DppONH2 (1.1 equiv.), CH2Cl2, r.t., 18 h, 77%; ii) NaBPh4, CH3CN, 
100%. 
Scheme 47: Isolation of hydrazinium salts 156 and 157 
 
When either salt 156 or 157 was stirred with trans-chalcone under the reaction 
conditions described above, the same ee and yield were observed (Entry 3), 
supporting the contention that the hydrazinium is the active catalytic species.21  
 
5.3.3 Page’s axially chiral aminocatalysts 
Due to the successes of Page’s axially chiral atom transfer organocatalysts, the next 
logical step was the development of related azepines for aminocatalysis. 
Aminocatalysis is a relatively recent endeavour for the Page group, and as such 
screening began with simple binaphthyl aminocatalyst 129 and mono-alkylated 
catalyst 158 for the aldol reaction of p-nitrobenzaldehyde 81 and acetone. Maruoka’s 
‘synthetic amino acid’ catalyst (S)-111 was shown to be very successful in this 
reaction and we envisaged that our catalysts, which share structural similarities, 
would show promising preliminary results.113 
 
 
Figure 15: Page’s group aminocatalysts 
 
Catalyst 129 was screened using optimum solvents as described by Maruoka (N,N-
dimethylformamide and dimethylsulfoxide); however, both attempts led to racemic 
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products and very poor conversions (<5%) (Entries 4 and 6, Table 15). Conversely, 
aprotic solvents such as tetrahydrofuran, acetone and acetonitrile gave full 
conversion to the hydroxyketone product, albeit with very low ee (Entries 2, 3 and 
5). Most polar and every non-polar solvents studied gave low enantioselectivities 
(<5%), and the (S)-enantiomer was the major enantiomer observed. Surprisingly, 
when water was used, the (R)-enantiomer was isolated in 16% ee (Entry 1). The 
same result was obtained, albeit with a poorer conversion, when catalyst 158 was 
used in a reaction conducted in water (Entry 11).  
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Table 15: Some preliminary screening of catalysts in aldol reaction 
 
Reagents and conditions: i) catalyst (10 mol%), PhCO2H (20 mol%), solvent, r.t. 72 h 
Entry Catalyst Temp. Solvent Conv. (%) ee (%) 
1 (R)-129 r.t. H2O 50 16 (R) 
2 (R)-129 r.t. neat 100 - 
3 (R)-129 r.t. THF 100 3 (S) 
4 (R)-129 r.t. DMF <5 - 
5 (R)-129 r.t. CH3CN 100 2 (S) 
6 (R)-129 r.t. DMSO <5 3 (S) 
7 (R)-129 r.t. Et2O 100 4 (S) 
8 (R)-129 r.t. MeOH 30 2 (S) 
9 (R)-129 r.t. EtOH 50 3 (S) 
10 (R)-129 r.t. iPrOH 40 3 (S) 
11 (R)-158 r.t. H2O 10 16 (R) 
12 (R)-158 r.t. CH3CN 65 6 (S) 
13 (R)-158 0 °C CH3CN 25 30 (S) 
14 (R)-158 r.t. THF 70 7 (S) 
15 (R)-158 0 °C THF 15 5 (S) 
16 (R)-158 r.t. Et2O 50 6 (S) 
17 (R)-158 0 °C Et2O 15 11 (S) 
18 (R)-158 r.t. Toluene 75 5 (S) 
19 (R)-158 0 °C Toluene 15 5 (S) 
  
Catalyst 158 was screened with several different solvents, and rather disappointing 
enantioselectivities were observed. Encouragingly, a reaction conducted in 
acetonitrile at 0 °C afforded the (S)-product in 30% ee (Entry 13). When aprotic 
solvents, such as THF and acetone, were used, full conversion to the hydroxyketone 
product, albeit in very low ee, was observed.  
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6.0 This project 
The aim of the project is to design and synthesize catalysts that are analogous in 
structure to previously reported organocatalysts such as amino acid proline 27, 
tetrazole 90,139 diarylprolinol silyl ether 100140 and binaphthyl functionalized amino 
acid 111. Our target catalysts are novel structures with axial chirality and a chiral 
centre on the azepine ring to exert enantiofacial selectivity. The R substituent should 
interact with the in situ generated iminium/enamine species by hydrogen bonding, 
ionic and/or steric interactions to induce enantiofacial selectivity, resulting in a 
highly enantioselective reaction. Installation of functionalities contained in 27, 90 
and 100 were sought in order to provide assessment of the effect of axial chirality on 
the selectivity of aminocatalysts (Figure 16).  
 
Figure 16: Our catalyst design 
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Chapter two: Results and Discussion 
1.0 Aim of project 
The project targeted the synthesis of novel axially chiral organocatalysts (Figure 17) 
and the evaluation of their effectiveness in a number of asymmetric processes. 
Maruoka’s aryl bifunctionalized organocatalysts, such as 111, have been shown to 
impart high levels of selectivity; however, the impact of a substituent in close 
proximity to the aminocatalytic centre has not yet been investigated in these systems. 
Our newly synthesized catalysts possess conformational stability, enforced by the 
presence of a fixed chiral backbone, and retain the chiral centre in the α-position, 
with regards to the azepine nitrogen atom, that has proven so successful in 
pyrrolidine species and in Page’s epoxidation catalysts. 
  
 
Figure 17: Targeted catalysts  
Synthetic strategies toward binaphthyl azepines are well documented;1,2,3 however, 
the introduction of a substituent at the 2-position of the azepine ring is less 
thoroughly reported, with only a handful of asymmetric additions of alkyl groups 
reported. To date, two approaches have been successful: Page’s diastereoselective 
addition of a Grignard reagent onto an iminium salt,4 or a base-mediated alkylation 
methodology as used by Superchi,1 Meyers,5 and Wallace (Scheme 48).6  
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Scheme 48: Approaches towards the synthesis of α-functionalized catalysts 
The choice of protecting group is integral to the reactivity of azepines: electron-
donating nitrogen protecting groups stabilize the iminium moiety and therefore 
would be preferred for pathway A, whereas electron-withdrawing substituents 
activate the position α to the azepine nitrogen for deprotonation and could be used in 
pathway B. 
 
2.0 Synthesis of the β-amino acid catalyst 
A catalyst analogous to proline was our primary objective, and consequently the 
installation of a carboxylic acid group was targeted. Several constrained or spatially 
modified β-amino acid proline analogues have been investigated in depth and their 
application tested in Mannich, such as 159 and 160,7 aldol, such as 161 and 162,8 
and Michael reactions, such as 163.9  
 
 
Figure 17: β-Amino acid catalysts 
The additional conformational flexibility allows these catalysts to exceed, in several 
examples, the catalytic activity obtained when using proline.10 For example, the 
Mannich reaction between 3-pentanone and α-imino amide 164 is catalysed 
effectively by 159 in 73% yield after 3 days whereas the (S)-proline catalysed 
reaction is very slow; <10% conversion after 4 days (Scheme 49).7  
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Reagents and conditions: i) 159 (20 mol%), DMSO:iPrOH (1:1), 3 d, r.t., 73%, anti/syn 83:17, 93% 
ee anti 
Scheme 49: 159 Catalysed anti-Mannich reaction  
 
Furthermore, an improvement in selectivity in the Hajos-Parrish-Eder-Sauer-
Wiechert reaction of 165 was observed when performed using (1R,2S)-cispentacin 
161 (86% ee), compared to (S)-proline (72% ee, Scheme 50).8  
 
Reagents and conditions: i) (S)-Proline (30 mol%), DMF, r.t., TsOH, toluene, Δ, 72% ee; ii) 161 (30 
mol%), DMF, r.t., TsOH, toluene, Δ, 86% ee 
Scheme 50: Harrish-Eder-Sauer-Wiechert reaction 
 
Axially chiral β-amino acids therefore appeared to be interesting and highly 
desirable synthetic targets for catalytic design. 
2.1 Initial retrosynthetic approaches to the β-amino acid catalyst 
The iminium salt pathway was the first route explored (pathway A) in the synthesis 
of catalyst 166 (Scheme 51), as the Page group developed the methodology. Indeed, 
as the addition of a Grignard reagent onto a binaphthyl azepinium species is fully 
diastereoselective, the selective introduction of a suitable nucleophilic reagent 
followed by conversion into the corresponding carboxylic acid 166 was targeted 
(Scheme 51). 
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Scheme 51: β-Amino acid catalyst target 
The nitrogen protecting group is required to allow iminium salt formation as well as 
subsequent synthetic steps and easy removal; indeed, tolerance of oxidizing, basic 
and nucleophilic conditions is needed. Thus, the p-methoxybenzyl group was 
chosen, as electron-rich groups provide extra stability to the iminium moiety. The 
allyl-azepine analogue was also prepared as Maruoka successfully used it as a 
precursor in the synthesis of his binaphthyl catalysts.11  
 
3.0 Azepine synthesis 
The synthesis of the first range of binaphthyl catalysts started with enantiopure (S)-
BINOL (Scheme 52).12 A DMAP-mediated triflate formation at low temperature 
using triflic anhydride and 2,6-lutidine provided bis-triflate 167 in quantitative yield. 
A Kumada cross-coupling reaction employing 1,2-bis-(diphenylphosphino)ethane 
dichloronickel(II) (Ni(dppe)2Cl2) as the catalyst and methyl magnesium bromide 
afforded 168 as a colourless solid following recrystallization in near quantitative 
yield. A benzylic radical bromination reaction, using initiator azobisisobutyronitrile 
and N-bromosuccimide, led to the formation of 169 in variable yields (usually 
upwards of 50%, but as high as 77%).2 The procedure is an improvement on the 
previous synthesis of 169, which consisted in heating the substrate under reflux in 
carbon tetrachloride and under visible light irradiation.1 
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Reagents and conditions: i) Tf2O, DMAP, 2,6-lutidine, CH2Cl2, −78 °C → r.t., quantitative; ii) 
MeMgBr, NiCl2(dppe)2, Et2O, −78 °C → r.t., 95%; iii) AIBN, NBS, cyclohexane, reflux, 4 h, 77% 
Scheme 52: Synthesis of dibromobinaphthyl 169 
 
Favourably, purification using column chromatography was not required during the 
first three steps as the products can be recrystallized or precipitated in very high 
purity with complete retention of absolute configuration.1 In addition, the reactions 
can be easily scaled up: the first step was performed regularly on 20g of BINOL. 
 
A double nucleophilic substitution reaction can then provide a variety of tertiary 
azepines for further derivatization. A general purpose reaction procedure, previously 
reported by Page for the synthesis of highly substituted biphenyl azepines,13 was 
employed to afford the azepines in moderate to high yields: the dibromo compound 
169 and a small excess of a primary amine were heated under reflux in the presence 
of anhydrous potassium carbonate in acetonitrile (Table 16). The reaction has 
previously been conducted at reflux in tetrahydrofuran with triethylamine; however, 
our method was considered more environmentally friendly yet equally effective.2  
 
 
 
 
 
OH
OH
OTf
OTf
Me
Me
Br
Br
ii)
iii)
i)
169
168167
   
82 
Table 16: Synthesis of N-protected azepines and iminium salts 
 
Conditions and reagents: i) amine (1.1 equiv.), K2CO3 (3 equiv.), CH3CN, reflux, 16 h; ii) NBS (1.05 
equiv.) CH2Cl2, 1 h, NaBPh4 (1.05 equiv.), EtOH, CH3CN, 10 min, r.t.  
 
The corresponding iminium salts were then prepared using an NBS oxidation 
followed by an anion exchange using sodium tetraphenylborate (Table 16).4 Both the 
PMB and allyl protecting groups responded well to oxidation, and their respective 
iminium salts were isolated in high yields. Notably, iminium species 175 was 
produced in 93% yield (Entry 1, Table 16) as a brightly coloured yellow salt, which 
was found to be exceptionally bench-stable and showed no degradation after two 
years at room temperature. Compound 172 was prepared in moderate yield (Entry 
3). However, when 172 was subjected to our oxidative conditions, the desired 
iminium salt was not observed, probably due to the strongly electron withdrawing 
nature of the sulfonyl substituent. With iminium species 175 and 176 in hand, we 
turned our attention to the diastereoselective addition of nucleophiles. 
Br
Br
NR NR
BPh4
i) ii)
Entry Reagent  Amine Yield (%) 
of amine 
Iminum  Yield (%) of 
iminium  
1 
 
170 91 175 93 
2 
 
 
171 
 
84 
 
176 81 
3 
 
172 71 - - 
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4.0 Diastereoselective addition to binaphthyl azepiniums 
4.1 Route 1: the malonate route  
Malonates were envisaged as good nucleophilic reagents, utilizing bases such as n-
butyllithium as depronating agents or employing cross coupling conditions to afford 
target 166. Decarboxylative procedures employing classical Krapcho conditions,14 
high temperature,15 strongly acidic conditions,16 or microwave irradiation under 
basic conditions17 followed by saponification could provide a route to the desired β-
acid. 
 
Scheme 53: Route to the β-acid catalyst 
2,2-Dimethyl-[1,3]-dioxane-4,6-dione, or Meldrum’s acid, was also chosen as a 
potential addition substrate because of its well documented thermal instability 
resulting in the generation of highly reactive ketene intermediates, which could 
allow access to carboxylic acid, ester and amide catalysts (Scheme 54).18,19  
 
 
Scheme 54: Pyrolysis of Meldrum’s acid 
 
Alternatively, nickel(II) acetylacetonate has been shown to facilitate the 
decarboxylation and methanolysis of Meldrum’s acid derivatives (Scheme 55), 
Spino et al. demonstrated the synthesis of anti-cancer quassinoid intermediate 178, 
in which a key step was the methanolysis and decarboxylation of the Meldrum’s acid 
moiety in 177.20  
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Reagents and conditions: i) Ni(acac)2, MeOH, 65 °C, 98%; ii) Ra-Ni, THF-H2O, 94% 
Scheme 55: Meldrum’s acid methanolysis in synthesis of anticancer compound 178 
 
This procedure could provide access to an ester derivative of our catalyst; 
saponification would then yield β-amino acid 166. 
 
4.2 Route 2: silyl-based reagents 
Similarly, the nucleophilic addition of pre-formed silyl enol ethers could provide a 
convenient route to β-amino acid 166. Silyl enol ethers are reactive nucleophiles and 
very important reagents in the formation of C-C bonds. Silyl enol ethers are 
produced from enolizable carbonyl compounds with either silyl halides or triflates in 
the presence of an amine. 
Conditions reported by Müller (Scheme 56), showed that silyl ketene acetals could 
add, in high yield and almost complete diastereoselectivity, to N-acyl iminium ions, 
such as 179, at room temperature in dichloromethane in the absence of Lewis 
acids.21  
 
Conditions and reagents: CH2Cl2, r.t., 72 h, then 10% aq. NaHCO3, d.r. >99:1, 68% 
Scheme 56: Silyl ketene acetal addition to N-acyl iminium ion 179 
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We envisaged that our iminium salts would have similar reactivity, and therefore 
would allow the facile installation of an ester group (Scheme 57).  
 
Reagents and conditions: i) CH2Cl2, TBAF, 0 °C→r.t. 
Scheme 57: Silyl ketene acetal addition to iminium salt  
 
4.3 Route 3: the Reformatsky reaction 
The Reformatsky reaction utilizes organo-zinc reagents, which, despite their 
similarities with Grignard reagents, have greater functional group tolerance. 
Traditionally, Reformatsky reagents are formed from the oxidative insertion of zinc 
into carbon-halide bonds of α-halo esters.22 Structural determination and X-ray 
crystallography of Reformatsky reagent ethyl bromozincacetate has established that 
it exists as THF stabilized dimer (BrZnCH2CO2Et·THF)2.23,24 Organo-zinc reagents 
add to carbonyl groups resulting in β-hydroxy ester products (Scheme 58). 
 
 
Reagents and conditions: i) Zn dust; ii) R1COR2; iii) H3O+ 
Scheme 58: Traditional Reformatsky reaction 
 
The Reformatsky reaction has been used to install functionality onto various 
substrates, the most widely studied being aldehydes and ketones; however, rare 
additions to both imine and iminium moieties have also been reported.25 
Encouragingly, a large-scale procedure for the addition of α-haloesters to iminium 
salt 180 was found, detailing the scale-up synthesis of anti-arteriosclerotic 
intermediate 181 (Scheme 59).26  
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Reagents and conditions: i) Zn (zinc activation: Zn, BrCH2CH2Br, THF, reflux), iminium salt, 10 °C, 
methyl bromoacetate, 3 h, 42% 
Scheme 59: Reformatsky reaction in anti-arteriosclerotic intermediate 181 synthesis 
 
Using this approach, the required ester group could be installed in one step and the 
corresponding acid would be obtained after saponification.  
 
 
 
Reagents and conditions: i) Zn, BrCH2CO2Me, THF; ii) NaOH, THF, r.t. 
Scheme 60: Reformatsky reaction 
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5.0 p-Methoxybenzyl azepine  
The synthesis towards our desired acid catalyst 166 (Scheme 49) commenced with 
p-methoxybenzyl azepine 170: the azepine was obtained in high yield and the 
protecting group removal procedure was expected to be a facile high-yielding 
hydrogenation procedure using palladium on carbon.27  
5.1 Nucleophile additions 
Reagents diethyl malonate and Meldrum’s acid were first treated with n-butyllithium 
at low temperature. The lithium enolate solutions were then added to solutions of the 
p-methoxybenzyl iminium salt 175 at −78 °C and the mixtures were allowed to reach 
ambient temperature over 12 h. 
Table 17: Nucleophile additions to iminium salt 175 
 
Conditions and reagents: i) Nucleophile (5 equiv.), base (5 equiv.), THF, −78 °C →r.t., 12 h 
Entry Nucleophile Base Yield (%) 
1 
 
Diethyl malonate n-BuLi - 
2 
 
Meldrum’s acid n-BuLi 20 
 
The reaction mixtures were analysed using 1H NMR spectroscopy, and the desired 
products were observed in both cases. Unfortunately, in the case of the diethyl 
malonate addition, the product was not stable enough and decomposed on contact 
with silica gel (Entry 1, Table 17). The addition of Meldrum’s acid afforded the 
desired product, albeit in low yield (Entry 2). Regrettably, the route was considered 
i)N
OMe
BPh4
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175
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too impractical to continue due to the low yield of the addition and the further 
synthetic steps still required to obtain the desired catalysts. 
 Assignments of the new stereocentres were made based on the assumption the 
substituents would follow experimentally observed preference and adopt the 
pseudoaxial orientation, as observed in the diastereoselective addition the Grignard 
reagents (Scheme 46).28  
5.2 Silyl enol ether additions 
The silyl enol ether addition was next targeted on azepinium salt 175. Silyl enol 
ethers were prepared from ethyl acetate and lithium diisopropylamide (LDA) in THF 
at −78 °C followed by addition of the corresponding silyl triflate or chloride 
(Scheme 61). The silyl enol ether solutions were used following an aqueous work up 
without any further purification. 
 
Reagents and conditions: i) TMSOTf (1.2 equiv.), EtOAc (1 equiv.), n-BuLi (1.1 equiv.), iPr2NH (1.2 
equiv.), THF, −78 °C, 3 h; ii) TBDMSCl (1.2 equiv.), EtOAc (1 equiv.), DMPU, n-BuLi (1.1 equiv.), 
iPr2NH (1.2 equiv.), THF, −78°C, 3 h 
Scheme 61: Synthesis of silyl enol ethers 
 
Accordingly, trimethylsilyl enol ether 182 (Entry 1, Table 18) and tert-
butyldimethylsilyl enol ether 183 (Entry 2) were stirred in dichloromethane with 
iminium salt 175 at 0 °C, and the reactions monitored using thin layer 
chromatography. Complex mixtures were obtained, and neither showed any 
formation of the desired ester product after 3 days. We presume that part of the 
reason these reactions were unsuccessful is because 182 and 183 are not particularly 
stable reagents and they used without purification. 
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Table 18: Silyl enol ether additions 
 
Conditions and reagents: i) Silyl enol ether (1.5 equiv.), CH2Cl2, 0 °C, 72 h 
Entry Nucleophile Additive Yield 
1 182 - - 
2 183 - - 
3 183 
TBAF (5 
equiv.) 
- 
4 183 AlCl3 (3 equiv.) - 
 
As the reactions with the enol ethers were unsuccessful, activation of the enol ether 
was tested. Fluoride-mediated desilylation using tetrabutylammonium fluoride 
(Entry 3)29 and Lewis acid activation (Entry 4) were attempted. Discouragingly, 
neither of these additives resulted in any conversion. We hypothesized that iminium 
salt 175, without an activating electron-withdrawing N-acyl group, lacked reactivity 
under these conditions to allow for the formation of the desired β-amino ester. 
Indeed, the electron-donating p-methoxybenzyl group might lower the 
electrophilicity of the iminium moiety. 
 
Another silyl-based reagent, ethyltrimethyl silyl acetate 184 (ETSA), has been 
shown, in combination with CsF, to add to N-methylquinolinium iodides (Scheme 
62).30  
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Reagents and conditions: CsF (1.1 equiv.), ETSA (1.1 equiv.), CH3CN, reflux, 1 h, 70% 
Scheme 62: ETSA addition to methylquinolinium salt 185 
 
The procedure is attractive because ETSA is a commercially available material and 
therefore the constraints and problems associated with silyl enol ethers and their 
syntheses, such as anhydrous reaction conditions and decomposition, can be avoided. 
Iminium 175 was submitted to the reaction conditions described in the literature. 
Unfortunately, only starting material was detected after three days (Scheme 63).  
 
 
Reagents and conditions: CsF (1.1 equiv.), ETSA (1.1 equiv.), CH3CN, reflux, 3 d 
Scheme 63: Attempted ETSA addition 
 
5.3 Reformatsky reaction 
After assessing the efficacy of silyl enol reagents with iminium species 175, the 
Reformatsky reaction was explored. The first step is the in situ generation (or 
isolation) of the organo-zinc reagent, formed from the addition of zinc into the 
carbon-halide bond. For this step to occur the zinc must first be sufficiently 
activated. Activation involves removal of the surface coat of zinc oxide and 
distributing the metal powder to provide as large a surface area as possible. Several 
activation methods can be employed, such as addition of iodine, 
trichloromethylsilane, copper halides, 1,2-dibromoethane in ethereal solvents 
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(generally at high temperature) or by washing with HCl.31  
 
Saidi reported a high yielding Reformatsky reaction onto iminium species 187, 
produced from the treatment of aldehyde 186 with pyrrolidine and lithium 
perchlorate (Scheme 64).34 Zn/Cu couple use has been used extensively since its first 
reported use in the Simmons-Smith cyclopropanation of alkenes,32 and has since 
been used successfully in the Reformatsky reaction.33 The levels of copper in these 
alloys vary from 1-3% composition, and no activation is required for their use.34 
 
 
Reagents and conditions: i) LiClO4, Et2O, r.t. 30 min; ii) BrZnCH2CO2Me (zinc activation: Zn-Cu, 
TMSCl, THF, reflux), Et2O, r.t., 2 h, 89%  
Scheme 64: Organo-zinc reagent nucleophilic addition to iminium species 187 
 
We adapted this method and large excesses of both zinc, in the form of zinc dust, 
and methyl bromoacetate were used initially. The zinc was stirred in tetrahydrofuran 
in the presence of trimethylsilyl chloride at room temperature followed by the 
addition of methyl bromoacetate. The resulting slurry was used without any 
purification. 
 
Reagents and conditions: i) Zn, TMSCl, THF, r.t., 1 h 
Scheme 65: Formation of the Reformatsky reagent 
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Iminium salt 175 was added to the slurry and the reaction mixture allowed to stir for 
1 h. The desired product was isolated in low yield (Entry 1, Table 19). Again, as 
only one diastereoisomer was isolated, an assumption was made that the new 
stereocentre would follow the trend of previously reported diastereoselective 
Grignard additions (Scheme 46) and the new substituent would solely occupy the 
pseudoaxial orientation (Scheme 66).28 
 
Reagents and conditions: i) 188, THF, r.t., 1 h, 14% 
Scheme 66: Reformatsky reagent addition 
 
In order to improve the yield, different methods of activating the zinc and higher 
temperatures were tested.35,36 The zinc dust was activated as a suspension in aqueous 
HCl (10 mol%), isolated through filtration, and washed using water and acetone.37 
The activated zinc was heated under reflux in anhydrous tetrahydrofuran while 
methyl bromoacetate was added dropwise and it was observed that the reaction 
mixture turned green. A solution of iminium salt 175 in anhydrous tetrahydrofuran 
was then transferred into the heated zinc slurry through a cannula, turning the 
reaction mixture bright red. The remaining methyl bromoacetate was added over 1 h. 
The reaction mixture was then quenched and product 189 was isolated in 43% yield, 
suggesting that the p-methoxybenzyl iminium species 175 is stable even at high 
temperature (Entry 2).38 Zinc activation using a more concentrated solution of HCl 
did not significantly impact upon the reaction yield (Entry 3).  
 
The yield of 189 was improved to 50% when the zinc dust was activated using a 
different methodology (Entry 4). A catalytic amount of 1,2-dibromoethane (5 
mol%) and trimethylsilyl chloride (4 mol%) were added to the zinc suspension under 
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reflux. After 30 min, the slurry was allowed to reach room temperature and methyl 
bromoacetate was added. A solution of iminium 175 in tetrahydrofuran was added 
and the reaction was stirred at 30 °C for 12 h.39 
Table 19: Reformatsky reaction conditions 
 
Reagents and conditions: i) Zinc powder (18 equiv.), methyl bromoacetate (15 equiv.), THF, reflux 
Entry Zinc Activation Temp (°C) Time (h) Yield (%) 
1 TMSCl (5 mol%) r.t. 1 14 
2 10% HCl 65 1 43 
3 35% HCl 65 1 40 
4 
TMSCl (4 mol%) 
1,2-BrCH2CH2Br  
(5 mol%) 
65→25→30 12 50 
 
5.4 p-Methoxybenzyl group removal  
With β-methyl ester substituted azepine 189 now in hand, it was necessary to remove 
the p-methoxybenzyl protecting group (PMB) to obtain the desired catalyst. PMB 
groups can be removed by hydrogenolysis, chemical or electrolytic oxidation, 
strongly acidic or by catalytic Lewis acid conditions.40 Surprisingly, the 
conventional Pd/C hydrogenation conditions, used by Maruoka,27 did not 
successfully yield the desired azepine 129, and only starting material was 
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recovered.41  
 
Reagents and conditions: i) Pd/C, H2, MeOH, 16 h 
Scheme 67: Hydrogenolysis of 17040 
 
Due to the poor yields obtained in the syntheses of the β-amino ester 189, a test 
substrate was prepared for the optimization of the deprotection reaction. Within our 
research group, a number of related compounds were prepared, and compound 190, 
possessing similar functional groups, was obtained in high yield.40 Ester 190 was 
synthesized through the addition of methyl propiolate to iminium salt 175 using a 
procedure employing copper catalysis in terminal alkyne additions to isoquinoline 
iminiums.42 The substituent was assumed to occupy solely the pseudoaxial 
orientation (Scheme 68).28 
 
Reagents and conditions: methyl propiolate (1.1 equiv.) CuI (5 mol%), DIPEA (1 equiv.), CH3CN, 
r.t., 2 h, 81% 
Scheme 68: Synthesis of deprotection test substrate 19040 
 
Stoichiometric single electron oxidants DDQ (2,3-dichloro-3,6-dicyano-1,4-
benzoquinone) and CAN (ammonium cerium IV nitrate) are well-known benzylic 
protecting group removal reagents.43,44  
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Figure 18: Oxidants DDQ and CAN 
 
Indeed, Wee reported the CAN-mediated oxidative debenzylation of δ-lactam 191, 
under mild conditions in short reaction times, and Uozumi utilized CAN in his 
deprotection of cyclic allylamine 192 (Scheme 69). 45  
 
Reagents and conditions: i) (NH4)2Ce(NO3)6 (4 equiv.), CH3CN:H2O, 0 °C, 30 min, 44%; ii) 
(NH4)2Ce(NO3)6 (5 equiv.), CH2Cl2:H2O, r.t. 1 h, 60-90% 
Scheme 69: p-Methoxybenzyl group removal using CAN 
 
Regrettably, these methods failed to cleave the PMB group of 190, and the starting 
material was recovered. Unfortunately, increasing the quantity of CAN (7 equiv.) 
present in solution resulted in the decomposition of the starting material (Entry 1, 
Table 20).46 Decomposition of starting material 190 was also observed when DDQ 
was used (Entry 2).43 
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Table 20: Attempted conventional DDQ and CAN removals of PMB group 
 
Entry Reagent Solvent Temp 
(°C) 
Time (h) Yield (%)  
1 CAN (7 equiv.) CH3CN:H2O 0 24 Decomposition 
2 DDQ (4 equiv.) CH2Cl2 r.t. 3 Decomposition 
 
The deprotection of PMB ethers can be achieved using DDQ in combination with an 
excess of ferric chloride. FeCl3 is used to regenerate DDQ from DDHQ 
(dichlorodicyanohydroquinone) and therefore only a catalytic amount of DDQ is 
required. We hoped that these mild conditions would be effective to remove the 
PMB group of 190; however, this failed to give the deprotection product, and 
starting material was recovered (Scheme 70).47  
 
 
Conditions and reagents: i) FeCl3 (3 equiv.), DDQ (10 mol %), CH2Cl2:H2O, 0 °C, 24 h 
Scheme 70: Attempted deprotection using 2,3-dichloro-3,6-dicyano-1,4-
benzoquinone with ferric chloride  
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Lewis acids such as ZrCl4, SnCl4, TiCl4 and AlCl3 are frequently employed to 
cleanly cleave PMB groups in high yield.48,49 Thiophenol is commonly used as an 
additive in these reactions, and helps to shorten reaction times.50 However, when 
deprotection using TiCl4 in combination with PhSH was attempted, only starting 
material was isolated and no conversion to the product was observed (Scheme 71). 
 
 
Conditions and reagents: i) TiCl
4
 (1.05 equiv.), PhSH (1.2 equiv.), CH2Cl2, −78 °C, 24 h 
Scheme 71: Lewis acid TiCl4 use for the removal of PMB group 
 
Fortunately, many other alternatives exist to these reagents, driven by the expense of 
reagents such as DDQ and the environmental and health concerns when using metal 
halides. MacMillan used strongly acidic conditions of PhSh and TFA in a global 
deprotection step in the total synthesis of (+)-minfiensine 193 (Scheme 72).51 
 
Conditions and reagents: i) Pd/C, H2, THF, −15 °C; >20:1 E/Z; ii) PhSH, TFA, r.t., 90% over two 
steps 
Scheme 72: Final deprotection step in the synthesis of (+)-Minfiensine 
 
These conditions also failed to provide our target product (Scheme 73). 
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Conditions and reagents: i) PhSH (10 equiv.), TFA (excess), r.t. 
Scheme 73: Attempted deprotection using MacMillan’s reported conditions 
 
Due to its low cost and toxicity, cerium (III) chloride in combination with soft 
nucleophiles such as sodium iodide has been used for the cleavage of PMB ethers, 
although high temperature and long reaction times are typically required (typically 
24 h).52 Unfortunately, we observed no conversion after 48 h (Scheme 74). 
Alternative oxidative cleavage procedures, such as the use of 
(diacetoxyiodo)benzene, PhI(OAc)2, also failed.53 
 
Conditions and reagents: i) CeCl
3
 (1.5 equiv.), NaI (1 equiv.), CH3CN, 80 °C, 48 h or; ii) PhI(OAc)2 
(4 equiv.), HCl (10 %), MeOH:EtOH, r.t., 12 h 
Scheme 74: Attempted removals of p-methoxybenzyl protecting group 
  
6.0 Allyl protecting group  
As the PMB protecting group proved challenging to remove, we turned our attention 
to allyl analogue 171, previously used by Maruoka.11 Allyl groups have been used 
widely for the protection of alcohol and amine moieties since the emergence of a 
convenient deprotection procedure of the conjugate base based on the Tsuji-Trost 
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reaction.54 Tsuji’s original palladium mediated allylation reaction proceeds by 
nucleophilic addition of diethyl malonate to the η3-diallyl dichlorodipalladium 
complex 194, affording both mono- and bis-allyl products.55 Further work by Trost 
showed that the addition of triphenylphosphine could reduce reaction time 
dramatically, and that the addition to η3 complex is dictated by both the steric and 
electronic properties of the nucleophile, as shown in the reaction of methyl 
(methylsulfonyl acetate) 197 where only one product (198) is isolated.56 This 
reaction has since evolved for removal of allyl groups using N,N-dimethylbarbituric 
acid 199 as a nucleophilic allyl scavenger (Scheme 75).57  
 
Reagents and conditions: i) [PdCl(allyl)]2, sodium, EtOH, DMSO, r.t., 195 37%, 196 40%; 
iii) [PdCl(2-propyl-1-pentene)]2, PPh3, THF/DMF, r.t., 80% 
iii) Pd(PPh3)4, N,N-dimethylbarbituric acid, CH2Cl2, 30 °C, 1.5 h, 100%  
Scheme 75: Allylation and deallylation procedures based on the Tsuji-Trost reaction 
 
N-Allyl 171 was prepared in high yield (Table 16, Entry 2), and, correspondingly, a 
facile palladium(0)-catalysed deallylation, employing tetrakis(triphenylphosphine) 
palladium and N,N-dimethylbarbituric acid, was performed (Scheme 76).56 The 
product was isolated as the corresponding hydrochloride salt 200 in excellent purity 
following recrystallization from hot chloroform.  
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Reagents and conditions: i) Pd(PPh3)4 (2 mol %), N,N-dimethylbarbituric acid (3 equiv.), CH2Cl2, 50 
°C, 16 h; then CH2Cl2, HCl(aq), 5 min, 80% 
Scheme 76: Palladium-catalysed deallylation of 171 
 
6.1 Oxidative cross coupling reactions 
Following the failure to install the α-functionality by classical coupling reactions of 
enols and enolates with azepinium salt 175, a series of ‘cross dehydrogenative 
coupling’ C-C bond forming reactions were attempted. CDC reactions typically 
occur where one reaction partner is converted into an electrophile through in situ 
oxidisation while the electron-rich coupling partner attacks. These reactions have 
high functional group tolerance and are efficient in functionalizing sp3 C-H bonds 
with sp, sp2 and sp3 hybridized starting materials, using inexpensive copper or iron 
salt catalysts.58 
   
Scheme 7762: CDC reaction between sp3 centers 
 
Fortunately, there are many reported oxidations of C-H bonds adjacent to nitrogen 
atoms in tertiary amines.59 Li et al. reported a coupling reaction between 
tetrahydroisoquinoline 201 and dimethyl malonate in the presence of t-BuOOH 
(TBHP) and catalytic quantities of copper bromide.60 Mild conditions afforded β-
diester tetrahydroisoquinoline derivative 202 at ambient temperature in 90% yield 
when dimethyl malonate was used as the solvent (Entry 1, Table 21). Itoh published 
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the first catalytic metal-free oxidative CDC reaction of tertiary amines using iodine 
as the catalyst in the presence of hydrogen peroxide (Entry 2, Table 21), producing 
tetrahydroisoquinoline derivative 202 in 73% yield.61  
Table 21: C-H sp3 CDC reaction of tetrahydroisoquinoline and dimethyl malonate 
  
Entry Catalyst Oxidant Temp (°C) Time (h) Yield (%) 
1 5 mol% CuBr TBHP (1 equiv.)  r.t. 16  90 
2 10 mol% I2  H2O2 (2 equiv.) 50 12 73 
 
Accordingly, azepine 171 was subjected to Li’s copper-catalysed reaction conditions 
with diethyl malonate. After 24 h, only starting material was detected in the reaction 
mixture (Entry 1, Table 22). Again, it was assumed that the newly introduced 
substituent would occupy solely the pseudoaxial orientation (Table 22).28 It was 
postulated that the poor solubility of azepine 171 in diethyl malonate was inhibiting 
the reaction. When dichloromethane was used as the solvent, no conversion was 
observed (Entry 2). When a combination of iodine and hydrogen peroxide was used 
at room temperature and at 50 °C (Entries 3, 4 and 5), no conversion was seen.  
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Table 22: Oxidative coupling of azepine 171 and diethyl malonate 
 
Reagents and conditions: i) Oxidant, catalyst, solvent, temperature, 24 h 
Entry Oxidant Catalyst Solvent Temp (°C) Yield (%) 
1[a] TBHP CuBr neat r.t. Starting material 
2[a] TBHP CuBr CH2Cl2 r.t. Starting material 
3[b] H2O2 I2 CH2Cl2 r.t. Starting material 
4[b] H2O2 I2 CH2Cl2 50 Starting material 
5[b] H2O2 I2 neat 50 Starting material 
[a] Diethyl malonate (except when used in excess; 3 equiv.), TBHP (1 equiv.), CuBr (5 mol%);  
[b] Diethyl malonate (except when used in excess; 2 equiv.), H2O2 (2 equiv.), I2 (10 mol%) 
 
Mechanistically, both CDC reactions rely on the generation of an electrophilic 
iminium ion. Li proposed that the role of copper is twofold: coordinating to 201 to 
facilitate the formation of an iminium intermediate by hydrogen abstraction at the α-
position of tetrahydroisoquinoline while also activating dimethyl malonate. Itoh 
hypothesized that hypoiodous acid (HOI), generated from iodine and hydrogen 
peroxide, is the active oxidant in the conversion of 201 into the iminium species. 
Interestingly, Todd published a CDC reaction between tetrahydroisoquinoline 201 
and dimethyl malonate using DDQ as an oxidant. However, the reaction only 
proceeded if iminium ion 204 was first isolated and then added to a solution of 
dimethyl malonate, producing 202 in 73% yield after 30 min (Scheme 78).61 
 
N
EtO OEt
OO
N
EtO2C
CO2Et
i)
171 203
   
103 
 
Reagents and conditions: i) dimethyl malonate (1.1 equiv.), CH2Cl2, r.t., 30 min, 73% 
Scheme 78: Coupling reaction with isolated DDQ iminium salt 204 
 
When the cross coupling was attempted as a one-pot two-step reaction, a complex 
mixture of products was obtained, as DDQ was thought to react preferentially with 
the malonate.61 We suspected that this could explain why the CDC reactions with 
azepine 171 were unsuccessful, and we therefore decided to first isolate the iminium 
salt and trial the copper-catalysed coupling conditions. 
 
NBS or DDQ oxidation, followed by counter-ion exchange with sodium 
tetraphenylborate, allowed for the generation and easy isolation of iminium salt 176 
as an orange solid. However, NBS oxidation at room temperature was found to be 
too severe and resulted in some decomposition and rather disappointing yields 
(Entry 1, Table 23). Consequently, low temperature oxidation was performed, 
leading to higher yields (Entry 2). A DDQ-mediated oxidation was also 
investigated,62 and, although DDQ oxidation afforded 176, the yield was lower than 
would be acceptable for large-scale synthesis (Entry 3).  
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Table 23: Oxidation of allyl 171 
 
Reagents and conditions: i) Oxidant, CH2Cl2; ii) NaBPh4 (1.1 equiv.), EtOH, CH3CN, 10 min 
Entry Reagent Temp (°C) Time (h) Yield (%) 
1 NBS (1.05 equiv.) r.t. 1 54 
2 NBS (1.05 equiv.) 0 2 81 
3 DDQ (2 equiv.) r.t. 1 46 
 
An alternative route to allyl iminium species 176 was explored. Dibromo compound 
169 was heated in a mixture of 1,4-dioxane and saturated aqueous sodium carbonate 
to form oxepine 205.20 A ring-opening reaction using molecular bromine afforded 
bromoaldehyde 206 in moderate yield. Finally, a cyclocondensation reaction with 
allylamine in ethanol followed by addition of sodium tetraphenylborate resulted in 
the desired iminium salt in 65% yield (Scheme 79). 
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Reagents and conditions: i) Sodium carbonate (sat. aq.), 1,4 dioxane (1:1), reflux, 12 h, 87%; ii) Br2 
(1.125 equiv.), cyclohexane, 0 °C→reflux, 1 h, 50%; iii) allylamine (1 equiv.), EtOH, 40 °C, 12 h, 
NaBPh4 (1.1 equiv.), CH3CN, 65% 
Scheme 79: Alternative synthesis of iminium salt 176 from bromoaldehyde 206 
 
With allyl iminium salt 176 in hand, the coupling conditions reported by Li were 
explored, both in the presence and absence of oxidant t-BuOOH (Entry 1 and 2, 
Table 24). The substituent would be assumed to occupy solely the pseudoaxial 
orientation (Table 24 and 25).28 
Table 24: Coupling reactions on preformed iminium salt 176 
 
Reagents and conditions: i) Diethyl malonate, TBHP (1 equiv.), CuBr (5 mol%), r.t., 16 h 
Entry Reagent Additive Solvent Yield (%) 
1 CuBr TBHP Diethyl malonate - 
2 CuBr - Diethyl malonate - 
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3 CuBr - CH2Cl2 - 
 
Unfortunately, after 16 h, complete decomposition of starting material iminium salt 
176 was observed with no formation of the anticipated diester product 203 (Table 
24).  
 
Promotion of CDC reactions by generation of a reactive ethoxy intermediate 208 has 
been reported.63 Intermediate 208, prepared from isoquinolinium bromide 207 and 
sodium ethoxide, was subjected to displacement by various ketones using either an 
ambient temperature ‘one-pot’ route or a higher temperature procedure after 
isolating ethoxide intermediate 208. The route employed and the yield of the reaction 
depended upon the ketone substrates used; acetone, for example, was one of the 
highest yielding substrates (Scheme 80). 
 
 
 Reagents and conditions: i) EtONa (2 equiv.), EtOH, 0 °C, 20 min; ii) CH3COCH3 (2 equiv.), r.t., 5 
h, 97% 
Scheme 80: Preparation of 209 by active intermediate 208 
 
Unfortunately when these conditions were replicated without attempting to isolate 
the reaction intermediate, addition of acetone at low temperature resulted in none of 
the desired product after 16 h (Entry 1 and 2). Reactions at higher temperature were 
also trialled; however, only starting material was recovered.  
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Table 25: Nucleophilic addition to iminium salt 176 
 
Reagents and conditions: i) EtONa (2 equiv.), EtOH, 0 °C, 20 min; ii) CH3COCH3 (2 equiv.), 
temperature  
Entry Reagent Temp (°C) Time (h) Yield (%) 
1 Acetone  0→40 5 - 
2 Acetone  0 16 - 
3 Acetone  0→r.t. 16 - 
 
6.2 Reformatsky reaction  
As described above (Table 19), ester 189 was prepared from iminium salt 175 using 
Reformatsky conditions in low to moderate yields; hence, allyl iminium salt 176 was 
also evaluated as a Reformatsky reagent acceptor. Haloester t-butyl bromoacetate 
was employed as we envisaged that the subsequent saponification step would require 
milder conditions.  
 
Zinc activation was achieved through heating a zinc suspension in tetrahydrofuran 
under reflux in the presence of additives 1,2-dibromoethane and 
chlorotrimethylsilane for 1 h. The optimum conditions described for the synthesis of 
189 were employed; unfortunately, only trace amounts of the desired t-butyl ester 
211 were observed (Entry 1). When the quantities of reagents necessary to prepare 
the organo-zinc reagent were increased, compound 211 was isolated in 19% yield as 
a colourless solid and a single diastereoisomer (Entry 2). Increasing the reaction 
time to 48 h and increasing the quantities of zinc activating additives to 
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stoichiometric quantities resulted in a minor improvement in yield to 23% (Entry 3). 
To further improve the yield, the reaction was conducted at 65 °C; however, no 
product 211 was observed (Entry 4). This led us to conclude that either the 
Reformatsky reagent 210 or iminium salt 176 were not stable at higher temperatures. 
 
Table 26: Reformatsky conditions 
 
Reagents and conditions: 210 (zinc activation: 65 °C, THF, additives), THF 
Entry 
t-butyl 
bromo-
acetate 
Zinc 
powder 
Activation of zinc 
Temp 
(°C) 
Time 
(h) 
Yield 
(%) 1,2-
BrCH2CH2Br 
TMSCl 
 
1 5 equiv. 6 equiv. 5 mol% 4 mol% 25→30 12 trace 
2 10 equiv. 10 equiv. 10 mol% 10 mol% 25→30 24 19 
3 10 equiv. 10 equiv. 1 equiv. 1 equiv. 25→30 48 23 
4 5 equiv. 6 equiv. 10 mol% 10 mol% 65 12 - 
 
Due to the possible instability of iminium salt 176 at elevated temperature, an 
alternative procedure was sought: chiral N-sulfinyl imine 213 had been reported to 
undergo Reformatsky reactions at low temperature to yield the corresponding ester 
214 in quantitative yield (Scheme 81). Interestingly, a novel zinc activation method 
employing DIBAL was also reported to be convenient for large-scale synthesis.64 
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Reagents and conditions: i) Zn (3.5 equiv.), THF, 30 °C, ethyl bromoacetate (0.1 equiv.), 20% wt 
DIBAL in toluene (4 mol%), 40 °C, ethyl bromoacetate (1.7 equiv.), 2 h; ii) 212, THF, −8 °C, 14 h, 
quant.; iii) 5M HCl/isopropanol, 20 °C, 18 h, 62% 
Scheme 81: DIBAL zinc activation and low temperature Reformatsky reaction of 
imine 213 
 
In our hands, DIBAL zinc activation and the substrate addition at low temperature 
afforded ester 211 in 28% yield (Entry 1, Table 27). Encouraged by the increase in 
yield, we focused our attention on the addition of iminium salt 176 at low 
temperature. The zinc was activated with a stoichiometric amount of TMSCl, and 
iminium salt 176 was added to the activated zinc slurry at 0 °C, providing a further 
increase in yield (Entry 2). Addition of the iminium species at −78 °C gave ester 
211 as a single diastereoisomer in 71% yield (Entry 3).  
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Table 27: Low temperature addition of 210 
 
Reagents and conditions: i) 210 (zinc activation: 40-65 °C, THF, additive, 1 h), THF, 0 or −78 
°C→r.t. 
Entry t-butyl bromoacetate 
Zinc 
powder 
Zinc Activation Temp* 
(°C) 
Time 
(h) 
Yield 
(%) Additive °C 
1 1.7 equiv. 3.5 
equiv. 
DIBAL 
(4 mol%) 
40 −78→r.t. 12 28 
2 10 equiv. 10 equiv. 
TMSCl 
(1 equiv.) 
65 0→r.t. 48 43 
3 10 equiv. 10 equiv. 
TMSCl 
(1 equiv.) 
65 −78→r.t. 48 71 
*Temperature at which iminium salt 176 is added to zinc slurry, the reaction is then allowed to reach 
r.t. 
 
Crystals of 211, suitable for single crystal X-ray crystallography, were obtained, and 
the relative conformation, where the β-t-butyl ester adopts a pseudo-axial 
orientation, was confirmed.40 
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Figure 19: Crystal structure of 21140 
Unfortunately, the synthesis of 211 can be capricious and the yields can vary greatly: 
very low yields were also obtained when the reaction conditions described in Entry 
3 were employed. Two factors could explain the variable yields: stringently dry 
conditions are essential as the smallest amount of moisture can drastically lower the 
yield, and freshly prepared starting material 176 is vital as the iminium salt 
decomposes over time.  
 
Deallylation of 211 was accomplished using the reported conditions,11 and azepine 
215 was obtained in 84% yield. t-Butyl group removal using trifluoroacetic acid 
afforded β-amino acid 166 in 94% yield (Scheme 82).  
 
 
Reagents and conditions: i) Pd(PPh3)4 (2 mol %), N,N-dimethylbarbituric acid (3 equiv.), CH2Cl2, 50 
°C, 24 h, 84%; ii) TFA (12 equiv.), CH2Cl2, r.t., 16 h, 94% 
Scheme 82: Protecting groups removal 
 
We predicted that a more sterically congested version of β-amino acid 166 might 
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provide further selectivity by increasing crowding close to the aminocatalytic centre, 
and consequently β-amino acid 216 was sought. 
 
 
Figure 20: Sterically congested β-amino acid 216 
 Using t-butyl bromoisobutyrate as a Reformatsky substrate, different reaction 
temperatures were screened. Ambient temperature addition surprisingly gave a better 
yield (Table 28, Entry 1) than seen previously using the t-butyl bromoacetate 
reagent (Table 26, Entry 4). Indeed, lower temperature additions were also higher 
yielding as compound 218 was isolated in up to 76% yield (Entry 3). 
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Table 28: Reformatsky conditions 
 
Reagents and conditions: i) 217 (zinc activation: 65 °C, THF, additives, 1 h), THF, 48 h 
Entry 
t-Butyl 
bromo 
isobutyrate 
Zn 
powder 
Zinc Activation 
Temp* 
(°C) 
Yield 
(%) 1,2-
BrCH2CH2Br 
TMSCl 
1 10 equiv. 10 equiv. 1 equiv. 1 equiv. 25→30 45 
2 15 equiv. 15 equiv. - 1 equiv. 0→r.t. 53 
3 10 equiv. 10 equiv. - 1 equiv. −78→r.t. 76 
*Temperature at which iminium salt 176 is added to the zinc slurry, then the reaction is allowed to 
warm to r.t. 
Exposure of 218 to palladium-catalysed deallylation conditions gave 219 in 69% 
yield. Finally, a trifluroacetic acid-mediated saponification afforded β-amino acid 
216 in moderate yield (Scheme 83).  
 
 
Reagents and conditions: i) Pd(PPh3)4 (2 mol %), N,N-dimethylbarbituric acid (3 equiv.), CH2Cl2, 50 
°C, 24 h, 62%; ii) TFA (12 equiv.), CH2Cl2, r.t., 16 h, 61% 
Scheme 83: Protecting groups removal  
 
To assess the effect of the Brønsted acidic sites of β-amino acid catalysts 166 and 
216, and to separate that effect from the steric influence, a comparative study of the 
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catalysts with a variety of alkyl groups was needed. Therefore, increasingly bulky 
alkyl substituents were introduced onto iminium species 176 using Grignard reagent 
addition (Table 29). The Grignard reagent in THF solutions were added to iminium 
species 176 at low temperature and were allowed to reach ambient temperature 
overnight. Addition of methylmagnesium bromide gave the highest yield (Entry 1) 
providing a single diastereoisomer with a characteristic upfield shifting of the 
pseudoaxial methyl group (δ 0.54 ppm, doublet). Similarly, addition of 
ethynylmagnesium bromide gave a single diastereoisomer with the newly introduced 
group occupying the pseudoaxial position (δ 1.27 ppm, doublet). Whereas addition 
of benzylmagnesium chloride gave only trace amounts of the product (Entry 3). 
Identification of trace quantities of the benzyl addition product were made by 1H 
NMR analysis of the reaction mixture, based on the expected number of aromatic 
signals (17 ArH) and a doublet of doublet signal (δ 4.03 ppm) which could 
correspond to the NCHCH2 coupling to the diastereotopic CH2 group of the benzyl. 
Deprotection gave moderate yields, and slightly longer reaction times and further 
additions of Pd(PPh3)4 were necessary.  
 
Table 29: Grignard reagent additions 
 
Reagents and conditions: i) Grignard reagent solution (10 equiv.), THF, −78 °C→r.t., 12 h; ii) 
Pd(PPh3)4 (2-4 mol %), N,N-dimethylbarbituric acid (3 equiv.), CH2Cl2, 50 °C, 36 h 
Entry Grignard solution i) Yield (%) ii) Yield (%) 
1  MeMgBr  70 55 
2 EthynylMgBr*  37  - 
3 Benzyl MgCl  Trace - 
*15 equiv. used 
N
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With a successful route to both β-amino acids 166 and 216 achieved, the installation 
of other hydrogen bonding functional groups was targeted. First, the addition of 2-
bromopyrimidine was examined using Reformatsky and Grignard conditions (Table 
30). Zinc was activated at 65 °C with TMSCl (5 mol%), 1,2 dibromoethane (3 
mol%), and magnesium was activated using iodine; 2-bromopyrimidine was then 
added over 1 h. After cooling, the organometallic reagents were added to a solution 
of allyl azepinium salt 176 in tetrahydrofuran at −78 °C and the reactions allowed to 
reach ambient temperature overnight. Surprisingly, neither the Reformatsky reaction 
nor the Grignard conditions produced the desired compound 220 and Grignard 
conditions resulted only in decomposition of starting material 176.  
Table 30: 2-Bromopyrimidine additions 
 
Reagents and conditions: i) Activated metal, 2-bromopyrimidine, THF, 65 °C, 1 h, 
−78 °C→r.t., 16 h 
Entry 2-Bromopyrimidine Metal Activation Yield (%) 
1 5 equiv. Zn (3.5 equiv.) 
TMSCl, 
1,2 dibromoethane 
- 
2 10 equiv. Mg (14 equiv.) Iodine - 
 
An axially chiral version of Ley’s tetrazole 90 was also targeted. Addition of sodium 
cyanide to iminium salt 176 afforded α-amino-nitrile 223, isolated cleanly following 
an aqueous work up. Compound 223 decomposed on silica gel and therefore was 
used without further purification in the attempted [3+2]-cycloaddition reaction with 
sodium azide and triethylamine hydrochloride (Scheme 84). 65,66,67 Trace amounts of 
N
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tetrazole 224 were detected by 1H NMR analysis of the reaction mixture after 24 h. 
The assignment was based on the full consumption of starting material 223, as 
observed by the disappearance of a singlet signal at δ 4.98 ppm (corresponding to the 
CHCN proton) and the appearance of a singlet at δ 4.11 ppm which we believe 
corresponds to CHC-tetrazole proton (tetrazole 90 CHNH δ 4.77 ppm68, Scheme 
85). Formation of 224 occurred alongside degradation of the starting material and so 
the reaction was not considered viable for continuing further synthetic steps. Acidic 
hydrolysis, to afford the α-acid derivative, was not considered at the time because of 
the unstable nature of compound 223.69,70 
 
Reagents and conditions: i) NaN3 (1.3 equiv.), Et3N.HCl (1.3 equiv.), toluene, 100 °C, 24 h, 75%65 
ii) NaCN (5 equiv.), CH2Cl2, H2O, r.t., 2 h; iii) NaN3 (1.3 equiv.), Et3N.HCl (1.3 equiv.), toluene, 100 
°C, 24 h, traces 
Scheme 84: Synthesis of tetrazole 224  
 
7.0 Initial retrosynthetic approaches to the α-amino acid catalyst 
With a route to β-amino acids 166 and 216 achieved, a comparison was necessary to 
assess the effect of the carboxylic acid group on the selectivity. The next synthetic 
target chosen for catalytic evaluation was α-amino acid 225, which could be 
generated asymmetrically through a lithiation and electrophilic trapping route 
(Scheme 85).  
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Scheme 85: α-Amino acid catalyst target 225 
Pathway B, a deprotonation route, requires metallation of our binaphthyl azepines 
using either an organo-lithium or a metal hydride base. The abstraction of the proton 
at the α-position requires the use of electron-withdrawing N-protecting groups, 
which increase the acidity at the α-position by stabilization of the intermediate 
anion.71 The anion can then be quenched by the addition of an electrophilic reagent, 
resulting in the production of an α-functionalized catalyst. Accordingly, the nitroso 
and Boc protected azepines were targeted as potential anion precursors. 
 
7.1 Nitroso protecting group  
Under basic conditions and at elevated temperature, the protons at the α-position of 
nitroso-protected methylpiperazine 226 have been shown to be labile, undergoing 
deuterium exchange (Scheme 86).72 This observation has been taken as evidence for 
the involvement of a stabilizing ‘α-nitrosoamino carbanion’, and consequently use of 
this protecting group has been explored in α-functionalization reactions.  
 
Reagents and conditions: i) 1.3 M NaOD; ii) D2O; iii) NaOD, D2O, 100 °C, 2.5 h, 100% 
incorporation 
Scheme 86: Influence of N-nitroso group70  
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For example, Superchi used the nitroso protecting group in his synthesis of 
binaphthyl azepine ligands for dialkylzinc addition to aldehydes.73 N-Nitroso 228 
was synthesized from 129 by treatment with sodium nitrite in acetic acid. Compound 
228 was then dimethylated by deprotonation using potassium hydride in 
tetrahydrofuran and addition of an excess of methyl iodide. Dimethyl N-nitroso 229 
was then deprotected in 59% yield using a Raney Nickel-mediated hydrogenolysis 
producing C2 symmetric 230, where the two pseudoaxial methyl groups are in a 
trans-configuration, as confirmed by analysis of the 1H NMR spectrum (Scheme 
87).  
 
Reagents and conditions: i) NaNO2 (3 equiv.), H2O, AcOH, r.t., 2 h, 87%; ii) KH (4 equiv.), THF, r.t., 
30 min, MeI (16 equiv.), reflux, 18 h, 84%; iii) EtOH, Ra-Ni, H2, 16 h, 59% 
Scheme 87: Ligand synthesis employing nitroso-protecting group  
 
Accordingly, we synthesized N-nitroso compound 228 in high yield, following the 
same procedure (Scheme 88).  
 
Reagents and conditions: i) NaNO2 (3 equiv.), H2O, AcOH, r.t., 2 h, 76% 
Scheme 88: N-Nitroso azepine synthesis 
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Preparation of an axially chiral analogue of Jørgensen’s biarylalcohol 99 species was 
targeted first. N-Nitroso 228 was stirred in tetrahydrofuran at 0 °C as potassium 
hydride was added in one portion. Benzophenone was added, as a solution in THF, 
and the mixture was allowed to reach ambient temperature overnight. The reaction 
was quenched and analysed using 1H NMR spectroscopy of the reaction mixture; 
but, unfortunately, only starting material was observed. 
 
 
Reagents and conditions: i) KH (4 equiv.), THF, 0 °C, 30 min, PhCO2Ph (6 equiv.), r.t., 16 h 
Scheme 89: Attempted synthesis of an axially chiral version of Jørgensen’s diaryl 
alcohol catalyst 
 
Nitroso-azepine 228 was deprotonated at –78 °C and the resulting anion next trapped 
with an electrophile that could be manipulated to obtain the α-amino acid. Ethyl 
chloroformate was chosen and a range of bases were screened (Table 31). Potassium 
hydride, employed by Superchi, and sec-BuLi provided trace amounts of the desired 
ester 232 (Entry 4), identified by the increasing complexicity in the aromatic signal 
region (suggesting the formation of an unsymmetrical monosubstituted azepine 
product) and the appearance of multiplet signals (δ 1.00-1.80 ppm) which could 
correspond to the two diastereotopic CH2CH3 ester signals. Sodium hydride and 
potassium hydride did not lead to the formation of the product (Entries 1 and 2). 
Sodium hydride did not lead to the formation of the product. Similarly, treatment 
with lithium diisopropylamide gave no conversion (Entry 3), presumably due to 
steric hindrance.  
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Table 31: Base screening for deprotonation of 228 
 
Reagents and conditions: i) Base, ethyl chloroformate, 16 h 
Entry Base Solvent Temp (°C) Yield (%) 
1 KH (1.2 equiv.) THF 0→ r.t. Starting material 
2 NaH (1.2 equiv.) THF 0→ r.t. Starting material 
3 LDA (2 equiv.) THF −78 °C→ r.t. Starting material 
4 s-BuLi (1.2 equiv.) THF −78 °C→ r.t. Trace 
 
7.2 Boc protecting group  
With disappointing preliminary results observed when using the nitroso group, N-
Boc azepine 233 was synthesized. Initially, addition of di-tert-butyl carbamate to 
129 afforded 233 in excellent yield. However, as with nitroso compound 228, the 
starting material required for this method is produced from the deprotection of N-
allyl azepine 171, causing this route to be neither time nor atom efficient.  
 
Reagents and conditions: i) di-tert-butyl carbamate (1.05 equiv.), tBuOH, r.t., 16 h, 
92% 
Scheme 90: Boc protection of azepine 233  
 
Therefore, a procedure employing dibromo compound 169 and tert-butyl carbamate 
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alongside sodium hydride in DMF, was adopted, and after 4 days, 233 was isolated 
in moderate yield (Entry 1, Table 32).74 Increasing the number of equivalents of 
base used resulted in improvements in yield (Entries 2 and 3). To reduce reaction 
time, gentle heating of the reaction mixture was trialled, following reagent addition 
at 0 °C, but, this resulted in reduced yields and an increasing number of inseparable 
side products (Entry 4). 
Table 32: Optimization of the synthesis of N-Boc azepine  
 
Reagents and conditions: i) NaH, tert-butyl carbamate (1 equiv.), DMF 
Entry NaH Time (d) Temp (°C) Yield (%) 
1 2.1 equiv. 4 0→ r.t. 58 
2 3 equiv. 4 0→ r.t. 65 
3 4 equiv. 4 0→ r.t. 87 
4 4 equiv. 1 0 → 50 37 
 
A significant quantity of side product oxepine 205 was detected when the N,N-
dimethylformamide was not freshly distilled or sufficiently dry and, unfortunately, 
this impurity co-eluted with N-Boc azepine 233 when purification was carried out 
using silica gel column chromatography.  
 
Figure 21: Oxepine side product 205 
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Blakemore’s asymmetric N-Boc pyrrolidine lithiation methodology was next 
tested.73 Blakemore employed 1.3 equivalents of sec-butyllithium and 3 equivalents 
of electrophile in the presence of (S, S)-diamine 234, for the synthesis of the N-Boc 
derivative of Jørgensen’s catalyst in 82% yield (Scheme 91). 
 
 
Reagents and conditions: i) s-BuLi (1.3 equiv.), (S,S)-234, Et2O, −78 °C, 1 h; ii) Ph2CO (3 equiv.), 
82%, 95% ee  
Scheme 91: Blakemore’s asymmetric N-Boc pyrrolidine lithiation methodology 
 
Diaryl alcohol analogue 235 was again targeted through the addition of 
benzophenone. When sec-butyllithium was added to the Boc-azepine 233, the 
reaction mixture changed from pale yellow to black with the colour persisting until 
the addition of benzophenone had been made. Unfortunately, starting materials were 
the major compounds isolated from the reaction mixture, alongside 235 in trace 
quantities (Scheme 92). Trace quantities of 235 were identified based on 1H NMR 
analysis of the reaction mixture:  aromatic signals matching the number of aromatic 
protons expected (22 ArH) and a deshielded singlet signal at δ 6.44 ppm which could 
correspond to the CHC(Ph)2OH proton. This signal is at a high chemical shift 
compared to that of the pyrrolidine catalyst 99 (CHC(Ph)2OH δ 4.26 ppm).75,76,77 
However, as the proton is positioned between two aromatic systems and it may be 
experiencing a ring current deshielding effect from both enviroments. We 
hypothesize that the acidic nature of silica may have promoted the deprotection of 
the Boc derivative during silica gel column chromatography purification.  
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Reagents and conditions: i) s-BuLi (1.3 equiv.), Et2O, –78 °C, 1 h; ii) PhCO2Ph (3 equiv.), −78 °C→ 
r.t., 16 h, traces  
Scheme 92: Addition of benzophenone and unintentional deprotection  
 
To obtain the α-amino acid 225, Boc-azepine 233 was deprotonated at –78 °C and 
the addition of alkyl chloroformates was next attempted (Table 33). Blakemore’s 
conditions were successful for the addition of alkyl chloroformates, although only 
starting material was recovered in the addition of tert-butyl anhydride (Entry 3).78 
An attempt at Boc-deprotection of 233 using mild microwave heating in water was 
unsuccessful as only starting material was observed.79 Deprotection of Boc-azepines 
236 and 237 was achieved using an excess of trifluoroacetic acid in 
dichloromethane, producing the free amine species in moderate to high yields. 
Heating under reflux with aqueous hydrochloric acid (6M) led to the isolation of the 
product in the highest yield. Furthermore, the hydrochloride salt product was easily 
purified by recrystallisation.80 
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Table 33: Ester catalyst synthesis 
 
Reagents and conditions: i) s-BuLi (1.3 equiv.), Et2O, −78 °C, 1 h; ii) electrophile (3 equiv.), −78 
°C→ r.t., 16 h; iii) HClaq (6M), acetone, 70 °C, 16 h 
Entry Electrophile i) Yield (%) Product ii) Yield (%) Product 
1 Ethyl chloroformate 73% 236 Quantitative 238 
2 Methyl chloroformate 81% 237 Quantitative 239 
3 Boc anhydride Starting material 
- 
 
- - 
 
On one occasion, 240 was isolated following treatment of 233 with s-BuLi and ethyl 
chloroformate, but only in trace quantities. We hypothesized that a double 
deprotonation could account for the formation of 240 (Scheme 93).  
 
 
Reagents and conditions: i) s-BuLi, Et2O, −78 °C→ r.t., 16 h, traces 
Scheme 93: Unexpected side product form ethyl chloroformate addition 
 
Both the methyl and ethyl ester exist as mixtures of two rotamers due to the 
conformational restrictions of the bulky tert-butyl ester. Variable temperature 1H 
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δ ppm.  
NMR experiments confirmed the presence of rotamers: coalescence of the duplicate 
peaks can be observed when increasing the temperature to 380 Kelvin (Figure 22).  
 
r.t.  
300 K 
340 K 
360 K 
380 K 
 
 
 
Figure 22: Variable temperature NMR of 237 
 
Alkyl chloroformate additions were fully diastereoselective, and single crystal X-ray 
crystallography of 241 confirmed that the ester group adopts a pseudo-axial 
orientation (Figure 23).  
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Figure 23: Pseudoaxial orientation of the ester group 
 
Interestingly, the selectivity observed on addition of alkyl chloroformates was a 
welcome, but unexpected outcome. Meyer’s lithiation of 233 with sec-BuLi and 
trapping with iodomethane was shown to result in a mixture of Sax,S and Sax,R 
diastereoisomers in a 1.5:1 ratio (Scheme 94). Upon repeating Meyer’s experiment, 
the same ratio of products was observed using 1H NMR spectrum analysis through 
the integration of the signals corresponding to the methyl group protons (Sax,R-242 
δMe 1.95 ppm and Sax,S-243 δMe 0.70 ppm).5 Whilst we are uncertain why we observe 
a diastereoselective addition when using chloroformates and not with iodomethane, 
we tentatively suggest that the selectivity may be affected by the size of the 
electrophile (Discussed further, Table 35). 
 
 
Reagents and conditions: i) s-BuLi (2 equiv.), THF, −78 °C, 30 min, MeI (1.3 equiv.), 1 h, 68% 
Scheme 94: Results from repeating Meyer’s N-Boc methylation conditions 
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Surprisingly, all conventional attempts to saponify the methyl and ethyl esters failed 
(Table 34). Both esters were subjected to strongly basic, acidic and high temperature 
conditions for prolonged periods of time, yet only starting materials were detected 
(Table 34). 81 Further, TMSCl (2 equiv.) used in combination with NaI (2 equiv.) 
failed to saponify the methyl ester, and instead these conditions favoured the 
deprotection of the Boc group (Entry 7).82 Heating under reflux in hydrochloric acid 
also resulted in the removal of the Boc group (Entry 9). When 18-crown-6 was used 
with potassium hydroxide, starting materials were the only products observed. 
Finally, when hydrazine was used, a complex mixture was obtained (Entry 11).83 
 
Table 34: Attempted saponification of methyl and ethyl esters 
 
Reagents and conditions: Base, solvent, temperature, 12-72 h 
Entry R R1 Reagent Solvent Temp (°C) Yield (%) 
1 Et H LiOH (1 equiv.) THF:H2O r.t. * 
Starting 
material 
2 Et H LiOH (1 equiv.) MeOH:H2O r.t. 
Starting 
material 
3 Et H LiOH (6 equiv.) CH3CN:H2O r.t.* 
Starting 
material 
4 Et H NaOH (3 equiv.) MeOH:H2O r.t. 
Starting 
material 
5 Et H LiOH (6 equiv.) EtOH:H2O r.t. 
Starting 
material 
6 Me Boc NaOH (1 equiv.) MeOH:H2O r.t.* 
Starting 
material 
NR1
CO2R
NR1
CO2H
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7 Me Boc TMSCl and NaI CH3CN r.t. 241 
8 Me H TMSCl and NaI CH3CN r.t. 
Starting 
material 
9 Et Boc HCl (6 M) - 70 238 
10 
Me 
 
Boc 
 
KOH 
18-crown-6 
MeOH:H2O r.t. 
Starting 
material 
11 Me Boc NH2NH2 (80%) H2O r.t. 
Complex 
mixture 
*also performed at reflux 
 
Extraordinarily, the inertness of the ester group also extended to lithium aluminium 
hydride reduction conditions. When three equivalents of reducing agent were used 
with 237, the desired product was not formed and only starting material was isolated 
(Entry 1, Table 35). We believed the bulkiness of the tert-butyl group could have 
prevented the reduction, and accordingly 241 was subjected to the same conditions, 
but only starting material was recovered (Entry 2). 
 
Table 55: Lithium aluminium hydride reduction attempts 
 
Reagents and conditions: LiAlH4 (3 equiv.), Et2O, 0 °C→ r.t., 16 h 
Entry R Compound Yield (%) 
1 Boc 237 Starting material 
2 H 241 Starting material 
 
As the saponification of esters 236 and 237 proved surprisingly difficult, we 
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endeavoured to find an alternative approach for the synthesis of 225. Asymmetric 
lithiation/carboxylation of Boc-pyrrolidine 244, reported by Beak, in the synthesis of 
(R)-proline was an encouraging lead.84 Beak employed the chiral additive (−)-
sparteine alongside sec-butyllithium to create a chiral organolithium reagent which 
could, in turn, selectively deprotonate 244 leading to the preferential formation of 
one enantiomer. Carbon dioxide gas was bubbled into the reaction mixture to 
generate 245 in moderate yield and 88% enantiomeric excess (Scheme 94). 
 
 
Reagents and conditions: i) (−)-sparteine 246 (1.2 equiv.), Et2O, −78 °C, s-BuLi (1.2 equiv.), 15 min, 
pyrrolidine (1 equiv.), −78 °C, 4 h; ii) CO2, −78 °C, 3 h, 55%, 88% ee 
Scheme 94: (−)-Sparteine mediated asymmetric lithiation  
 
Accordingly, we attempted a similar methodology: sec-BuLi was added to a solution 
of 233 at −78 °C and left for 1 h and CO2 gas, from sublimation of cardice, was 
bubbled into the reaction mixture via a CaCl3 drying tube. The reaction mixture 
allowed to stir for 1 h before it was quenched using saturated aqueous ammonium 
chloride. Diastereoisomeric acids 247 and 248 were isolated in 34% and 31% yield, 
respectively (Entry 1, Table 35). Side product 249 was also isolated in 13% yield. 
Increasing the reaction time to 16 h did not greatly affect the yield; however, 
increasing the quantity of sec-butyllithium and the reaction time, following the 
addition of CO2, resulted in a significant reduction in the yield (Entry 3). Addition 
of carbon dioxide in the form of dry ice pellets resulted in a slight decrease in the 
yield of products 247 and 248 (Entries 4 and 5).  
 
 
N
Boc
N Li
O O NBoc
CO2Hi) ii)
N
NH
H H
244 245 246
   
130 
Table 35: Addition of CO2  
 
Reagents and conditions: i) s-BuLi, Et2O, −78 °C, 1 h; ii) CO2, −78 °C→ r.t. iii) NH4Cl solution 
Entry s-BuLi CO2 
Time 
(h) 
Yield of 
247 (%) 
Yield  
of 248 (%) 
Yield of 
249 (%) 
1 1.3 Gas 2 34 31 13 
2 1.3 Gas 16 30 33 17 
3 2 Gas 24 12 12 14 
4 1.3 Solid 2 25 28 7 
5 2 Solid 16 24 23 10 
 
We are not able to confidently explain how side product 249 is produced; the 
suggested structure matches all the assignments made using mass, NMR and IR 
spectral analysis. The yield of 249 seems unaffected by the quantity of sec-
butyllithium used or by reaction time, and it was not isolated in any of the alkyl 
chloroformate addition reactions.  
 
The identification of 247 and 248 was based on the differing chemical shifts of the 
signals corresponding to the pseudoaxial and pseudoequatorial protons on the carbon 
atom α to the acid group. This technique has been employed widely in 
conformational assignments of this type of azepinal structure (Figure 24). 
Pseudoaxial substituents experience a clear upfield shifting in 1H NMR spectrum, 
compared to their pseudoequatorial counterparts, due to the effect of the 
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neighbouring aromatic ring or ‘ring current effect’. 5,85,86,87,88  
 
Figure 24: Conformational assignments based on 1H NMR spectroscopy 
 
Variable temperature 1H NMR experiments (up to 360 K) were performed in order to 
increase the resolution to identify the splitting patterns for diastereoisomer (Sax,S)-
248 and to define the chemical shifts of the protons for diastereoisomer (Sax,R)-247 
as the presence of rotamers doubled the number of signals (Figure 25). In (Sax,S)-
248, the pseudoaxial proton experiences greater shielding from the proximal 
naphthalene group and therefore the signal is found further upfield (δH 4.36 ppm) 
compared to the pseudoequatorial proton in (Sax,R)-247 (δH 5.72 ppm).6  
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Figure 25: Variable temperature 1H NMR chemical shifts of methylene protons of 
diastereoisomers 247 and 248 at increasing temperature  
When analysing the 1H NMR spectra of (Sax,S)-248, the pseudoaxial proton (shown 
in red) experiences greater shielding from the proximal naphthalene group and 
therefore the signal is found further upfield (δH 4.36 ppm) compared to the 
pseudoequatorial proton in (Sax,R)-247 (δH 5.72 ppm).6 
Accordingly, compound 247 was assigned as having a pseudoaxial carboxylic acid 
substituent based on the chemical shift corresponding to the α-proton, indicating a 
pseudoequatorial orientation. In addition this value follows the trend of the other 
catalyst precursors with pseudoaxial substituents (Figure 26). Compounds 236, 237 
and 247, all of which have alpha substituents in the pseudoaxial orientation, have 
very similar chemical shift values for the signal corresponding to their 
pseudoequatorial protons (δH 5.82 ppm, δH 5.85 ppm, δH 5.72 ppm, respectively). 
These assignments are further supported by the absolute configuration of 236, 
following Boc group removal, which has been confirmed by X-ray crystallography 
(Figure 23).  
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Figure 26: Chemical shifts of α-amino esters and acids, 236, 237, 247 and 248 
If we extend this reasoning, we can be confident of our previous assignments of the 
β-amino acid catalyst precursors, such as 189. The absolute configuration of 211 has 
been confirmed by X-ray crystallography (Figure 19) where the β-amino ester group 
was shown to occupy the pseudoaxial position. The chemical shift values for the 
CHCR2COOR protons of compounds 189, 211 and 218 (Figure 27) are very similar 
(δH 4.38 ppm, δH 4.41 ppm, δH 4.55 ppm, respectively) which supports our previous 
stereochemical assignment for compound 189. Whilst the recorded chemical shift 
values for the pseudoequatorial protons appear upfield, compared to the 
pseudoequatorial protons of the α-acids and esters, the distance to the electron-
withdrawing carbonyl explains the difference. Conversely, in the Meldrum’s acid 
derived compound, the pseudoequatorial proton is close to two electron withdrawing 
substituents which leads to a chemical shift value (δH 5.08 ppm) nearer to that of 
236, 237 and 247.  
 
Figure 27: Chemical shifts of beta-amino esters and derivatives 
 
In both cases, deprotection of 247 and 248 was achieved in quantitative yield 
through heating under reflux in a mixture of acetone and aqueous hydrochloric acid 
overnight (Table 36).  
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Table 36: Deprotection of 247 and 248 
 
Reagents and conditions: i) HClaq (6M), acetone, 70 °C, 16 h 
Entry Compound  Yield (%) Compound 
1 247 Quantitative  250.HCl 
2 248 Quantitative 251.HCl 
 
Alternatively a trifluoroacetic acid-mediated deprotection afforded amines 250 and 
251 in high yields (Table 37).89 
 
Table 37: Trifluoroacetic acid deprotection 
 
Reagents and conditions: i) TFA (14 equiv.), CH2Cl2, r.t., 16 h 
Entry Compound  Yield (%) Compound 
1 247 82 250 
2 248 71 251 
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8.0 Biphenyl catalysts 
Having successfully synthesized a series of novel binaphthyl-based axially chiral 
amino acids for screening in catalysis, we turned our attention to the biphenyl 
analogues. Indeed, as mentioned previously, Maruoka reported that compared to 
111, compound 144 was more a reactive catalyst, due its biphenyl structure and 
activating aryl methoxy groups, and consequently required much lower catalyst 
loadings (Table 10).90 
 
Our synthesis of the related biphenyl catalysts started from achiral dibromo 
compound 252 (Scheme 96). From this achiral starting material, we intended to 
introduce a chiral nitrogen-protecting group, and observe whether this substituent 
would induce any selectivity in nucleophilic additions to the corresponding iminium 
salt derivative. 4 
A double nucleophilic substitution ring closing reaction, using (R)-(+)-1-
phenylpropylamine, afforded 253 in 88% yield, and an NBS oxidation and counter-
ion exchange gave iminium salt 254 in 64% yield (Scheme 95).  
 
 
Reagents and conditions: i) (R)-(+)-1-phenylpropylamine (1 equiv.), CsCO3 (1.8 equiv.), CH3CN, 
80 °C, 16 h, 88%; ii) NBS (1.05 equiv.), CH2Cl2, 0 °C, 2 h, then NaBPh4 (1.05 equiv.), MeCH3, 
EtOH, 64% 
Scheme 95: Synthesis of iminium salt 254 
 
As a test reaction, we had hoped that the presence of a chiral nitrogen-protecting 
group would provide some selectivity in the addition of methyl Grignard reagent 
Br
Br
Ni) N
BPh4
ii)
252 253 254
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onto iminium salt 254. Ideally, had the addition demonstrated some 
diastereoselectivity, Reformatsky reactions would have been attempted to synthesize 
the β-amino acid analogues. Disappointingly, the addition resulted in an inseparable 
mixture of diastereoisomers in a 1:1 ratio (Scheme 96). 
 
 
Reagents and conditions: i) MeMgBr (10 equiv.), THF, −78 °C→ r.t., 16 h, d.r. 1:1, 86% 
Scheme 96: Addition of methyl Grignard reagent to iminium salt 254 
 
As the addition proved non-selective, we turned our attention to the preparation of an 
axially chiral biphenyl backbone, hoping that a fixed chirality, as observed in the 
case of the binaphthyl analogue, would afford the addition products as single 
diastereoisomers. Such an axially chiral biphenyl backbone has been reported by 
Denmark,91 and was used to prepare epoxidation catalysts within the Page group.92 
Our target aminocatalysts would then be accessed using the methodology described 
above for the binaphthyl analogues. The first step was a copper(I) diazonium salt 
homocoupling reaction of commercially available 2-amino-3-methylbenzoic acid, 
affording racemic 6,6'-dimethyl-dicarboxylic acid 255 and the azo-containing side 
product 256 in 54% and 18% yields, respectively (Scheme 97). Resolution of (±)-
255 was achieved using quinine, and the resulting salt was recrystallized from hot 
ethanol (90%) to achieve the selective isolation of diastereoisomerically pure quinine 
salt 257. Treatment of salt 257 with hydrochloric acid led to the formation of (+)-255 
as a single diastereoisomer, as confirmed by optical rotation measurements.86  
ii) N NN
BPh4
254
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Reagents and conditions: i) NaOH (1.3 equiv.), NaNO2 (1 equiv.), H2O, 0 °C, 4M HCl, CuSO4.5H2O 
(1.7 equiv.), 30 % NH4OH, NH2OH (prepared from (NH2OH)2.H2SO4 (1.9 equiv.), 3M NaOH, 0 °C), 
110 °C, 1 h, conc. HCl, r.t. 12 h, 255 54%, 256 18%; ii) Quinine (1 equiv.), 90% EtOH, 70 °C→ r.t.; 
iii) EtOAc, 3M HCl, 16 h, 37% 
Scheme 97: Synthesis and resolution of bis-acid 255 
 
Bis-acid (+)-255 was then converted into the corresponding bis-methyl ester 258. 
Reduction of both ester moieties using LiAlH4 afforded bis-alcohol (−)-259 in 
quantitative yield. An Appel reaction employing phosphorus tribromide and pyridine 
gave dibromo compound (+)-260 in 88% yield (Scheme 98). 
 
 
Reagents and conditions: i) MeOH, conc. H2SO4, 70 °C, 16 h, 82%; ii) Et2O, LiAlH4, 0 °C, quant.; iii) 
pyridine (0.1 equiv.), toluene, PBr3 (3 equiv.), 60 °C, 3 h, 88% 
Scheme 98: Synthesis of dibromo compound 260 
 
With (+)-260 in hand, and employing the conditions used in the synthesis of the 
binaphthyl analogue 233, N-Boc analogue (−)-261 was isolated in high yield, despite 
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small amounts of the corresponding oxepine impurity detected. Azepine (−)-261 was 
lithiated using sec-butyllithium, causing the reaction mixture to change from a pale 
yellow to a deep red colour; the anion was trapped using methyl chloroformate to 
form 262 in 79% yield. A trifluoroacetic acid-mediated deprotection gave free amine 
263 in 74% yield (Scheme 99).  
 
Reagents and conditions: i) DMF, NaH (2.05 equiv.), 0 °C, tert-butyl carbamate (1 equiv.), 88%; ii) 
Et2O, −78 °C, s-BuLi (2 equiv.), 1 h, ClCO2Me (1.5 equiv.), 1 h, −78 °C, 79%; iii) TFA, DCM, r.t., 1 
h, 74% 
Scheme 99: Synthesis of methyl ester catalyst 263  
 
Finally, α-amino acid derivative 264 was isolated in 45% yield when CO2 gas was 
used as the electrophile (Scheme 101). Deprotection of 264 could be achieved by 
trifluoroacetic acid treatment, producing 265.TFA in 50% yield (Scheme 100). 
 
 
Reagents and conditions: i) Et2O, −78 °C, s-BuLi (2 equiv.), 1 h, CO2 gas, 1 h, −78 °C→ r.t., 45 %; 
iii) TFA, DCM, r.t., 1 h, 50% 
Scheme 100: Synthesis of 265 
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Variable temperature 1H NMR experiments were performed on 264 to resolve 
signals corresponding to the two rotamers present at room temperature in solution. 
At 360 K we observed coalescence of the rotameric signals (Figure 28).  
 
 
Figure 28: Variable temperature NMR of 264 
The absolute configuration of the acid group of 265 was confirmed by single crystal 
X-ray crystallography and the acid group adopts a pseudoaxial conformation (Figure 
29).  
  
 
Figure 29: Crystal structure of 265 
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Interestingly, the complete diastereoselectivity observed in the synthesis of 264 does 
not follow the selectivity observed when preparing binaphthyl acids 247 and 248, 
where a mixture of diastereoisomeric acids was generated from the same lithiation 
and decarboxylation conditions.  
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9.0 Catalyst testing 
9.1 Aldol reaction 
Aminocatalysis is a relatively recent endeavor for the Page group and as such, 
screening began with catalysts 166 and 251 for the aldol reaction of 
nitrobenzaldehyde 81 and acetone. This reaction relies on enamine activation of the 
ketone substrate by aminocatalyst (Scheme 101).  
 
Scheme 101: General catalytic cycle of organocatalysed aldol reaction 
 
As seen above, Maruoka’s ‘synthetic amino acid’ catalyst (S)-111 was shown to be 
very successful in this reaction, affording aldol products in up to 99% ee (Tables 8 
and 9). We envisaged that our catalysts, which share structural similarities, 
especially in the case of 166 and 251, would show equally promising preliminary 
results.113 
 
 
O
R2
N
H
R1
R2
N
R1
R2
N
R1
R2
N
R1
R
OH
O
R
OH
H
O
R
   
142 
 
Figure 30: Previous studies of Page group aminocatalysts for the aldol reaction 
 
Catalyst 166 and 251 were screened using the optimum solvent described by 
Maruoka and List (DMSO); however remarkably, in both cases, no conversion was 
detected after several days (Entries 4 and 6, Table 38).113,93 Similarly, when 
acetonitrile was used as a solvent for 251 and 216, no conversion to the 
hydroxyketone was observed (Entries 3 and 5).  
 
Table 38: Aldol reaction  
 
Reagents and conditions: Catalyst (10 mol%), acetone (27 equiv.), nitrobenzaldehyde (1 equiv.), 
solvent, r.t., 72 h 
Entry Catalyst Temp (°C) Solvent 
Conversion 
(%)[a] 
ee 
(%)[b],[c] 
1 - r.t. neat - - 
2 27[d],[e] r.t. DMSO 80 34 (R) 
3 166 r.t. CH3CN - - 
4 166[d],[e] r.t. DMSO - - 
5 251 r.t. CH3CN - - 
6 251[d],[e] r.t. DMSO - - 
NH
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H
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27 166 251
O
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O OH
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7 251 r.t. MeOH - - 
8 251 r.t. toluene - - 
[a] Conversion determined from 1H NMR spectra analysis of the reaction mixture [b] Enantiomeric 
excess was determined using HPLC with Chiralcel® IC column: (hexane/iPrOH=92:8, λ=220 nm), 
0.5 mL; tR= major enantiomer 45.5 min, minor enantiomer 43.1 min. [c] absolute configuration was 
determined by comparison with known HPLC retention times [d] 30 mol% [e] additive PhCO2H used 
(20 mol%) 
 
It was surmised that the inactivity of 166 compared to (S)-proline could be explained 
by the reduced acidity of the carboxylic acid group and its larger distance from the 
aminocatalytic centre. Indeed, α-amino acids (S)-proline, 2-piperidinecarboxylic acid 
and 268 have carboxylic acid pKa values of 2.0, 2.5 and 2.5 respectively, whereas β-
alanine and 269 are much less acidic, with values of 3.6 and 4.0 (Figure 31).94,95 It 
was concluded that a more acidic group and nucleophilic nitrogen may be required 
for this reaction to proceed smoothly. 
 
 
Figure 31: Computational and experimental pKa values of α- and β-amino-
acid derivatives 
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9.2 Michael reaction  
As the aldol reaction showed little in the way of encouraging results, we decided to 
evaluate the Michael reaction, hoping that our catalysts would be more successful in 
an iminium activation pathway. Indeed, secondary amines such as MacMillan’s 70 
and Jørgensen’s 100 have proven very effective in catalysis through such an iminium 
ion activation mechanism (Scheme 102).96,97 The conjugate 1,4-addition of 
malonates to α,β-unsaturated enones was explored first (Table 39).  
 
Scheme 102: General catalytic cycle of organocatalysed Michael reaction  
 
We selected catalysts 166, 216 and 251 to screen and followed conditions reported 
by Ley, who employed tetrazole catalyst 90 in combination with a stoichiometric 
quantity of base in the reaction of dibenzyl malonate additions to cyclohexenone.98 
Ley reported that tetrazole catalyst 90, when employed alongside piperidine, 
provided the product in 62% yield and 82% ee in two days.94 The reaction is 
promoted by a bifunctional Lewis/Brønsted basic type activation; the chiral amine 
catalyst activates the α,β-unsaturated carbonyl compound via an iminium 
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intermediate whilst the addition of a basic additive activates the nucleophilic reagent 
by deprotonation.99 Ley reported piperidine was the most successful base of those 
screened;99 however, previous work within our group showed that piperidine was not 
suitable in combination with catalysts 166 and 216 and that, surprisingly, inorganic 
base LiOH gave the best enantioselectivities.40 Thus, initially we explored the effect 
of other bases and preliminary results suggested the reaction occurs, albeit slowly, in 
the absence of our catalysts, when LiOH and K2CO3 are used (Entries 1-3). We 
hoped that because the base-mediated reaction was slow, the contribution of our 
aminocatalysts would be significant: conferring enantioselectivity and increasing the 
speed of reaction.  
Table 39: Michael addition of dibenzyl malonate onto cyclohexenone 
 
Reagents and conditions: i) Enone (1 equiv.), malonate (1 equiv.), catalyst (10 mol%), additive (1 
equiv.), solvent, r.t. 
Entry Catalyst Additive Solvent Temp 
(°C)  
Time 
(h) 
Conversion 
(%)[a] 
Ee 
(%)[b],[c] 
1 - LiOH CH2Cl2 r.t. 144 100 - 
2 - K2CO3 CH2Cl2 r.t. 144 100 - 
3 166 LiOH CH3CN r.t. 24 100 5 
4 166 LiOH THF r.t. 24 100 5 
5 166 LiOH xylene r.t. 30 100 4 
6 166 LiOH H2O r.t. 24 100 12 
8 216 LiOH toluene − 5 120 100 12 
9 216 LiOH CH2Cl2 − 5 120 - - 
BnO OBn
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10 216 LiOH toluene r.t. 24 100 4 
11 251 LiOH CH2Cl2 r.t. 144 100 - 
12 251 - Neat r.t. 144 - - 
13 251 - Et2O r.t. 144 - - 
14 251 - CH3CN r.t. 144 - - 
15 251 PhCO2H 
[d] 
CHCl3 r.t. 144 - - 
[a] Conversion determined from 1H NMR spectra analysis of the reaction mixture [b] Enantiomeric 
excess was determined using HPLC with Chiralcel® AI-3 column: (hexane/iPrOH=60:40, λ=220 
nm), 0.7 mL; tR= major enamtiomer 20.2 min, minor enantiomer 20.6 min [c] absolute configuration 
was determined by comparison of the HPLC in the literature [d] 10 mol% additive used 
 
The reaction conditions employing stoichiometric quantities of inorganic base, and 
10 mol% of catalyst, led to full conversion; however, the addition products were 
obtained in very low ee or as racemic mixtures. Unsurprisingly, considering the 
water has a pKa value of 15.7, and, is therefore far more basic than Ley’s favoured 
base, piperidine (pKa 12).100 Indeed, when no base was used and the reaction was 
stirred for six days no formation of product was detected (Entry 12). In order to 
ascertain whether the catalyst was forming the activated iminium intermediate, a 
periodic 1H NMR experiment was performed: 1 equivalent of catalyst 251 and 1 
equivalent of cyclohexenone 270 in (CD3)2SO, were monitored using 1H NMR 
spectroscopy over a 24 h period. (CD3)2SO was used for NMR spectral analysis as 
the solvent as it did not interfere with substrate signals and signals were found to be 
better resolved when using this solvent.  
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Figure 32: Catalyst 251 and cyclohexenone 270 in d6-DMSO 
 
A change in splitting patterns and/or chemical shifts would indicate the formation of 
the active iminium intermediate. After 24 h, no sign of activation was observed 
(conducted with and without the presence of benzoic acid) using NMR spectral 
analysis and consequently cyclohexenone was abandoned as a substrate for catalysis 
(Figure 33). 
 
251 
 
270 
t=0 
t=1 d 
Figure 33: Evolution of the 1H NMR spectrum of a mixture of catalyst 251 and 
cyclohexenone over 1 d 
 
A more reactive α,β-unsaturated carbonyl substrate was considered; a mixture of 
trans-cinnamaldehyde (271) and catalyst 251 was examined by periodic 1H NMR 
experiments over a 24 h period (Figure 34). 
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251 
 
271 
t=0 
t=1 d 
Figure 34: Evolution of the 1H NMR spectrum of a mixture of catalyst 251 and 
trans-cinnamaldehyde 271 over 1 d 
 
An obvious shifting of signals was observed over 24 h, as the peaks corresponding to 
substrate 271 were shifted downfield (Figures 34 and 35). This suggests that these 
sp2 hybrized proton environments were becoming progressively more deshielded, an 
observation consistent with the formation of a positively charged iminium 
intermediate 272 (Figure 35).101,102  
 
 
Figure 35: Catalyst 251 and trans-cinnamaldehyde 271 in d6-DMSO 
 
The Michael addition of dibenzyl malonate onto trans-cinnamaldehyde has been 
widely used for comparative studies of asymmetric catalysis.103,104,105,106,107 Excellent 
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enantioselectivities are frequently reported for 1,4-additions of nucleophiles to 
electron-deficient alkenes. Therefore, this reaction is considered one of the most 
selective for the stereocontrolled formation of carbon-carbon bonds.108 The Michael 
reaction employing iminium ion catalysis of α,β-unsaturated aldehydes has only 
recently been established; consequently, development of this reaction is in 
demand,104 as it can be used in the synthesis of important pharmaceutical 
compounds. Indeed, Jørgensen used this very selective reaction in the first step of the 
synthesis of antidepressant (−)-paroxetine (Scheme 103).109 Compound 273 
undergoes a selective Michael addition reaction with dibenzyl malonate affording 
274 in 86% ee. Imine formation, reduction and lactamization gave 275 in high yield, 
and (−)-paroxetine can then be accessed using literature procedures.110,111,112,113 
 
Reagents and conditions: Dibenzyl malonate (0.5 equiv.), catalyst 95 (10 mol%), EtOH, 0 °C, 96 h, 
72%, 86% ee; ii) PhCH2NH2, NaBH(OAc)3, dioxane, 70% d.r.: 13:1; further steps 
Scheme 103: Synthesis of (−)-paroxetine 
 
As trans-cinnamaldehyde was identified as a suitable substrate, catalyst screening 
was carried out using catalysts 250 and 251 (Figure 34, Table 40).  
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Figure 34: Catalysts 250 and 251 
 
Jørgensen reported that the optimum solvent for the Michael reaction of 
cinnamaldehyde and dibenzyl malonate was ethanol and, other than DMSO, no 
conversion was noted using non-alcoholic solvents.104,114 Additionally, Pfaltz 
discovered that the addition of water and benzoic acid accelerated the reaction when 
using Jørgensen’s diaryl prolinol catalyst 95.97 The presence of an acid additive has 
been extensively explored in this reaction as it is hypothesized to aid the formation 
of the iminium species 276. In addition, the presence of acid may also favour the 
iminium species 278 in the iminium/enamine equilibrium of the reaction product; the 
iminium species subsequently undergoes hydrolysis to form 279 (Scheme 104).97  
 
 
Scheme 104: Lewis acid/Brønsted acid catalysis using Jørgensen’s catalyst 95 
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the rate and selectivity of organocatalytic reactions.115 In particular, the effect of 
benzoic acid was investigated as Lewis acid/Brønsted acid catalysis has been shown 
to have a sizeable influence in this reaction. Following the isolation of conjugate 
addition product 280, it was converted into methyl ester derivative 281 to allow for 
resolution of the peaks corresponding to each enantiomer using chiral stationary 
phase HPLC. Transformation to 281 was achieved by treatment of 280 with 
potassium permanganate and trimethylsilyldiazomethane.103  
 
Table 40: Michael addition of dibenzyl malonate onto trans-cinnamaldehyde 271 
 
Reagents and conditions: i) Catalyst (10 mol%), dibenzyl malonate (1 equiv.), additive, solvent, r.t.; 
ii) 1M KMnO4, 1M NaH2PO4, NaHSO3, 1M HCl, TMSCHN2 
Entry 
Catalyst 
(10 mol%) 
Additive (10 
mol%) 
Solvent 
Time 
(d) 
Conversion 
(%)[a] 
Ee (%) 
[b],[c] 
1 - - 90% EtOH 5 - - 
2 - PhCO2H EtOH (90%) 5 - - 
3 129.HCl PhCO2H EtOH (90%) 1 80 4 (S) 
4 (S)-proline PhCO2H EtOH (90%) 1 11 4 (R) 
5 251 - EtOH (90%) 8 31 3 (S) 
6 251.HCl PhCO2H EtOH (90%) 1 53 3 (S) 
7 251 PhCO2H EtOH (90%) 1 31 14 (S) 
8 251 - CH2Cl2 8 77 20 (S) 
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9 251 NaOH[d] CH2Cl2 1 28 0 
10 251 - CHCl3 3 27 17 (S) 
11 251 PhCO2H CHCl3 8 23 22 (S) 
12 251 PhCO2H[e] CHCl3 7 74 20 (S) 
13 251 - CCl4 8 5 - 
14 251 - toluene 8 20 10 (S) 
15 251 - DMSO 5 - - 
16 250 - EtOH (90%) 8 23 4 (S) 
17 250 PhCO2H EtOH (90%) 8 38 8 (S) 
18 250.HCl PhCO2H EtOH (90%) 1 43 6 (S) 
19 250 - CH2Cl2 7 50 16 (S) 
20 250 - CHCl3 8 28 14 (S) 
21 250 PhCO2H CHCl3 7 64 18 (S) 
[a] Conversion determined from 1H NMR spectra analysis of the reaction mixture [b] Enantiomeric 
excess was determined using HPLC with Chiralcel® AD-H column: (hexane/iPrOH=80:20, λ=254 
nm), 1.0 mL; tR= major enantiomer 26.5 min, minor enantiomer 18.7 min [c] absolute configuration 
was determined by comparison with known HPLC retention times [d] 1 equiv. [e] 2 equiv. 
 
When EtOH (90%) was used in combination with benzoic acid and a catalyst 251 
was used, 281 was obtained in 14% ee with a disappointing conversion (Entry 7). 
The reaction conditions show that the reaction is heavily solvent-dependent: indeed, 
when DMSO was used, no product formation was detected after four days (Entry 
15). Chloroform provided the highest ee (22%, Entry 11), whereas dichloromethane 
showed a reduction in both conversion and ee, and carbon tetrachloride suppressed 
the reaction completely (Entries 8 and 13). Increasing the quantities of benzoic acid 
to stoichiometric quantities accelerated the reaction, though at the expense of a 
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reduction in selectivity (Entry 12). Basic additives have been shown, in combination 
with LUMO-lowering catalysts, to provide high turnover and enantioselectivity.99 
However, when NaOH was used (Entry 9), a racemic product was obtained; 
presumably, the base-catalysed pathway was faster than the aminocatalysed reaction. 
 
Similar results were obtained when the reaction was performed in EtOH (90%) using 
catalyst 250 (Entry 16). Likewise, the addition of benzoic acid slightly improved the 
conversion and ee. Halogenated solvents gave higher enantioselectivities and the 
highest ee was observed when chloroform was used with benzoic acid (Entry 21). 
 
Axially chiral biphenyl catalysts 263 and 265 were also tested under the same 
reaction conditions (Table 41). 
 
Figure 37: Catalysts 263 and 265 
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Table 41: 1,4-Michael addition of dibenzyl malonate to trans-cinnamaldehyde  
 
Reagents and conditions: i) Catalyst (10 mol%), dibenzyl malonate (1 equiv.), additive (1 equiv.), 
solvent, r.t.; ii) 1M KMnO4, 1M NaH2PO4, NaHSO3, 1M HCl, TMSCHN2 
Entry Catalyst  Additive  Solvent Time 
(d) 
Conversion 
(%)[a] 
Ee 
(%)[b], [c] 
1 265.TFA PhCO2H[d] 90% EtOH 1 71 3 (S) 
2 265.TFA NaOH[e] CH2Cl2 5 30 0 
3 263 - 90% EtOH 3 95 2 (S) 
4 263 - CHCl3 8 39 1 (S) 
[a] Conversion determined from 1H NMR spectra analysis of the reaction mixture [b] Enantiomeric 
excess was determined using HPLC with Chiralcel® AD-H column: (hexane/iPrOH=80:20, λ=254 
nm), 1.0 mL; tR= major enantiomer 26.5 min, minor enantiomer 18.7 min [c] absolute configuration 
was determined by comparison with known HPLC retention times [d] 10 mol% [e] 1 equiv. 
Conversely, when EtOH (90%) and 263 or 265 were used, high conversion was 
observed, although the product isolated was racemic in both cases (Entries 1 and 3). 
Halogenated solvents slowed the rate of conversion whilst also giving racemic 
products (Entries 2 and 4).  
 
 
 
 
 
 
BnO OBn
OO
O
O
i)
Ph
Ph
CO2Bn
BnO2C
O
Ph
CO2Bn
BnO2C
ii) MeO
280 281271
   
155 
9.3 Diels-Alder Reaction  
trans-Cinnamaldehyde 271 was also employed as the dienophile for Diels-Alder 
reactions. As with the Michael reaction, the organocatalytic Diels-Alder reaction 
relies on the activation of the dienophile through LUMO energy lowering due to 
iminium ion formation. The [4+2] reaction is wide-reaching, with an extensive 
application for the synthesis of six membered rings with defined stereo- and regio-
chemical control. The use of chiral amines as organocatalysts for this type of Diels-
Alder reaction has exploded in popularity since MacMillan’s seminal publication in 
2000.116,117 There are now many examples of total syntheses employing a pivotal 
aminocatalytic Diels-Alder step.118,119,120 The rate-determining step, as postulated by 
MacMillan, is the condensation step between the amine and carbonyl groups 
resulting in the formation of an iminium ion. We therefore felt that our bifunctional 
catalysts with Brønsted acid/Lewis basic character should be ideal for the promotion 
of this reaction (Figure 38). 
 
Figure 38: Amino acid catalysts screened 
 
In addition to the effect on the selectivity of a chiral acid functionality, we were 
intrigued to see if the backbone had a noticeable effect, and specifically, whether our 
binaphthyl or biphenyl backbone catalysts provided a higher degree of exo:endo 
selectivity. Indeed Maruoka found that, in the reaction of cinnamaldehyde and 
cyclopentadiene, (±)-binaphthyl 282 gave slightly improved selectivity compared to 
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(±)-biphenyl 283 (Table 42).121 
 
Table 42: Maruoka’s binaphthyl and biphenyl diamine catalysts 
 
Reagents and conditions: i) 12 mol% catalyst, 10 mol% TfOH, CH2Cl2, r.t. 
Entry Catalyst Time (h) Yield (%) 
exo:endo 
284:285 
1 (±)-282 20 99 9.2:1 
2 (±)-283 23 83 8.0:1 
 
Utilizing conditions optimized for the reaction of trans-cinnamaldehyde and 
cyclopentadiene, reported by MacMillan using imidazolidinone catalyst 70, we 
began screening carboxylic acid catalysts (Figure 38).111 In addition, as MacMillan 
utilized 70 as the corresponding hydrochloride salt, we assessed both the free amine 
and hydrochloride salt derivatives of many of our catalysts.  
The products, 284 and 285, were partially converted in situ to corresponding 
dimethyl acetals. TFA mediated hydrolysis allowed the conversion to be calculated 
by crude NMR analysis and assignment of the diastereomeric ratio of aldehydes (exo 
δ 9.86 (1H, d, J= 2.0 Hz, CHO): endo δ 9.59 (1H, d, J= 2.2 Hz, CHO)). Following 
isolation of the bicyclic exo and endo products 284 and 285, respectively, 
O
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compounds 284 and 285 were converted into the corresponding alcohols 284a and 
285a, respectively, through a lithium aluminium hydride-mediated reduction, to 
allow the separation of enantiomers on chiral stationary phase HPLC (Table 43). 
Assignments of the major enantiomers could be made by comparison with literature 
HPLC elution times.120 
Table 43: Amino acid catalyst screening 
 
Reagents and conditions: i) cyclopentadiene (3 equiv.), cinnamaldehyde (1 equiv.), catalyst (10 
mol%), MeOH:H2O (95:5 v/v), r.t.; ii) LiAlH4, Et2O, 0 °C, 2 h 
Entry Catalyst 
Time 
(d) 
Conv. 
(%)[a] 
exo:endo  
284:285[
b] 
endo ee 
(%)[c],[d] 
exo ee 
(%)[c],[d] 
1 - 5 - - - - 
2[e] Pyrrolidine 5 73 1:1 0 0 
3 (S)-proline 5 74 1:0.6 21 (2S,3S) 43 (2S,3S) 
4 70.HCl 2 100 1:1.1 95 (2R,3R) 89 (2R,3R) 
5 166.HCl 7 44 1:0.5 14 (2R,3R) 26 (2R,3R) 
6 216.HCl 7 68 1.0.5 13 (2R,3R) 30 (2R,3R) 
7 265.TFA 5 14 1:0.8 9 (2R,3R) 43 (2R,3R) 
8 251 5 21 1:1.6 2 (2S,3S) 1 (2R,3R) 
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9 251.HCl 7 3 1.1.6 4 (2S,3S) 7 (2R,3R) 
10 250 7 23 1:1.2 4 (2S,3S) 4 (2R,3R) 
11 250.HCl 7 12 1:1.4 1 (2S,3S) 11 (2R,3R) 
[a] Conversion determined from 1H NMR spectra analysis of the reaction mixture of bicyclic 
aldehydes 284 and 285 [b] Ratio determined by 1H NMR spectra analysis of crude reaction mixture [c] 
Enantiomeric excess was determined using HPLC with Chiralcel® OJ column (hexane/iPrOH=90:10, 
λ=222 nm), 1.0 mL; endo isomer (tR1 15 min, 35 min) exo isomer (tR1 47 min, 65 min)) [d] 
configuration was determined by comparison with known HPLC retention times [e] reaction 
performed in toluene 
 
In order to assess the effect of the carboxylic acid functionality in a non-axially 
chiral system, (S)-proline was also evaluated under these conditions (Entry 3, Table 
43). (S)-Proline provided modest exo selectivity and delivered the exo adduct in 43% 
ee. In addition, we tested MacMillan’s imidazolidinone catalyst 70 (Entry 4); a fast 
reaction time and excellent enantioselectivity were noted; but poor 
diastereoselectivity was observed. Strikingly, in contrast to the Diels-Alder class of 
reaction, catalysts 166, 216 and 265 favoured the formation of the exo isomer 
(Entries 5-7). β-Amino acid species 166 and 216, employed as their respective 
hydrochloride salts, produced moderate diastereoselectivities in favour of the exo 
isomer (Entries 4 and 5). Salt 216.HCl out-performed 166.HCl in terms of 
reactivity, perhaps surprisingly due to its crowded structure, as well as 
enantioselectivity. Supporting Maruoka’s observations, biphenyl 265 did indeed give 
reduced exo:endo selectivity, compared to the corresponding binaphthyl version 250. 
However, 265 imparted higher levels of enantioselectivity, affording the exo adduct 
in 43% ee (Entries 7 and 10). Interestingly, α-amino acid catalysts 250 and 251 
showed slight endo selectivity (Entries 7-10). Both salts 250.HCl and 251.HCl 
showed reduced activity compared to the free amine form, alongside lower 
enantioselectivities. 
 
The α-effect, related to the increasing nucleophilicity of an atom bearing a lone pair 
as a result of an adjacent heteroatom, was explored by Tomkinson in the Diels-Alder 
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reaction utilizing acyclic hydrazines as catalysts.122 In addition, Tomkinson found 
that while pyrrolidine hydrochloride 286 was a poor catalyst for this reaction, proline 
methyl ester hydrochloride 287 was efficient in affording adducts 284 and 285 in 
85% yield, suggesting that an electron-withdrawing ester functional group can also 
help facilitate generation of the iminium intermediate (Table 44). 
Table 44: Diels-Alder reaction of cinnamaldehyde and cyclopentadiene 
 
Reagents and conditions: i) Catalyst (10 mol%), MeOH:H2O (19:1), r.t.  
Entry Catalyst Time (h) 
exo:endo 
284:285 
Yield (%) 
1 
 
24 68:32 9 
2 
 
48 71:29 85 
 
Consequently, we were curious to discover whether our α-ester functionalised 
catalysts 238, 239 and 263 (Table 45) would show improved reactivity and endo/exo 
diastereoselectivity. 
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Table 45: α-Ester catalyst screening  
 
Reagents and conditions: i) cyclopentadiene (3 equiv.), cinnamaldehyde (1 equiv.), catalyst (10 
mol%), MeOH:H2O (95:5 v/v), r.t; ii) LiAlH4, Et2O, 0 °C, 2 h 
Entry Catalyst Solvent 
Time 
(d) 
Conv. 
(%)[a] 
exo: 
endo 
284:285
[b] 
endo ee 
(%)[c],[d] 
exo ee 
(%)[c],[d] 
1 287.HCl MeOH:H2O 7 100 1:0.4 43 (2S,3S) 47 (2S,3S) 
2 263 MeOH:H2O 5 70 1:0.7 21 (2R,3R) 51 (2R,3R) 
3 239 MeOH:H2O 5 26 1.0.7 17 (2R,3R) 43 (2R,3R) 
4 239.HCl MeOH:H2O 5 100 1:0.5 34 (2R,3R) 56 (2R,3R) 
5 238 MeOH:H2O 4 36 1:0.4 31 (2R,3R) 57 (2R,3R) 
6 238.HCl MeOH:H2O 5 92 1:0.4 34 (2R,3R) 58 (2R,3R) 
[a] Conversion determined from 1H NMR spectra analysis of the reaction mixture of bicyclic 
aldehydes 284 and 285 [b] Ratio determined by 1H NMR spectra analysis of crude reaction mixture [c] 
Enantiomeric excess was determined using HPLC with Chiralcel® OJ column (hexane/iPrOH=90:10, 
λ=222 nm), 1.0 mL; endo isomer (tR1 15 min, 35 min) exo isomer (tR1 47 min, 65 min)) [d] 
configuration was determined by comparison with known HPLC retention times  
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We evaluated (S)-proline methyl ester hydrochloride salt 287 under our conditions 
(Entry 1) and discovered a much improved endo ee and slightly enhanced 
diastereoselectivity compared to (S)-proline (Table 43). In contrast to the amino acid 
catalysts screened (Table 43), the α-ester catalysts were exo selective and were also, 
broadly, more active catalysts, requiring shorter reaction times and resulting in 
higher conversions. Encouragingly, exo-selective catalyst-controlled Diels-Alder 
reactions are uncommon, due to competing endo-selective secondary orbital 
interactions; consequently, methodologies providing the preferential generation of 
exo adducts are highly sought.123,124 Biphenyl methyl ester 263 gave 51% ee of the 
exo enantiomer whilst 239, the binaphthyl methyl ester species, as well as being a 
less reactive catalyst, gave only 43% ee of the exo isomer (Entries 2 and 3). 
Conversely, salt 239.HCl gave higher enantioselectivities and better exo:endo 
selectivity (Entry 4). Ethyl ester 238 provided improved diastereoselectivity and ee 
compared to methyl ester 239, supporting the assumption that an increase in the size 
of the α-substituent leads to an increase in selectivity.125 Again, the hydrochloride 
salt 239.HCl was more reactive than the free amine 239, although similar ees were 
observed (Entry 6). 
The reaction conditions were then optimized for salt 239.HCl by screening a variety 
of solvents (Table 46).  
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Table 46: Solvent screening  
 
Reagents and conditions: i) Cyclopentadiene (3 equiv.), cinnamaldehyde (1 equiv.), catalyst 239.HCl 
(10 mol%), solvent, r.t.; ii) LiAlH4, Et2O, 0 °C, 2 h 
Entry Solvent 
Time 
(d) 
Conv. 
(%) [a] 
exo:endo 
284:285[b] 
endo ee 
(%) [c],[d] 
exo ee 
(%) [c],[d] 
1 MeOH:H2O 5 100 1:0.5 34 (2R,3R) 56 (2R,3R) 
2[e] MeOH:H2O 7 77 1:0.4 39 (2R,3R) 62 (2R,3R) 
3 CH2Cl2 5 61 1:0.4 28 (2R,3R) 34 (2R,3R) 
4 MeOH 2 100 1:1 36 (2R,3R) 58 (2R,3R) 
5 DMSO:H2O 5 69 1:0.6 29 (2R,3R) 42 (2R,3R) 
6 THF:H2O 5 41 1:0.5 32 (2R,3R) 42 (2R,3R) 
7 DMF:H2O 5 57 1:0.6 28 (2R,3R) 42 (2R,3R) 
8 CH2NO2: H2O 5 96 1:0.4 22 (2R,3R) 47 (2R,3R) 
9 CH3CN:H2O 5 97 1:0.4 30 (2R,3R) 46 (2R,3R) 
10 EtOH:H2O 5 94 1:0.5 35 (2R,3R) 55 (2R,3R) 
[a] Conversion determined from 1H NMR spectra analysis of the reaction mixture of bicyclic 
aldehydes 284 and 285 [b] Ratio determined by 1H NMR spectra analysis of crude reaction mixture [c] 
Enantiomeric excess was determined using HPLC with Chiralcel® OJ column (hexane/iPrOH=90:10, 
λ=222 nm), 1.0 mL; endo isomer (tR1 15 min, 35 min) exo isomer (tR1 47 min, 65 min)) [d] 
configuration was determined by comparison with known HPLC retention times [e] conducted at 0°C 
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When dichloromethane was used, a reduction in the activity of the catalyst and lower 
ees were observed (Entry 3). The highest enantioselectivities were observed when 
the reaction was conducted in polar solvents, with water and alcoholic mixtures 
showing a marginal improvement over all others (Entries 1 and 10). Water was 
found to be essential in providing selectivity, as, when the reaction was conducted in 
methanol, the diastereoisomeric ratio was reduced to 1:1, although the reaction time 
was reduced (Entry 4). Furthermore, lowering the reaction temperature improved 
both the exo selectivity and the enantioselectivity of both adducts (Entry 2). 
We were further encouraged by results published by Maruoka, who improved the 
enantioselectivity attained when using axially chiral diamine 115 (Figure 11) in an 
exo-selective Diels-Alder by addition of trifluoromethanesulfonic acid (10 mol%).126 
The behaviour of methyl ester catalyst 239.HCl was therefore assessed alongside 
various Brønsted acid co-catalysts (Table 47). Blank reactions were run, without 
catalyst, to determine whether the acid co-catalysts were capable of catalysing the 
reaction in a competing achiral process, but no conversion was noted. 
 
The addition of Brønsted acid additives increased the reaction rate in all cases, 
postulated to be as a result of accelerated iminium ion formation and subsequent 
hydrolysis, as mentioned above (Scheme 104). When using salt 239.HCl with most 
co-catalysts, enantioselectivities were not greatly affected. (±)-Camphorsulfonic acid 
was an exception as the exo isomer ee dropped to 31% (Entry 5). When triflic acid 
was employed, a slight decrease in yield was observed, suggesting that this strong 
acid additive may cause some decomposition; the ee was, however, unchanged, 
indicating that strong acids are not detrimental to selectivity (Entry 6). Additionally, 
the exo:endo ratio was slightly improved when acetic acid was used as additive 
(Entry 3). 
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Table 47: Brønsted acid additive screening 
 
Reagents and conditions: i) Cyclopentadiene (3 equiv.), cinnamaldehyde (1 equiv.), catalyst 239.HCl 
(10 mol%), Additive (10 mol%), MeOH:H2O (95:5 v/v), r.t.; ii) LiAlH4, Et2O, 0 °C, 2 h 
Entry 
Co-
catalyst 
pKa
127 
Time 
(d) 
Conv. 
(%)[a] 
exo:endo 
284:285 
[b] 
endo ee 
(%)[c],[d] 
exo ee 
(%)[c],[d] 
1 - - 5 100 1:0.5 34 (2R,3R) 56 (2R,3R) 
2 CH3CO2H 4.8 3 98 1:0.4 33 (2R,3R) 57 (2R,3R) 
3 PhCO2H 4.2 3 94 1:0.5 35 (2R,3R) 56 (2R,3R) 
4 CF3CO2H −0.3 4 100 1:0.5 34 (2R,3R) 56 (2R,3R) 
5 (±)-CSA −3 3 97 1:0.5 31 (2R,3R) 36 (2R,3R) 
6 CF3SO3H −14 3 82 1:0.5 36 (2R,3R) 57 (2R,3R) 
[a] Conversion determined from 1H NMR spectra analysis of the reaction mixture of bicyclic 
aldehydes 284 and 285 [b] Ratio determined by 1H NMR spectra analysis of crude reaction mixture [c] 
Enantiomeric excess was determined using HPLC with Chiralcel® OJ column (hexane/iPrOH=90:10, 
λ=222 nm), 1.0 mL; endo isomer (tR1 15 min, 35 min) exo isomer (tR1 47 min, 65 min)) [d] 
configuration was determined by comparison with known HPLC retention times  
 
The effect of catalyst loading was investigated under the optimized reaction 
conditions (Table 48). Upon increasing the catalyst loading to 20 mol%, a faster 
reaction time and a minor increase in enantioselectivity from 31% to 39% in the case 
of the endo isomer was detected (Entry 3). 
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Table 48: Effect of catalyst loading  
 
Reagents and conditions: i) Cyclopentadiene (3 equiv.), cinnamaldehyde (1 equiv.), catalyst 239.HCl, 
MeOH:H2O (95:5 v/v), r.t.; ii) LiAlH4, Et2O, 0 °C, 2 h 
Entry 
Cat. loading 
(mol%) 
Time 
(d) 
Conv. 
(%)[a] 
exo:endo[b] 
endo ee 
(%)[c],[d] 
exo ee 
(%)[c],[d] 
1 10 5 100 1:0.5 34 (2R,3R) 56 (2R,3R) 
2 5 5 77 1:0.5 31 (2R,3R) 56 (2R,3R) 
3 20 2 96 1:0.5 36 (2R,3R) 59 (2R,3R) 
[a] Conversion determined from 1H NMR spectra analysis of the reaction mixture of bicyclic 
aldehydes 284 and 285 [b] Ratio determined by 1H NMR spectra analysis of crude reaction mixture [c] 
Enantiomeric excess was determined using HPLC with Chiralcel® OJ column (hexane/iPrOH=90:10, 
λ=222 nm), 1.0 mL; endo isomer (tR1 15 min, 35 min) exo isomer (tR1 47 min, 65 min)) [d] 
configuration was determined by comparison with known HPLC retention times  
 
The Diels-Alder reaction can be a reversible process, depending on the reaction 
conditions. Due to the modest ees and the long reaction times observed using 
catalyst 239.HCl, we sought to determine whether a competing retro-Diels-Alder 
(rDA) was occurring. The imidazolethione 288-catalysed DA reaction using 
cinnamaldehyde and cyclopentadiene was investigated by Su (Table 49).128 
Deracemization experiments were performed on racemic DA adducts and reaction 
parameters varied: the effect of catalyst and co-catalyst loading was explored, 
alongside temperature and solvent system. It was found that the reaction conducted 
in CH3CN:H2O resulted in slight changes in the dr and ees of the adducts (Entries 2 
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and 3, Table 49), suggesting that a rDA reaction was occurring. An increased ratio 
in favour of the exo isomer was observed and the ees of the (2S)-adducts were 
slightly reduced in comparison to the (2R)-adducts, which could suggest a more 
facile rDA for the endo and (2S)-adducts, in an CH3CN:H2O solvent system 
 
Table 49: Evidence for rDA reaction128 
 
Reagents and conditions: catalyst 288 (equiv.), TFA (equiv.), solvent system, r.t., 48 h 
Entry Catalyst 
(mol%) 
TFA 
(mol%)  
Solvent  exo:endo exo ee 
(%) 
endo ee 
(%) 
1 - 0.2 CH3CN:H2O 1.2:1 0 0 
2 0.2 0.2 CH3CN:H2O 1.4:1 2 6 
3 0.2 0.2 CH3OH:H2O 1.2:1 0 0 
4 0.2 1 CH3CN:H2O 1.7:1 8 10 
5 1 1 CH3CN:H2O 1.8:1 8 12 
6[a] 0.2 1 CH3CN:H2O 1.8:1 30 40 
[a] Reaction performed at 50 °C 
We therefore set out to ascertain whether our reaction conditions could be 
facilitating a rDA process. We examined whether the ees of the adducts or the 
relative ratios of the endo and exo diastereoisomers changed after 25 days using 
catalyst 239.HCl (Table 50). After 25 days, no reduction in diastereoselectivity and 
a (very slight) increase in ee of the (2R)-adduct were observed. From this we can 
conclude that very little, if any, rDA is taking place. Our results match Su’s reported 
observation that when the reaction was performed in a CH3OH:H2O mixture, the 
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ratio of exo:endo isomers, and their ee values, are stable. Su hypothesized this to be 
as a result of formation of the dimethyl acetal derivatives of the aldehyde adducts, 
which prevent the reverse reaction.  
 
Table 50: Evaluating changes in enantioselectivity with time 
 
Reagents and conditions: i) Cyclopentadiene (3 equiv.), cinnamaldehyde (1 equiv.), catalyst 239.HCl 
(10 mol%), MeOH:H2O (95:5 v/v), r.t., .; ii) LiAlH4, Et2O, 0 °C, 2 h 
Entry 
Time 
(d) 
Conv. 
(%)[a] 
exo:endo 
284:285[b] 
endo ee 
(%)[c],[d] 
exo ee 
(%)[c],[d] 
1 5 100 1:0.5 32 (2R,3R) 56 (2R,3R) 
2 25 100 1:0.5 35 (2R,3R) 56 (2R,3R) 
[a] Conversion determined from 1H NMR spectra analysis of the reaction mixture of bicyclic 
aldehydes 284 and 285 [b] Ratio determined by 1H NMR spectra analysis of crude reaction mixture [c] 
Enantiomeric excess was determined using HPLC with Chiralcel® OJ column (hexane/iPrOH=90:10, 
λ=222 nm), 1.0 mL; endo isomer (tR1 15 min, 35 min) exo isomer (tR1 47 min, 65 min)) [d] 
configuration was determined by comparison with known HPLC retention times  
 
We next sought to extend the substrate scope, and used salt 239.HCl in the Diels-
Alder reaction between cyclopentadiene and o- and p-substituted cinnamaldehyde 
derivatives with electron-withdrawing and -donating groups (Table 51). When 
possible, catalyst 70 was screened to provide a standard comparison against salt 
239.HCl. We found the electronic nature of the aromatic ring to have little impact in 
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the outcome of the reaction: both substrates with electron-donating and -withdrawing 
substituents were well tolerated and gave comparable ees. Favourably, catalyst 
239.HCl provided greater dr than 70 in the reactions screened. In most cases we 
were able to assign the major enantiomers by comparison with literature HPLC 
retention times.124,125 We noted an increased endo enantioselectivity in all cases, with 
respect to employing cinnamaldehyde 271. Electron-withdrawing p-
nitrocinnamaldehyde gave the best conversion, presumably because of the increased 
reactivity of this substrate, while also providing the greatest exo/endo selectivity 
(Entry 5). 129,130 
Table 51: Screening dienophiles  
 
Reagents and conditions: i) Cyclopentadiene (3 equiv.), dienophile (1 equiv.), Catalyst (10 mol%), 
MeOH:H2O (95:5 v/v), r.t., .; ii) LiAlH4, Et2O, 0 °C, 2 h 
Entry Catalyst Dienophile 
Time 
(d) 
Conv. 
(%)[a] 
exo: 
endo 
284:285[b] 
endo ee 
(%) 
exo ee 
(%) 
1[c]125 70 p-C6H5OMe 4 62 1:0.8 
90 
(2S,3S) 
76 
(2S,3S) 
2[c]125 239.HCl p-C6H5OMe 4 20 1:0.6 
54 
(2S,3S) 
30 
(2S,3S) 
3[d] 70 o-C6H5OMe 4 100 1:0.7 93 90 
4[d] 239.HCl o-C6H5OMe 4 78 1:0.6 46 29 
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5[e]125 239.HCl p-C6H5NO2 4 90 1:0.5 
53 
(2R,3R) 
30 
(2S,3S) 
6[f]124 239.HCl o-C6H5NO2 4 57 1:0.8 
54 
(2S,3S) 
51 
(2R,3R) 
[a] Conversion determined from 1H NMR spectra analysis of the reaction mixture of bicyclic 
aldehydes [b] Ratio determined by 1H NMR spectra analysis of crude reaction mixture [c] Enantiomeric 
excess was determined using Chiralcel® AS-3 column (hexane/iPrOH=95:5, λ=222 nm), 0.5 mL; 
endo isomer (tR1 35 min, 59 min) exo isomer (tR1 39 min, 56 min)) [d] Chiralcel® AD-H column 
(hexane/iPrOH=98:2, λ=222 nm), 0.5 mL; endo isomer (tR1 65 min, 80 min) exo isomer (tR1 57 min, 
69 min)) [e] Chiralcel® AD-H column (hexane/iPrOH=90:10, λ=254 nm), 0.5 mL; endo isomer (tR1 49 
min, 57 min) exo isomer (tR1 43 min, 53 min)) [f] Chiralcel® AD-H column (hexane/iPrOH=95:5, 
λ=254 nm), 0.5 mL; endo isomer (tR1 37 min, 39 min) exo isomer (tR1 41 min, 50 min)). 
 
Unfortunately, attempts using a different diene failed; the reactions employing 1,3-
cyclohexadiene were unsuccessful and only trace amounts of cycloadducts were 
observed alongside starting material (Table 52). 
Table 52: Screening dienes
 
Reagents and conditions: i) 1,3 cyclohexadiene (1 equiv.), dienophile (1 equiv.), Catalyst 239.HCl 
(10 mol%), MeOH:H2O (95:5 v/v), r.t.,  
O
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Entry R Time (d) Conv. (%) Exo:endo Endo 
ee (%) 
Exo 
ee 
1 CH3 5 - - - - 
2 H 5 - - - - 
3 Ph 5 - - - - 
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10.0 General conclusion  
The aim of this project was to develop a route toward axially chiral aminocatalysts, 
inspired from known successful pyrrolidine analogues. With the recent successes 
reported using organocatalysis, it is now crucial to understand and evaluate what 
structural features aminocatalysts are required to possess in order to induce even 
greater degrees of selectivity. Accordingly, we have pioneered the synthesis of three 
novel axially chiral proline-type aminocatalysts, possessing Lewis basic/Brønsted 
acidic bifunctionality (Figure 39).  
 
 
Figure 39: α-Amino acid-type organocatalysts 
 
The binaphthyl α-amino acid derivatives are bench-stable and prepared following a 
6-step procedure, with a key divergent lithiation/carboxylation step, simplifying 
access to both α-acid diastereoisomeric catalysts. Compounds 251 and 250 were 
obtained in 14% and 18% yield overall, respectively (Scheme 105).  
 
 
Key steps: i) Lithiation and carboxylation; ii) Boc deprotection 
Scheme 105: Synthetic route to compound 250 
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In addition, we have developed the synthesis of biphenyl catalyst 265, which was 
prepared in 8 steps in 4% overall yield from 2-amino-3-methylbenzoic acid. The key 
steps in the synthesis include a diazonium salt homocoupling, a quinine-mediated 
resolution and a diastereoselective lithiation/carboxylation step (Scheme 106). 
 
Key steps: i) Copper-mediated homocoupling, ii) Resolution, iii) Lithiation and carboxylation, iv) Boc 
deprotection 
Scheme 106: Preparation of biphenyl catalyst 265 
 
We envisaged that the introduction of an additional carbon unit between the amino 
and carboxylic acid group functionalities would allow us to assess the influence of 
distal Brønsted acidic sites. Optimization of the synthesis of β-amino acid 166 was 
accomplished, following an 8-step procedure, which included a diastereoselective 
Reformatsky addition to iminium salt 176. The synthesis was complete in 28% yield 
overall. We anticipated increased conformational flexibility with this system, and 
therefore sought to derivatize the β-carbon unit, with respect to the amino 
functionality, to provide a more selective catalyst. Consequently, we directed the 
synthesis toward bulkier catalyst 216, which we were able to isolate in a 16% overall 
yield (Scheme 107).  
 
Key steps: i) Reformatsky reaction, ii) Deallylation reaction, iii) tButyl group removal 
Scheme 107: Synthesis of β-amino acid catalysts 
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In addition, we have also synthesized the corresponding biphenyl and binaphthyl α-
ester derivatives of these amino acid aminocatalysts (Figure 40). The synthesis of 
these esters was high-yielding and fully diastereoselective.  
 
 
Figure 40: α-Ester derivatives 
In order to assess whether our axially chiral species have increased reactivity and 
selectivity over non-axially chiral analogues, we have applied them in several 
asymmetric processes. Assessments of their ability to activate substrates by HOMO 
energy raising enamine and LUMO energy lowering iminium activation were made, 
and the majority of our catalysts were screened in three separate organocatalytic 
transformations; the aldol, Michael and Diels-Alder reactions. After discouraging 
results in the aldol reaction, catalyst 251 was assessed using 1H-NMR spectral 
analysis with ketone, enone and enal substrates, and demonstrated suitable iminium 
ion activation with cinnamaldehyde. Correspondingly, this substrate was used in the 
addition of malonates in the Michael reaction (Table 39). The most encouraging 
results were found when 239.HCl was applied in the Diels-Alder reaction of 
cinnamaldehyde, and several derivatives, with cyclopentadiene (Scheme 108).  
 
Key steps: i) 10 mol% 239.HCl, MeOH:H2O, 0 °C ii) LiAlH4 reduction 
Scheme 108: Low temperature Diels-Alder reaction employing catalyst 239.HCl 
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In creating these novel aminocatalysts, we have been able to further understand the 
structural characteristics necessary for the design of highly selective catalysts. From 
assessing α-amino acid catalysts, we can conclude that carboxylic acid sites on an 
azepine ring with an axially chiral backbone were not selective catalysts in our 
chosen screening reactions. α-Ester derivatives, however, promote the formation of 
the active iminium intermediates in the Michael and Diels-Alder reactions. Moderate 
diastereoselectivity and enantioselectivity were obtained, implying steric influence is 
an important feature in this type of reaction.  
 
10.1 Future work: Substrate screening 
Further screening of the Diels-Alder reaction is necessary, with simple α,β-
unsaturated aliphatic aldehydes such as acrolein and crotonaldehyde requiring 
assessment. Methacroleins would be interesting substrates to evaluate because, aside 
from the generation of highly sought-after quaternary stereocentres, α,β-unsaturated 
aldehydes, possessing an α-alkyl substituent, should have more demanding steric 
constraints (Scheme 109). Consequently the generation of the iminium intermediate 
should be more discriminatory and induce greater selectivity.  
 
 
Scheme 109: Proposed preferred iminium ion conformation of catalyst 239 and 
methacrolein 
In addition, reactions conditions require optimization to allow other substrates (other 
cyclic dienes, such as 1,3-cyclohexadiene, 1,3-pentadiene and acyclic dienes, such as 
2-methylbutadiene) to be studied.  
N CO2Me
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N CO2Me
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10.2 Catalyst design  
From the preliminary results acquired using catalyst 239, it has become apparent 
that, in order to achieve superior enantioselectivities, our catalysts need to possess 
greater structural complexity. It appears that it is not sufficient to have one 
enantiofacial-discriminating substituent; indeed, many of the most successful 
catalysts possess features that encourage double asymmetric control (Figure 41). 
 
 
Figure 41: Highly selective catalysts possessing two-fold enantiofacial control 
 
Smith described acyclic chiral hydrazide catalyst 288 affording excellent endo-
diastereoselectivity and good enantioselectivity in the Diels-Alder reaction (up to 
86% ee).131 He attributed the selectivity of this catalyst to the stereoinduction of both 
chiral influencing groups; particularly the (5S)-trifluoromethyl group. nOe spectral 
analysis confirmed the Z-geometry of the C=N bond of the iminium salt of 288 with 
substrate cinnamaldehyde, leaving the re face of the dienophile free for the reaction 
with cyclopentadiene. In a similar manner, MacMillan reported the importance of the 
stereodirecting germinal methyl substituents of catalyst 70, which influence the 
predominant formation of an iminium C=N bond with E-geometry, facilitating 
benzyl group re face shielding, promoting selective si face cycloaddition.111,132 
Second generation imidazolidinone catalyst, with a sterically hindered tert-butyl 
substituent in place of the geminal dimethyl groups of 70, resulted in superior yields 
and enantioselectivities in intramolecular Diels-Alder reactions.133 Again, 
computational modelling predicted that the E-geometry is the preferred isomer, due 
to repulsive non-bonding interactions of the substrate and the tert-butyl substituent, 
whilst the benzyl substituent shields the re face.134 Jørgensen’s catalyst 289, which 
was employed as a mixture of diastereoisomeric acids, also confers selectivity 
through re face shielding from the benzyl group or proposed π-stacking interactions 
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between the benzyl group and cinnamaldehyde’s phenyl group.135 Furthermore, 
Bonini’s aziridine-type catalyst 290 provided good selectivity in Diels-Alder and 
Friedel-Crafts alkylation reactions.136 Conversely, Hayashi, employing 95, found that 
the steric bulk of a singular CF3-disubstituted diphenyl OTMS α-substituent was 
sufficient to produce excellent ees.137,138 Therefore instalment of a single sterically 
demanding substituent should also be targeted. Optimization of the synthesis of 234 
(Scheme 92) and silyl protection, would provide bulky Jørgensen-type catalyst for 
future catalysis screening (Figure 42).  
 
 
Figure 42: Catalyst for screening  
 
To assess the extent of predicted facial selectivity when employing the most 
selective of these catalysts, we decided to investigate the energy minima of iminium 
isomers derived from catalysts 70 and 100, and their enal substrates 
(cinnamaldehyde and acrolein), using MM2 calculations (software Chem3D Pro). 
While the calculations are not as accurate as the MM3 methodology used by 
MacMillan, they can give us a broad idea of the preferred isomer of the reaction 
intermediates.111 The trans isomer was the favoured intermediate in both cases and, 
as anticipated, we saw dramatically different energy differences in the trans and cis 
isomers, which could explain the high degree of selectivity, observed when using 
these catalysts (Figure 43). 
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Figure 43: Calculated energy minima values of cinnamaldehyde- and acrolein-
derived iminium species  
 
Applying this set of calculations to catalyst 239, a much smaller energy difference 
between the cis and trans isomers was seen (Entry 1, Table 53). This estimate of a 
much-reduced energy difference in the trans/cis isomers was confirmed 
experimentally, as both catalysts 70 and 100 outperform 239 in the Diels-Alder 
reaction. We then set out to identify the optimum substitution pattern for future 
binaphthyl azepine catalyst structures. 
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Table 53: Predicted energy minima values using MM2 
 
Entry R1 R2 Cis isomer 
(kcal/mol) 
Trans isomer 
(kcal/mol) 
1 CO2Me H 21.4958 22.5201 
2 C(C6H5)2OTMS H 40.7286 41.5442 
3 Bn Me 24.4785 25.4070 
4 Bn nPr 25.2676 26.3338 
5 Ph iPr 24.8141 25.6477 
6 iPr CO2Me 30.7768 26.0680 
7 iPr CO2Et 30.3076 25.5896 
 
Assuming these calculations are broadly predictive of experimental observations, as 
postulated by MacMillan,111 future modifications of our catalyst design should be 
directed toward the installment of two enantiodiscriminating groups in both the α 
positions. Entry 6 and 7 show the highest degree of energy differentiation between 
the cis and trans isomers and, gratifyingly, these catalysts could be synthesized using 
steps previously explored in this body of work. An NBS oxidation and 
diastereoselective nucleophilic Grignard addition could furnish 291, followed by an 
allyl/Boc deprotection and protection step. An asymmetric lithiation and 
chloroformate addition and deprotection sequence could theoretically provide us 
with a route toward a better catalyst, such as 293 (Scheme 101).4 
 
N R1R2 N R1R2
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Reagents and conditions: i) iPrMgBr, THF, − 78 °C; ii) Pd(PPh3)4, N,N-dimethylbarbituric acid, 
CH2Cl2, 50 °C; iii) di-tert-butyl carbamate, tBuOH, r.t.; iv) s-BuLi, Et2O, −78 °C; v) ethyl 
chloroformate, −78 °C→ r.t; vi) HClaq (6M), acetone, 70 °C 
Scheme 110: Future catalyst design 
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Chapter three: Experimental section 
Melting points were recorded using a Büchi B-545 Melting Point apparatus. Optical 
rotations were obtained using a Bellingham and Stanley Ltd ADP440 polarimeter 
and the solvents used for these measurements were of HPLC-grade quality. IR 
spectra were recorded on a Perkin-Elmer 100 FT-IR spectrophotometer and samples 
were used as thin film DCM solutions on KBr plates. NMR spectra were recorded on 
a Bruker 500 MHz Spectrometer. Chemical shifts were recorded in parts per million 
(ppm), J values are given in Hertz (Hz) and are referenced against tetramethylsilane 
or the residual deuterated solvents peak. High-resolution mass spectra were obtained 
from the EPSRC Mass Spectrometry Unit at the University of Swansea. 
Enantiomeric excesses were determined by chiral high performance liquid 
chromatography using a Hitachi Elite LaChrom HPLC system using an L-2200 
autosampler, L-2130 pump and L-2400 UV detector. All HPLC samples were run 
against racemate as a standard and using a hexane-isopropanol mixture. Conditions 
varied and are provided in detail below. 
 
Unless otherwise stated, all starting materials were sourced from commercial 
suppliers and were used without any purification. Reactions which required the use 
of anhydrous solvents were, in the case of THF and Et2O, dried and distilled over 
sodium and benzophenone. Toluene, DCM and CH3CN were distilled over CaH2 and 
DMF was distilled over MgSO4. Needles and glassware were oven-dried were and 
allowed to cool under a positive pressure of nitrogen gas prior to use. Light 
petroleum ether was distilled at 40-60 °C to remove impurities. Dicyclopentadiene 
was cracked on the day of use to distil cyclopentadiene. 
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1.0 Synthesis of azepines 
(S)-[1,1’]-Binaphthalene-2,2’-diol bis-trifluoromethanesulfonate 1672  
 
 
 
(S)-[1,1]-2-2’-Binaphthalene diol (10.00 g, 35 mmol) and 4-dimethylaminopyridine 
(1.71 g, 14 mmol, 0.4 equiv.) were dissolved in anhydrous dichloromethane (300 
mL). The reaction mixture was cooled to –78 °C. 2,6-Lutidine (12.2 mL, 104 mmol, 
3.0 equiv.) and trifluoromethanesulfonic anhydride (18.0 mL, 104 mmol, 3.0 equiv.) 
were added to the mixture. The solution turned from yellow to pink and was allowed 
to reach room temperature overnight. Over this time period the reaction mixture 
turned from pale pink to dark brown. Silica gel was added (~10 g) and the solvent 
was removed under reduced pressure. Silica gel was placed on a sintered funnel and 
washed repeatedly with petroleum ether (~2 L). The petroleum ether fractions were 
combined and the solvents removed under reduced pressure to yield the title 
compound as a colourless solid (19.2 g, quant.). This was employed in the next step 
without further purification. 
m.p. 86-88 °C (Lit 83-85 °C)1,2; [α]D22.5 +144 ° [(c=1.00, CHCl3); Lit [α]D21: +148 º, 
(c 1.00, CHCl3)]1,2; νmax(CH2Cl2)/cm-1 3060 (C-H aromatic stretch), 1592, 1509, 
1423 (C=C aromatic stretch, multiple), 1219 (C-F stretch, strong), 1140 (S=O 
stretching), 1066, 963, 941, 739, 704, 634; 1H NMR (500 MHz; CDCl3) 8.14 (2H, d, 
J= 9.0 Hz, CH arom), 8.01 (2H, d, J= 8.2 Hz, CH arom), 7.62 (2H, d, J= 9.0 Hz, CH 
arom), 7.59 (2H, ddd, J= 8.1, 6.8, 1.1 Hz, CH arom), 7.41 (2H, ddd, J= 8.1, 6.8, 1.1 
Hz, CH arom), 7.27-7.23 (2H, m, CH arom); 13C NMR (126 MHz, CDCl3) δ 145.5, 
133.2, 132.4, 132.1, 128.4, 128.0, 127.4, 126.8, 123.5, 119.4, 118.1 (q, JC-F= 316.5 
Hz). 
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(S)-2,2'-Dimethyl-[1,1']binaphthalene 1682 
 
 
(S)-[1,1’]-Binaphthalene-2,2’-diol-bis-trifluoromethanesulfonate (15.50 g, 28 mmol) 
and 1,3-bis(diphenylphosphino)propane nickel (II) chloride (1.07 g, 1.97 mmol, 0.07 
equiv.) were dissolved in anhydrous Et2O (300 mL). The reaction mixture was 
cooled to –78 °C. A solution of methyl magnesium bromide (3M in Et2O, 38 mL, 
113 mmol, 4.0 equiv.) was added slowly and the reaction mixture was allowed to 
reach room temperature overnight. The excess Grignard reagent was quenched at 0 
°C with H2O (50 mL) and the reaction mixture was diluted with Et2O (100 mL). The 
solution was stirred for 30 min. The solids were filtered over a plug of celite and 
washed with Et2O (~50 mL). The filtrate was transferred to a separating funnel and a 
few drops of aqueous HCl (37%) were added. The organic layer was washed with 
H2O (5 x 50 mL), a saturated brine solution (2 x 30 mL), dried over anhydrous 
MgSO4. The solvents were removed under reduced pressure. The residue was 
recrystallized (hot methanol) to yield the title compound as colourless crystals (7.5 g, 
95%).  
m.p. 75–77 °C (Lit 77–79 °C)3; [α]D22.5 +36.5 ° [(c 1.00, CHCl3); Lit [α]D21 +37.7 °, 
(c 1.00, CHCl3)]3; νmax(CH2Cl2)/cm-1 3049 (C-H aromatic stretch, strong), 3007, 
2858 (C-H stretch), 1506 (C=C aromatic stretch), 1443, 1421, 1351 (C-H bending), 
1219; 1H NMR (500 MHz, CDCl3) 7.88 (4H, t, J= 8.0 Hz, CH arom) 7.50 (2H, d, J= 
8.5 Hz, CH arom) 7.38 (2H, ddd, J= 8.0, 6.8, 1.1 Hz, CH arom), 7.20 (2H, ddd, J= 
8.0, 6.8, 1.1 Hz, CH arom), 7.04 (2H, d, J= 8.1 Hz, CH arom), 2.03 (6H, s, CH3); 
13C NMR (126 MHz, CDCl3) δ 135.1, 134.3, 132.8, 132.2, 128.7, 127.9, 127.4, 
126.1, 125.6, 124.9, 20.0.  
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(S)-2,2’-Bis-bromomethyl-[1,1’]binaphthalene 1694  
 
 
(S)-2,2’-Dimethyl [1,1’] binaphthalene (4.00 g, 14.2 mmol), N-bromosuccinimide 
(6.30 g, 35.4 mmol, 2.5 equiv.) and azobisisobutyronitrile (0.23 g, 1.4 mmol, 0.1 
equiv.) were dissolved in cyclohexane (28 mL, 14 % w/v solution). The reaction was 
heated at reflux for 4 h until completion was observed using TLC. The reaction 
mixture was cooled to 0 °C and EtOAc (9 mL, 1/3 of the volume of cyclohexane) 
and distilled water (56 mL, twice the volume of cyclohexane) were added. The 
biphasic solution was stirred for 1 h to allow for precipitation and filtration yielded 
the title compound as a beige solid (4.76 g, 77%).  
m.p. 188-190 °C (Lit 180-183 °C)2 [α]D22.5 −174.4 ° [(c 1.00, CHCl3); Lit [α]D20 (for 
(R)-2,2’-Bis-bromomethyl-[1,1’]binaphthalene) +186.4 °, (c 1.00, benzene)]2; 
νmax(CH2Cl2)/cm-1 3054 (C-H aromatic stretch), 2986 (C-H stretch), 2305, 1723 
(C=C aromatic stretch), 1421, 1265 (C-H bending), 896, 740, 705 (C-Br stretch, 
strong); 1H NMR (500 MHz, CDCl3) 8.02 (2H, d, J= 8.6 Hz, CH arom), 7.92 (2H, d, 
J= 8.2 Hz, CH arom), 7.75 (2H, d, J= 8.6 Hz, CH arom), 7.49 (2H, ddd, J= 8.0, 6.8, 
1.0 Hz, CH arom), 7.27 (2H, ddd, J= 8.0, 6.8, 1.1 Hz, CH arom), 7.08-7.07 (2H, d, 
J= 8.5 Hz, CH arom), 4.25 (4H, s, CH2Br); 13C NMR (126 MHz, CDCl3) δ 134.2, 
134.1, 133.3, 132.5, 129.4, 128.0, 127.8, 126.9, 126.8, 126.8, 32.6.  
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(S)-4-Tosyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine 172  
 
p-Toluenesulfonamide (0.43 g, 2.5 mmol, 1.1 equiv.), (S)-2,2’-bis-(bromomethyl)-
[1-1’]-binaphthalene (1.00 g, 2.27 mmol) and potassium carbonate (0.94 g, 6.81 
mmol, 3.0 equiv.) were dissolved in acetonitrile (10 mL). The reaction mixture was 
heated at reflux overnight or until completion was observed using TLC. The reaction 
mixture was allowed to reach room temperature, dichloromethane (30 mL) was 
added and the solution filtered to remove excess potassium carbonate. The filtrate 
was transferred to a separating funnel and the organic layer was washed with H2O (4 
x 10 mL), a saturated brine solution (2 x 20 mL), dried over anhydrous MgSO4. The 
solvents were removed under reduced pressure to give an orange solid. The residue 
was purified using column chromatography on silica gel (light petroleum 
ether/EtOAc, 15:1) to yield the title compound as a yellow solid (0.73 g, 71%).  
m.p. 164-166 °C; [α]D21.4 +105.6 ° (c 1.00, CHCl3); νmax(CH2Cl2)/cm-1 3054 (C-H 
aromatic stretch), 2986 (C-H stretch), 2932, 2685, 2525, 2418, 2305, 1597 (C=C 
aromatic stretch), 1508, 1421(C-H bending), 1339 (C-O stretch), 1329, 1265, 1158 
(C-N stretch), 1094, 1038, 928, 896, 820; 1H NMR (500 MHz, CDCl3) δ 7.90 (2H, d, 
J= 8.2 Hz, CH arom), 7.84 (2H, d, J= 8.4 Hz, CH arom), 7.73–7.68 (2H, m, CH 
arom), 7.46 (2H, ddd, J= 8.1, 6.7, 1.2 Hz, CH arom), 7.36 (4H, t, J= 8.4 Hz, CH 
arom), 7.27–7.20 (4H, m, CH arom), 4.75 (2H, d, J= 13.0 Hz), 3.67 (2H, d, J= 13.0 
Hz), 2.39 (3H, s, Ar-CH3); 13C NMR (126 MHz, CDCl3) δ 143.3, 136.8, 135.0, 
133.4, 131.2, 131.0, 129.6, 129.1, 128.3, 127.4, 127.4, 127.3, 126.1, 126.0, 49.2, 
21.5; HRMS (CI+): m/z found for [M+H]+: 450.1522; [C29H24NO2S]+ requires 
450.1522.  
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(S)-3,5-Dihydrodinaphtho[2,1-c:1',2'-e]oxepine 2052 
 
 
(S)-2,2’-Bis(bromomethyl)-[1-1’]-binaphthalene (3.20 g, 7.3 mmol) was suspended 
in a mixture of saturated aqueous sodium carbonate solution and 1,4-dioxane (1:1, 
100 mL) and heated at reflux for 12 h. The reaction mixture was allowed to cool to 
room temperature and the mixture transferred to a separating funnel and extracted 
with Et2O (3 x 30 mL). The organic layers were combined and washed with H2O (20 
mL), a saturated brine solution (2 x 40 mL), dried over anhydrous MgSO4. The 
solvents were removed under reduced pressure and the resultant yellow oil was 
purified using column chromatography on silica gel (100:0-90:10 light petroleum 
ether/EtOAc) to give a colourless solid. Recrystallization of the solid (CHCl3 in 
hexane) yielded the title compound as a colourless solid (1.88 g, 87%). 
m.p. 170-173 °C (Lit 180-183 °C)2; [α]D20 +527.0 ° [(c 1.00, CHCl3); 
vmax(CH2Cl2)/cm-1 3054 (C-H aromatic stretch), 2986 (C-H stretching), 2304, 1420 
(C-H bending, C=C aromatic bending), 1265, 1055 (C-O stretch, strong), 896, 820; 
1H NMR (500 MHz, CDCl3) δ 8.02 (2H, d, J= 8.2 Hz), 7.98 (2H, d, J= 8.2 Hz), 7.64 
(2H, d, J= 8.3 Hz, CH arom), 7.55 (2H, dd, J= 8.6, 0.6 Hz, CH arom), 7.51 (2H, ddd, 
J= 8.1, 6.8, 1.2 Hz, CH arom), 7.31 (2H, ddd, J= 8.3, 6.8, 1.3 Hz, CH arom) 4.65 
(2H, d, J= 11.3 Hz, CH2O), 4.21 (2H, d, J= 11.3 Hz, CH2O); 13C NMR (126 MHz, 
CDCl3) δ 135.5, 134.0, 133.6, 131.2, 129.2, 128.4, 127.7, 127.4, 126.0, 126.0, 67.5.  
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(S)-2'-Bromomethyl-[1,1']binaphthalene-2-carboxaldehyde 2062  
 
 
(S)-2,7-Dihydrodinaphtho[2,1-c;1’,2’-e]oxepine (4.80 g, 16.2 mmol) was dissolved 
in cyclohexane (80 mL) and the solution cooled in an ice bath. The solution turned 
dark red as molecular bromine (0.9 mL, 18.2 mmol, 1.125 equiv.) was added slowly. 
The ice bath was removed and the reaction mixture heated at reflux for 1 h, which 
caused the reaction mixture to turn yellow in colour. The solvent was removed under 
reduced pressure and the residue redissolved in Et2O (70 mL). The solution was 
transferred to a separating funnel and the organic layer was washed with saturated 
aqueous sodium hydrogen carbonate (2 x 50 mL), a saturated brine solution (2 x 60 
mL), dried over anhydrous MgSO4. The solvent was removed under reduced 
pressure and was purified using column chromatography on silica gel (9:1 light 
petroleum/EtOAc) to yield the title compound as a colourless solid (3.04 g, 50%).  
m.p. 147-149 °C (Lit 151-153 °C)2; [α]D22.5 −142.0 ° [(c 1.00, CHCl3); Lit [α]D20 (for 
(R)-2'-Bromomethyl-[1,1']binaphthalene-2-carboxaldehyde) +144.7 ° (c 1.02, 
CHCl3)]
2; vmax(CH2Cl2)/cm-1 3054 (C-H aromatic stretch), 2986 (C-H stretch, =C-H 
stretch), 2305, 1689 (C=O, strong), 1422 (C-H bend), 1265, 896, 740, 705, 600 (C-
Br stretch); 1H NMR (500 MHz, CDCl3) δ 9.59 (1H, d, J= 1.0 Hz, CHO), 8.24 (1H, 
d, J= 8.5 Hz, CH arom), 8.13 (1H, d, J= 8.5 Hz, CH arom), 8.09 (1H, d, J= 8.5 Hz, 
CH arom), 8.03 (1H, d, J= 8.5 Hz, CH arom), 7.98 (1H, d, J= 8.0 Hz, CH arom), 
7.76 (1H, d, J= 8.5 Hz, CH arom), 7.66 (1H, ddd, J= 8.0, 7.0, 1.0 Hz, CH arom), 
7.53 (1H, ddd, J= 8.0, 7.0, 1.0 Hz, CH arom), 7.38 (1H, ddd, J= 8.5, 7.0, 1.5 Hz, 1H, 
CH arom), 7.32 (1H, ddd, J= 8.5, 7.0, 1.5 Hz, CH arom), 7.27 (1H, dd, J= 8.0, 0.5 
Hz, CH arom), 7.05 (1H, dd, J= 8.5, 0.5 Hz, CH arom), 4.37 (1H, d, J= 10.0 Hz, 
CH2Br), 4.12 (1H, d, J= 10.0 Hz, CH2Br); 13C NMR (126 MHz, CDCl3) δ 191.8, 
141.6, 136.3, 134.6, 133.6, 133.0, 132.5, 132.42, 132.42, 129.9, 129.4, 129.3, 129.2, 
128.5, 128.2, 127.41, 127.40, 127.0, 126.6, 122.4, 31.9.  
O
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(S)-Allyl-4,5-dihydro-3H-4-aza-cyclohepta[2,1-a;3,4-a']dinaphthalene 1715  
 
  
(S)-2,2’-Bis-(bromomethyl)-[1-1’]-binaphthalene (2.50 g, 5.7 mmol) and allylamine 
(0.5 mL, 6.25 mmol, 1.1 equiv.) were dissolved in acetonitrile (25 mL). Anhydrous 
potassium carbonate (2.36 g, 17.1 mmol, 3.0 equiv.) was added and the reaction 
mixture heated at reflux overnight or until completion was observed using TLC. The 
reaction mixture was cooled to room temperature, diluted with dichloromethane (40 
mL) and filtered to remove potassium carbonate. The filtrate was transferred to a 
separating funnel and the organic layer washed with H2O (3 x 10 mL), a saturated 
brine solution (2 x 20 mL), dried over anhydrous MgSO4. The solvent was removed 
under reduced pressure yielding an orange solid. Recrystallization (hot acetone) 
yielded the title compound as a pale yellow solid (1.60 g, 84%).  
m.p. 167-169 °C (Lit 148-149 °C)6; [α]D22.5 +396.2 ° (c 1.80, CHCl3); 
νmax(CH2Cl2)/cm-1 3944, 3054 (=C-H stretch, C-H aromatic stretch, strong), 2987 
(C-H stretch, strong), 2829, 2685, 2410, 2305, 1508 (C-C aromatic stretch), 1421 
(C-H bending), 1263 (C-N stretch), 1156, 896, 820; 1H NMR (500 MHz, CDCl3) 
8.00 (4H, d, J= 8.3 Hz, CH arom), 7.59 (2H, d, J= 8.2 Hz, CH arom), 7.52-7.49 (4H, 
m, CH arom), 7.31 (2H, ddd, J= 8.3, 6.8, 1.1 Hz, CH arom), 6.09-6.01 (1H, m, 
NCH2CHCH2), 5.32 (1H, dd, J= 17.1, 1.3 Hz, NCH2CHCH2), 5.28 (1H, d, J= 10.0 
Hz, NCH2CHCH2), 3.79 (2H, d, J= 12.5 Hz, ArCH2N), 3.21 (2H, d, J= 12.5 Hz, 
ArNCH2), 3.21-3.13 (2H, m, NCH2CHCH2); 13C NMR (125 MHz, CDCl3) 136.3, 
135.1, 133.4, 133.2, 131.4, 128.4, 128.3, 127.8, 127.5, 125.8, 125.5, 118.1, 58.5, 
54.8.  
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(S)-4-Allyl-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium bromide  
 
 
(S)-Allyl-4,5-dihydro-3H-4-aza-cyclohepta[2,1-a;3,4-a']dinaphthalene (1.00 g, 3.0 
mmol) was dissolved in dichloromethane (50 mL). The flask was placed in an ice 
bath and N-bromosuccimide (0.56 g, 3.13 mmol, 1.05 equiv.) was added and the 
solution was stirred for 1 h or until completion was observed using TLC. The solvent 
was removed under reduced pressure to yield the crude bromide salt as an orange 
foamy solid (3.83 g crude mass, not routinely isolated).  
m.p.* 110 °C (*decomp); [α]D22.5 +316.0 ° (c 1.00, CHCl3); νmax(CH2Cl2)/cm-1 3684, 
3409, 3019 (=C-H stretch, C-H aromatic stretch), 2956 (C-H stretch, strong), 2400, 
1780, 1753, 1722, 1650, 1521 (C-C aromatic stretch), 1430 (C=N stretching, C-H 
bending), 1343, 1160 (C-N stretch), 1016; 1H NMR (500 MHz, CDCl3) δ 10.88 (1H, 
s, ArCHN+), 8.50 (1H, d, J= 8.6 Hz, CH arom), 8.16 (1H, d, J= 8.8 Hz, CH arom), 
8.10 (1H, d, J= 8.4 Hz, CH arom), 8.05 (1H, d, J= 8.3 Hz, CH arom), 7.96 (1H, d, J= 
8.2 Hz, CH arom), 7.70 (1H, ddd, J= 8.1, 6.8, 1.1 Hz, CH arom), 7.61 (1H, d, J= 8.4 
Hz, CH arom), 7.53–7.49 (2H, m, CH arom), 7.37 (1H, ddd, J= 8.1, 6.8, 1.2 Hz, CH 
arom), 7.25 (1H, ddd, J= 8.1, 6.8, 1.2 Hz, CH arom), 7.06-7.05 (1H, d, J= 8.4 Hz, 
CH arom), 5.92 (1H, m, NCH2CHCH2), 5.71 (1H, d, J= 17.0 Hz, NCH2CHCH2 
trans), 5.57 (1H, d, J= 10.0 Hz, NCH2CHCH2 cis), 5.35 (1H, dd, J= 14.2, 6.6 Hz, 
NCH2CHCH2), 5.23 (1H, dd, J= 14.2, 6.6 Hz, NCH2CHCH2), 5.02 (1H, d, J= 13.3 
Hz, ArCH2N), 4.57 (1H, d, J= 13.3 Hz, ArCH2N); 13C NMR (126 MHz, CDCl3) δ 
177.2, 169.9, 141.4, 135.4, 134.7, 133.7, 132.0, 131.52, 131.48, 130.3, 129.6, 129.4, 
128.7, 128.6, 127.5, 127.4, 127.3, 127.22, 127.18, 127.0, 125.3, 125.2, 64.6, 56.6, 
29.6. 
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(S)-4-Allyl-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium tetraphenylborate 176  
 
 
Crude (S)-4-Allyl-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium bromide (3.83 g) was 
dissolved in a minimum volume of ethanol and sodium tetraphenylborate (1.13 g, 3.3 
mmol, 1.1 equiv., in the minimum volume of acetonitrile) was added. The solution 
was stirred for 10 min. A bright yellow precipitate formed instantly, the solid was 
collected by filtration and washed with cold ethanol to yield the title compound as a 
yellow solid which was dried at 70 °C overnight (1.55 g, 80%).  
m.p.* 160 °C (*decomp.); [α]D22.5 +410.5 ° (c 1.00, MeCN); νmax(CH2Cl2)/cm-1 3054 
(=C-H stretch, C-H aromatic stretch), 2987 (C-H stretch, strong), 2685, 2410, 2305, 
1521 (C-C aromatic stretch), 1263 (C=N stretch), 1156 (C-N stretch), 896; 1H NMR 
(500 MHz, DMSO) δ 9.58 (1H, s, ArCHN+), 8.40 (1H, d, J= 8.6 Hz, CH arom), 8.28 
(2H, t, J= 8.8 Hz, CH arom), 8.10 (2H, dd, J= 14.3, 8.3 Hz, CH arom), 7.87 (1H, d, 
J= 8.5 Hz, CH arom), 7.81 (1H, t, J= 7.4 Hz, CH arom), 7.57 (1H, t, J= 7.5 Hz, CH 
arom), 7.51 (1H, t, J= 7.6 Hz, CH arom), 7.46 (1H, d, J= 8.5 Hz, CH arom), 7.32 
(1H, t, J= 7.7 Hz, CH arom), 7.20 (8H, s, BPh4 arom), 7.01 (1H, d, J= 8.7 Hz, CH 
arom), 6.94 (8H, t, J= 7.3 Hz, BPh4 arom), 6.81 (4H, t, J= 7.1 Hz, BPh4 arom), 6.04–
5.90 (1H, m, NHCH2CHCH2), 5.67 (1H, d, J= 17.5 Hz, NHCH2CHCH2 trans), 5.55 
(1H, d, J= 10.1 Hz, NHCH2CHCH2 cis), 5.16 (1H, d, J= 13.5 Hz, ArCH2N), 4.86 
(2H, d, J= 5.5 Hz, NHCH2CHCH2), 4.71 (1H, d, J= 13.6 Hz, ArCH2N); 13C NMR 
(126 MHz, DMSO) δ 179.9, 164.5, 164.1, 163.7, 163.3, 141.0, 136.6, 136.0, 135.2, 
133.8, 131.8, 131.5, 131.3, 131.2, 130.5, 129.8, 129.6, 129.5, 129.2, 128.1, 127.5, 
127.2, 126.9, 126.7, 125.80, 125.78, 125.76, 125.74, 124.3, 122.0, 64.1; HRMS 
(NSI+) m/z found for [M-BPh4]+: 334.1595 [C25H20N]+ requires 334.1590. 
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Alternative procedures for the synthesis of (S)-4-Allyl-3H-dinaphtho[2,1-c:1',2'-
e]azepin-4-ium tetraphenylborate 176: 
 
 
 (S)-Allyl-4,5-dihydro-3H-4-aza-cyclohepta[2,1-a;3,4-a']dinaphthalene (2.12 g, 6.3 
mmol) was dissolved in anhydrous dichloromethane (100 mL). Dried crushed 
molecular sieves and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (2.87 g, 12.6 
mmol, 2 equiv.) were added. The solution was stirred at ambient temperature for 2 h 
or until completion was observed using TLC. Sodium tetraphenylborate (2.37 g, 6.93 
mmol, 1.1 equiv., in the minimum volume of acetonitrile) was added and the 
reaction stirred for a further 10 min. The solvent was removed under reduced 
pressure and the orange residue triturated in hot EtOH to yield the title compound as 
a bright yellow solid (1.9 g, 46%). 
 
 
(S)-2'-Bromomethyl-[1,1']binaphthalene-2-carboxaldehyde (1.41 g, 3.76 mmol) was 
dissolved in EtOH (15 mL) and allylamine (0.3 mL, 3.76 mmol, 1 equiv., as a 
solution in ethanol, 0.5 mL) was added dropwise. The reaction mixture was warmed 
to 35 °C and stirred for 4 h or until consumption of starting material was seen by 
TLC. The solution was allowed to reach room temperature and sodium 
tetraphenylborate (1.42 g, 4.14 mmol, 1.10 equiv., in the minimum volume of 
acetonitrile) was added. After 10 min of stirring, the solvents were removed under 
reduced pressure and the crude residue triturated in hot EtOH to yield the title 
compound as a bright yellow solid (1.59 g, 65%).  
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(3S,11cS)-4-Allyl-3-methyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine  
 
  
(S)-4-Allyl-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium tetraphenylborate (843 mg, 1.29 
mmol) was dissolved in anhydrous THF (20 mL). The solution was cooled to –78 °C 
and a solution of methyl magnesium bromide (3M in Et2O, 2.2 mL, 6.45 mmol, 5 
equiv.) was added slowly. The reaction mixture was allowed to reach room 
temperature overnight. The excess Grignard reagent was quenched with H2O (5 mL) 
and the reaction mixture was diluted with Et2O (30 mL). The organic layer was 
washed with H2O (20 mL), a saturated brine solution (10 mL), dried over anhydrous 
MgSO4. The solvents were removed under reduced pressure and the residue was 
purified using column chromatography on silica gel (7:3 light petroleum/EtOAc 3% 
TEA) to yield the title compound as a colourless oil (388 mg, 86%).  
[α]D24.8 +317 ° (c 1.00, CHCl3); νmax(CH2Cl2)/cm-1 3048 (C-H aromatic stretch), 
3005, 2959 (C-H stretch), 2928, 2904, 2805, 2866, 1506 (C-H bend), 1366 (C-C 
aromatic stretch), 1264, 1112 (C-N stretch), 819, 750, 738; 1H NMR (500 MHz, 
CDCl3) δ 7.95-7.87 (4H, m, CH arom), 7.65 (1H, d, J= 8.3 Hz, CH arom), 7.48 (1H, 
dd, J= 8.6, 0.7 Hz, CH arom), 7.44–7.38 (3H, m, CH arom), 7.33 (1H, d, J= 8.3 Hz, 
CH arom), 7.21 (2H, appt dddd, J= 8.1, 7.0, 5.7, 1.3 Hz, CH arom), 6.00 (1H, dddd, 
J= 17.6, 10.1, 7.6, 5.5 Hz, CH2CH=CH2), 5.25 (1H, dd, J= 17.0, 1.5 Hz, 
NCH2CH=CH2 trans), 5.19 (1H, dd, J= 11.0, 1.0 Hz, NCH2CH=CH2 cis), 4.04 (1H, 
q, J= 7.3 Hz, CHCH3), 3.72 (1H, d, J= 11.0 Hz, NCH2Ar), 3.26 (1H, appt ddt, J= 
13.6, 5.4, 1.4 Hz, NCH2CH=CH2), 3.15 (1H, dd, J= 13.7, 7.6 Hz, NCH2CH=CH2), 
3.10 (1H, d, J= 11.0 Hz, NCH2Ar), 0.54 (3H, d, J= 7.4 Hz, CHCH3); 13C NMR (126 
MHz, CDCl3) δ 137.4, 136.6, 135.8, 135.1, 133.3, 133.2, 132.9, 132.1, 132.0, 129.2, 
128.8, 128.4, 128.1, 128.0, 127.42, 127.40, 125.9, 125.7, 125.5, 117.9, 61.9, 61.0, 
56.8, 22.2; HRMS (NSI+) m/z found for [M+H]+: 350.1902; [C26H24N]+ requires 
350.1903. 
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 (3S,11cS)-3-Methyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine 267 
 
 
(3S,11cS)-4-Allyl-3-methyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine (700 
mg, 2.00 mmol) was dissolved in anhydrous dichloromethane (20 mL). Pd(PPh3)4 
(92 mg, 0.08 mmol, 0.04 equiv.) and 1,3-dimethylbarbituric acid (937 mg, 6.00 
mmol, 3 equiv.) were added and the reaction mixture was heated at reflux overnight 
or until TLC showed complete consumption of the starting material. The reaction 
was cooled to room temperature and the organic layers washed with 1 M NaOH (2 x 
15 mL), H2O (2 x 10 mL), a saturated brine solution (2 x 10 mL) and dried over 
anhydrous MgSO4. The solvent was removed under reduced pressure and the 
product purified using column chromatography on silica gel (10% MeOH in CH2Cl2) 
to yield the title compound as a yellow foam (341 mg, 55%).  
m.p. 110-112 °C, [α]D22.6 +498.0 ° (c 1.00, CHCl3); νmax(CH2Cl2)/cm-1 3049 (N-H 
bend, C-H aromatic stretch), 2951 (C-H stretch), 2923, 2864, 1673, 1594 (C-H 
bend), 1075 (br, NH wag), 819, 750; 1H NMR (500 MHz, CDCl3) δ 7.99–7.89 (4H, 
m, CH arom), 7.61 (1H, d, J= 8.3 Hz, CH arom), 7.50–7.45 (3H, m, CH arom), 7.41 
(1H, d, J= 8.2 Hz), 7.37 (1H, d, J= 8.3 Hz) 7.29–7.21 (2H, m, CH arom), 4.41 (1H, 
q, J= 7.3 Hz, CHCH3), 3.86 (1H, d, J= 12.4 Hz, CH2), 3.78 (1H, d, J= 12.3 Hz, 
CH2), 2.31 (1H, s, NH), 0.72 (3H, d, J= 7.2 Hz, CH3); 13C NMR (126 MHz, CDCl3) 
δ 138.5, 135.4, 133.5, 133.3, 133.2, 132.20, 132.17, 129.2, 129.1, 128.4, 128.2, 
127.3, 127.2, 127.0, 126.1, 125.8, 125.7, 125.7, 57.3, 48.4, 22.5; HRMS (NSI+) m/z 
found for [M+H]+: 310.1589; [C23H20N]+ requires 310.1590. 
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(3S,11cS)-4-Allyl-3-ethynyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine  
 
 
(S)-4-Allyl-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium (1.00 g, 1.52 mmol) was 
dissolved in anhydrous THF (30 mL). The reaction mixture was cooled to –78 °C 
and a solution of ethynylmagnesium bromide (0.5M solution in THF, 46 mL, 22.8 
mmol, 15 equiv.) was added slowly. The reaction was allowed to reach room 
temperature overnight. The reaction mixture was quenched at 0 °C with saturated 
ammonium chloride solution (5 mL) and diluted with Et2O (50 mL). The mixture 
was transferred to a separating funnel and the organic layer washed with H2O (2 x 10 
mL), saturated brine solution (10 mL), dried over anhydrous MgSO4. The solvent 
was removed under reduced pressure and the residue purified using column 
chromatography on silica gel (10:1, light petroleum ether/EtOAc) to yield the title 
compound as a colourless solid (200 mg, 37%). 
[α]D22.5 +271 ° (c 1.00, CHCl3); νmax(CH2Cl2)/cm-1 3921, 3092 (=C-H stretch, C-H 
aromatic stretch, strong), 2767 (C-H stretch, strong), 2825, 2684, 2680, 2201 (C≡C 
stretch), 1503 (C-C aromatic stretch), 1470 (C-H bending), 1206 (C-N stretch), 
1152; 1H NMR (500 MHz, CDCl3) δ 8.01-7.89 (4H, m, CH arom), 7.59-7.57 (2H, m, 
CH arom), 7.50 (1H, ddd, J= 8.1, 6.8, 1.1 Hz, CH arom), 7.45-7.42 (3H, m, CH 
arom), 7.30 (1H, ddd, J= 8.1, 6.7, 1.5 Hz CH arom), 7.26-7.22 (1H, m, CH arom), 
6.03 (1H, dddd, J= 17.6, 10.1, 7.7, 5.5 Hz, NCH2CHCH2), 5.34 (1H, dd, J= 17.1, 1.3 
Hz, NCH2CHCH2 trans), 5.27 (1H d, J= 10.2 Hz, NCH2CHCH2 cis), 4.85 (1H, d, J= 
2.6 Hz, CHC≡CH), 3.76 (1H, d, J= 11.9 Hz, NCH2Ar), 3.36-3.28 (1H, m, 
NCH2CHCH2), 3.22-3.17 (1H, m, NCH2CHCH2), 3.18 (1H, d, J= 12.0 Hz, 
NCH2Ar), 1.27 (1H, d, J= 2.6 Hz, CHC≡CH); 13C NMR (126 MHz, CDCl3) δ 136.0, 
135.7, 134.7, 133.3, 133.3, 132.8, 132.3, 131.9, 128.9, 128.8, 128.6, 128.2, 128.1, 
127.8, 127.5, 127.5, 127.4, 126.0, 125.9, 125.7, 125.3, 118.6, 82.1, 70.4, 58.1, 55.5, 
55.1; HRMS (NSI+) m/z found for [M+H]+ 360.1750; [C27H22N]+ requires 360.1747. 
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(S)-4,5-Dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepinium hydrochloride 200 
 
 
 (S)-Allyl-4,5-dihydro-3H-4-aza-cyclohepta[2,1-a;3,4-a']dinaphthalene (760 mg, 
2.26 mmol) was dissolved in anhydrous dichloromethane (20 mL). 1,3-
Dimethylbarbituric acid (1060 mg, 6.8 mmol, 3 equiv.) and Pd(PPh3)4 (52 mg, 0.045 
mmol, 0.02 equiv.) were added. The solution was heated at reflux overnight or until 
full consumption of the starting material was seen by TLC. The reaction mixture was 
cooled to room temperature and the solvent removed under reduced pressure. The 
residue was redissolved in Et2O (30 mL) and the organic layer washed with 1 M 
NaOH (2 x 20 mL), H2O (2 x 20 mL) and a saturated brine solution (2 x 20 mL). The 
organic layers were dried over anhydrous MgSO4. To the filtrate a few drops of HCl 
(37%) were added and solution stirred for 10 min. The solvent was removed reduced 
pressure and the residue was recrystallized (hot CHCl3) to yield the title compound 
as a pale beige solid (600 mg, 80%).  
m.p.* 320-322 °C (*decomp.); [α]D21.9 +436.4 ° (c 1.00, MeOH); vmax(CH2Cl2)/cm-1 
3944, 3689, 3054 (=C-H aromatic stretching), 2986 (N-H streching, strong), 2827, 
2726, 2600, 2410, 2305, 1596 (C=C aromatic stretch), 1581, 1421 (C-H stretch, 
C=C aromatic stretch), 1263, 1217 (C-N stretch), 896, 819 (N-H wag); 1H NMR 
(500 MHz, DMSO) 10.16 (1H, s, NH.HCl) 9.89 (1H, s, NH.HCl), 8.22 (2H, d, J= 
8.0 Hz, CH arom), 8.15 (2H, d, J= 8.0 Hz, CH arom), 7.81 (2H, d, J= 7.0 Hz, CH 
arom), 7.41 (2H, t, J= 8.0 Hz, CH arom), 7.61 (2H, t, J= 7.5 Hz, CH arom), 7.29 
(2H, d, J= 8.5 Hz, CH arom), 4.38 (2H, d, J= 13.0 Hz, CH2), 3.54 (2H, d, J= 12.5 
Hz, CH2); 13C NMR (126 MHz, d6-DMSO) δ 134.7, 133.6, 130.6, 129.3, 128.9, 
128.63, 128.56, 128.1, 128.0, 126.7, 45.0; HRMS (NSI+) m/z found for [M-Cl]+: 
296.1432; [C22H18N]+ requires 296.1434. 
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(S)-4,5-Dihydro-3H-4-aza-cyclohepta[2,1-a;3,4-a’]dinaphthalene 1294 
 
 
(S)-4,5-Dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepinium hydrochloride (696 mg, 2.09 
mmol) was dissolved in dichloromethane (5 mL) and saturated sodium hydrogen 
carbonate solution (5 mL) was added. The biphasic solution was stirred for 30 min at 
room temperature. The organic layer was separated, washed with H2O (3 x 5 mL), 
saturated brine solution, dried over anhydrous MgSO4. The solvent was removed 
under reduced pressure to yield the title compound as a yellow foamy solid (620 mg, 
quant.).  
M.p. 80-89 °C; (Lit 73-84 °C)7; [α]D22.3 +578 ° [(c 1.00, CHCl3); Lit [α]D20 +620 °(c 
0.78, CHCl3)]7; vmax(CH2Cl2)/cm-1 3040 (=C-H aromatic stretch, N-H bend), 2967, 
2823, 1578 (C=C aromatic stretch), 1490, 1412, 1389, 1325 (C-H stretch), 1058 (C-
N stretch), 1022, 812 (N-H wag), 751; 1H NMR (500 MHz, CDCl3) δ 8.00 (4H, dd, 
J= 11.7, 8.5 Hz, CH arom), 7.61 (2H, d, J= 8.5 Hz, CH arom), 7.48-7.51 (4H, m, 
CH arom), 7.29-7.32 (2H, m, CH arom), 3.89 (2H, d, J= 12.4 Hz, CH2), 3.56 (2H, d, 
J= 12.5 Hz, CH2) 2.74 (1H, s, NH); 13C NMR (126 MHz, CDCl3) δ 135.0, 134.9, 
133.2, 131.4, 128.9, 128.3, 127.4, 127.1, 125.8, 125.4, 48.7.  
 
 
 
 
 
 
 
 
 
 
NH.HCl
200
NH
129
   
204 
(S)-4-(4-Methoxybenzyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine 170 
 
 
(S)-2,2’bis(bromomethyl)-[1-1’]binaphthalene (2.21 g, 5.0 mmol) and p-methoxy-
benzylamine (0.72 mL, 5.5 mmol, 1.1 equiv.) were dissolved in acetonitrile (20 mL). 
Anhydrous potassium carbonate (2.10 g, 15.0 mmol, 3 equiv.) was added and the 
reaction was heated at reflux for 4 h or until consumption of the starting material was 
observed by TLC. The reaction mixture was diluted with dichloromethane (40 mL) 
and filtered to remove potassium carbonate. The filtrate was transferred to a 
separating funnel and washed with H2O (2 x 60 mL), saturated brine solution (2 x 20 
mL) and dried over anhydrous MgSO4 and the solvent removed under reduced 
pressure. Purification using column chromatography on silica gel (0.5 % 
MeOH:CH2Cl2) afforded the title compound as a colourless solid (1.9 g, 91%).  
m.p. 207-209 °C; [α]D22.5 +129 ° (c 1.00, CHCl3); νmax(CH2Cl2)/cm-1 3945, 3688, 
3054 (=C-H aromatic stretch), 2987, 2685, 2305, 1512 (C=C aromatic stretch, C-C 
stretch aromatic), 1422 (C-H stretch), 1264 (C-O stretch, C-N stretch), 896; 1H 
NMR (500 MHz, CDCl3) δ 7.95 (4H, d, J= 8.2 Hz, CH arom), 7.53 (2H, d, J= 8.3 
Hz, CH arom), 7.49-7.42 (4H, m, CH arom), 7.34 (2H, d, J= 8.7 Hz, CH arom), 
7.29-7.25 (2H, m, CH arom), 6.90 (2H, d, J= 8.7 Hz, CH arom), 3.83 (3H, s, OMe), 
3.66 (2H, d, J= 12.3 Hz, CH2), 3.62 (2H, d, J= 12.8 Hz, NCH2PhOMe), 3.51 (2H, d, 
J= 12.8 Hz, NCH2PhOMe), 3.18 (2H, d, J= 12.3 Hz, CH2); 13C NMR (126 MHz, 
CDCl3) δ 158.8, 135.1, 133.7, 133.2, 131.5, 131.2, 130.4, 128.3, 128.3, 127.9, 127.5, 
125.7, 125.4, 113.8, 59.1, 55.3, 55.1; HRMS (CI+) m/z found for [M+H]+: 416.2010; 
[C30H26NO]+ requires 416.2009.  
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(S)-4-(4-Methoxybenzyl)-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium 175 
 
 
(S)-4-(4-methoxybenzyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine (1.90 g, 
4.58 mmol) and N-bromosuccinimide (0.86 g, 4.80 mmol, 1.05 equiv.) were 
dissolved in dichloromethane (50 mL). The reaction mixture was stirred for 1 h at 
room temperature or until full consumption of the starting material was seen by 
TLC. The solution was transferred to a separating funnel and the organic layer was 
washed with H2O (30 mL), saturated brine solution (2 x 30 mL), dried over 
anhydrous MgSO4 and concentrated under reduced pressure. The iminium bromide 
(3.20 g) was isolated as an orange foam and dissolved in a minimum volume of 
EtOH. Sodium tetraphenylborate (1.65 g, 4.80 mmol, 1.05 equiv., dissolved in the 
minimum volume of acetonitrile) was added and the solution was stirred for 10 min. 
The solvent was removed under reduced pressure and the residue triturated in hot 
EtOH to yield the title compound as a bright yellow solid (3.12 g, 93%).  
m.p.* 188-189 °C (*decomp.); [α]D22.4 +234 ° (c 1.00, CHCl3); νmax(CH2Cl2)/cm-1 
3054 (=C-H aromatic stretch), 3005, 1693 (C=N stretch), 1638, 1610, 1594 (C-C 
stretch aromatic), 1547, 1513, 1462 (C=C aromatic stretch, C-H stretch), 1429, 
1360, 1255 (C-O stretch), 1180 (C-N stretch), 1030, 869, 818, 734, 705, 612; 1H 
NMR (400 MHz, DMSO) δ 9.86 (1H, s, ArCHN+), 8.40 (1H d, J = 8.6 Hz, CH 
arom), 8.25 (1H d, J = 8.3 Hz, CH arom), 8.12 (1H d, J = 8.6 Hz, CH arom), 8.03 
(2H t, J = 8.0 Hz, CH arom), 7.78 (1H, t, J= 7.5 Hz, CH arom), 7.52 (3H, t, J = 7.4 
Hz, CH arom), 7.46 (1H, d, J = 7.1 Hz, CH arom), 7.39 (1H, d, J = 8.5 Hz, CH 
arom), 7.29 (1H, d, J = 7.9 Hz, CH arom), 7.25 (1H, d, J = 8.5 Hz, CH arom), 7.18 
(8H, d, J = 1.1 Hz, CH arom), 6.94 (11H, dt, J = 14.6, 7.4 Hz, CH arom), 6.79 (4H, t, 
J = 7.1 Hz, CH arom), 5.35 (2H, s,), 5.08 (1H, d, J = 13.6 Hz,), 4.65 (1H, d, J = 13.5 
Hz,), 3.79 (3H, s, OMe); 13C NMR (101 MHz, DMSO) δ 169.2, 164.6, 164.1, 163.6, 
163.1, 160.6, 136.8, 136.0, 136.0, 132.0 131.6, 130.9, 130.4, 129.6, 129.4, 129.1, 
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129.1, 128.0, 127.4, 127.4, 127.1, 127.1, 126.7, 126.2, 125.8, 125.8, 125.7, 124.2, 
122.0, 114.8, 64.2, 55.8; HRMS (CI+): m/z found for [M-BPh4]+: 414.1853; 
[C30H24NO]+ requires 414.1852.  
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5-((3S,11cS)-4-(4-Methoxybenzyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-
e]azepin-3-yl)-2,2-dimethyl-1,3-dioxane-4,6-dione  
 
2,2 Dimethyl [1, 3] dioxane 4, 6 dione (490 mg, 3.40 mmol, 5 equiv.) was dissolved 
in THF (20 mL) and cooled to −78 °C. n-BuLi (2.5 M in hexane, 1.36 mL, 3.40 
mmol, 5 equiv.) was added and the reaction mixture was stirred for 1 h. This solution 
was then transferred to a flask containing the (S)-4-(4-methoxybenzyl)-3H-
dinaphtho[2,1-c:1',2'-e]azepin-4-ium (500 mg, 0.68 mmol), in THF (30 mL), cooled 
to −78 °C. The reaction was allowed to reach ambient overnight. The reaction 
mixture was quenched with saturated solution of ammonium chloride (10 mL), 
diluted with Et2O (50 mL) and washed and separated with H2O (2 x 20 mL). The 
organic layers were dried using saturated brine solution (30 mL) and MgSO4. 
Purified by column chromatography (2:1 light petroleum ether/ CH2Cl2) afforded the 
title compound as a yellow oil (100 mg, 26%).  
νmax(CH2Cl2)/cm-1 3055 (=C-H aromatic stretch), 2987 (=C-H aromatic stretch), 
2306, 1674 (C=O aromatic stretch), 1596 (C=C aromatic stretch, C-H stretch), 
1421 (C-N stretch, C-O stretch), 896, 747, 704; 1H NMR (500 MHz, CDCl3) δ 10.72 
(1H, br s, NCHCH), 8.05 (1H, d, J= 8.2 Hz, CH arom), 7.96 (2H, t, J= 8.8 Hz, CH 
arom), 7.86 (2H, dd, J= 8.5, 2.8 Hz, CH arom), 7.54 (1H, ddd, J= 8.1, 6.8, 1.1 Hz, 
CH arom), 7.51 (1H, d, J= 8.3 Hz, CH arom), 7.46 (1H, d, J= 8.1 Hz, CH arom), 
7.41 (1H, ddd, J= 8.1, 5.7, 2.2 Hz, CH arom), 7.37 (2H, d, J= 8.7 Hz, CH arom), 
7.31 (1H, ddd, J= 8.3, 6.8, 1.2 Hz, CH arom), 7.15 (2H, dd, J= 5.7, 1.1 Hz, CH 
arom), 6.97-6.93 (2H, m, CH arom), 5.08 (1H, d, J= 7.5 Hz, NCHCH), 4.48 (1H, d, 
J= 13.7 Hz, NCH2C6H4OMe), 3.88 (1H, d, J= 13.3 Hz, NCH2Ar), 3.78 (3H, s, 
OMe), 3.76-3.68 (1H, m, NCH2Ar), 3.68-3.60 (1H, m, NCH2C6H4OMe), 1.92 (3H, 
s, CH3), 1.70 (3H, s, CH3); 13C NMR (126 MHz, CDCl3) δ 169.4, 165.7, 160.7, 
137.2, 134.8, 134.3, 134.1, 132.1, 132.0, 131.5, 131.1, 129.8, 129.5, 128.4, 128.4, 
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128.3, 127.6, 127.4, 127.4, 127.0, 126.7, 126.4, 126.0, 124.6, 122.9, 115.2, 103.3, 
67.8, 65.0, 55.5, 53.5, 49.2, 31.0, 27.7, 25.0. 
 
Methyl 2-((3S,11cS)-4-(4-methoxybenzyl)-4,5-dihydro-3H dinaphtho[2,1c:1',2'e] 
azepin-3-yl) acetate 189 
 
Zinc powder (800 mg, 12.2 mmol, 18 equiv.) and anhydrous THF (30 mL) were 
added to a flame-dried nitrogen-purged round-bottom flask. 1,2 BrCH2CH2Br (2.9 
mL, 0.034 mmol, 0.05 equiv.) and TMSCl (3.4 mL, 0.027 mmol, 0.04 equiv.) were 
added and the reaction was stirred at reflux for 30 min. The reaction mixture was 
removed from the heat and allowed to reach room temperature. Methyl bromoacetate 
(3 drops) was added and the reaction was stirred for a further 15 min. (S)-4-(4-
methoxybenzyl)-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium (500 mg, 0.68 mmol) was 
added in one portion. Methyl bromoacetate (1 mL, 10.2 mmol, 15 equiv.) was added 
slowly over the course of over 1 h, causing the reaction mixture to turn red. The 
reaction mixture was stirred for 12 h at 30 °C after which it was diluted with Et2O 
(45 mL) and filtered through a pad of celite. Potassium carbonate solution (50% w/v, 
15 mL) was added and the biphasic solution was stirred for 30 min. The solution was 
then transferred to a separating funnel and the organic layers washed with H2O (3 x 
10 mL), saturated brine solution, and dried over anhydrous Na2SO4. The solvent was 
removed under reduced pressure and the residue was purified using column 
chromatography on silica gel (6:1 light petroleum ether/EtOAc) to isolate the title 
compound as a colourless solid (166 mg, 50%).  
m.p. 76-78 °C; [α]D22.5 +152 ° (c 1.00, CHCl3); νmax(CH2Cl2)/cm-1 3054 (=C-H 
aromatic stretch), 2987, 1776 (C=O stretch), 1533 (C=C aromatic stretch), 1437 
(C-H stretch), 1265 (C-N stretch), 1320 (C-O stretch) 1010, 739; 1H NMR (500 
MHz, CDCl3) δ 7.93-7.80 (4H, m, CH arom), 7.45 (1H, d, J= 8.3 Hz, CH arom), 
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7.42-7.35 (4H m, CH arom), 7.28 (1H, d, J= 8.1 Hz, CH arom), 7.23-7.14 (2H, m, 
CH arom), 6.89-6.73 (2H, m, CH arom), 4.38 (1H, t, J= 7.6 Hz, NCHCH2CO2CH3), 
3.76 (1H, d, J= 13.0 Hz, NCH2PhOCH3), 3.75 (3H, s, PhOCH3), 3.57 (1H, d, J= 12.8 
Hz, NCH2PhOCH3), 3.55 (1H, d, J= 10.8 Hz, NCH2Ar), 3.28 (3H, s, CO2CH3), 2.91 
(1H, d, J= 10.9 Hz, NCH2Ar), 1.64-1.59 (2H, m, NCHCH2CO2CH3); 13C NMR (126 
MHz, CDCl3) δ 172.6, 158.8, 135.4, 135.2, 135.2, 133.5, 133.2, 133.1, 131.9, 131.8, 
131.7, 130.0, 129.5, 129.0, 128.4, 128.4, 128.1, 127.9, 127.4, 127.3, 125.8, 125.8, 
125.6, 125.6, 119.5, 119.4, 113.7, 64.9, 62.1, 55.5, 55.3, 51.1, 41.2; HRMS (CI+): 
m/z found for [M+H]+: 488.2240; [C33H30NO3]+ requires 488.2209.  
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2.0 Synthesis of of β-amino acid and derivatives 
Tert-butyl 2-((3S,11cS)-4-allyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e] azepin-
3-yl) acetate 2118 
 
Zinc dust (1.90 g, 29.1 mmol, 10 equiv.), anhydrous THF (40 mL) and TMSCl (0.37 
mL, 2.9 mmol, 1 equiv.) were added to a flame-dried nitrogen-purged round-bottom 
flask. The reaction mixture was heated at reflux for 30 min. tert-Butyl bromoacetate 
(0.43 mL, 2.9 mmol) was added and the reaction was heated at reflux for a further 30 
min. The mixture was cooled to –78 °C. (S)-4-Allyl-3H-dinaphtho[2,1-c:1',2'-
e]azepin-4-ium (1.90 g, 2.9 mmol) was dissolved in anhydrous THF (40 mL) in a 
separate flame-dried round-bottom flask. The iminium salt solution was then 
transferred into the zinc slurry at –78 °C using a cannula. The reaction mixture was 
stirred at –78 °C for 1 h and t-butyl bromoacetate (4.3 mL, 29.1 mmol, 10 equiv.) 
was added in small portions over 20 min, whilst maintaining the temperature. The 
reaction vessel was allowed to reach room temperature and monitored by TLC. The 
reaction mixture was quenched using a saturated ammonium chloride solution (5 
mL), Et2O (50 mL) was added and the mixture filtered through a pad of celite. The 
filtrate was transferred to a separating funnel and the organic layer washed with H2O 
(3 x 20 mL), saturated brine solution (3 x 20 mL), and dried over anhydrous MgSO4. 
The solvent was removed under reduced pressure to give a yellow oil. The product 
was purified using column chromatography on silica gel (9:1 light petroleum ether/ 
EtOAc) to yield the title compound as a colourless oil (932 mg, 71%).  
[α]D22.4 +158 ° (c 1.00, CHCl3); νmax(CH2Cl2)/cm-1 3052 (=C-H stretch,=C-H 
aromatic stretch), 2978, 1724 (C=O stretch), 1507 (C=C stretch, C=C aromatic 
stretch), 1367, 1264 (C-O stretch), 1150 (C-N stretch), 820; 1H NMR (500 MHz, 
CDCl3) δ 7.98-7.90 (4H, m, CH arom), 7.62 (1H, d, J= 8.3 Hz, CH arom), 7.48-7.41 
(4H, m, CH arom), 7.36 (1H, d, J= 8.1 Hz, CH arom), 7.27-7.19 (2H, m, CH arom), 
N
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5.97 (1H, m, NCH2CHCH2), 5.25 (1H, dd, J= 17.1, 1.5 Hz, NCH2CHCH2) 5.19 (1H, 
appt d, J= 10.2 Hz, NCH2CHCH2) 4.41 (1H, t, J= 7.8 Hz, CHCH2CO2tBu), 3.71 
(1H, d, J= 10.9 Hz, NCH2Ar), 3.35–3.20 (2H, m, NCH2CHCH2), 3.08 (1H, d, J= 
10.9 Hz, NCH2Ar), 1.73 (1H, dd, J= 15.1, 7.0 Hz, CHCH2CO2tBu), 1.51 (1H, dd, J= 
15.1, 8.4 Hz, CHCH2CO2tBu), 1.15 (9H, s, CHCH2CO2tBu); 13C NMR (126 MHz, 
CDCl3) δ 171.3, 136.1, 135.5, 135.2, 135.0, 133.5, 133.3, 133.0, 131.9, 131.8, 129.9, 
129.0, 128.4, 128.3, 128.1, 128.0, 127.6, 127.4, 125.9, 125.7, 125.6, 125.6, 118.0, 
79.9, 64.1, 61.4, 56.1, 42.6, 27.9; HRMS (CI+): m/z found for [M+H]+: 450.2424; 
[C31H32NO2]+ requires 450.2428.  
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Tert-butyl 2-((3S,11cS)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl) 
acetate 215  
 
 
tert-Butyl 2-((3S,11cS)-4-allyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-
yl)acetate (1.20 g, 2.67 mmol) was dissolved in anhydrous dichloromethane (60 
mL). 1,3-Dimethylbarbituric acid (1.25 g, 8.00 mmol, 3 equiv.) and Pd(PPh3)4 (0.06 
g, 0.05 mmol, 0.02 equiv.) were added and reaction mixture gently heated at reflux 
overnight or until full consumption of the starting material was observed by TLC. 
The reaction was allowed to reach room temperature and the solvent was removed 
under reduced pressure. The residue was redissolved in Et2O (50 mL) and transferred 
to a separating funnel. The organic layer was washed with 1 M NaOH solution (2 x 
10 mL), H2O (2 x 10 mL), saturated brine solution (10 mL), dried over anhydrous 
MgSO4. The solvents were removed under reduced pressure and the residue was 
purified using column chromatography on silica gel (6:4 light petroleum 
ether/EtOAc, elution with EtOAc) to yield the title compound as a fluffy pale yellow 
foam (0.92 g, 84%).  
m.p. 78-79 °C; [α]D22.4 +206 ° (c 1.00, CHCl3); νmax(CH2Cl2)/cm-1 3052 (=C-H 
aromatic stretch, N-H bend), 2976, 1719 (C=O stretch), 1507, 1437 (C=C aromatic 
stretch, C-H stretch), 1366, 1293, 1219 (C-N stretch), 1148 (C-O stretch), 1118; 1H 
NMR (500 MHz, CDCl3) δ 8.02-7.91 (4H, m, CH arom), 7.59 (1H, d, J= 8.3 Hz, CH 
arom), 7.52 (1H, d, J= 8.4 Hz, CH arom), 7.50-7.43 (2H, m, CH arom), 7.40 (1H, d, 
J= 8.6 Hz, CH arom), 7.35 (1H, d, J= 8.3 Hz, CH arom), 7.29–7.20 (2H, m, CH 
arom), 4.63 (1H, t, J= 7.6 Hz, CHCH2CO2tBu), 3.79 (1H, d, J= 12.2 Hz, ArCH2N), 
3.72 (1H, d, J= 12.2 Hz, ArCH2N), 2.50 (1H, s), 1.77 (1H, dd, J= 15.3, 7.6 Hz, 
CHCH2CO2tBu), 1.71 (1H, dd, J= 15.2, 7.7 Hz, CHCH2CO2tBu), 1.18 (9H, s, 
CHCH2CO2tBu); 13C NMR (126 MHz, CDCl3) δ 171.4, 137.4, 136.7, 134.9, 133.83, 
133.2, 133.1, 132.2, 132.1, 129.3, 129.1, 128.8, 128.6, 128.5, 128.3, 128.1, 127.5, 
NH
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127.4, 127.0, 125.9, 125.7, 125.6, 125.5, 80.2, 59.1, 48.8, 43.0, 27.9; HRMS (CI+): 
m/z found for [M+H]+: 410.2114; [C28H28NO2]+ requires 410.2115.  
 
2-((3S,11cS)-4,5-Dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)acetic acid 166 
 
tert-Butyl 2-((3S,11cS)-4-allyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-
yl)acetate (660 g, 1.6 mmol) was dissolved in dichloromethane (30 mL) and 
trifluoroacetic acid (1.5 mL, 19.3 mmol, 12 equiv.) was added. The reaction was 
stirred until consumption of the starting material was seen by TLC. A saturated 
sodium hydrogen carbonate solution was added until the pH of the solution was 
neutral. The biphasic mixture was transferred to a separating funnel and the organic 
layer washed using H2O (15 mL), a saturated brine solution (2 x 10 mL), dried over 
anhydrous MgSO4. The solvent was removed under reduced pressure and the residue 
recrystallized (CH2Cl2 and light petroleum ether) to yield the title compound as a 
white solid (535mg, 94%).  
m.p. 228–230 °C; [α]D22.4 +264 ° (c 1.00, CHCl3); νmax(CH2Cl2)/cm-1 3345 (O-H 
stretch), 3072 (=C-H aromatic stretch), 2971, 1719 (C=O stretch), 1597, 1507 
(C=C aromatic stretch, C-H stretch), 1375, 1204 (C-N stretch), 1152 (C-O stretch); 
1H NMR (400 MHz, DMSO) δ 8.09 (2H, d, J = 8.3 Hz, CH arom), 8.06 (2H, d, J = 
8.3 Hz, CH arom), 7.72 (1H, d, J = 8.3 Hz, CH arom), 7.62 (1H, d, J = 8.4 Hz, CH 
arom), 7.57-7.48 (2H, m, CH arom), 7.37-7.28 (2H, m, CH arom), 7.23 (1H, d, J = 
8.5 Hz, CH arom), 7.15 (1H, d, J = 8.4 Hz, CH arom), 4.73 (1H, dd, J = 10.5, 5.8 
Hz, NCHCH2CO2H), 4.02 (1H, d, J = 12.0 Hz, ArCH2N), 3.54 (1H, d, J = 11.9 Hz, 
ArCH2N), 1.74 (1H, dd, J = 16.2, 5.8 Hz, CHCH2CO2H), 1.37 (1H, dd, J = 16.2, 5.8 
Hz, CHCH2CO2H); 13C NMR (101 MHz, DMSO) δ 135.3, 133.5, 133.4, 133.3, 
131.7, 131.6, 129.7, 129.6, 129.4, 129.0, 128.8, 128.1, 126.9, 126.8, 126.7, 126.6, 
NH
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57.2, 46.6, 38.1; HRMS (CI+): m/z found for [M+H]+: 354.1487; [C24H20NO2]+ 
requires 354.1489 
2-((3S,11cS)-4,5-Dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)acetic acid 
166.HCl  
 
tert-Butyl 2-((3S,11cS)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)acetate 
(481 mg, 1.2 mmol) was dissolved in dichloromethane (20 mL) and trifluoroacetic 
acid (1.3 mL, 16.4 mmol, 14 equiv.) was added. The reaction was stirred until 
consumption of the starting material was seen by TLC. A saturated sodium hydrogen 
carbonate solution was added until the pH of the solution was neutral. The biphasic 
mixture was transferred to a separating funnel and the organic layer washed using 
H2O (10 mL), a saturated brine solution (2 x 10 mL), dried over anhydrous MgSO4. 
HCl (37%, 3 drops) was added and the solution stirred for 10 min. The solvent was 
removed under reduced pressure and the residue recrystallized (hot CHCl3) to yield 
the title compound as a white solid (398 mg, 85%).  
m.p. 293-295 °C; [α]D22.8 +378 ° (c 0.5, CHCl3); νmax(CH2Cl2)/cm-1 2916 (=C-H 
aromatic stretch, N-H bend), 2811 (O-H bend), 2720, 2433, 1723 (C=O stretch), 
1587, 1413 (C=C aromatic stretch, C-H stretch), 1398, 1289, 1191 (C-N stretch), 
899 (O-H bend); 1H NMR (500 MHz, DMSO) δ 12.46 (1H, s, CO2H), 10.21 (1H, s, 
NH.HCl), 9.53 (1H, s, NH) 8.21 (2H, dd, J= 19.0, 8.4 Hz, CH arom), 8.14 (2H, dd, 
J= 13.0, 8.5 Hz, CH arom), 7.79 (1H, d, J= 8.0 Hz, CH arom), 7.72 (1H, d, J= 8.5 
Hz, CH arom), 7.62 (2H, dd, J= 15.6, 8.3 Hz, CH arom), 7.46-7.34 (2H, m, CH 
arom), 7.26-7.16 (2H, dd, J= 13.5, 8.5 Hz, CH arom), 5.11 (1H, t, J= 7.0 Hz, 
CHCH2CO2H), 4.30 (1H, d, J= 13.0 Hz, ArCH2N), 3.78 (1H, d, J= 13.0 Hz, 
ArCH2N), 1.94 (2H, m, CHCH2CO2H); 13C NMR (126 MHz, DMSO) δ 171.3, 
135.5, 134.00, 133.98, 133.8, 132.9, 131.6, 131.5, 130.0, 129.78, 129.76, 129.6, 
129.1, 128.9, 128.68, 128.67, 127.41, 127.35, 127.1, 127.0, 126.9, 56.6, 46.1, 36.8; 
NH.HCl
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HRMS (NSI−) m/z found for [M−H]−: 388.1118; [C24H19ClNO2]− requires 388.1110.  
 
Tert-butyl 2-((3R,11cS)-4-allyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-
3-yl)-2-methylpropanoate 218  
 
Zinc dust (2.0 g, 30.6 mmol, 10 equiv.) and anhydrous THF (40 mL) were added to a 
flame-dried nitrogen-purged round-bottom flask. TMSCl (0.4 mL, 3.06 mmol, 1 
equiv.) was added and the reaction mixture was heated at reflux for 30 min. tert-
Butyl α-bromoisobutyrate (0.57 mL, 3.06 mmol, 1 equiv.) was added and the 
reaction mixture heated at reflux for a further 30 min. The reaction mixture was 
cooled to –78 °C. (S)-4-Allyl-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium (2.0 g, 3.06 
mmol) was dissolved in anhydrous THF (40 mL) in a separate flame-dried one-
necked round-bottom flask and transferred into the activated zinc slurry using a 
cannula. The reaction was stirred for 1 h at –78 °C. tert-Butyl α-isobromobutyrate 
(5.7 mL, 30.6 mmol, 10 equiv.) was added in small portions over 20 min, 
maintaining the temperature at –78 °C. The reaction vessel was allowed to reach 
room temperature and monitored by TLC. The reaction was quenched using a 
saturated ammonium chloride solution (5 mL), diluted with Et2O (50 mL) and 
filtered through a pad of celite. The filtrate was transferred to a separating funnel and 
the organic layer washed with H2O (3 x 20 mL), saturated brine solution (3 x 20 
mL), dried over anhydrous MgSO4. The solvent was removed under reduced 
pressure and the residue purified using column chromatography on silica gel (9:1 
light petroleum ether/EtOAc) to yield the title compound as a colourless oil (1.1 g, 
76%). (NB: inseparable impurities). 
[α]D18.9 +102.8 ° (c 1.3, CHCl3); νmax(CHCl3)/cm-1 2977 (=C-H aromatic stretch, 
=C-H stretch), 2934, 2872, 1722 (C=C stretch, C=O stretch), 1475 (C=C aromatic 
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stretch), 1458 (C-H stretch), 1391, 1367, 1254 (C-O stretch), 1141 (C-N stretch), 
1119, 918, 850, 819, 755, 667; 1H NMR (500 MHz, CDCl3) δ 7.89–7.87 (4H, m, CH 
arom), 7.55 (1H, d, J= 8.2 Hz, CH arom), 7.46–7.39 (3H, m, CH arom), 7.37 (1H, d, 
J= 8.5 Hz, CH arom), 7.30 (1H, d, J= 8.3 Hz, CH arom), 7.25–7.20 (1H, m, CH 
arom), 7.20–7.15 (1H, m, CH arom), 5.93 (1H, dddd, J= 17.1, 10.0, 7.0, 5.6 Hz, 
NCH2CHCH2), 5.23 (1H, dd, J= 17.2, 1.6 Hz, NCH2CHCH2), 5.13 (1H, dd, J= 10.7, 
1.4 Hz, NCH2CHCH2), 4.54 (1H, s, CHC(CH3)2CO2tBu), 3.65 (1H, d, J= 11.4 Hz, 
NCH2Ar), 3.53–3.44 (2H, m, NCH2CHCH2), 3.41 (1H, d, J= 11.3 Hz, NCH2Ar), 
1.29 (9H, s, tBu), 0.42 (3H, s, CH3), 0.29 (3H, s, CH3); 13C NMR (126 MHz, CDCl3) 
δ 177.1, 136.6, 136.2, 136.1, 135.9, 134.3, 133.2, 133.1, 132.9, 132.3, 128.8, 128.44, 
128.37, 128.3, 128.1, 127.9, 127.7, 125.9, 125.7, 125.5, 125.3, 117.3, 80.0, 64.7, 
55.2, 51.2, 28.1, 25.3, 24.0, 22.7, 22.5; HRMS (CI+) m/z found for [M+H]+: 
478.2735 [C33H36NO2]+ requires 478.2741. 
  
Tert-butyl 2-((3R,11cS)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)-2-
methylpropanoate 219 
 
 
 
tert-Butyl 2-((3R,11cS)-4-allyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)-
2-methylpropanoate (1.12 g, 2.3 mmol) was dissolved in anhydrous dichloromethane 
(70 mL). 1,3-Dimethylbarbituric acid (1.08 g, 6.9 mmol, 3 equiv.) and Pd(PPh3)4 
(0.05 g, 0.046 mmol, 0.02 equiv.) were added and the reaction mixture was heated at 
reflux overnight or until full consumption of the starting material was observed by 
TLC. The reaction was cooled to room temperature and the solvent removed under 
reduced pressure. The residue was redissolved in Et2O (60 mL) and transferred to a 
separating funnel. The organic layer was washed with 1M NaOH (2 x 15 mL), H2O 
(2 x 20 mL), saturated brine solution (2 x 20 mL) and dried over anhydrous MgSO4. 
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The solvent was removed under reduced pressure and column chromatography on 
silica gel (1:1 light petroleum ether/EtOAc) yielded the title compound as a 
colourless foam (623 mg, 62%).  
m.p. 87-89 °C; [α]D20.1 +314.0 ° (c 1.00, CHCl3); νmax(CH2Cl2)/cm-1 3019 (=C-H 
aromatic stretch, N-H bend), 2980, 2935, 2400, 1710 (C=O stretch), 1598, 1509 
(C=C aromatic stretch), 1437 (C-H stretch), 1420, 1366 (C-O stretch), 1215 (C-N 
stretch), 1153, 1132, 1031, 928, 849 (N-H wag), 819; 1H NMR (500 MHz, CDCl3) δ 
7.88 (4H, dd, J= 8.0, 5.0 Hz, CH arom), 7.49 (1H, d, J= 8.0 Hz, CH arom), 7.45 (1H, 
d, J= 8.0 Hz, CH arom), 7.42- 7.38 (2H, m, CH arom), 7.26- 7.24 (2H, m, CH arom), 
7.20 (1H, ddd, J= 8.2, 6.7, 1.5 Hz, CH arom), 7.15 (1H, ddd, J= 8.2, 6.7, 1.5 Hz, CH 
arom), 4.89 (1H, s, CHC(CH3)2CO2tBu), 3.95 (1H, d, J= 12.5 Hz, NCH2Ar), 3.73 
(1H, d, J= 12.5 Hz, NCH2Ar), 1.35 (9H, s, tBu), 0.73 (3H, s, CH3), 0.23 (3H, s, 
CH3); 13C NMR (126 MHz, CDCl3) δ 176.8, 138.9, 136.4, 134.8, 134.6, 133.4, 
132.9, 132.8, 132.7, 132.4, 128.8, 128.4, 128.1, 127.9, 127.7, 127.5, 126.7, 125.8, 
125.7, 125.4, 125.0, 80.1, 70.3, 50.7, 49.4, 28.0, 23.7, 19.6; HRMS (CI+) m/z found 
for [M+H]+: 438.2424; [C30H32NO2]+ requires 438.2428.  
 
2-((3R,11cS)-4,5-Dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)-2-
methylpropanoic acid hydrochloride 216.HCl 
 
 
tert-Butyl 2-((3R,11cS)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)-2-
methyl propanoate (643 mg, 1.47 mmol) was dissolved in dichloromethane (20 mL). 
Trifluoroacetic acid (1.3 mL, 17.6 mmol, 12 equiv.) was added and the reaction was 
stirred until consumption of the starting material was observed by TLC. A saturated 
sodium hydrogen carbonate solution was added until the pH of the solution was 
neutral. The biphasic mixture was transferred to a separating funnel and the organic 
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layer washed H2O (15 mL), saturated brine solution (2 x 15 mL), dried over 
anhydrous MgSO4. The residue was subjected to column chromatography on silica 
gel (EtOAc). HClaq (37%, 3 drops) was added and the reaction stirred for 10 min. 
The solvent was then removed under reduced pressure and the residue was 
recrystallized (Et2O and light petroleum ether) to yield the title compound as a 
colourless solid (469 mg, 76%). 
m.p. 222-225 °C; [α]D22.7 +283 ° (c 0.5, CHCl3); νmax(CH2Cl2)/cm-1 3500 (broad O-H 
stretch), 2928 (=C-H aromatic stretch), 2833 (N-H bend), 2728, 1703 (C=O 
stretch), 1566 (C=C aromatic stretch), 1460 (C-H stretch), 1189 (C-O stretch), 
1154, 1134, 1034, 726; 1H NMR (500 MHz, DMSO) δ 13.01 (1H, s, CO2H), 10.92 
(1H, s, NH.HCl), 9.05 (1H, s, NH), 8.13 (2H, t, J= 8.5 Hz, CH arom), 8.07 (2H, dd, 
J= 8.0, 4.5 Hz, CH arom), 7.75 (1H, d, J= 8.5 Hz, CH arom), 7.69 (1H, dd, J= 8.0, 
3.3 Hz, CH arom), 7.59-7.55 (2H, m, CH arom), 7.35 (1H, t, J= 8.5 Hz, CH arom), 
7.27 (1H, t, J= 8.5 Hz, CH arom), 7.15 (1H, d, J= 8.5 Hz, CH arom), 7.08 (1H, d, J= 
8.5 Hz, CH arom), 5.24 (1H, s, CHC(CH3)2CO2H), 4.25 (1H, d, J= 13.5 Hz, 
NCH2Ar), 3.88 (1H, d, J= 13.0 Hz, NCH2Ar), 0.82 (3H, s, CH3), 0.18 (3H, s, CH3); 
13C NMR (126 MHz, DMSO) δ 176.6, 135.2, 133.41, 133.35, 133.2, 132.1, 131.6, 
131.5, 131.1, 129.5, 129.1, 129.1, 128.9, 128.7, 128.5, 128.2, 127.2, 126.9, 126.7, 
126.5, 126.3, 66.5, 47.4, 47.0, 25.0, 19.3; HRMS (NSI+) m/z found for [M-Cl]+: 
382.1791; [C26H24NO2]+ requires 382.1802.  
 
2-((3S,11cS)-4,5-Dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)-2- 
methylpropanoic acid 216  
 
tert-Butyl 2-((3R,11cS)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)-2- 
methylpropanoate (300 mg, 0.69 mmol) was dissolved in dichloromethane (20 mL) 
NH
216
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and trifluoroacetic acid (0.63 mL, 8.2 mmol, 12 equiv.) was added. The reaction was 
stirred until consumption of the starting material was seen by TLC. A saturated 
sodium hydrogen carbonate solution was added until the pH of the solution was 
neutral. The biphasic mixture was transferred to a separating funnel and the organic 
layer washed using H2O (20 mL), a saturated brine solution (2 x 10 mL), dried over 
anhydrous MgSO4. The solvent was removed under reduced pressure and the residue 
subjected to column chromatography (EtOAc). Recrystallization (CHCl3 and light 
petroleum ether) yielded the title compound as a beige solid (161 mg, 61%). 
m.p. 192-194 °C; [α]D24.9 +138.1 °(c 0.9, CHCl3); νmax(CH2Cl2)/cm-1 3400 (OH 
broad stretch), 3054, 2979 (=C-H aromatic stretch), 2850 (N-H bend), 1673 (C=O 
stretch) , 1598 (C=C aromatic stretch), 1470 (C-H stretch), 1200 (C-O stretch), 
1135, 821, 751; 1H NMR (500 MHz, CDCl3) δ 7.98 (1H, d, J= 8.5 Hz, CH arom), 
7.94 (1H, d, J= 8.2 Hz, CH arom), 7.89 (1H, d, J= 8.2 Hz, CH arom), 7.78 (1H, d, J= 
7.8 Hz, CH arom), 7.58 (5H, d, J= 8.1 Hz, CH arom), 7.56-7.46 (3H, m, CH arom), 
7.26-7.30 (2H, m, CH arom), 7.24-7.17 (2H, m, CH arom), 5.35 (5H, s), 4.39 (2H, d, 
J = 12.9 Hz), 4.09 (2H, d, J = 12.8 Hz), 1.16 (3H, s), 0.01 (3H, s); 13C NMR (126 
MHz, CDCl3) δ 179.6, 136.1, 133.9, 133.9, 133.6, 132.9, 132.4, 131.7, 131.8, 129.6, 
129.4, 129.2, 128.7, 128.1, 128.0, 127.6, 127.5, 126.8, 126.6, 126.3, 126.1, 77.2, 
67.8, 47.2, 27.6, 26.6; HRMS (CI+) m/z found for [M+H]+: 382.1803; [C26H24NO2]+ 
requires 382.1802. 
 
3.0 Synthesis of α-amino acid derivatives  
(S)-4-Nitroso-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine 2289  
 
 
(S)-4,5-Dihydro-3H-4-aza-cyclohepta[2,1-a;3,4-a’]dinaphthalene (800 mg, 2.71 
mmol) was dissolved in acetic acid (28 mL). NaNO2 (561 mg, 8.13 mmol, 3 equiv.) 
NH
129
NNO
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in H2O (8 mL) was added and the reaction mixture was stirred for 2 h at room 
temperature or until full consumption of the starting material was seen by TLC. The 
reaction mixture was poured into an ice bath-cooled flask cooled and a solution of 
NaOH (10M, 10 mL) was added and the mixture transferred to a separating funnel. 
Toluene (2 x 30 mL) was added and the organic layers washed with H2O (3 x 30 
mL), saturated brine solution (2 x 20 mL) and dried over anhydrous Na2SO4. The 
solvent was removed under reduced pressure to yield the title compound as a foamy 
pale yellow solid (660 mg, 75%).  
m.p. 57-59 °C (Lit 57-58 °C)9; [α]D22.7 −197.0 °[(c 1.00 CHCl3); Lit [α]D25 −212.3 ° 
(c 0.68, CHCl3)]9; vmax(CH2Cl2)/cm-1 3054 (C=H aromatic stretch), 2987, 2685, 
2410, 2305, 1596, 1556 (N-O stretch), 1422 (=C-H stretch, C-H bend), 1323 (C-H 
stretch), 1345 (N-O stretch), 1265, 1127 (C-N stretch), 896; 1H NMR (500 MHz, 
CDCl3) δ 7.90-7.80 (4H, m, CH arom), 7.53 (1H, d, J= 8.5 Hz, CH arom), 7.43-7.34 
(3H, m, CH arom), 7.30 (1H, d, J= 8.7 Hz, CH arom), 7.19-7.13 (2H, m, CH arom), 
7.05 (1H, d, J = 7.2 Hz, CH arom), 5.56 (1H, d, J= 13.5 Hz), 5.52 (1H, d, J= 15.3 
Hz), 4.57 (1H, d, J= 13.5 Hz), 3.50 (1H, d, J= 15.2 Hz); 13C NMR (126 MHz, 
CDCl3) δ 135.9, 134.4, 133.7, 133.5, 131.7, 131.7, 131.4, 130.4, 129.9, 129.5, 128.5, 
128.5, 127.7, 127.5, 127.4, 126.6, 126.6, 126.5, 126.5, 54.5, 47.2. 
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(S)-Tert-butyl 3H-dinaphtho[2,1-c:1',2'-e]azepine-4(5H)-carboxylate 23310,11 
 
 
 
(S)-4,5-Dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine (1.32 g, 4.5 mmol) was 
dissolved in warmed t-BuOH (30 mL). Di-tert-butyl dicarbonate (1.02 g, 4.7 mmol, 
1.05 equiv.) in a solution of t-BuOH (10 mL) was added and the solution was stirred 
at room temperature for 3 h. A further portion of di-tert-butyl dicarbonate (0.12 
equiv.) was added and the solution was stirred until full consumption of the starting 
material was seen by TLC. The solvent was removed under reduced pressure and the 
residue redissolved in EtOAc and the organic layer washed with H2O (2 x 20 mL), 
saturated brine solution (20 mL), dried over anhydrous MgSO4. The solvent was 
removed under reduced pressure to yield the product as a pale yellow solid; no 
further purification was required (1.65 g, 92%).  
Alternative synthesis: 
 
(S)-2,2’-Bis-bromomethyl-[1,1’]binaphthalene (600 mg, 1.36 mmol) was dissolved 
in anhydrous DMF (30 mL). The pale yellow solution was cooled to 0 °C and NaH 
(130 mg, 5.45 mmol, 4 equiv.) was added in one portion. t-Butyl carbamate (160 mg, 
1.36 mmol, 1 equiv.) was added slowly in small portions. The reaction mixture was 
stirred for 4 days or until full consumption of the starting material was seen by TLC 
and it was observed the colour of solution changed to a pale pink. The reaction was 
quenched by addition of ammonium chloride (10 mL) at 0 °C and the majority of the 
solvent was removed under reduced pressure. Et2O (100 mL) was added to the 
NH
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mixture and the organic layer washed with H2O (5 x 20 mL), saturated brine solution 
(3 x 20 mL), and dried over anhydrous MgSO4. Recrystallization (hot acetone) 
yielded the title compound as a colourless solid (469 mg, 87%).  
m.p. 219- 221 °C; [α]D22.5 −7.0 ° (c 1.00, CHCl3); νmax(CH2Cl2)/cm-1 3057 (=C-H 
aromatic stretch), 2979, 2933, 2253, 1819, 1682 (C=O stretch), 1508 (C=C 
aromatic stretch), 1464(C-H stretch), 1405, 1367, 1275 (C-O stretch), 1252, 1219 
(C-N stretch), 1163, 1106, 908, 867, 819; 1H NMR (500 MHz, CDCl3) δ 7.99-7.91 
(4H, m, CH arom), 7.60 (2H, d, J= 8.0 Hz, CH arom), 7.47 (2H, ddd, J= 8.0, 7.0, 1.0 
Hz, CH arom), 7.43 (2H, d, J= 8.5 Hz, CH arom), 7.26 (2H, ddd, J= 8.5, 7.0, 1.0 Hz, 
CH arom), 4.93 (2H, br s), 3.65 (2H, d, J= 13.0 Hz), 1.51 (9H, s); 13C NMR (126 
MHz, CDCl3) δ 154.4, 135.0, 133.33, 133.28, 131.5, 129.2, 128.3, 127.51, 127.47, 
126.0, 125.8, 85.2, 80.0, 28.6, 27.4; HRMS (NSI+) m/z found 396.1955 [M+H]+; 
[C27H25NO2+H]+ requires 396.158.  
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(3R,11cS)-4-Tert-butyl 3-ethyl 3H-dinaphtho[2,1-c:1',2'-e]azepine-3,4(5H)-
dicarboxylate 236 
 
(S)-Tert-butyl 3H-dinaphtho[2,1-c:1',2'-e]azepine-4(5H)-carboxylate (200 mg, 0.51 
mmol) was dissolved in anhydrous Et2O (20 mL) and cooled to  ̶ 78 °C. sec-BuLi 
(0.47 mL, 0.66 mmol, 1.3 equiv., 1.4 M solution in cyclohexane) was added 
dropwise; the pale yellow solution instantly turned black on addition. The solution 
was stirred at  ̶ 78 °C for 1 h. Ethyl chloroformate (0.15 mL, 1.53 mmol, 3 equiv.) 
was added in one portion causing the solution to turn from black to bright yellow. 
The reaction was allowed to reach room overnight, or until full consumption of the 
starting material was seen by TLC. The reaction was quenched with saturated 
ammonium chloride solution (10 mL) at 0 °C. The organic layers were washed with 
H2O (3 x 10 mL), saturated brine solution (3 x 10 mL), dried over anhydrous 
MgSO4, and the solvent removed under reduced pressure. Column chromatography 
on silica gel (7:3 light petroleum ether/EtOAc) yielded the title compound as a 
colourless solid (174 mg, 73%). 
m.p. 101-103 °C; [α]D22.1 −17.6 ° (c 1.00, CHCl3); νmax(CH2Cl2)/cm-1 3052 (=C-H 
aromatic stretch), 2976, 2931, 1748 (C=O stretch), 1695 (C=O stretch), 1508 (C=C 
aromatic stretch), 1475, 1461 (C-H stretch), 1392, 1366, 1297, 1252 (C-N stretch), 
1243 (C-O stretch), 1217, 1164, 1155, 1107, 1027, 945, 911, 897, 864, 825, 814; 1H 
NMR (500 MHz, DMSO at 360 K) δ 8.14 (1H, d, J= 8.3 Hz, CH arom), 8.09 (1H, d, 
J= 8.2 Hz, CH arom), 8.05 (1H, d, J= 8.4 Hz, CH arom), 8.01 (1H, d, J= 8.1 Hz, CH 
arom), 7.79 (1H, d, J= 8.4 Hz, CH arom), 7.62 (1H, d, J= 8.3 Hz, CH arom), 7.56 
(1H, ddd, J= 8.1, 6.7, 1.2 Hz, CH arom), 7.50 (1H, ddd, J= 8.1, 6.8, 1.1 Hz, CH 
arom), 7.37-7.25 (3H, m, CH arom), 7.18 (1H, d, J= 8.5 Hz, CH arom), 5.82 (1H, s, 
CHCO2Et), 5.13 (1H, br s, NCH2Ar), 3.59 (1H, br s, NCH2Ar), 2.94-2.85 (1H, m, 
CO2CH2CH3), 2.55-2.53 (1H, dis m, CO2CH2CH3), 1.52 (9H, s, tBu), 0.46 (3H, t, J= 
7.1 Hz, CO2CH2CH3); 13C NMR (126 MHz, DMSO at 360 K) δ 169.5, 153.9, 134.4, 
NBoc
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134.2, 134.0, 133.7, 133.5, 133.4, 131.6, 129.8, 129.7, 129.2, 128.8, 128.6, 128.3, 
127.1, 127.1, 126.71, 126.68, 126.4, 126.2, 80.4, 62.0, 60.6, 28.6, 13.5; HRMS 
(NSI+) m/z found 468.2165 [M+H]+; [C30H29NO4+H]+ requires 468.2169.  
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(3R,11cS)-Ethyl 4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-3-carboxylate 
238  
 
(3R,11cS)-4-Tert-butyl 3-ethyl 3H-dinaphtho[2,1-c:1',2'-e]azepine-3,4(5H)-
dicarboxylate (90 mg, 0.2 mmol) was dissolved in dichloromethane (5 mL). 
Trifluoroacetic acid (0.2 mL, 2.8 mmol, 14 equiv.) was added and the reaction 
mixture was stirred until consumption of the starting material was seen by TLC. 
Saturated sodium hydrogen carbonate solution was added until the pH of the solution 
was neutral. The solvent was removed reduced pressure and the residue redissolved 
in EtOAc (5 mL). The organic layer was then washed with H2O (3 x 5 mL), 
saturated brine solution (3 x 5 mL) and dried over anhydrous MgSO4 and the solvent 
removed under reduced pressure. Purified by column chromatography on silica gel 
(EtOAc), which gave product as a yellow oil (60 mg, 81%). 
[α]D23.1 +386.0 ° (c 1.00, CHCl3); νmax(CH2Cl2)/cm-1 3583 (N-H bend), 2980 (=C-H 
aromatic stretch), 2253, 1742 (C=O stretch), 1710, 1394 (C=C aromatic stretch), 
1366 (C-H stretch), 1222 (C-N stretch), 1156, 1109 (C-O stretch), 1027, 909 (N-H 
wag), 826; 1H NMR (500 MHz, CDCl3) δ 8.01 (1H, d, J= 8.5 Hz, CH arom), 7.98–
7.91 (2H, m, CH arom), 7.89 (1H, d, J= 8.5 Hz, CH arom), 7.63 (1H, d, J= 8.5 Hz, 
CH arom), 7.51-7.44 (2H, m, CH arom), 7.44–7.34 (3H, m, CH arom), 7.29-7.20 
(2H, m, CH arom), 4.59 (1H, s, NCHCO2Et), 3.83 (1H, d, J= 13.5 Hz, ArCH2N), 
3.55 (1H, d, J= 13.5 Hz, ArCH2N), 3.36 (1H, s, NH), 3.22 (1H, dq, J= 10.7, 7.1 Hz, 
CO2CH2CH3), 2.58 (1H, dq, J= 10.7, 7.2 Hz, CO2CH2CH3), 0.49 (3H, t, J= 7.5 Hz, 
CO2CH2CH3); 13C NMR (126 MHz, CDCl3) δ 174.1, 137.5, 134.9, 134.0, 133.4, 
133.3, 132.9, 131.60, 131.57, 129.6, 129.0, 128.8, 128.34, 128.28, 127.4, 127.2, 
126.9, 125.98, 125.95, 125.9, 125.4, 62.5, 61.1, 48.5, 13.3; HRMS (ESI+) m/z found 
368.1645 [M+H]+; [C25H21NO2+H]+ requires 368.1645. 
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(3R,11cS)-Ethyl 4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-3-carboxylate 
hydrochloride 238.HCl 
 
 
(3R,11cS)-4-Tert-butyl 3-ethyl 3H-dinaphtho[2,1-c:1',2'-e]azepine-3,4(5H)-
dicarboxylate (300 mg, 0.64 mmol) was dissolved in acetone (30 mL) and 
concentrated HCl (3 drops) was added. The reaction mixture was heated at reflux 
overnight. The reaction mixture was cooled to room temperature and the solvent 
removed under reduced pressure. Recrystallization (Et2O and light petroleum ether) 
yielded the title compound as a yellow solid (260 mg, quant.). 
m.p.* 219-221 °C (*decomp); [α]D22.6 +340 ° (c 1.03, CHCl3); νmax(solid)/cm-1 3394 
(N-H bend), 2928 (=C-H aromatic stretch), 2661, 1736 (C=O stretch), 1671, 1595, 
1545, 1443 (C=C aromatic stretch), 1369 (C-H stretch), 1299 (C-O stretch), 1236 
(C-N stretch), 1195, 1055, 1027, 961 (N-H wag), 897, 820, 796, 749, 705, 624; 1H 
NMR (500 MHz, DMSO) δ 10.99 (1H, s, NH.HCl), 9.42 (1H, s, NH.HCl), 8.02 (1H, 
d, J= 8.4 Hz, CH arom), 7.94 (2H, dd, J= 8.3, 4.8 Hz, CH arom), 7.88 (1H, d, J= 8.2 
Hz, CH arom), 7.58 (1H, d, J= 8.4 Hz, CH arom), 7.48 (1H, d, J= 8.4 Hz, CH arom), 
7.45-7.40 (1H, m, CH arom), 7.37 (1H, t, J= 7.5 Hz, CH arom), 7.24-7.14 (2H, m, 
CH arom), 7.03 (1H, d, J= 8.6 Hz, CH arom), 6.96 (1H, d, J= 8.5 Hz, CH arom), 
5.63 (1H, s, ArCHCO2Et), 4.14 (1H, d, J= 13.5 Hz, ArCH2NH), 3.46 (1H, d, J= 13.0 
Hz, ArCH2NH), 3.03 (1H, dq, J= 10.8, 7.1 Hz, CO2CH2CH3), 2.38 (1H, dq, J= 10.8, 
7.1 Hz, CO2CH2CH3), 0.16 (3H, t, J= 7.1 Hz, CO2CH2CH3); 13C NMR (126 MHz, 
DMSO) δ 167.3, 134.1, 133.6, 133.4, 130.7, 130.6, 129.9, 129.7, 129.5, 129.2, 
129.1, 128.5, 128.0, 127.1, 126.8, 126.8, 126.7, 126.6, 126.5, 61.8, 58.7, 45.4, 12.8; 
HRMS (ESI+) m/z found 368.1645 [M−Cl]+; [C25H22NO2]+ requires 368.1645.  
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Side product (trace): (S)-Ethyl 3H-dinaphtho[2,1-c:1',2'-e]azepine-5-
carboxylate 240 
 
 
Trace amount isolated.  
νmax(CH2Cl2)/cm-1 3054 (=C-H aromatic stretch), 2960, 2925, 2853, 1720 (C=O 
stretch), 1609 (C=N stretch), 1596, 1506 (C=C aromatic stretch), 1367 (C-H 
stretch), 1304, (C-O stretch) 1218, 1190 (C-N stretch), 1093, 1053, 1029, 866, 821; 
1H NMR (500 MHz, CDCl3) δ 7.98 (1H, d, J= 6.6 Hz, CH arom), 7.97 (1H, d, J= 5.7 
Hz, CH arom), 7.93 (1H, d, J= 8.4 Hz, CH arom), 7.90 (1H, d, J= 8.2 Hz, CH arom), 
7.77 (1H, d, J= 8.6 Hz), 7.69 (1H, d, J= 8.3 Hz), 7.55 (1H, ddd, J= 8.1, 6.8, 1.1 Hz, 
CH arom), 7.50 (1H, d, J= 8.6 Hz, CH arom), 7.42 (1H, ddd, J= 8.1, 6.8, 1.1 Hz, CH 
arom), 7.32 (1H, d, J= 8.6 Hz, CH arom), 7.28 (1H, ddd, J= 8.5, 6.8, 1.2 Hz, CH 
arom), 7.20 (1H, ddd, J= 8.5, 6.8, 1.2 Hz, CH arom), 5.11 (1H, d, J= 10.1 Hz, 
NCH2), 4.35 (2H, m, CO2CH2CH3), 3.99 (1H, d, J= 10.1 Hz, NCH2), 1.36 (3H, t, J= 
7.1 Hz, CO2CH2CH3); 13C NMR (126 MHz, CDCl3) δ 164.5 (N=C), 160.6 (CO2Et), 
140.9, 137.9, 133.3, 133.0, 132.7, 131.1, 130.9, 130.6, 129.1, 128.9, 128.3, 128.3, 
127.8, 127.6, 127.4, 126.3, 126.03, 125.96, 125.5, 124.5, 62.3, 56.5, 14.2; HRMS 
(NSI+) m/z found 366.1486 [M+H]+; [C25H19NO2+H]+ requires 366.1489. 
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(3R,11cS)-4-Tert-butyl 3-methyl 3H-dinaphtho[2,1-c:1',2'-e]azepine-3,4(5H)-
dicarboxylate 237  
 
(S)-Tert-butyl 3H-dinaphtho[2,1-c:1',2'-e]azepine-4(5H)-carboxylate (900 mg, 2.3 
mmol) was dissolved in anhydrous Et2O (50 mL). The solution was cooled to   ̶78 °C 
and sec-BuLi (2.3 mL, 3.0 mmol, 1.3 equiv., 1.3 M in cyclohexane) was added 
dropwise causing the pale yellow solution to turn black. The solution was stirred at -
78 °C for 1 h then methyl chloroformate (0.53 mL, 6.8 mmol, 3 equiv.) was added 
causing the solution to turn bright yellow. The reaction was allowed to reach room 
temperature over 12 h, or until consumption of the starting material was seen by 
TLC, and quenched with saturated ammonium chloride solution (5 mL) at 0 °C. The 
organic layer was washed with H2O (2 x 20 mL), saturated brine solution (2 x 10 
mL) and dried over anhydrous MgSO4 and concentrated under reduced pressure. The 
title compound was isolated using column chromatography on silica gel (9:1 light 
petroleum ether/EtOAc) as a colourless fluffy solid (845 mg, 81%). 
m.p. 124-126 °C; [α]D22.6 −20.8 ° (c 0.5, CHCl3); νmax(CH2Cl2)/cm-1 3053 (=C-H 
aromatic stretch), 2975, 2946, 2884, 1751 (C=O stretch), 1696 (C=O stretch), 1508 
(C=C aromatic stretch), 1456, 1392, 1366 (C-H stretch), 1296 (C-O stretch), 1164 
(C-N stretch), 960, 823; 1H NMR (500 MHz, DMSO at 380 K) δ 8.13 (1H, d, J= 8.3 
Hz, CH arom), 8.08 (1H, d, J= 8.2 Hz, CH arom), 8.04 (1H, d, J= 8.3 Hz, CH arom), 
8.01 (1H, d, J= 8.2 Hz, CH arom), 7.76 (1H, d, J= 8.3 Hz, CH arom), 7.60 (1H, d, J= 
8.3 Hz, CH arom), 7.56 (1H, ddd, J= 8.1, 6.6, 1.3 Hz, CH arom), 7.51 (1H, ddd, J= 
8.1, 6.8, 1.1 Hz, CH arom), 7.37-7.32 (1H, m, CH arom), 7.32–7.28 (2H, m, CH 
arom), 7.19 (1H, d, J= 8.5 Hz, CH arom), 5.85 (1H, s, CHCO2Me), 5.10 (1H, d, J= 
13.3 Hz, CH2), 3.61 (1H, d, J= 13.4 Hz, CH2), 2.54 (3H, s, CO2CH3), 1.50 (9H, s, 
CO2C(CH3)3); 13C NMR (126 MHz, DMSO at 380 K) δ 169.9, 153.9, 134.5, 134.3, 
134.2, 133.7, 133.6, 133.5, 131.63, 131.58, 129.8, 129.7, 128.9, 128.7, 128.6, 128.3, 
127.1, 126.9, 126.73, 126.67, 126.4, 126.2, 80.5, 79.6, 51.2, 28.7, 28.6; HRMS 
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(ESI+) m/z found 476.1832 [M+Na]+; [C27H27NO4Na] requires 476.183. 
 
(3R,11cS)-Methyl 4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-3-carboxylate 
239  
 
 
(3R,11cS)-4-Tert-butyl 3-methyl 3H-dinaphtho[2,1-c:1',2'-e]azepine-3,4(5H)-
dicarboxylate (600 mg, 1.32 mmol) was dissolved in dichloromethane (10 mL) and 
trifluoroacetic acid (1.4 mL, 18.5 mmol, 14 equiv.) was added. The solution was 
stirred for 30 min after which time the pH was neutralised by addition of saturated 
solution of sodium hydrogen carbonate. The solvent was removed under reduced 
pressure and the residue redissolved in EtOAc (30 mL). The organic layer was then 
washed with H2O (3 x 20 mL), saturated brine solution (3 x 20 mL), dried over 
anhydrous MgSO4 and the solvent removed under reduced pressure. The brown 
residue was then recrystallized (CHCl3 and light petroleum ether) to yield the title 
compound (364 mg, 78%).  
m.p. 214-216 °C; [α]D21.4 +420 ° (c 1.03, CHCl3); νmax(CH2Cl2)/cm-1 3318 (N-H 
bend), 3050 (=C-H aromatic stretch), 2947, 2874, 1730 (C=O stretch), 1508 (C=C 
stretch), 1448 (C-H stretch), 1432 (C-O stretch), 1223, 1207 (C-N stretch), 1110, 
992, 866 (N-H wag), 822; 1H NMR (500 MHz, CDCl3) δ 8.02 (1H, d, J= 8.0 Hz, CH 
arom), 7.97-7.93 (2H, m, CH arom), 7.91 (1H, d, J= 8.0 Hz, CH arom), 7.64 (1H, d, 
J= 8.5 Hz, CH arom), 7.52-7.47 (2H, m, CH arom), 7.44-7.42 (2H, m, CH arom), 
7.36 (1H, d, J= 8.5 Hz, CH arom), 7.28 (1H, d, J= 7.6 Hz, CH arom), 7.24 (1H, d, J= 
7.5 Hz, CH arom), 4.62 (1H, s, CHCO2Me), 3.84 (1H, d, J= 14.0 Hz, ArCH2N), 3.57 
(1H, d, J= 13.7 Hz, ArCH2N), 2.49 (3H, s, CO2Me); 13C NMR (126 MHz, CDCl3) δ 
174.4, 137.4, 135.0, 133.7, 133.4, 133.3, 132.9, 131.5, 131.4, 129.7, 129.1, 128.4, 
NH
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128.34, 128.29, 127.3, 127.0, 126.8, 126.1, 126.0, 125.9, 125.5, 62.2, 51.6, 48.4; 
HRMS (ESI+) m/z found 354.1479 [M+H]+; [C24H19NO2+H]+ requires 354.1489.  
 
(3R,11cS)-Methyl 4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-3-carboxylate 
hydrochloride 239.HCl  
 
(3R,11cS)-4-Tert-butyl 3-methyl 3H-dinaphtho[2,1-c:1',2'-e]azepine-3,4(5H)-
dicarboxylate (258 mg, 0.57 mmol) was dissolved in acetone (30 mL) and 
concentrated HCl (3 drops) was added. The reaction mixture was heated at reflux 
overnight. The reaction mixture was cooled to room temperature and the solvent 
removed under reduced pressure. The product was isolated by recrystallization 
(MeOH and Et2O) to give a biege solid (222 mg, quant.). 
m.p. 220-230 °C; [α]D21.4 + 296.0 ° (c 1.00, CHCl3); νmax(solid)/cm-1 3406 (N-H 
bend), 3053 (=C-H aromatic stretch), 2950, 2673, 1746 (C=O stretch), 1596, 1508 
(C=C aromatic stretch), 1439 (C-H stretch), 1371, 1248 (C-N stretch), 1212 (C-O 
stretch), 1058, 864, 822; 1H NMR (500 MHz, DMSO) δ 9.67 (1H, s), 8.26 (1H, d, J= 
8.0 Hz, CH arom), 8.17-8.15 (2H, m, CH arom), 8.12 (1H, d, J= 8.5 Hz, CH arom), 
7.81 (1H, d, J= 8.5 Hz, CH arom), 7.71 (1H, d, J= 8.3 Hz, CH arom), 7.65 (1H, ddd, 
J= 8.0, 6.6, 1.0 Hz, CH arom), 7.61 (1H, ddd, J= 8.1, 6.8, 1.0 Hz, CH arom), 7.42-
7.37 (2H, m, CH arom), 7.27 (1H, d, J= 8.4 Hz, CH arom), 7.16 (1H, d, J= 8.5 Hz, 
CH arom), 5.86 (1H, s, CHCO2Me), 4.36 (1H, d, J= 13.2 Hz, ArCH2N), 3.70 (1H, d, 
J= 13.2 Hz, ArCH2N), 2.45 (3H, s, CO2Me); 13C NMR (126 MHz, DMSO) δ 167.8, 
134.2, 134.1, 133.6, 133.4, 130.74, 130.66, 130.5, 130.0, 129.9, 129.5, 129.2, 128.8, 
128.5, 127.9, 127.1, 126.9, 126.8, 126.5, 126.3 58.6, 52.0, 45.4; HRMS (NSI+) m/z 
found for [M−Cl]+: 354.1488; [C24H20NO2]+ requires 354.1489.  
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(11cS)-4-(Tert-butoxycarbonyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-
e]azepine-3-carboxylic acid synthesis 
 
 
(S)-Tert-butyl 3H-dinaphtho[2,1-c:1',2'-e]azepine-4(5H)-carboxylate (500 mg, 1.26 
mmol) was dissolved in anhydrous Et2O (30 mL). The reaction mixture was cooled 
to  ̶ 78 °C. A positive pressure of argon was continuously bubbled over the reaction 
as sec-Buli (1.2 mL, 1.6 mmol, 1.3 equiv., 1.4 M solution in cyclohexane) was 
added, causing the solution to turn from a pale yellow solution to a black colour. The 
reaction was stirred at  ̶ 78 °C for 1 h. CO2 gas was bubbled directly into the solution 
via drying tube filled with CaCl3. The reaction mixture was stirred overnight at  ̶ 78 
°C under an atmosphere of argon. The reaction was quenched at 0 °C with 
ammonium chloride (10 mL) and EtOAc (20 mL) was added. The organic layers 
were washed with H2O (2 x 20 mL), saturated brine solution (2 x 20 mL), dried over 
anhydrous Na2SO4 and the solvent removed under reduced pressure.  
1st eluting diastereoisomer:  
(3R,11cS)-4-(Tert-butoxycarbonyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-
e]azepine-3-carboxylic acid 247 
  
Eluted using column chromatography on silica gel (4:1 light petroleum 
ether/EtOAc). Title compound isolated as a colourless solid (188 mg, 34%).  
m.p. 164-167 °C; [α]D23.9 −47.2 ° (c 1.00, CHCl3); νmax(CHCl3)/cm-1 3056 (O-H 
stretch, =C-H aromatic stretch), 2976 (O-H stretch), 2937, 1754, 1694 (C=C 
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aromatic stretch, C=O stretch), 1393, 1367 (C-H stretch), 1303 (C=O stretch), 1245 
(C-N stretch), 1156, 912 (O-H bend), 819, 749; 1H NMR (500 MHz, DMSO, VT at 
363 K) δ 8.07 (1H, d, J= 8.7 Hz, CH arom), 8.02 (1H, d, J= 8.7 Hz, CH arom), 7.98–
7.94 (2H, m, CH arom), 7.70 (1H, d, J= 8.6 Hz, CH arom), 7.57 (1H, d, J= 8.2 Hz, 
CH arom), 7.49 (1H, ddd, J= 8.1, 6.8, 1.5 Hz, CH arom), 7.44 (1H, ddd, J= 8.1, 6.8, 
1.5 Hz, CH arom), 7.25 (2H, m, CH arom), 7.20-7.15 (2H, m, CH arom), 5.72 (1H, 
s, CHCO2H), 5.07 (1H, d, J= 15.5 Hz, NCH2Ar), 3.56 (1H, d, J= 15.5 Hz, NCH2Ar), 
1.45 (9H, s, tBu); 13C NMR (126 MHz, DMSO, VT at 363 K) δ 170.5, 154.0, 134.3, 
133.5, 131.8, 131.7, 129.5, 129.4, 128.7, 128.6, 128.4, 127.4, 127.2, 126.5, 126.2, 
126.0, 80.2, 62.1, 47.4, 28.7.; HRMS (NSI+) m/z found for [M+H]+: 440.1854; 
[C28H25NO4+H]+ requires 440.1856. 
 
2nd eluting diastereoisomer:  
(3S,11cS)-4-(Tert-butoxycarbonyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-
e]azepine-3-carboxylic acid 248 
 
 
Purified using column chromatography on silica gel (EtOAc), isolated as a 
colourless solid (170 mg, 31%). 
m.p. 255-257 °C; [α]D23.9 +58.4 ° (c 1.00, CHCl3); νmax(CHCl3)/cm-1 3052 (=C-H 
aromatic stretch, O-H stretch), 3006, 2976, 2927, 1751 (C=O stretch), 1725, 1696 
(C=C aromatic stretch, C=O stretch), 1395, 1367 (C-H stretch), 1251 (C-N stretch), 
1219, 1151, 820 (O-H bend), 772, 759, 677; 1H NMR (500 MHz, DMSO, VT NMR 
at 353 K) δ 8.07 (2H, d, J= 8.3 Hz, CH arom), 8.02 (2H, dd, J= 11.6, 8.3 Hz, CH 
arom), 7.66 (1H, d, J= 9.0 Hz, CH arom), 7.58 (1H, d, J= 9.0 Hz, CH arom), 7.52-
7.48 (2H, m, CH arom), 7.35-7.31 (2H, m, CH arom), 7.27-7.24 (1H, m, CH arom), 
7.16 (1H, d, J= 8.7 Hz, CH arom), 4.95 (1H, d, J =15.0 Hz, NCH2Ar), 4.36 (1H, s, 
CHCO2H), 3.55 (1H, d, J =15.0 Hz, NCH2Ar), 1.40 (9H, s, tBu); 13C NMR (126 
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MHz, DMSO, VT NMR at 353 K) δ 171.4, 155.75, 136.3, 135.1, 133.5, 133.4, 
132.6, 132.3, 131.7, 131.5, 129.8, 129.2, 128.9, 128.7, 127.21, 127.16, 126.8, 126.8, 
126.7, 126.3, 126.1, 125.2, 81.1, 62.7, 48.7, 28.4; HRMS (NSI+) m/z found for 
[M+H]+: 440.1852; [C28H25NO4+H]+ requires 440.1856. 
 
Side product:  
(S)-Tert-butyl ((2'-formyl-[1,1'-binaphthalen]-2-yl)methyl)carbamate 
 
 
Eluted first in on silica gel (4:1 light petroleum ether/EtOAc) as colourless oil (69 
mg, 13%). 
[α]D23.7 +6.0 ° (c 0.5, CHCl3); νmax(CH2Cl2)/cm-1 3355 (N-H bend), 3059 (=C-H 
aromatic stretch), 3008, 2977, 2930, 2867 (H-C=O stretch), 1762 (C=O stretch), 
1690 1594, 1508 (C=C aromatic stretch), 1457 (C-H stretch), 1429, 1391, 1366, 
1324, 1230 (C-N stretch), 1168, 1027, 865 (N-H wag), 821; 1H NMR (500 MHz, 
CDCl3) δ 9.58 (1H, s, CHO), 8.16 (1H, d, J= 8.6 Hz, CH arom), 8.04 (2H, dd, J= 
8.5, 5.7 Hz, CH arom), 7.98 (1H, d, J= 8.0 Hz, CH arom), 7.94 (1H, d, J= 8.0 Hz, 
CH arom), 7.72 (1H, d, J= 8.6 Hz, CH arom), 7.60 (1H, ddd, J= 1.0, 6.8, 7.9 Hz, CH 
arom), 7.46 (1H, ddd, J= 7.9, 6.8, 1.0 Hz, CH arom), 7.33 (1H, ddd, J= 7.9, 6.8, 1.0 
Hz, CH arom), 7.27-7.22 (2H, m, CH arom), 7.01 (1H, d, J= 8.5, 0.6 Hz CH arom), 
4.57 (1H, s), 4.02 (2H, d, J= 5.9 Hz), 1.36 (9H, s); 13C NMR (126 MHz, CDCl3) δ 
192.0, 155.6, 142.7, 136.4, 136.2, 133.6, 132.6, 132.2, 130.9, 129.4, 129.2, 129.1, 
128.6, 128.1, 127.5, 127.0, 126.8, 126.2, 125.9, 122.3, 79.5, 42.8, 29.4, 28.3; HRMS 
(NSI+) m/z found 412.1907 [M+H]+; [C27H25NO3+H]+ requires 412.1907.  
O
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 (3R,11cS)-4,5-Dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-3-carboxylic acid 
hydrochloride 250.HCl 
 
 
(3R,11cS)-4-(Tert-butoxycarbonyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-
3-carboxylic acid (230 mg, 0.52 mmol) was dissolved in acetone (20 mL) and 
concentrated HCl (3 drops) was added. The reaction mixture was heated at reflux 
overnight. The reaction mixture was cooled to room temperature and the solvent 
removed under reduced pressure. The product was isolated by recrystalization 
(MeOH and light petroleum ether) to give a pale yellow solid (197 mg, quant.) 
m.p. 265-267 °C; [α]D21.5 +294 ° (c 1.00, MeOH); νmax(CH2Cl2)/cm-1 3019 (=C-H 
aromatic stretch, O-H stretch, N-H stretch), 2400, 1741 (C=O stretch), 1528 (C=C 
stretch, C-H stretch), 1425, 1215 (C-N stretch, =C-O stretch), 928, 757, 669 (N-H 
wag), 625; 1H NMR (500 MHz, DMSO) δ 13.26 (1H, s, CO2H), 11.10 (1H, s, 
NH.HCl), 9.43 (1H, s, NH), 8.23 (1H, d, J= 8.4 Hz, CH arom), 8.15 (2H, dd, J= 8.3, 
3.7 Hz, CH arom), 8.09 (1H, d, J= 8.2 Hz, CH arom), 7.80 (1H, d, J= 8.4 Hz, CH 
arom), 7.71 (1H, d, J= 8.4 Hz, CH arom), 7.66-7.54 (2H, m, CH arom), 7.43-7.34 
(2H, m, CH arom), 7.18 (2H, t, J= 8.0 Hz, CH arom), 5.71 (1H, s, CHCO2H), 4.34 
(1H, d, J= 13.1 Hz, CH2), 3.67 (1H, d, J= 13.1 Hz, CH2); 13C NMR (126 MHz, 
DMSO) δ 168.9, 134.7, 134.6, 134.0, 132.2, 131.34, 131.25, 130.2, 129.9, 129.8, 
129.68, 129.65, 129.6, 129.0, 128.9, 128.4, 127.4, 127.3, 127.2, 127.1, 127.0, 59.4, 
46.0; HRMS (NSI+) m/z found 340.1333 [M−Cl]+; [C23H18NO2−Cl]+; requires 
340.1332.  
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(3R,11cS)-4,5-Dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-3-carboxylic acid 
250  
 
(3R,11cS)-4-(Tert-butoxycarbonyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-
3-carboxylic acid (1.55g, 3.53 mmol) was dissolved in dichloromethane (30 mL) and 
trifluoroacetic acid (3.8 mL, 49.4 mmol, 14 equiv.) was added. The solution was 
stirred for 30 min after which time the pH was neutralised by addition of saturated 
solution of sodium hydrogen carbonate. The solvent was removed under reduced 
pressure and the residue redissolved in EtOAc (30 mL). The organic layer was then 
washed with H2O (3 x 20 mL), saturated brine solution (3 x 20 mL), dried over 
anhydrous MgSO4 and the solvent removed under reduced pressure. The residue was 
then recrystallized (CHCl3 and light petroleum ether) to yield the title compound 
(983 mg, 82%). 
m.p. 269-271 °C; [α]D24.5 +272.8 ° (c 1.00, CHCl3); νmax(solid)/cm-1 3400 (O-H 
stretch), 3067 (N-H bend), 2926 (=C-H aromatic stretch), 2876, 2521, 1722 (C=O 
stretch), 1670, 1367 (C-H stretch), 1367, 1194 (C-N stretch), 1139, 820 (O-H bend), 
749 (N-H wag); 1H NMR (500 MHz, DMSO) δ 8.21 (1H, d, J= 8.0 Hz, CH arom), 
8.13 (2H, dd, J= 8.0, 2.0 Hz, CH arom), 8.08 (1H, d, J= 8.0 Hz, CH arom), 7.77 (1H, 
d, J= 8.0 Hz, CH arom), 7.69 (1H, d, J= 8.0 Hz, CH arom), 7.60 (2H, dt, J= 15.9, 
7.5, CH arom), 7.37 (2H, ddd, J= 8.0, 6.5, 1.0 Hz, CH arom), 7.17 (2H, dd, J= 8.5, 
5.3 Hz, CH arom), 5.49 (1H, s), 4.30 (1H, d, J= 13.1 Hz), 3.63 (1H, d, J= 13.1 Hz); 
13C NMR (126 MHz, DMSO) δ 168.9, 134.7, 134.3, 133.92, 133.86, 131.4, 131.3, 
131.3, 131.1, 130.5, 129.9, 129.8, 129.7, 128.9, 128.8, 128.3, 127.4, 127.2, 127.0, 
126.92, 126.86, 60.1, 46.1; HRMS (NSI−) m/z found 338.1181 [M−H]−; 
[C23H17NO2−H]− requires 338.1187.	
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(3S,11cS)-4,5-Dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-3-carboxylic acid 
hydrochloride 251.HCl 
 
 
(3S,11cS)-4-(Tert-butoxycarbonyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-
3-carboxylic acid (346 mg, 0.79 mmol) was dissolved in acetone (35 mL) and 
concentrated HCl (3 drops) was added. The reaction mixture was heated at reflux 
overnight. The reaction mixture was cooled to room temperature and the solvent 
removed under reduced pressure. The product was isolated by recrystalization 
(diethyl ether and light petroleum ether) to give a yellow solid (296 mg, quant.) 
m.p.* 290-292 °C (*decomp); [α]D21.5 +282 ° (c 1.00, MeOH); νmax(solid)/cm-1 3247 
(=C-H aromatic stretch, O-H stretch), 2737 (N-H bend), 1961, 1714 (C=O stretch), 
1594, 1461 (C=C aromatic stretch), 1430 (C-H stretch), 1310 (C=O stretch), 1276, 
1235(C-N stretch), 1028, 816, 780, 665 (N-H wag), 640; 1H NMR (500 MHz, 
DMSO) δ 10.51 (1H, s), 10.09 (1H, s), 8.29 (1H, d, J= 8.5 Hz, CH arom), 8.24 (1H, 
d, J= 8.0 Hz, CH arom), 8.17 (2H, d, J= 8.0 Hz, CH arom), 7.79 (1H, d, J= 8.5 Hz, 
CH arom), 7.68–7.62 (2H, m, CH arom), 7.54 (1H, d, J= 8.5 Hz, CH arom), 7.47-
7.42 (2H, m, CH arom), 7.35 (1H d, J= 8.5 Hz, CH arom), 7.29 (1H, d, J= 8.6 Hz, 
CH arom), 4.61 (1H, s, CHCO2H), 4.41 (1H, d, J= 13.0 Hz, CH2), 3.45 (dist, 1H, d, 
J= 13.0 Hz, CH2); 13C NMR (126 MHz, DMSO) δ 169.1, 135.7, 134.5, 134.3, 134.1, 
131.1, 130.8, 130.4, 130.1, 129.7, 129.1, 128.5, 127.8, 127.6, 127.5, 127.4, 127.34, 
127.32, 127.1, 124.6, 58.3, 46.2; HRMS (NSI+) m/z found 340.1336 [M−HCl+H]+; 
[C23H18NO2−Cl]+ requires 340.1332.  
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(3S,11cS)-4,5-Dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-3-carboxylic acid 251  
 
(3S,11cS)-4-(Tert-butoxycarbonyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-
3-carboxylic acid (1.60 g, 3.64 mmol) was dissolved in dichloromethane (30 mL) 
and trifluoroacetic acid (3.9 mL, 50.96 mmol, 14 equiv.) was added. The solution 
was stirred for 30 min after which time the pH was neutralised by addition of 
saturated solution of sodium hydrogen carbonate. The solvent was removed under 
reduced pressure and the residue redissolved in EtOAc (30 mL). The organic layer 
was then washed with H2O (3 x 20 mL), saturated brine solution (3 x 20 mL), dried 
over anhydrous MgSO4 and the solvent removed under reduced pressure. The 
residue was then recrystallized (CHCl3 and light petroleum ether) to yield the title 
compound (877 mg, 71%).  
m.p. 276-280 °C; [α]D24.5 +196.0 ° (c 1.00, CHCl3); νmax(CH2Cl2)/cm-1 3408 (N-H 
bend), 3053 (O-H stretch), 3009 (=C-H aromatic stretch), 2974, 2974, 2784, 2595, 
1760 (C=O stretch), 1633 (C=C aromatic stretch), 1400 (C-H stretch), 1392, 1340 
(C-O stretch), 1201 (C-N stretch), 1029 (O-H bend), 820 (N-H wag), 739; 1H NMR 
(500 MHz, DMSO) δ 8.09 (4H, m, CH arom), 7.70 (2H, d, J= 8.3 Hz, CH arom), 
7.58 (2H, m, CH arom), 7.42–7.26 (3H, m, CH arom), 7.22 (1H, d, J= 8.6 Hz, CH 
arom), 4.10 (1H, d, J= 12.7 Hz, CH2), 3.85 (1H, s, CHCO2H), 3.35 (1H, dis d, J= 
12.7 Hz, CH2); 13C NMR (126 MHz, DMSO) δ 134.7, 134.5, 133.2, 133.1, 132.2, 
131.0, 130.6, 130.3, 129.0, 128.7, 128.6, 128.4, 127.6, 126.6, 126.6, 126.5, 126.3, 
126.3, 126.2, 126.2, 60.2, 45.8; HRMS (NSI+) m/z found 340.1335 [M+H]+; 
[C23H17NO2+H]+ requires 340.1332. 
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4.0 Biphenyl catalyst synthesis 
5,7-Dihydrodibenzo[c,e]oxepine12  
 
 
A suspension of 2,2-biphenyl dimethanol (5.90 g, 27.5 mmol) in hydrobromic acid 
(24% in water, 84 mL) was heated to 100 °C for 40 minutes. The cloudy solution 
was allowed to cool to room temperature and the aqueous phase extracted with Et2O 
(3 x 50 mL). The organic layers were washed with water (2 x 10 mL), sodium 
hydrogen carbonate solution (50 mL) and saturated brine solution (50 mL). The 
organic layers were dried over anhydrous MgSO4 and the solvent removed under 
reduced pressure. Recrystallization (EtOAc and light petroleum ether) of the title 
compound as a colourless solid was achieved (4.0 g, 74%).  
νmax(CH2Cl2)/cm-1 1567 (C=C aromatic stretch), 1197 (C-O stretch), 1073, 1042, 
903, 891, 754 (C-H aromatic stretch), 602; 1H NMR (500 MHz, CDCl3) δ 7.60 (2H, 
d, J= 7.6 Hz, CH arom), 7.55 (2H, td, J= 7.1, 2.0 Hz, CH arom), 7.49-7.44 (4H, m, 
CH arom), 4.41 (4H, s); 13C NMR (126 MHz, CDCl3) δ 141.2, 135.2, 129.7, 129.0, 
128.3, 127.5, 67.6. 
Data in agreement with literature.14 
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2-[2-(Bromoethyl)phenyl]benzene carbaldehyde12  
 
 
A solution of 5,7-dihydrodibenzo[c,e]oxepine (2.20 g, 11.2 mmol) in cyclohexane 
(50 mL) was cooled to 0 °C. Molecular bromine (0.6 mL, 11.8 mmol, 1.05 equiv., as 
a solution in cyclohexane (5 mL)) was added over a period of 5 minutes causing the 
solution turned from pale yellow to dark red. After five minutes the ice bath was 
removed and reaction mixture heated at reflux until pale yellow solution is observed 
and HBr ceases to be liberated (~1 h). The solvent was removed under reduced 
pressure and the residue redissolved in Et2O. The organic layers were washed with 
saturated sodium hydrogen carbonate solution (20 mL) and saturated brine solution 
(20 mL). The organic layers were dried over anhydrous MgSO4 and the solvents 
removed under reduced pressure to yield yellow oil. The title compound was 
crystallised as a colourless solid from hexane and CHCl3 (1.50 g, 49%).  
νmax(CH2Cl2)/cm-1 3054 (C-H aromatic stretch), 2986 (O=C-H), 2861, 2761, 2762, 
2662, 2691, 2306, 1694 (C=O), 1596 (C=C aromatic stretch), 1445, 1421, 1266, 
1122, 1196, 896 (C-H aromatic bend); 1H NMR (500 MHz, CDCl3) δ 9.64 (1H, s, 
CHO), 7.97 (1H, d, J= 8.0 Hz, CH arom), 7.57 (1H t, J= 7.5 Hz, CH arom), 7.46 
(2H, t, J= 8.2 Hz, CH arom), 7.35-7.29 (2H, m, CH arom), 7.28 (1H, t, J= 7.6 Hz, 
CH arom), 7.11 (1H, d, J= 7.5 Hz, CH arom), 4.26 (1H, d, J= 10.2 Hz), 4.16 (1H, d, 
J= 10.2 Hz); 13C NMR (126 MHz, CDCl3) δ 191.7, 143.3, 137.9, 136.0, 134.2, 
133.6, 131.1, 130.7, 130.7, 129.1, 128.5, 128.4, 127.7, 31.4. 
Data in agreement with literature.12 
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6-Allyl-5H-dibenzo[c,e]azepin-6-ium  
 
 
2-[2-(Bromoethyl)phenyl]benzene carbaldehyde (4.71 g, 17.1 mmol) was dissolved 
in ethanol (50 mL) and the solution was cooled to 0 °C. Allylamine (1.4 mL, 18.8 
mmol, 1.1 equiv., as a solution in ethanol (10 mL)) was added dropwise to the 
reaction mixture. The reaction was allowed to reach ambient temperature overnight. 
Sodium tetraphenylborate (6.43 g, 18.8 mmol, 1.1 equiv.) was dissolved in a 
minimum volume of acetonitrile and added in one portion. The reaction mixture was 
stirred for 5 minutes then the solvents removed under reduced pressure. The residue 
was dissolved in a minimum volume of ethanol and a minimum volume of water was 
added to facilitate precipitation. The resulting solid was collected by filtration and 
washed with cold ethanol. The title compound was collected as a bright orange solid 
after being dried in a vacuum oven at 70 °C overnight (7.00 g, 74 %). 
m.p.* 175-177 °C (*decomp); νmax(CH2Cl2)/cm-1 3412, 3054 (C-H aromatic stretch, 
=C-H stretch), 2986, 2685, 2305, 1712, 1653 (C=C stretch), 1480 (C=C aromatic 
stretch), 1422, 1265, 1223 (C-N stretch), 896 (=C-H bend), 740 (C-H aromatic 
bend), 600; 1H NMR (500 MHz, DMSO) δ 9.43 (1H, s, N+=CH), 8.11 (1H, d, J= 7.5 
Hz, CH arom), 8.06 (1H, dd, J= 7.5, 0.8 Hz, CH arom), 8.01 (1H, ddd, J= 8.5, 7.5, 
1.0 Hz, CH arom), 7.85-7.81 (2H, m, CH arom), 7.66-7.62 (3H, m, CH arom), 7.23-
7.18 (8H, m, CH arom), 6.94 (8H, t, J= 7.5 Hz, CH arom), 6.81 (4H, t, J= 7.0 Hz, 
CH arom), 6.02 (1H, ddt, J= 16.6, 10.0, 6.5 Hz, NCH2CHCH2), 5.69 (1H, dd, J= 
17.0, 1.0 Hz, NCH2CHCH2 trans), 5.55 (1H, dd, J= 10.2, 0.5 Hz, NCH2CHCH2 cis), 
4.85 (2H, d, J= 6.0 Hz, NCH2CHCH2), 3.33 (2H, m, ArCH2N); 13C NMR (126 MHz, 
DMSO) δ 170.4, 164.4, 164.1, 163.7, 163.3, 141.4, 137.3, 136.0, 134.9, 134.5, 
130.6, 130.5, 130.5, 129.9, 129.8, 129.1, 127.2, 125.8, 125.8, 125.8, 125.8, 124.2, 
122.0, 64.2, 55.5; HRMS (NSI+) m/z found 235.1307 [M−BPh4]+; C17H16N+ requires 
235.1311	 
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(S)-6-(1-Phenylpropyl)-6,7-dihydro-5H-dibenzo[c,e]azepine 253  
 
 
 
2,2'-Bis (bromomethyl)-1,1'-biphenyl (1.00 g, 2.94 mmol) was dissolved in 
acetonitrile (30 mL) and CsCO3 (1.73g, 5.29 mmol, 1.8 equiv.) and (R)-(+)-1-
phenylpropylamine (0.43 mL, 2.94 mmol, 1 equiv.) were added. The reaction 
mixture was heated at reflux at 80 °C overnight. After consumption of starting 
material was seen by TLC analysis the reaction mixture was then diluted with 
dichloromethane (40 mL) and filtered into a separating funnel to remove the excess 
CsCO3. The organic layers were washed with H2O (3 x 20 mL) and saturated brine 
solution (2 x 10 mL) and dried over anhydrous MgSO4 and the solvent removed 
under reduced pressure. Column chromatography (10:1 light petroleum 
ether/EtOAc) afforded the title compound as a colourless oil (810 mg, 88%).  
[α]D22.6 +64.0 ° (c 1.03, CHCl3); νmax(CH2Cl2)/cm-1 3684, 3019 (C-H aromatic 
stretch), 2975, 2934, 2400, 1492 (C=C aromatic stretch), 1480, 1265 (C-N stretch), 
1215, 928; 1H NMR (500 MHz, CDCl3) δ 7.61 (2H, dd, J= 7.6, 1.2 Hz, CH arom), 
7.59-7.55 (2H, m, CH arom), 7.53-7.48 (4H, m, CH arom), 7.45 (2H, ddd, J= 8.5, 
7.0, 1.0 Hz, CH arom), 7.43-7.38 (3H, m, CH arom), 3.71 (2H, d, J= 12.5 Hz, 
ArCH2N), 3.54 (1H, dd, J= 9.6, 3.5 Hz, NCH(CH2CH3)Ph), 3.42 (2H, d, J= 12.5 Hz, 
ArCH2N), 2.26-2.13 (1H, m, NCH(CH2CH3)Ph), 1.96-1.77 (1H, m, 
NCH(CH2CH3)Ph), 0.81 (3H, t, J= 7.5 Hz, NCH(CH2CH3)Ph); 13C NMR (126 MHz, 
CDCl3) δ 143.5, 141.4, 135.4, 130.0, 128.9, 128.5, 128.0, 127.7, 127.6, 127.2, 69.1, 
53.4, 27.5, 10.6; HRMS (NSI+) m/z found 314.1902 [M+H]+; [C23H23N]+ requires 
314.1903. 
Br
Br
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(S)-6-(1-Phenylpropyl)-5H-dibenzo[c,e]azepin-6-ium 254  
 
 
(S)-6-(1-Phenylpropyl)-6,7-dihydro-5H-dibenzo[c,e]azepine (810 mg, 2.58 mmol) 
was dissolved in dichloromethane (50 mL). The solution was cooled to 0 °C and N-
bromosuccinimide (483 mg, 2.71 mmol, 1.05 equiv.) was added slowly, causing the 
reaction mixture to turn bright yellow. The reaction mixture was stirred for 2 h or 
until full consumption of the starting material was seen by TLC. The solvent was 
removed under reduced pressure and the residue redissolved in a minimum volume 
of ethanol. Sodium tetraphenylborate (927 mg, 2.71 mmol, 1.05 equiv., in a 
minimum volume of acetonitrile) was added dropwise. The title compound 
precipitated as a pale yellow solid (1.05g, 64%).  
m.p. 202-204 °C; [α]D22.2 +26.5 ° (c 1.60, CHCl3); νmax(CH2Cl2)/cm-1 3412, 3055 (C-
H aromatic stretch), 3001, 2984, 1637 (C=C aromatic stretch), 1599, 1579, 1556, 
1479, 1454, 1426, 1316, 1274, 1265, 1209 (C-N stretch), 1135, 1065, 1031, 845; 1H 
NMR (500 MHz, DMSO) δ 9.73 (1H, s, CH=N+), 8.21 (1H, d, J= 8.0 Hz, CH arom), 
8.07 (1H, d, J= 7.95 Hz, CH arom), 8.03 (1H, t, J= 7.5 Hz, CH arom), 7.85 (1H, t, J= 
8.0 Hz, CH arom), 7.78 (1H, d, J= 7.5 Hz, CH arom), 7.68-7.60 (2H, m, CH arom), 
7.56 (1H, t, J= 7.5 Hz, CH arom), 7.50-7.43 (3H, m, CH arom), 7.40 (1H, t, J= 7.5 
Hz, CH arom), 7.24-7.21 (8H, m, CH arom), 7.09-7.03 (1H, m, CH arom), 6.93 (8H, 
t, J= 7.3 Hz, CH arom), 6.80 (4H, t, J= 7.5 Hz, CH arom), 5.53 (1H, t, J= 8.0 Hz), 
4.72 (2H, s), 2.43 (2H, m), 0.90 (3H, t, J= 6.9 Hz); 13C NMR (126 MHz, DMSO) δ 
164.4, 164.0, 163.7, 163.3, 141.5, 136.2, 136.0, 130.5, 130.4, 130.1, 130.1, 129.6, 
129.6, 129.5, 129.4, 129.4, 129.4, 129.1, 129.1, 127.2, 125.8, 125.8, 125.8, 125.7, 
122.0, 94.7, 67.2, 45.8, 10.6; HRMS (NSI+) m/z found 313.1780 [M-BPh4]+; 
[C23H22N]+ requires 313.1781. 
 
N
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5-Methyl-6-1-phenylpropyl)-6,7-dihydro-5H-dibenzo[c,e]azepine  
 
 
 (S)-6-(1-Phenylpropyl)-5H-dibenzo[c,e]azepin-6-ium (200 mg, 0.32 mmol) was 
dissolved in anhydrous THF (20 mL) and the solution was cooled to −78 °C. A 
solution of methyl magnesuim bromide (1.1 mL, 3.2 mmol, 10 equiv., 3M in Et2O) 
added. The reaction mixture was allowed to reach ambient temperature overnight 
and the excess Grignard quenched with H2O. The solvent was evaporated under 
reduced pressure and the residue redissolved in dichloromethane and the organic 
layers washed with H2O (2 x 10 mL) and dried with saturated brine solution (2 x 10 
mL). The organic layers were dried over anhydrous MgSO4 and the solvent removed 
under reduced pressure. The title product was isolated, following column 
chromatography on silica gel (12:1 light petroleum ether/EtOAc), as colourless oil in 
a mixture of inseparable diastereoisomers (90 mg, 86%).  
νmax(CH2Cl2)/cm-1 3061, 3025 (C-H aromatic stretch), 2962, 2929, 2873, 2800, 
1681, 1619, 1605 (C=C aromatic stretch), 1491, 1481, 1377, 1364, 1196, 1087 (C-N 
stretch), 1038; 1H NMR (500 MHz, CDCl3) δ 7.52-7.18 (24H, m, CH arom), 7.01 
(1H, dd, J= 7.5, 1.0 Hz, CH arom), 6.95 (1H, d, J= 7.0, 1.0 Hz, CH arom), 4.19-4.04 
(1H, m), 3.97-3.81 (2H, m), 3.70 (1H, dd, J= 9.0, 5.1 Hz), 3.60 (1H, dd, J= 9.1, 4.3 
Hz), 3.56 (1H, d, J= 11.1 Hz), 3.17 (1H, d, J= 11.1 Hz), 3.16-3.12 (1H, m), 2.08 
(1H, ddd, J= 12.7, 7.3, 5.2 Hz), 2.04-1.87 (2H, m), 1.85-1.75 (1H, m), 0.87 (3H, t, 
J= 7.3 Hz), 0.77-0.70 (6H, m), 0.62 (3H, d, J= 7.2 Hz); 13C NMR (126 MHz, CDCl3) 
δ 143.3, 142.4, 141.8, 141.2, 140.5, 139.5, 139.3, 139.2, 137.4, 137.2, 131.4, 131.3, 
130.3, 130.0, 129.8, 129.3, 129.2, 128.7, 128.7, 128.6, 128.5, 128.5, 128.2, 128.1, 
128.0, 127.9, 127.8, 127.7, 127.7, 127.6, 127.5, 127.4, 127.2, 127.0, 126.9, 126.9, 
70.9, 70.8, 60.9, 60.3, 53.7, 51.8, 26.7, 25.7, 23.7, 22.9, 11.5, 10.8; HRMS (NSI+) 
m/z found 328.2059 [M+H]+; [C24H26N]+ requires 328.2060. 
 
N
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Tert-butyl 5H-dibenzo[c,e]azepine-6(7H)-carboxylate  
 
 
NaH (72 mg, 3 mmol, 2.05 equiv.) and 2,2'-bis(bromomethyl)-1,1'-biphenyl (500 
mg, 1.47 mmol) were dissolved in anhydrous DMF (12 mL). The flask was then 
cooled to 0 °C and tert-butyl carbamate (172 mg, 1.47 mmol, 1 equiv., as a solution 
in anhydrous DMF) was added dropwise to the reaction mixture. The ice bath was 
removed and the reaction mixture was stirred at ambient temperature for 4 days. To 
the solution was added a small amount of ice and the solvent was removed under 
reduced pressure. The residue was redissolved in Et2O (20 mL) and the ethereal 
solutions washed with H2O (3 x 10 mL) and saturated brine solution (2 x 10 mL) and 
dried over MgSO4. The solvent was removed under reduced pressure and column 
chromatography (4:1 light petroleum ether/EtOAc) gave the title compound as a 
yellow oil (247 mg, 57%).  
νmax(CH2Cl2)/cm-1 3065, 3020 (C-H aromatic stretch), 2976, 2930, 2864, 1764, 1693 
(C=O stretch), 1601, 1481, 1453, 1399, 1248, 1342, 1264, 1224, 1158, 1115 (C-N 
stretch), 1080, 1008, 994, 940, 876; 1H NMR (500 MHz, CDCl3) δ 7.49-7.28 (8H, 
m, CH arom), 4.14 (4H, s, ArCH2N), 1.52 (9H, s, NCO2tBu); 13C NMR (126 MHz, 
CDCl3) δ 154.3, 141.2, 140.7, 135.1, 134.4, 129.8, 129.7, 129.0, 128.5, 128.5, 128.3, 
128.2, 127.5, 80.0, 67.6, 28.6, 28.4; HRMS (NSI−) m/z found 294.1490 [M−H]−; 
[C19H21NO2−H]− requires 294.1489. 
 
Br
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(+/-) 6,6'-Dimethyl-[1,1'-biphenyl]-2,2'-dicarboxylic acid 25513  
 
 
NaOH (5.88 g, 147 mmol) and 2-amino-3-methylbenzoic acid (17 g, 113 mmol) 
were dissolved in water and cooled to 0 °C. NaNO2 (7.8 g, 113 mol, 1 equiv.) was 
added. The solution stirred until homogeneous. 4M HCl (240 mL) was added 
dropwise keeping the temperature below 8 °C. After addition the reaction mixture 
was stirred at 0 °C for 30 minutes. In a separate 1 L flask CuSO4.5H2O (48 g, 192 
mmol) and water (150 mL) were cooled to 0 °C and ammonium hydroxide (95 mL, 
215 mmol) was added. NH2OH was added (prepared from (NH2OH)2.H2SO4 (17.6 g, 
107 mmol) with 3M NaOH (75 mL)) and the solution effervesced. The diazonium 
salt prepared above was added in 40 mL portions via syringe with the needle below 
the surface of the reaction mixture. The addition was completed as quickly as 
possible whilst maintaining the temperature below 8 °C. The resulting mixture was 
refluxed for 30 minutes at 115 °C and then cooled to room temperature and HCl 
(12M, 80 mL) was added. The solution was left overnight and the precipitate that 
had formed was filtered giving a brown solid which was dried at 60 °C for 12 h (17.5 
g). The solid was dissolved in boiling ethanol and cooled to room temperature from 
which yellow solid crashes out: the major side product 256 of this reaction (3.05 g, 
18%).  
m.p. 252-254 °C; νmax(CH2Cl2)/cm-1 3944, 3691, 3054 (C-H aromatic stretch), 2987, 
2685 (O-H stretch), 2410, 2305, 1682 (C=C aromatic stretch, C=O stretch), 1421 
(O-H bend), 1314 (C-O bend), 1265, 1158, 1125 (C-N stretch), 961, 896; 1H NMR 
(500 MHz, DMSO) δ 12.66 (2H, s, CO2H), 7.50 (2H, d, J= 7.3 Hz, CH arom), 7.46 
(2H, t, J= 7.5 Hz, CH arom), 7.37 (2H, d, J= 7.2 Hz, CH arom), 2.56 (6H, s, CH3); 
13C NMR (126 MHz, DMSO) δ 170.1, 148.8, 137.5, 133.0, 130.6, 126.8, 126.4, 
18.2.  
The remaining filtrate was rotatory evaporated and redissolved in hot ethanol and 
NH2
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H2O (100 mL) was added. The title compound 255 precipitated as a red-brown 
solid, which was collected by suction filtration (8.2 g, 30.3 mmol, 54%). 
m.p. 208-210 °C (Lit 220-230 °C); νmax(CH2Cl2)/cm-1 3054 (C-H aromatic stretch), 
2986, 2923, 2832, 2685, 2560 (O-H stretch), 2411, 2305, 1702 (C=O stretch), 1682, 
1592 (C=C aromatic stretch), 1579, 1421, 1296, 1264 (C-O stretch), 1187, 1159, 
1111, 934, 896 (C-H bend), 819; 1H NMR (500 MHz, DMSO) δ 12.39 (2H, s, 
CO2H), 7.72 (2H, d, J= 7.6 Hz, CH arom), 7.46 (2H, d, J= 7.4 Hz, CH arom), 7.33 
(2H, t, J= 7.6 Hz, CH arom ), 1.83 (6H, s, CH3); 13C NMR (126 MHz, DMSO) δ 
168.5, 141.1, 136.4, 133.3, 130.9, 127.7, 127.1, 20.2; HRMS (NSI−) m/z found for 
[M−H]−: 269.0812; [C16H13O4−H]− requires 269.0819. 
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(S)-6,6'-Dimethyl-[1,1'-biphenyl]-2,2'-dicarboxylic acid (+)-255 
 
 
(±) 6,6'-dimethyl-[1,1'-biphenyl]-2,2'-dicarboxylic acid (3.5 g, 12.9 mmol) was 
dissolved in 90 % boiling EtOH (16 mL) and quinine (4.2 g, 12.9 mmol, 1 equiv.) 
was added in one portion. The solution was allowed to cool to room temperature and 
a white precipitate of the quinine monohydrate salt formed (4.90 g). The quinine salt 
was then dissolved in EtOAc (70 mL) and 3 M HCl (80 mL) was added. The organic 
layers were washed and separated with H2O (3 x 20 mL), dried with saturated brine 
solution (2 x 10 mL) and dried over anhydrous MgSO4 and concentrated under 
reduced pressure to yield an orange solid (1.3 g, 37%).  
[α]D20.7 +20.8 ° [(c 1.00, MeOH) (Lit [α]D25 +19.2 °, c 1.00, MeOH)] 
m.p. 225-227 °C (Lit 220-230 °C) 
CO2H
CO2H
CO2H
CO2H
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(S)-Dimethyl 6,6'-dimethyl-[1,1'-biphenyl]-2,2'-dicarboxylate 258  
 
 
6,6'-Dimethyl-[1,1'-biphenyl]-2,2'-dicarboxylic acid (200 mg, 0.74 mmol) was 
dissolved in MeOH (10 mL). Concentrated H2SO4 (95%, 1 mL) was added and the 
red-brown reaction mixture was heated at refluxed at 70 °C overnight. The reaction 
was quenched at 0 °C with saturated sodium hydrogen carbonate solution and the 
solvent was removed under reduced pressure. The residue was redissolved in 
dichloromethane (20 mL) and the organic layers were washed with H2O (3 x 10 mL) 
and saturated brine solution (2 x 10 mL) and dried over MgSO4. The solvent was 
removed under reduced pressure and the resultant brown oil was subjected to column 
chromatography (4:1 light petroleum ether/EtOAc) to give the product as a dark 
yellow oil (181 mg, 82%).  
νmax(CH2Cl2)/cm-1 3059 (C-H aromatic stretch), 2992, 2951, 2921, 2841, 1727 
(C=O stretch), 1593 (C=C aromatic stretch), 1578, 1460, 1434, 1291, 1267, 1193, 
1174, 1141, 1105 (C-O stretch), 1016, 877; 1H NMR (500 MHz, CDCl3) δ 7.88-7.84 
(2H, m, CH arom), 7.44 (2H, ddd, J= 7.6, 1.3, 0.7 Hz, CH arom), 7.33 (2H, t, J= 7.7 
Hz, CH arom), 3.58 (6H, s, CO2CH3), 1.91 (6H, s, CH3); 13C NMR (126 MHz, 
CDCl3) δ 167.5, 141.2, 136.6, 133.6, 129.4, 127.7, 126.9, 51.7, 20.0. 
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(S)-(6,6'-Dimethyl-[1,1'-biphenyl]-2,2'-diyl)dimethanol 25914  
 
 
Dimethyl 6,6'-dimethyl-[1,1'-biphenyl]-2,2'-dicarboxylate (144 mg, 0.48 mmol) was 
dissolved in anhydrous Et2O (10 mL) and the solution was cooled to 0 °C. LiAlH4 
(73 mg, 1.93 mmol, 4 equiv.) was added and the reaction was monitored by TLC. 
After 5 h the reaction mixture was quenched with H2O (10 mL). The reaction 
mixture was filtered through a pad of celite and the organic layers washed with H2O 
(3 x 15 mL) with saturated brine solution (2 x 10 mL) then dried over anhydrous 
MgSO4. The solvent was removed under reduced pressure to give the product as an 
orange solid (117 mg, quant.). This was employed in the next step without further 
purification.  
m.p. 208-210 °C (Lit 116-118 °C)16; [α]D22.1 −74.7 ° [(c 1.00, CHCl3); Lit [α]D −30 ° 
(c 0.4, CHCl3)]16; νmax(CH2Cl2)/cm-1 3064 (O-H stretch), 3018 (C-H aromatic 
stretch), 2970, 2918, 2856, 1459 (C=C aromatic stretch), 1437, 1381, 1246, 1210, 
1166 (C-O stretch), 788 (C-H aromatic bend), 755, 735, 626, 613; 1H NMR (500 
MHz, CDCl3) δ 7.36 (2H, dd, J= 7.4, 1.0 Hz, CH arom), 7.31 (2H, t, J= 7.5 Hz, CH 
arom), 7.26 (2H, t, J= 6.1 Hz, CH arom), 4.29 (2H, d, J= 11.5 Hz), 4.14 (2H, d, J= 
11.5 Hz), 2.27 (2H, br s, OH), 1.87 (6H, s, ArCH3); 13C NMR (126 MHz, CDCl3) δ 
138.4, 138.2, 136.0, 129.8, 127.9, 127.5, 63.0, 20.1.  
Data in agreement with literature values.16 
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(±) 6,6'-Dimethyl-[1,1'-biphenyl]-2,2'-dicarbaldehyde  
 
 
(6,6'-Dimethyl-[1,1'-biphenyl]-2,2'-diyl)dimethanol (172 mg, 0.71 mmol) was 
dissolved in dichloromethane (10 mL) and pyridinium chlorochromate (459 mg, 2.13 
mmol, 3 equiv.) was added. The solution was stirred at ambient temperature 
overnight. Et2O (20 mL) and a spatula of celite were added to the solution and the 
reaction mixture was stirred for a further 30 minutes. The solution was then filtered 
through a pad of celite and the solvent was removed under reduced pressure. The 
product was isolated without further purification as an orange solid (162 mg, 96%). 
νmax(CH2Cl2)/cm-1 3063, 3003 (C-H aromatic stretch), 2956, 2921, 2852 (O=C-H 
stretch), 2810, 2748, 1685 (C=O stretch), 1590 (C=C aromatic stretch), 1574, 1457, 
1384, 1280, 1238, 1217, 1168, 1001, 918 (C-H aromatic bend); 1H NMR (500 MHz, 
CDCl3) δ 9.60 (2H, s, ArCHO), 7.91 (2H, d, J= 7.6 Hz, CH arom), 7.59 (2H, d, J= 
7.4 Hz, CH arom), 7.50 (2H, t, J= 7.6 Hz, CH arom), 1.98 (6H, s, ArCH3); 13C NMR 
(126 MHz, CDCl3) δ 191.4, 139.9, 137.5, 135.9, 134.5, 128.6, 126.4, 19.6. 
Data in agreement with literature values. 
 
(±) 6-Allyl-1,11-dimethyl-6,7-dihydro-5H-dibenzo[c,e]azepine  
 
 
6,6'-Dimethyl-[1,1'-biphenyl]-2,2'-dicarbaldehyde (500 mg, 2.10 mmol) was 
dissolved in MeOH (80 mL). Allyamine (0.16 mL, 2.10 mmol, 1 equiv.) was added 
and the solution was stirred for 5 minutes. NaBH3CN (264 mg, 4.20 mmol, 2 equiv.) 
O
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was added in one portion and glacial acetic acid (1 mL) was added immediately 
after. The reaction mixture was stirred overnight. The reach mixture was quenched 
by the addition of 1M NaOH (20 mL) and Et2O (50 mL) was added. The solution 
was washed and separated with H2O (2 x 30 mL) and saturated brine solution (2 x 20 
mL) and dried over anhydrous MgSO4. The solvent was removed under reduced 
pressure to yield the title compound as an orange oil (352 mg, 64%).  
νmax(CH2Cl2)/cm-1 3067, 3019 (C-H aromatic stretch), 2930, 2877, 2804, 1646 (C=C 
aromatic stretch), 1453, 1377, 1336, 1219, 1163, 1101 (C-N stretch), 996, 919, 810 
(C-H aromatic bend); 1H NMR (500 MHz, CDCl3) δ 7.25 (4H, d, J= 4.8 Hz, CH 
arom), 7.12 (2H, t, J= 4.4 Hz, CH arom), 5.95 (1H, ddt, J= 17.1, 10.1, 6.6 Hz, 
NCH2CHCH2), 5.28-5.15 (2H, m, NCH2CHCH2), 3.52 (2H, d, J= 12.4 Hz, 
NCH2Ar), 3.01 (2H, dd, J= 6.7, 1.0 Hz, NCH2CHCH2), 2.95 (2H, d, J= 12.3 Hz, 
NCH2Ar), 2.19 (6H, s, ArCH3); 13C NMR (126 MHz, CDCl3) δ 138.5, 136.3, 135.7, 
134.3, 129.5, 127.2, 126.5, 117.8, 57.9, 54.5, 19.8; HRMS (NSI+) m/z found 
264.1747 [M+H]+; [C19H22N]+ requires 264.1747.  
 
 
(±) 6-Allyl-1,11-dimethyl-5H-dibenzo[c,e]azepin-6-ium  
 
 
6-Allyl-1,11-dimethyl-6,7-dihydro-5H-dibenzo[c,e]azepine (542 mg, 2.1 mmol) and 
N-bromosuccinimide (385 mg, 2.2 mmol, 1.05 equiv.) were dissolved in 
dichloromethane (30 mL). The reaction mixture was stirred for 1 h. The solvent was 
removed under reduced pressure and the residue redissolved in a minimum volume 
of EtOH. Sodium tetraphenylborate (790 mg, 2.3 mmol, 1.1 equiv., in a minimum 
volume of acetonitrile) was added to the solution. A bright orange precipitate was 
collected by suction filtration and washed with cold EtOH to give the title compound 
as a orange solid which was dried at 70 °C in a vacuum oven (983 mg, 80%).  
m.p.* 129-131°C (*decomp.); νmax(CH2Cl2)/cm-1 3425, 3054 (C-H aromatic stretch), 
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3002, 2987, 2922, 2845, 1775, 1705, 1648, 1637, 1583 (C=C aromatic stretch), 
1478, 1440, 1426, 1378, 1348, 1298, 1265, 1183, 1036 (C-N stretch), 853, 791 (C-H 
aromatic bend), 733, 707, 706, 612; 1H NMR (500 MHz, DMSO) δ 9.36 (1H, s, 
ArCH=N+), 7.87 (1H, d, J= 7.6 Hz, CH arom), 7.82 (1H, d, J= 7.6 Hz, CH arom), 
7.70 (1H, t, J= 7.7 Hz, CH arom), 7.48 (1H, d, J= 6.7 Hz, CH arom), 7.22-7.15 (9H, 
m, CH arom), 6.94 (9H, t, J= 7.4 Hz, CH arom), 6.81 (4H, t, J= 7.2 Hz, CH arom), 
5.96 (1H, ddt, J= 16.6, 10.3, 6.4 Hz, NCH2CHCH2), 5.61 (1H, d, J= 17.1 Hz, 
NCH2CHCH2 trans), 5.51 (1H, d, J= 10.2 Hz, NCH2CHCH2 cis), 4.85 (1H, d, J= 13.4 
Hz, ArCH2N), 4.80-4.68 (2H, m, NCH2CHCH2), 4.41 (1H, d, J= 13.4 Hz, ArCH2N), 
2.30 (3H, s, ArCH3), 2.09 (3H, s, ArCH3); 13C NMR (126 MHz, DMSO) δ 179.9, 
170.0, 164.4, 164.0, 163.7, 163.3, 140.0, 139.1, 138.1, 138.1, 136.7, 136.0, 134.6, 
132.1, 130.7, 129.7, 129.2, 129.1, 128.8, 128.4, 126.7, 125.8, 125.8, 125.8, 125.7, 
124.1, 122.0, 63.8, 56.2, 30.0, 20.2, 20.2; HRMS (NSI+) m/z found 262.1592 
[M−BPh4]+; C19H20N+ requires 262.1590.  
 
2,2'-Bis(bromomethyl)-6,6'-dimethyl-1,1'-biphenyl 260  
 
(6,6'-Dimethyl-[1,1'-biphenyl]-2,2'-diyl)dimethanol (500 mg, 2.1 mmol) and 
pyridine (19 µL, 0.23 mmol, 0.11 equiv.) were dissolved in anhydrous toluene (50 
mL). Phosphorous tribromide (0.6 mL, 6.3 mmol, 3 equiv.) was added dropwise to 
the solution. After the addition was complete, the reaction was heated to 60 °C for 3 
h. The reaction was quenched by addition of H2O (50 mL) and the resulting biphasic 
mixture was washed with saturated sodium hydrogen carbonate solution (20 mL) and 
the organic layers dried over anhydrous MgSO4 and decolourised with a spatula of 
carbon black, filtered and the solvent was removed under reduced pressure to yield 
the title compound as an orange solid (677 mg, 88%).  
m.p. 45-47 °C; [α]D19.4 +35.2 ° (c 1.00, CHCl3); νmax(CH2Cl2)/cm-1 3064, 3018 (C-H 
aromatic stretch), 2970, 2918, 2856, 1593 (C=C aromatic stretch), 1459, 1437, 
OH
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1381, 1246, 1210, 1166, 1005, 935, 788 (C-H aromatic bend), 755, 735, 626, 613; 
1H NMR (500 MHz, CDCl3) δ 7.43 (2H, d, J= 7.6 Hz, CH arom), 7.32 (2H, t, J= 7.6 
Hz, CH arom), 7.26 (2H, d, J= 7.6 Hz, CH arom), 4.15 (4H, q, J= 10.1 Hz), 1.98 
(6H, s); 13C NMR (126 MHz, CDCl3) δ 137.7, 136.7, 135.4, 130.5, 128.6, 128.4, 
32.4, 20.2.  
 
Tert-butyl 1,11-dimethyl-5H-dibenzo[c,e]azepine-6(7H)-carboxylate 261  
 
2,2'-Bis(bromomethyl)-6,6'-dimethyl-1,1'-biphenyl (500 mg, 1.36 mmol) was 
dissolved in anhydrous DMF (30 mL) and NaH (67 mg, 2.78 mmol, 2.05 equiv.) was 
added. The solution was cooled to 0 °C and tert-butyl carbamate (159 mg, 1.36 
mmol, 1 equiv.) was added in one portion. The reaction was monitored by TLC and 
once complete, DMF was removed under reduced pressure and the residue 
redissolved in EtOAc (60 mL). The organic layers were washed repeatedly with H2O 
(5 x 10 mL) and saturated brine solution (2 x 20 mL). The organic layers were dried 
over anhydrous MgSO4 and the solvent removed under reduced pressure. Column 
chromatography (9:1 light petroleum ether/EtOAc) afforded the product as a 
colourless oil (385 mg, 88%). (NB: unable to remove 10% oxepine impurity) 
[α]D22.3 −238 ° (c 1.50, CHCl3); νmax(CH2Cl2)/cm-1 3063 (C-H aromatic stretch), 
2974, 2927, 2866, 1691 (C=C aromatic stretch, C=O), 1459, 1400, 1364, 1036 (C-O 
stretch), 1247, 1216, 1158, 1100 (C-N stretch), 869; 1H NMR (500 MHz, CDCl3) δ 
7.42-7.10 (6H, m, CH arom), 4.71 (2H, d, J= 9.7 Hz), 3.45 (2H, d, J= 13.1 Hz), 2.18 
(6H, s), 1.48 (9H, s); 13C NMR (126 MHz, CDCl3) δ 154.3, 138.2, 136.1, 134.9, 
130.0, 127.9, 126.5, 79.7, 47.8, 28.6, 19.7; HRMS (NSI+) m/z found 324.1960 
[M+H]+; [C21H25NO2+H]+ requires 324.1958.  
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(5R,11bS)-6-Tert-butyl 5-methyl 1,11-dimethyl-5H-dibenzo[c,e]azepine-
5,6(7H)-dicarboxylate 262  
 
tert-butyl 1,11-dimethyl-5H-dibenzo[c,e]azepine-6(7H)-carboxylate (645 mg, 1.99 
mmol) was dissolved in anhydrous Et2O (60 mL) and cooled to −78 °C. s-BuLi (2.85 
mL, 3.99 mmol, 2 equiv., 1.4 M in cyclohexane) was added to the solution and the 
reaction mixture turned from a pale yellow to deep red. The reaction was stirred for 
1 h. Methyl chloroformate (0.23 mL, 2.99 mmol, 1.5 equiv.) was added and the 
reaction mixture returned an orange colour. The reaction mixture was stirred for 1 h 
at −78 °C and then quenched at 0 °C with saturated ammonium chloride solution. 
The organic layers were washed and separated with H2O (2 x 30 mL) and saturated 
brine solution (2 x 10 mL) and dried over anhydrous MgSO4 and the solvents 
removed under reduced pressure. Column chromatography (9:1 light petroleum 
ether/EtOAc) afforded the product as a colourless fluffy solid (600 mg, 79%).  
m.p. 74-76 °C; [α]D22.5 −248 ° (c 1.00, CHCl3); νmax(CHCl3)/cm-1 3065, 3002 (C-H 
aromatic stretch), 2975, 2948, 2930, 2872, 2250, 1752 (C=O stretch), 1686 (C=O 
stretch), 1600 (C=C aromatic stretch), 1474, 1458, 1433, 1392, 1366, 1355, 1308, 
1255, 1221, 1206, 1161, 1105 (C-N stretch), 1004 (C-O stretch), 912, 875 (C-H 
aromatic bend); 1H NMR (500 MHz, DMSO at 373 K) δ 7.42-7.16 (6H, m, CH 
arom), 5.61 (1H, s, CHCO2Me), 4.85 (1H, d, J= 13.3 Hz, CH2), 3.38 (1H, d, J= 13.1 
Hz, CH2), 3.10 (3H, s, CO2CH3), 2.13 (3H s, ArCH3), 2.07 (3H, s, ArCH3), 1.47 (9H, 
s, CO2C(CH3)3); 13C NMR (126 MHz, CDCl3, at ambient temperature) δ 170.8, 
170.5, 154.3, 153.9, 137.5, 137.3, 137.2, 136.9, 136.7, 136.6, 136.4, 135.2, 134.9, 
134.7, 134.6, 130.6, 130.4, 129.8, 129.7, 128.5, 128.5, 128.2, 128.1, 128.04, 128.01, 
127.3, 127.1, 80.5, 80.4, 62.1, 60.8, 51.7, 47.7, 46.4, 28.5, 28.4, 19.5, 19.4; HRMS 
(NSI+) m/z found for [M+H]+: 382.2013; [C23H27NO4+H]+ requires 382.2013. 
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(5R,11bS)-Methyl1,11-dimethyl-6,7-dihydro-5H-dibenzo[c,e]azepine-5-
carboxylate 263 
 
(5R,11bS)-6-Tert-butyl 5-methyl 1,11-dimethyl-5H-dibenzo[c,e]azepine-5,6(7H)-
dicarboxylate (100 mg, 0.26 mmol) was dissolved in dichloromethane (8 mL) and 
trifluoroacetic acid (0.28 mL, 3.64 mmol, 14 equiv.) was added in one portion. The 
solution was stirred for 30 minutes after which time the pH was neutralised by 
addition of saturated solution of sodium hydrogen carbonate. The solvent was 
removed under reduced pressure and the residue redissolved in EtOAc (10 mL). The 
organic layer was then washed with H2O (3 x 10 mL) and saturated brine solution (3 
x 5 mL) and dried over anhydrous MgSO4. The solvent was removed under reduced 
pressure and the brown residue recrystallized (CHCl3) as a colourless solid (55 mg, 
75%).  
νmax(CH2Cl2)/cm-1 3316, 3062, 3017 (C-H aromatic stretch), 2948, 2926, 2867, 1732 
(C=O stretch), 1493 (C=C aromatic stretch), 1432, 1378, 1302, 1265, 1228, 1211, 
1122, 1099 (C-O stretch), 994, 785, 770, 741 (C-H aromatic stretch), 680; 1H NMR 
(500 MHz, CDCl3) δ 7.36-7.29 (2H, m, CH arom), 7.29-7.22 (2H, m, CH arom), 
7.18 (1H, d, J= 7.4 Hz, CH arom), 7.11 (1H, d, J= 7.3 Hz, CH arom), 4.44 (1H, s, 
CHCO2Me), 3.64 (1H, d, J= 13.6 Hz, CH2), 3.35 (1H, d, J= 13.6 Hz, CH2), 3.22 
(3H, s, CO2CH3), 2.64 (1H, s, NH), 2.15 (3H, s, CH3Ar), 2.12 (3H, s, CH3Ar); 13C 
NMR (126 MHz, CDCl3) δ 174.3, 138.3, 137.9, 136.9, 136.6, 136.3, 135.1, 130.3, 
129.2, 128.5, 128.0, 127.9, 125.6, 62.4, 51.9, 48.3, 19.5, 19.4; HRMS (NSI+) m/z 
found 282.1489 [M+H]+; [C18H20NO2]+ requires 282.1489. 
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(5R,11bS)-6-(Tert-butoxycarbonyl)-1,11-dimethyl-6,7-dihydro-5Hdibenzo[c,e] 
azepine-5-carboxylic acid 264 
 
tert-butyl 1,11-dimethyl-5H-dibenzo[c,e]azepine-6(7H)-carboxylate (645 mg, 1.99 
mmol) was dissolved in anhydrous Et2O (60 mL). The solution was cooled to −78 °C 
and s-BuLi (2.85 mL, 4.00 mmol, 2 equiv., 1.4 M in cyclohexane) was added and the 
reaction mixture turned red. After 1 h at −78 °C CO2 gas (syringe in directly through 
a drying tube of CaCl2) was bubbled into reaction mixture for 1 h, this caused the 
reaction to turn yellow. The reaction was allowed to warm to ambient temperature 
overnight then quenched with saturated ammonium chloride solution at 0 °C. The 
resulting biphasic mixture was washed with H2O (2 x 20 mL) and saturated brine 
solution (2 x 10 mL) and dried over MgSO4. Organic layers concentrated under 
reduced pressure and column chromatography (4:1 light petroleum ether/EtOAc) 
gave the product as a colourless solid (330 mg, 45%). 
m.p. 117-119 °C; [α]D23.6 −250 ° (c 1.00, CHCl3); νmax(CHCl3)/cm-1 3066, 3009 (C-H 
aromatic stretch), 2976, 2928, 2782 (O-H stretch), 1751, 1717 (C=O stretch), 1601 
(C=C aromatic stretch), 1456, 1394, 1367, 1310 (C-O stretch), 1254, 1219, 1160 
(C-N stretch), 883 (C-H aromatic bend), 760, 744; 1H NMR (VT NMR at 380 K, 
500 MHz, DMSO) δ 11.35 (1H, s, CO2H), 7.37-7.32 (2H, m, CH arom), 7.29-7.21 
(3H, m, CH arom), 7.17 (1H dd, J= 6.7, 2.0 Hz, CH arom), 5.52 (1H, s, CHCO2H), 
4.84 (1H, d, J= 13.1 Hz, CH2), 3.39 (1H, d, J= 13.2 Hz, CH2), 2.13 (3H, s, CH3Ar), 
2.08 (3H, s, CH3Ar), 1.47 (9H, s, CO2C(CH3)3); 13C NMR (VT NMR at 380 K, 126 
MHz, DMSO) δ 170.7, 153.9, 137.8, 137.7, 136.9, 136.3, 135.7, 135.2, 130.5, 130.0, 
128.6, 128.4, 128.3, 127.4, 80.0, 63.4, 28.7, 28.7, 19.7, 19.5; HRMS	 (NSI−) m/z 
found 366.1702 [M−H]−; [C22H25NO4-H]− requires 366.1711. 
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(5R,11bS)-1,11-Dimethyl-6,7-dihydro-5H-dibenzo[c,e]azepine-5-carboxylic acid 
trifluoroacetic acid 265  
 
 
 
(5R,11bS)-6-(tert-butoxycarbonyl)-1,11-dimethyl-6,7-dihydro-5H 
dibenzo[c,e]azepine-5-carboxylic acid (250 mg, 0.68 mmol) was dissolved in 
dichloromethane (10 mL) and trifluoroacetic acid (0.71 mL, 9.53 mmol, 14 equiv.) 
was added in one portion. The solution was stirred for 30 minutes. The solvent was 
removed under reduced pressure and the residue redissolved in EtOAc (10 mL). The 
organic layer was then washed with H2O (3 x 10 mL) and dried with saturated brine 
solution (3 x 5 mL) and anhydrous MgSO4 and the solvent removed under reduced 
pressure. The brown residue was then recrystallized (CHCl3) as a colourless solid 
(128 mg, 50%).  
m.p. 250-252 °C; [α]D23.6 −34.8 ° (c 1.02, MeOH); νmax(solid)/cm-1 3169 (N-H 
stretch), 2800 (C-H aromatic stretch, O-H stretch), 1729 (C=O stretch), 1643, 1566 
(C=C aromatic stretch), 1433, 1379, 1348, 1285 (C-O stretch), 1249, 1150, 1136, 
1059 (C-N stretch), 839, 786, 725 (C-H aromatic stretch), 675; 1H NMR (500 MHz, 
DMSO) δ 13.49 (1H, s, CO2H), 10.10 (1H, s), 9.13 (1H, s), 7.52-7.28 (6H, m, CH 
arom), 5.43 (1H, s, CHCO2H), 4.09 (1H, d, J = 12.9 Hz, CH2), 3.43 (1H d, J = 12.9 
Hz, CH2), 2.11 (3H, s, CH3), 2.08 (3H, s, CH3); 13C NMR (126 MHz, DMSO) δ 
168.7, 137.2, 136.9, 136.7, 136.4, 131.8, 131.5, 130.5, 130.0, 129.3, 128.5, 128.2, 
128.0, 59.0, 45.6, 19.2, 19.0; HRMS (NSI−) m/z found for [M−CF3CO2H2]−: 
266.1187; [C17H16NO2]− requires 266.1184. 
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5.0 Catalyst testing  
Procedure for the aldol reaction of acetone and nitrobenzaladehyde 81: 
 
 
Acetone (1 mL, 13.5 mmol, 27 equiv.) and 4-nitrobenzaldhyde 81 (75.6 mg, 0.5 
mmol, 1 equiv.) were dissolved in solvent (4 mL). Catalyst (10 mol%) was added 
and the reaction was stirred for 72 h or until it was observed by TLC that the starting 
material had been consumed. The reaction mixture was diluted with EtOAc and was 
treated with saturated ammonium chloride solution (2 mL). The organic layers were 
washed with water (5 mL) and saturated brine solution (5 mL) and dried over 
MgSO4. The solvent was removed under reduced pressure and the title compound 
isolated as a colourless solid following column chromatography on silica gel (4:1 
light petroleum ether/EtOAc).  
1H NMR (500 MHz, CDCl3) δ 8.24-8.18 (2H, m, CH arom), 7.57-7.52 (2H, m, CH 
arom), 5.27 (1H, dd, J = 7.6, 4.6 Hz,), 3.69 – 3.59 (1H, s), 2.86 (2H, dd, J = 6.1, 2.5 
Hz), 2.23 (3H, s); 13C NMR (126 MHz, CDCl3) δ 208.5, 150.0, 147.4, 126.4, 123.8, 
68.9, 51.5, 30.7. Enantiomeric excess was determined using HPLC with Chiralcel® 
IC column: (hexane/iPrOH=92:8, λ=220 nm), 0.5 mL; tR= major enantiomer 45.5 
min, minor enantiomer 43.1 min. 
 
General procedure for the Michael addition reaction of cyclohexenone 270 and 
dibenzylmalonate: 
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Cyclohexenone 270 (24 µL, 0.25 mmol, 1 equiv.) and dibenzyl malonate (62.5 µL, 
0.25 mmol, 1 equiv.) were dissiolved in solvent (5 mL). LiOH (6 mg, 025 mmol, 1 
equiv.) and catalyst (10 mol%) were added. The reaction was stirred for 6 d or until 
it was observed by TLC that the starting material had been consumed. The reaction 
mixture was diluted with DCM and the organic layers were washed with water (10 
mL) and saturated brine solution (10 mL) and dried over MgSO4. The solvent was 
removed under reduced pressure and the title compound isolated following column 
chromatography on silica gel (6:4 light petroleum ether/EtOAc). 
1H NMR (500 MHz, CDCl3) δ 7.36-7.30 (m, 6H), 7.29 (4H, m), 5.15 (2H, s), 5.14 
(2H, s), 3.41 (1H, d, J = 7.7 Hz), 2.56 (1H, m), 2.44 (1H, m), 2.39-2.33 (1H, m), 
2.29-2.14 (2H, m), 2.02 (1H, m), 1.94-1.86 (1H, m), 1.67-1.59 (1H, m), 1.46 (1H, 
m); 13C NMR (126 MHz, CDCl3) δ 209.4, 167.5, 135.1, 128.6, 128.3, 67.3, 67.3, 
56.8, 45.1, 41.0, 38.1, 28.7, 24.5. Enantiomeric excess was determined using HPLC 
with Chiralcel® AI-3 column: (hexane/iPrOH=60:40, λ=220 nm), 0.7 mL; tR= 
major enamtiomer 20.2 min, minor enantiomer 20.6 min  
 
General procedure for the Michael addition reaction of dibenzyl malonate to 
cinnamaldehyde 271: 
Dibenzyl 2-(3-oxo-1-phenylpropyl)malonate 280 
 
 
 
Catalyst (10 mol%) was dissolved in solvent (3 mL) and cinnamaldehyde 271 (63 
µL, 0.5 mmol, 1 equiv.) was added followed by the addition of dibenzyl malonate 
(125 µL, 0.5 mmol, 1 equiv.). The reaction was stirred and monitored by TLC and 
once judged complete, the reaction mixture was filtered on a pad silica gel and 
washed with dichloromethane. The solvents were removed under reduced pressure 
and the crude product by purified by column chromatography on silica gel (9:1 light 
petroleum ether/EtOAc).  
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1H NMR (500 MHz, CDCl3) δ 9.54 (1H, t, J= 1.8 Hz, CHO), 7.36-7.19 (13H, m, CH 
arom), 7.06 (2H, dd, J= 1.5, 8 Hz, CH arom), 5.17-5.11 (2H, m, CO2CH2Ph), 4.96-
4.81 (2H, m, CO2CH2Ph), 4.04-4.06 (1H, m, CHOCH2CH), 3.83 (1H, d, J= 9.5 Hz, 
CH(CO2Bn)2), 2.95-2.81 (2H, m, CHOCH2CH); 13C NMR (126 MHz, CDCl3) δ 
200.0, 167.7, 167.2, 139.6, 135.0, 135.0, 128.8, 128.6, 128.5, 128.3, 128.2, 128.1, 
127.6, 67.5, 67.3, 57.5, 47.2, 39.5.  
 
General oxidation procedure for HPLC analysis: 1,1-Dibenzyl 3-methyl 2-
phenylpropane-1,1,3-tricarboxylate 281 
  
Michael addition product (50 mg, 0.10 mmol, 1 equiv.) was dissolved in t-BuOH (3 
mL) and NaH2PO4 (1 M, aq., 3 mL) and KMnO4 (1 M, 3 mL) were added. After 
stirring for 5 minutes NaHSO3 (5 mL) was added followed by HCl (1 M, dropwise 
until pH was acidic). The addition of the HCl made the solution colourless. EtOAc 
(10 mL) was added and the resulting mixture was extracted with EtOAc (2 x 10 mL) 
and the organic layers were washed with H2O (2 x 10 mL) and saturated brine 
solution (10 mL). The organic solvent was removed under reduced pressure and the 
crude product redissolved in toluene (2 mL) and MeOH (5 mL). TMSCHN2 (2 M in 
hexane) was added dropwise until the reaction mixture turned from colourless to 
yellow. The reaction was stirred for 15 min and then the TMSCHN2 was quenched 
by addition of a small quantity of AcOH. The solvents were removed under reduced 
pressure and the product was purified by column chromatography (10:1 light 
petroleum ether/EtOAc) to give a colourless solid.  
1H NMR (500 MHz, CDCl3) δ 7.35-7.18 (13H, m, CH arom), 7.05 (2H, dd, J= 8.0, 
1.5 Hz, CH arom), 5.22-5.11 (2H, m, CO2CH2Ph), 4.95-4.80 (2H, m, CO2CH2Ph), 
3.96 (1H, m, MeO2CCH2Ph), 3.87 (1H, d, J= 10.5 Hz, CH(CO2Bn)2), 3.50 (3H, s, 
OMe), 2.83 (1H, dd, J= 16.0, 4.5 Hz, CHPh), 2.73 (1H, dd, J= 16.0, 9.5 Hz, 
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MeO2CCH2); 13C NMR (126 MHz, CDCl3) δ 171.5, 167.7, 167.3, 139.7, 135.2, 
135.0, 128.6, 128.6, 128.5, 128.2, 128.2, 128.1, 127.4, 67.4, 67.2, 57.2, 51.6, 41.5, 
38.4. Enantiomeric excess was determined using HPLC with Chiralcel® AD-H 
column: (hexane/iPrOH=80:20, λ=254 nm), 1.0 mL; tR= major enantiomer 26.5 
min, minor enantiomer 18.7 min  
 
General procedure for the organocatalytic Diels Alder reaction: 
Catalyst (10 mol%) was dissolved in MeOH:H2O (95/5 v/v, 1 mL) and an α-β 
unsaturated aldehyde (1.0 mmol, 1 equiv.) was added. After 5 minutes the diene was 
added (3 mmol, 3 equiv.). The reaction mixture was monitored by TLC and upon 
consumption of cinnamaldehyde the reaction was diluted with Et2O (5 mL). The 
reaction mixture was washed with H2O (3 x 5 mL) and saturated brine solution (2 x 
5 mL) and concentrated under reduced pressure. Hydrolysis of the methyl diacetal 
adduct was performed stirring in TFA:H2O:CHCl3 (1:1:2) for 2 h. Neutralisation 
with sodium hydrogen carbonate solution and extraction with Et2O (2 x 10 mL) and 
saturated brine solution (2 x 5 mL). Column chromatography to purify the adduct 
product. Reduction to the corresponding alcohol was performed in anhydrous Et2O 
and LiAlH4 to allow separation on HPLC columns.  
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3-Phenylbicyclo[2.2.1]hept-5-ene-2-carbaldehyde  
 
Catalyst (10 mol%) was dissolved in MeOH: H2O (95/5 v/v, 1 mL) and (E)-
cinnamaldehyde (126 µL, 1.0 mmol, 1 equiv.) was added. The solution stirred for 5 
minutes before the addition of cyclopentadiene (252 µL, 3 mmol, 3 equiv., freshly 
distilled). The reaction was followed by analysis of TLC. After hydrolysis of 
diacetal, crude NMR analysis allowed conversion to be calculated and assignment of 
the diastereomeric ratio (exo δ 9.86 (1H, d, J= 2.0 Hz, CHO): endo δ 9.59 (1H, d, J= 
2.2 Hz, CHO)). Column chromatography (15% EtOAc in petroleum ether) afforded 
the product as an inseparable mixture of diastereoisomers as a colourless oil. Data 
matches literature reported values.15 
Exo compound 284 1H NMR (500 MHz, CDCl3) δ 9.86 (1H, d, J= 2.0 Hz, CHO), 
7.30-7.10 (5H, m, CH arom), 6.29 (1H, dd, J= 5.5, 3.5 Hz, CH=CH), 6.03 (1H, dd, 
J= 5.5, 3.0 Hz, CH=CH), 3.69 (1H, dd, J= 5.0, 3.5 Hz, CHPh), 3.18-3.16 (2H, m, 
CHCH2), 2.55 (1H, m, CHCHO), 1.61-1.54 (2H, m, CHCH2CH). 
Endo compound 285 1H NMR (500 MHz, CDCl3) δ 9.55 (1H, d, J= 2.2 Hz, CHO), 
7.30-7.10 (5H, m, CH arom), 6.37 (1H, dd, J= 5.7, 3.2 Hz, CH=CH), 6.13 (1H, dd, 
J= 5.7, 2.8 Hz, CH=CH), 3.30-3.26 (1H, m, CHCH2), 3.08- 3.07 (1H, m, CHCH2), 
3.06 (1H, dd, J= 4.5, 1.0 Hz, CHPh), 2.93-2.90 (1H, m, CHCHO), 1.79-1.74 (1H, m, 
CHCH2CH), 1.51 (1H, m, CHCH2CH);  
For the mixture: νmax(CHCl3)/cm-1 3059, 3026, 2970, 2950, 2898, 2828, 1718, 1600, 
1496, 1450, 1333, 1131,1059, 720, 699; 13C NMR (126 MHz, CDCl3) δ 203.5, 
202.8, 143.6, 142.6, 139.2, 136.6, 136.3, 133.8, 128.6, 128.2, 127.9, 127.4, 126.3, 
126.2, 60.9, 59.5, 48.5, 48.4, 47.6, 47.2, 45.7, 45.5, 45.5, 45.2; HRMS (NSI−) m/z 
found for [M−H]−: 197.0960; [C14H14O−H]− requires 197.0961. 
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3-Phenylbicyclo[2.2.1]hept-5-en-2-yl)methanol16 
 
Following purification, the adduct (150 mg, 0.76 mmol) was dissolved in anhydrous 
Et2O (10 mL). LiAlH4 (30 mg, 0.76 mmol, 1 equiv.) was added the reaction stirred 
until competition was observed by TLC. Purification by column chromatography 
(4:1 light petroleum ether/EtOAc) afforded the products as an inseparable mixture of 
diastereoisomers as a colourless oil. 
Data of a mixture endo: exo:  
νmax(CHCl3)/cm-1 3339 (br), 3058, 2965, 2872, 1030, 717, 698; 1H NMR (500 MHz, 
CDCl3) δ 7.32-7.14 (10H, m, CH arom), 6.37 (1H, dd, J= 5.5, 3.0 Hz), 6.34 (1H, dd, 
J= 5.5, 3.0 Hz), 6.16 (1H, dd, J= 5.7, 3.0 Hz), 5.94 (1H, dd, J= 5.5, 3.0 Hz), 3.90 
(1H, dd, J= 10.5, 6.0 Hz), 3.70- 3.62 (2H, m), 3.40 (1H, dd, J= 10.5, 9.0 Hz), 3.03 
(2H, br m), 2.87 (2H, br m) 2.84 (1H, dd, J= 5.0, 3.5 Hz), 2.40-2.32 (1H, m), 2.14 
(1H, dd, J= 5.5, 2.0 Hz), 1.94-1.90 (1H, m), 1.80-1.77 (1H, m), 1.66-1.64 (1H, m), 
1.61-1.57 (1H, m), 1.54 (2H, m); 13C NMR (126 MHz, CDCl3) δ 145.0, 144.0, 
138.7, 137.6, 134.6, 134.3, 128.5, 128.0, 127.5, 126.0, 125.9, 66.9, 66.5, 50.3, 49.9, 
49.0, 48.7, 48.4, 47.8, 47.1, 47.1, 44.8, 44.1; HRMS (NSI+) m/z found 218.1541 
[M+NH4]+; [C14H20ON]+ requires 218.1539; Enantiomeric excesses were determined 
using HPLC with Chiralcel® OJ column (hexane/iPrOH=90:10, λ=222 nm), 1.0 mL; 
endo isomer (tR1 15 min, 35 min) exo isomer (tR1 47 min, 65 min))  
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3-(2-Methoxyphenyl)bicyclo[2.2.1]hept-5-ene-2-carbaldehyde17 
 
(E)- 2-Methoxycinnamaldehyde (162 mg, 1.0 mmol, 1 equiv.) and catalyst (10 
mol%) were dissolved in MeOH: H2O (95/5 v/v, 1 mL). The solution stirred for 5 
minutes before the addition of cyclopentadiene (252 µL, 3 mmol, 3 equiv., freshly 
distilled). The reaction was followed by analysis of TLC. After hydrolysis of 
diacetal, crude NMR analysis allowed conversion to be calculated and assignment of 
the diastereomeric ratio (exo δ 9.93 (1H, d, J= 3.0 Hz, CHO): endo δ 9.50 (1H, d, J= 
4.0 Hz, CHO)). Column chromatography (15% EtOAc in light petroleum ether) 
afforded the product as an inseparable mixture of diastereoisomers as a colourless oil 
(210 mg, 0.92 mmol, 92%). In agreement with literature values.17 
Exo compound 1H NMR (500 MHz, CDCl3) δ 9.93 (1H, d, J= 3.0 Hz, CHO), 7.26-
6.79 (4H, m, CH arom), 6.27 (1H, dd, J= 6.0, 3.5 Hz), 6.17 (1H, dd, J= 6.0, 3.0 Hz), 
3.88 (1H, dd, J= 5.5, 3.0 Hz), 3.78 (3H, s, OMe), 3.29 (1H, m), 3.10-3.07 (1H, m), 
2.38-2.31 (1H, m), 1.61 (1H, ddd, J= 8.5, 3.5, 1.5 Hz), 1.55 (1H, ddd, J= 8.5, 3.5, 1.5 
Hz);  
Endo compound 1H NMR (500 MHz, CDCl3) δ 9.50 (1H, d, J= 4.0 Hz, CHO), 7.26 
– 6.79 (4H, m, CH arom), 6.42 (1H, dd, J= 6.0, 3.5 Hz), 6.17 (1H, dd, J= 6.0, 3.0 
Hz), 3.73 (3H, s, OMe), 3.26-3.22 (1H, m), 3.20 (1H, s), 3.16 (1H, d, J= 4.0 Hz), 
2.55 (1H, dt, J= 5.0, 3.8 Hz), 1.72 (1H, s) 1.57-1.55 (1H, m);  
νmax(CHCl3)/cm-1 2969, 2716, 1717, 1490, 1243, 1111, 1028, 753, 719; 13C NMR 
(126 MHz, CDCl3) δ 206.3, 204.2, 157.6, 157.5, 138.5, 136.9, 136.4, 134.2, 132.4, 
131.0, 127.3, 127.2, 127.2, 125.6, 120.4, 120.0, 110.0, 109.9, 59.7, 58.0, 55.0, 54.9, 
47.8, 47.4, 47.0, 46.3, 46.2, 45.6, 40.8, 40.2; HRMS (NSI−) m/z found 227.1065 
[M−H]−; [C15H15O2]− requires 227.1067 
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3-(2-Methoxyphenyl)bicyclo[2.2.1]hept-5-en-2-yl)methanol  
 
Following purification, the adduct (210 mg, 0.92 mmol) was dissolved in anhydrous 
Et2O (10 mL). LiAlH4 (35 mg, 0.92 mmol, 1 equiv.) was added the reaction stirred 
until competition was observed by TLC. Purification by column chromatography 
(9:1, light petroleum ether/EtOAc) afforded the product as an inseparable mixture of 
diastereoisomers as a colourless oil. 
Data of a mixture endo: exo:  
νmax(CHCl3)/cm-1 3368, 2962, 2941, 1598, 1490, 1463, 1242, 1029, 752, 736, 716; 
1H NMR (500 MHz, CDCl3) δ 7.32 (1H, dd, J= 8.0, 1.5 Hz, CH arom), 7.22-7.16 
(1H, m, CH arom), 7.16 – 7.12 (1H, m, CH arom), 7.05 (1H, dd, J= 8.0, 2.0 Hz, CH 
arom), 6.96 (1H, td, J= 7.5, 1.0 Hz, CH arom), 6.86 (1H, dd, J= 8.2, 1.0 Hz, CH 
arom), 6.83-6.80 (2H, m, CH arom), 6.36 (2H, dt, J= 5.8, 3.0 Hz), 6.13 (1H, dd, J= 
6.0, 3.0 Hz), 5.84 (1H, dd, J= 6.0, 3.0 Hz), 3.84 (6H, s), 3.83 (1H, m), 3.80 (1H, m) 
3.62 (1H, dd, J= 10.6, 8.5 Hz), 3.54 (1H, dd, J= 10.8, 7.5 Hz), 3.45 (1H, dd, J= 10.8, 
6.8 Hz), 3.27 (1H, dd, J= 5.4, 3.2 Hz), 3.00 (1H, s), 2.96 (1H, s), 2.86 (2H, s), 2.50 
(1H, dd, J= 5.0, 1.0 Hz), 2.24-2.15 (1H, m), 1.97-1.89 (1H, m), 1.82 (1H, d, J= 8.4 
Hz), 1.73 (1H, br s), 1.68 (1H, d, J= 8.6 Hz), 1.58 (1H, ddd, J= 8.4, 3.3, 1.6 Hz), 
1.50 (1H, ddd, J= 8.6, 3.4, 1.5 Hz); 13C NMR (126 MHz, CDCl3) δ 157.6, 156.80, 
138.7, 137.3, 134.9, 134.6, 133.7, 131.8, 127.5, 126.8, 126.8, 126.6, 121.1, 120.0, 
110.4, 109.9, 67.2, 67.0, 55.4, 50.89, 48.7, 48.6, 47.6, 47.5, 47.4, 44.9, 44.8, 40.9, 
40.3; HRMS (NSI+) m/z found 231.1380 [M+H]+; [C15H19O2]+ requires 231.1380; 
Enantiomeric excesses were determined using Chiralcel® AD-H column 
(hexane/iPrOH=98:2, λ=222 nm), 0.5 mL; endo isomer (tR1 65 min, 80 min) exo 
isomer (tR1 57 min, 69 min)). 
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(4-Methoxyphenyl)bicyclo[2.2.1]hept-5-ene-2-carbaldehyde17 
 
(E)-4-Methoxycinnamaldehyde (162 mg, 1.0 mmol, 1 equiv.) and catalyst (10 
mol%) were dissolved in MeOH: H2O (95/5 v/v, 1 mL). The solution stirred for 5 
minutes before the addition of cyclopentadiene (252 µL, 3 mmol, 3 equiv., freshly 
distilled). The reaction was followed by analysis of TLC. After hydrolysis of 
diacetal, crude NMR analysis allowed conversion to be calculated and assignment of 
the diastereomeric ratio (exo δ 9.88 (1H, d, J= 2.0 Hz, CHO): endo δ 9.56 (1H, d, J= 
2.3 Hz, CHO)). Column chromatography (15% EtOAc in light petroleum ether) 
afforded the product as an inseparable mixture of diastereoisomers as a colourless 
oil. Data matches literature reported values.17 
Exo compound 1H NMR (500 MHz, CDCl3) δ 9.88 (1H, d, J= 2.0 Hz, CHO), 7.08-
7.03 (2H, m, CH arom), 6.79-6.76 (2H, m, CH arom), 6.31 (1H, dd, J= 5.6, 3.0 Hz, 
CH=CH), 6.05 (1H, dd, J= 5.6, 3.0 Hz, CH=CH), 3.75 (3H, s, OMe), 3.64 (1H, dd, 
J= 5.2, 3.5 Hz, CHAr), 3.19-3.16 (1H, m, CHCH2), 3.16-3.14 (1H, m, CHCH2), 2.51 
(1H, dt, J= 5.3, 2.0 Hz, CHCHO), 1.61-1.56 (1H, m, CH2), 1.53 (1H, m, CH2);  
Endo compound 1H NMR (500 MHz, CDCl3) δ 9.56 (1H, d, J= 2.3 Hz, CHO), 
7.19-7.15 (2H, m, CH arom), 6.87-6.82 (2H, m, CH arom), 6.39 (1H, dd, J= 5.6, 3.0 
Hz, CH=CH), 6.14 (1H, dd, J= 5.6, 3.0 Hz, CH=CH), 3.76 (3H, s, OMe), 3.31-3.28 
(1H, m, CHAr), 3.06-3.03 (1H, m, CHCH2), 3.02-2.99 (1H, m, CHCH2), 2.91 (1H, 
ddd, J= 5.0, 3.4, 2.4 Hz, CHCHO), 1.78-1.76 (1H, m, CH2), 1.61-1.58 (1H, m, CH2);  
For the mixture: νmax(CHCl3)/cm-1 2968, 2835, 2718, 1715, 1611, 1513, 1463, 1247, 
1180, 1035, 726; 13C NMR (126 MHz, CDCl3) δ 203.7, 202.9, 158.2, 158.0, 139.3, 
136.6, 136.3, 135.6, 134.7, 133.7, 128.8, 128.3, 114.0, 113.6, 61.0, 59.7, 55.3, 55.2, 
48.7, 48.6, 47.6, 47.1, 45.5, 45.1, 45.1, 44.7. 
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3-(4-Methoxyphenyl)bicyclo[2.2.1]hept-5-en-2-yl)methanol 
 
Following purification, the adduct (158 mg, 0.69 mmol) was dissolved in anhydrous 
Et2O (10 mL). LiAlH4 (26 mg, 0.69 mmol, 1 equiv.) was added the reaction stirred 
until competition was observed by TLC. Purification by column chromatography 
(9:1, light petroleum ether/EtOAc) afforded the product as an inseparable mixture of 
diastereoisomers as a colourless oil.  
Data of a mixture endo:exo:  
νmax(CHCl3)/cm-1 3400, 3056, 2964, 1611, 1580, 1511, 1464, 1265, 1246, 1034, 910, 
743; 1H NMR (500 MHz, CDCl3) δ 7.25-7.07 (4H, m, CH arom), 6.90-6.73 (4H, m, 
CH arom), 6.37- 6.32 (1H, m), 6.14 (1H, dd, J= 5.7, 2.8 Hz), 5.94 (1H, dd, J= 5.7, 
2.8 Hz), 3.88 (1H, dd, J= 10.5, 6.0 Hz), 3.79 (3H, m), 3.76 (3H, m), 3.66 (1H, dd, J= 
10.5, 9.0 Hz) 3.61 (1H, dd, J= 10.5, 6.0 Hz), 3.38 (1H, dd, J= 10.5, 9.0 Hz), 3.01 
(2H, br d, J= 17.5 Hz), 2.84 (1H, dd, J= 14.6, 1.5 Hz), 2.79 (1H, dd, J= 5.0, 3.5 Hz), 
2.37-2.27 (1H, m), 2.11-2.07 (1H, m), 1.88-1.84 (2H, m), 1.75 (1H, d, J= 8.5 Hz), 
1.63 (1H, d, J= 8.5 Hz), 1.59-1.54 (2H, m), 1.54-1.50 (1H, m), 1.26 (1H, s), 1.21 
(1H, d, J= 6.1 Hz); 13C NMR (126 MHz, CDCl3) δ 157.9, 157.8, 138.7, 137.5, 137.0, 
136.1, 134.6, 134.1, 129.0, 128.9, 128.4, 113.8, 113.4, 66.9, 66.6, 55.3, 55.2, 50.8, 
50.4, 50.1, 49.4, 49.2, 48.8, 47.5, 47.1, 47.0, 47.0, 44.8, 44.1. HRMS (NSI+) m/z 
found 248.1646 [M+NH4]+; [C15H22O2N]+ requires 248.1645; Enantiomeric excesses 
were determined using Chiralcel® AS-3 column (hexane/iPrOH=95:5, λ=222 nm), 
0.5 mL; endo isomer (tR1 35 min, 59 min) exo isomer (tR1 39 min, 56 min)). 
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3-(2-Nitrophenyl)bicyclo[2.2.1]hept-5-ene-2-carbaldehyde17  
 
(E)-2-Nitrocinnamaldehyde (177 mg, 1.0 mmol, 1 equiv.) and catalyst (10 mol%) 
were dissolved in MeOH:H2O (95/5 v/v, 1 mL). The solution stirred for 5 minutes 
before the addition of cyclopentadiene (252 µL, 3 mmol, 3 equiv., freshly distilled). 
The reaction was followed by analysis of TLC. After hydrolysis of diacetal, crude 
NMR analysis allowed conversion to be calculated and assignment of the 
diastereomeric ratio (exo δ 9.80 (1H, d, J= 2.2 Hz, CHO): endo δ 9.40 (1H, d, J= 3.5 
Hz, CHO)). Column chromatography (9:1 light petroleum ether/EtOAc) afforded the 
product as an inseparable mixture of diastereoisomers as a yellow oil. Data matches 
literature reported values.17 
Exo compound 1H NMR (500 MHz, CDCl3) δ 9.81 (1H, d, J= 2.2 Hz, CHO), 7.72 
(1H, dd, J= 8.0, 1.5 Hz, CH arom), 7.45-7.41 (1H, m, CH arom), 7.36-7.30 (1H, m, 
CH arom), 7.18 (1H, dd, J= 8.0, 1.0 Hz, CH arom), 6.47 (1H, dd, J= 5.6, 3.2 Hz, 
CH=CH), 6.02 (1H, dd, J= 5.6, 3.0 Hz, CH=CH), 4.09 (1H, dd, J= 5.2, 3.3 Hz, 
CHAr), 3.37 (1H, br s, CHCH2), 3.31-3.26 (1H, m, CHCH2), 2.63-2.58 (1H, m, 
CHCHO), 1.67-1.60 (1H, m, CH2), 1.60-1.57 (1H, m, CH2);  
Endo compound 1H NMR (500 MHz, CDCl3) δ 9.40 (1H, d, J= 3.5 Hz, CHO), 7.82 
(1H, dd, J= 8.0, 1.5 Hz, CH arom), 7.59-7.52 (2H, m, CH arom), 7.39 (1H, ddd, J= 
8.4, 7.3, 1.5 Hz, CH arom), 6.50 (1H, dd, J= 5.6, 3.2 Hz, CH=CH), 6.22 (1H, dd, J= 
5.7, 2.8 Hz, CH=CH), 3.44 (1H, dd, J= 5.0, 1.0 Hz, CHAr), 3.34-3.30 (1H, m, 
CHCH2), 3.13-3.11 (1H, m, CHCH2), 2.95 (1H, dt, J= 5.2, 3.6 Hz, CHCHO), 1.84 
(1H, dt, J= 9.0, 1.5 Hz, CH2), 1.69-1.68 (1H, m, CH2); 
For the mixture: νmax(CHCl3)/cm-1 3054, 2986, 2825, 2305, 2254, 1717, 1687, 1527, 
1421, 1351, 1263, 746, 705; 13C NMR (126 MHz, CDCl3) δ 203.6, 201.5, 139.2, 
137.3, 137.0, 136.3, 136.1, 134.2, 132.8, 131.8, 128.9, 127.9, 127.4, 127.3, 124.8, 
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124.0, 59.3, 59.0, 49.8, 49.2, 48.2, 47.2, 46.6, 46.3, 41.7, 40.1; HRMS (NSI−) m/z 
found 242.0811 [M-H]−; [C14H12NO3]− requires 242.0812. 
 
3-(2-Nitrophenyl)bicyclo[2.2.1]hept-5-en-2-yl)methanol compound  
 
Following purification, the adduct (140 mg, 0.58 mmol) was dissolved in anhydrous 
Et2O (10 mL). LiAlH4 (22 mg, 0.58 mmol, 1 equiv.) was added the reaction stirred 
until competition was observed by TLC. Purification by column chromatography 
(9:1, light petroleum ether/EtOAc) afforded the product as an inseparable mixture of 
diastereoisomers as a pale yellow oil.  
Data of a mixture endo:exo:  
νmax(CHCl3)/cm-1 3064, 2973, 1717, 1523, 1351, 723; 1H NMR (500 MHz, CDCl3) δ 
7.70 (1H, dd, J = 8.0, 1.4 Hz, CH arom), 7.63 (2H, ddd, J = 8.0, 3.5, 1.1 Hz, CH 
arom), 7.54 (1H, td, J = 7.8, 1.4 Hz, CH arom), 7.40 (1H, dd, J = 7.3, 1.0 Hz, CH 
arom), 7.36 – 7.26 (3H, m, CH arom), 6.47 (1H, dd, J = 5.6, 3.2 Hz), 6.42 (1H, dd, J 
= 5.6, 3.1 Hz), 6.15 (1H, dd, J = 5.7, 2.9 Hz), 5.89 (1H, dd, J = 5.6, 2.9 Hz), 3.76 
(1H, dd, J = 10.6, 6.3 Hz), 3.63 (1H, dd, J = 10.5, 8.2 Hz), 3.45 (1H, dd, J = 10.6, 
6.0 Hz), 3.35 (1H, dd, J = 10.6, 8.0 Hz), 3.18 (1H, dd, J = 5.2, 3.2 Hz), 3.11 (2H, dd, 
J = 7.5, 1.8 Hz), 2.91 (1H, d, J = 1.4 Hz), 2.80 (1H, d, J = 1.4 Hz), 2.58-2.50 (2H, 
m), 2.00-1.93 (2H, m), 1.77 (2H, d, J = 8.9 Hz), 1.69 (2H, d, J = 8.8 Hz), 1.58-1.52 
(2H, m); 13C NMR (126 MHz, CDCl3) δ 138.3, 137.4, 134.0, 131.5, 129.1, 126.8, 
123.4, 66.5, 50.7, 49.3, 48.0, 45.1, 42.6, 14.2; HRMS (NSI+) m/z found 246.1124 
[M+H]+; [C14H16NO3]+ requires 246.1125; Enantiomeric excesses were determined 
using Chiralcel® AD-H column (hexane/iPrOH=95:5, λ=254 nm), 0.5 mL; endo 
isomer (tR1 37 min, 39 min) exo isomer (tR1 41 min, 50 min)). 
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3-(4-Nitrophenyl)bicyclo[2.2.1]hept-5-ene-2-carbaldehyde17  
 
(E)-4-Nitrocinnamaldehyde (177 mg, 1.0 mmol, 1 equiv.) and catalyst (10 mol%) 
were dissolved in MeOH: H2O (95/5 v/v, 1 mL). The solution stirred for 5 minutes 
before the addition of cyclopentadiene (252 µL, 3 mmol, 3 equiv., freshly distilled). 
The reaction was monitored by TLC. After hydrolysis of diacetal, crude NMR 
analysis allowed conversion to be calculated and assignment of the diastereomeric 
ratio (exo δ 9.92 (1H, d, J= 2.0 Hz, CHO): endo δ 9.65 (1H, d, J= 2.0 Hz, CHO)). 
Column chromatography (9:1 light petroleum ether/EtOAc) afforded the product as 
an inseparable mixture of diastereoisomers as a yellow oil. Data matches literature 
reported values.17 
Exo compound 1H NMR (500 MHz, CDCl3) δ 9.92 (1H, d, J= 2.0 Hz, CHO), 8.12-
8.01 (2H, m, CH arom), 7.36-7.26 (2H, m, CH arom), 6.41 (1H, dd, J= 5.5, 3.0 Hz, 
CH=CH), 6.05 (1H, dd, J= 5.5, 3.0 Hz, CH=CH), 3.89 (1H, dd, J= 5.0, 3.5 Hz, 
CHAr), 3.34-3.29 (1H, m, CHCH2), 3.26 (1H, br s, CHCH2), 2.64 (1H, d, J= 5.2 Hz, 
CHCHO), 1.62-1.59 (2H, m, CH2);  
Endo compound 1H NMR (500 MHz, CDCl3) δ 9.65 (1H, d, J= 2.0 Hz, CHO), 
8.22-8.12 (2H, m, CH arom), 7.48-7.35 (2H, m, CH arom), 6.44 (1H, dd, J= 6.0, 3.5 
Hz, CH=CH), 6.20 (1H, dd, J= 6.0, 3.0 Hz, CH=CH), 3.44 (1H, br s, CHCH2), 3.21-
3.19 (2H, m, CHAr, CHCH2), 2.98 (1H, ddd, J= 5.0, 3.5, 1.7 Hz, CHCHO), 1.78-
1.68 (2H, m, CH2); 
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For the mixture: νmax(CHCl3)/cm-1 2972, 1715, 1596, 1515, 1495, 1345, 1107, 721; 
13C NMR (126 MHz, CDCl3) δ 202.1, 201.6, 171.1, 151.7, 150.6, 146.5, 146.3, 
139.0, 137.0, 135.9, 134.0, 128.7, 128.2, 123.7, 123.3, 61.1, 60.3, 59.5, 48.4, 47.9, 
47.6, 47.1, 45.6, 45.5, 45.1, 45.0, 21.0, 14.2; HRMS (NSI−) m/z found 242.0811 
[M−H]−; [C14H12NO3]− requires 242.0812. 
 
3-(4-Nitrophenyl)bicyclo[2.2.1]hept-5-en-2-yl)methanol  
 
Following purification, the adduct (210 mg, 0.86 mmol) was dissolved in anhydrous 
Et2O (10 mL). LiAlH4 (32 mg, 0.86 mmol, 1 equiv.) was added the reaction stirred 
until competition was observed by TLC. Purification by column chromatography 
(9:1, light petroleum ether/EtOAc) afforded the product as an inseparable mixture of 
diastereoisomers as a colourless oil. 
Data of a mixture endo: exo:  
1H NMR (500 MHz, CDCl3) δ 8.18-8.12 (2H, m, CH arom), 8.10-8.06 (2H, m, CH 
arom), 7.51-7.46 (2H, m, CH arom), 7.38-7.34 (2H, m, CH arom), 6.40-6.37 (2H, 
m), 6.19 (1H, dd, J= 6.0, 3.0 Hz), 5.91 (1H, dd, J= 6.0, 3.0 Hz), 3.85 (1H, dd, J= 
10.5, 7.0 Hz), 3.75 (1H, dd, J= 10.5, 8.0 Hz), 3.58 (1H, dd, J= 10.5, 7.0 Hz), 3.51 
(1H, dd, J= 10.5, 8.0 Hz), 3.09 (1H, s), 3.07 (1H, s), 3.04-2.98 (1H, m), 2.97-2.95 
(1H, br m), 2.90-2.89 (1H, br m), 2.38-2.31 (1H, m), 2.31-2.28 (1H, br m), 1.98-1.92 
(1H, m), 1.72 (2H, br dd, J= 15.5, 8.5 Hz), 1.64 (1H, ddd, J= 8.8, 3.3, 1.7 Hz), 1.59 
(1H, ddd, J= 8.8, 3.3, 1.6 Hz), 1.53 (2H, br s); νmax(CHCl3)/cm-1 3418, 3054, 2986, 
1265, 739; 13C NMR (126 MHz, CDCl3) δ 153.3, 152.2, 146.4, 146.2, 138.3, 138.3, 
134.8, 134.0, 128.8, 128.3, 123.6, 123.2, 66.7, 66.4, 50.8, 50.0, 48.9, 48.8, 48.7, 
48.1, 47.4, 47.1, 45.0, 44.4; HRMS (NSI+) m/z found 263.1390 [M+NH4]+; 
[C14H19N2O3]+ requires 263.1386; Enantiomeric excesses were determined using 
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Chiralcel® AD-H column (hexane/iPrOH=90:10, λ=254 nm), 0.5 mL; endo isomer 
(tR1 49 min, 57 min) exo isomer (tR1 43 min, 53 min)). 
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Appendix 
HPLC traces 
Racemic trace: 
 
 
 
 
Area % Report 
 
Data File: C:\EZChrom Elite\Enterprise\Projects\Fran\diels alder\fk80a 80.20 60 
min ojnew col 222nm new OJ.dat  
Method: C:\EZChrom Elite\Enterprise\Projects\Fran\diels alder\80.20 1ml 222nm 60 
min.met  
Acquired: 11/08/2015 17:07:43  
Printed: 12/08/2015 09:43:30  
Minutes
0 10 20 30 40 50 60 70
Vo
lts
0
200
400
Vo
lts
0
200
400
13
.2
20
33
.7
43
45
.6
20
62
.1
67
UV
Retention Time
 
UV Results     
Retention Time Area Area % Height Height % 
13.220 64536756 25.71 1928102 57.55 
33.743 65498431 26.09 677564 20.22 
45.620 60424958 24.07 436586 13.03 
62.167 60578598 24.13 308081 9.20 
     
Totals     
 251038743 100.00 3350333 100.00 
CH2OH
Ph
endo
(1R,2R,3R,4S)-285
Ph
CH2OH
(1S,2S,3S,4R)-285
CH2OH
Ph
exo
(1R,2S,3S,4S)-284
Ph
CH2OH
(1S,2R,3R,4R)-284
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Area % Report 
Major products: 
 
 
 
 
Data File: C:\EZChrom Elite\Enterprise\Projects\Fran\diels alder\fk141A 
80.20 70 min OJ 222nm 1 ml.dat  
Method: C:\EZChrom Elite\Enterprise\Projects\Fran\diels alder\80.20 1ml 222nm 70 
min.met  
Acquired: 27/08/2015 13:40:54  
Printed: 27/08/2015 15:01:49  
Minutes
0 10 20 30 40 50 60 70
Vo
lts
0
100
200
Vo
lts
0
100
200
13
.2
43
33
.8
73
45
.5
73
61
.5
70UVRetention Time
 
 
 
UV Results     
Retention Time Area Area % Height Height % 
13.243 24066176 10.00 733768 35.40 
33.873 54790835 22.76 567050 27.36 
45.573 30757918 12.78 224860 10.85 
61.570 131091183 54.46 546904 26.39 
     
Totals     
 240706112 100.00 2072582 100.00 
 
 
CH2OH
Ph
(1R,2R,3R,4S)-285
Ph
CH2OH
(1S,2R,3R,4R)-284
exo:endo
1:0.4
endo 39% ee
exo 62% ee
 13.2 and 33.9 min45.6 and 61.6 min
